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Abstract 
It is important for cells to respond to external signals. Central to these responses 
are the sensing and signalling pathways that communicate with the nucleus and facilitate 
necessary changes in gene expression. Of particular importance are the mitogen-activated 
protein kinase (MAPK) and the mammalian target of rapamycin (mTOR) pathways. Both of 
these pathways have been shown to be involved in cell growth, proliferation, motility and 
survival. They are under intensive investigation in connection with cancer with recent 
evidence suggests their role in mediating lipogenesis. Lipogenesis accompanies a variety 
of disease states, including the formation of brain tumours. Malignant brain tumours are 
rapidly growing and often invade surrounding healthy tissue, resulting in poor prognosis 
for the patient.  The ability to limit tumour growth and reduce invasion through a better 
understanding of tumour associated lipid formation may offer targets for the 
development of new therapies.  
Yeast is frequently used as a paradimic organism for the study of human diseases. 
In this study a Nile red assay has been developed, optimised and validated to measure 
levels of both polar and neutral lipids within yeast cells. This method has been utilised in 
the yeast species, Saccharomyces cerevisiae and Schizosaccharomyces pombe, to study 
the role of the MAPK pathways in regulating lipid accumulation. Data in this thesis 
demonstrates that stress-activated protein kinase pathways (SAPK) play a key role in 
regulating lipid accumulation upon nitrogen limitation, as cells enter the stationary phase 
of growth. Evidence from S. cerevisiae proposes that the lipogenic switch occurs in two 
phases, with the central MAPK (Hog1) activated in both a MAPKK (Pbs2) independent and 
dependent manner. Analysis of Hog1 phosphorylation during various growth phases, 
suggests that there are previously uncharacterised sites on Hog1 which are potentially 
phosphorylated during phase one by the protein kinase Sch9, a target of the Tor1 
complex. The second phase results in Hog1 being dually phosphorylated by the canonical 
pathway, via Pbs2p. It is proposed that Hog1 may have a number of downstream 
cytoplasmic and nuclear targets, including lipid related enzymes (Dga1) and transcription 
factors (Msn2/4).   Data also suggests that lipid accumulation in S. pombe is also regulated 
in a similar manner. 
The oleaginous yeast Lipomyces starkeyi is able to accumulate high levels of lipid 
and has similarity to lipid enzymes found in mammalian cells. As such, it was proposed 
that L. starkeyi may be utilised as a model organism to further characterise the role of 
MAPK in lipid accumulation. Information from stress response studies and bioinformatics 
suggests the MAPK pathway in L. starkeyi is highly conserved. However, the application of 
yeast molecular tools to L. starkeyi was unsuccessful, demonstrating that further work is 
required to develop its use as a model organism.   
Data in this thesis has shown a novel role for the SAPK pathways in regulating lipid 
accumulation in yeast. It has also demonstrated cross talk between the MAPK and TOR 
pathways, resulting in an integrated cellular response. The high level of conservation of 
these pathways across species, suggests that directly targeting these pathways in cancer 
cells may reduce tumour associated lipogenesis, therefore inhibiting growth of glioma. 
With current treatments only delivering limited results, this could help extend patient 
survival.       
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1. Introduction 
1.1 Cancer – The problem and ultimate aims 
Cancer is, at a functional level, both a genomic and proteomic disease (Wulfkuhle et al. 
2004) that is vastly complex and heterogeneous (Roukos 2011). Cancer is one of the major 
causes of death worldwide with predictions, that by 2030, approximately 26 million new 
cases of cancer will be diagnosed resulting in an estimated 17 million deaths per year 
(Thun et al. 2010).  Alterations occurring in cellular DNA, which may lead to cancer, can 
result from a combination of many factors including immune responses to infectious 
agents (Karin et al. 2006), environmental factors such as poor diet, smoking as well as 
exposure to pollution (Colditz 2009) and indeed genetic factors.   
Modifications in the DNA may be present as amplifications, deletions, insertions, 
rearrangements, translocations and epigenetic changes. These changes have the potential 
to disrupt normal functioning of proto-oncogenes, tumour suppressor genes and cellular 
communications which may contribute to the conversion of non-cancerous cells into 
those that are proliferative and cancerous in nature, thus forming tumours (Martinkova et 
al. 2009). 
Although uncontrolled proliferation leading to tumourigenesis has been known for many 
decades, the biological mechanisms which underpinned the conversion of cells and 
progression of tumours remained largely unknown.  Due to this surgery was often the only 
form of treatment until radiotherapy, which still could not combat metastatic cancer 
completely (Chabner and Roberts 2005).   
Even centuries later with improved understanding of molecular cancer biology along with 
current cancer treatments including surgery, radiotherapy and chemotherapy complete 
success is limited.  Relapse often occurs as a result of micrometatases of dormant tumour 
cells (Zitvogel et al. 2008) or resistance of cancer to drugs after a period of time.  Along 
with this treatments are often not discriminative which may lead to a number of 
deleterious side effects for the patient (Feyer et al. 2008), with further problems arising in 
cases of cancer where tumours are difficult to treat or inoperable, such as with brain 
tumours (gliomas) (Jiang and Wang 2010). 
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For clinicians the ability to detect cancer type, identify treatments that will be beneficial to 
the patient and successfully predict disease outcome will help in tailoring patient 
treatment. This will help avoid unnecessary treatment and toxic side effects resulting from 
the aforementioned adjuvant therapies (Goodison et al. 2010).  In order to avoid 
subjective, flawed prediction based on demographic data and unreliable clinical 
observations, the identification of individual novel molecular targets is ultimately required 
for precise assessment of effective treatment and improved clinical outcome (Weigelt et 
al. 2010).  The importance of this is further increased as, although tumours from patient 
to patient may exhibit similar histology, they can encompass differing mutations and 
therefore different signalling behaviours, which in turn means potentially different 
responses to therapeutic intervention. 
The aim, therefore, is to further improve understanding of the molecular basis of cancer, 
leading to treatment for patients on an individual level through the identification and 
analysis of novel molecular targets (Weigelt et al. 2010).  The ultimate goal of anti-cancer 
therapy would be development of tailored therapeutic strategies targeted at specific 
types of cancers and tumours where the molecular profile has been defined.  Such 
treatment will serve to reduce cancer-related mortality whilst conserving quality of life for 
patients and reducing costs by avoiding use of treatment plans with little or no efficacy 
(Goodison et al. 2010). 
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1.2 Glioma 
Malignant gliomas are the most common form of primary central nervous system (CNS) 
neoplasm (Lim et al. 2011).  Gliomas are a set of invasive, heterogeneous tumours which 
are derived from and display histological similarity to glial cells. They incorporate 
astrocytes, ependyma and oligodendrocytes (Lim et al. 2011, Wen and Kesari 2008) with 
gliomas being broadly classified based on which cell type they hold the closest 
resemblance.  Of all the glioma subtypes, glioblastoma (also known as glioblastoma 
multiforme (GBM)), accounts for approximately 60-70% of malignancies. Astrocytomas 
account for 10-15%, oligodendrogliomas and oligoastrocytomas (mixed glioma) for 10%, 
with less prevalent tumours such as gangliogliomas and ependymomas accounting for the 
remainder (Louis et al. 2007).  Although in absolute numbers the overall incidence of 
gliomas accounts for only a small proportion of total cancers diagnosed (fewer than 2% in 
England and Wales), it is important to note that a disproportionately high rate of 
morbidity and mortality is associated with glial tumours (Yoon et al. 2010). 
1.2.1 Classification and Tumour types 
The World Health Organisation (WHO) grading of CNS tumours establishes a malignancy 
scale which is based on the histological features of tumours ranging from grade I to IV. 
This grading is also utilised to predict neoplasm behaviour and it clinically influences the 
choice of therapy for the patient.  See Table 1.1 for tumour types and classification.   
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Table 1.1: Main tumour types and their sub-types with corresponding graded classifications based on 
histological features (WHO criteria).  Adapted from Louis at al. (2007). 
Tumour type Grade I Grade II Grade III Grade IV 
Astrocytomas  
Pilocytic ✔    
Diffuse  ✔   
Anaplastic   ✔  
Glioblastoma    ✔ 
Oligodendrogliomas  
Oligodendroglioma  ✔   
Anaplastic   ✔  
Mixed gliomas  
Oligoastrocytomas  ✔   
Anaplastic Oligoastrocytoma   ✔  
Ependymoma  
Subependymoma ✔    
Ependymoma  ✔   
Anaplastic   ✔  
 
Under this classification system, low grade tumours (I and II) are classified as benign and 
high grade tumours (III and IV) classified as malignant.  WHO grade I lesions are 
characterised by low proliferative potential.  Grade II lesions are usually infiltrating in spite 
of low levels of proliferation and often recur with some tumour types progressing to those 
of greater malignancy (Louis et al. 2007).  Grade III lesions encompass histological 
evidence of malignancy, usually in the form of mitotic activity with infiltrative capability, 
nuclear atypica and anaplasia.  Finally grade IV lesions are characterised as being 
mitotically active, prone to necrosis and are usually associated with a rapid pre and post-
operative evolution of disease state (Louis et al. 2007). 
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1.2.1.1 Astrocytic tumours 
Tumours of astrocytic origin form the majority of gliomas in adults (Lim et al. 2011), 
however, pilocytic astrocytomas (WHO grade I) occur mainly in children or young adults 
but are slow growing and rarely fatal (Burger et al. 2000).  
Diffuse astrocytomas are classified under the WHO system as grade II, they are well 
differentiated and, again, slow growing tumours (Lim et al. 2011).  They are, however, 
infiltrative in nature with increased cellularity and cytological atypica (Louis et al. 2007).  
As a result they harbour the ability to recur after surgical resection and may transform to 
more malignant forms, WHO grade III and IV (Ohgaki and Kleihues 2009). 
Anaplastic astrocytomas are grade III lesions that may arise de novo or from a diffuse 
astrocytoma (Kleihues et al. 2000b).  They exhibit increased cellularity, distinct nuclear 
atypica and heightened mitotic activity in comparison to their diffuse counterparts (Louis 
et al. 2007) whilst also possessing an intrinsic tendency to develop into GBM. 
1.2.1.2 Glioblastoma multiforme (GBM) 
GBM is the most common and malignant CNS neoplasm that most often develops de novo 
with no evidence of a less malignant precursor lesion (primary GBM), or less commonly 
from a diffuse or anaplastic astrocytoma (secondary GBM) (Kleihues et al. 2000a).  GBM is 
highly malignant, highly proliferative and often results in fatality within 15 months of 
diagnosis (Lim et al. 2011).  Although secondary GBM exhibits a better median survival it 
otherwise differs very little histologically from that of a primary malignancy, with the two 
forms often only distinguishable by differing genetic aberrations present (Ohgaki et al. 
2004, Ohgaki and Kleihues 2007).   
Characteristics of GBM include increased intratumoral heterogeneity, invasive pattern of 
growth, high mitotic activity and resistance to therapeutic intervention (Furnari et al. 
2007, Holland 2000, Maher et al. 2001, Wen and Kesari 2008) with cells often being 
pleomorphic in nature and exhibiting nuclear aplasia (Louis et al. 2007).  Also, widespread 
central necrosis is often observed with a “halo” of viable cells (pseudopalisading) (Lim et 
al. 2011, Louis et al. 2007, Wen and Kesari 2008). Along with this vascular thrombosis with 
microvascular proliferation may also be observed (Lacob and Dinca 2009) (Figure 1.1). This 
central necrosis observed in GBM is illustrative of the aggressiveness of the cancerous 
cells as they outgrow their blood supply (Lacob and Dinca 2009). 
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Figure 1.1: Histological features of glioblastoma A: Pseudopalisades are indicated by the black arrow and 
show tumour cells aggregating around a clear zone with some apoptotic cells. B: Low magnification image 
showing pseudopalisading (arrowhead).  Microvascular hyperplasia, a form of angiogenesis induced by 
pseudopalisading hypoxic cells is shown by the black arrow.  Taken from Rong et al. (2006).  
 
1.2.1.3 Oligodendroglial tumours 
Occurring less frequently and exhibiting a better prognosis than astrocytomas of similar 
grading, oligodendroglial grade II tumours are well differentiated, slow growing and 
diffusely infiltrating (Louis et al. 2007). 
Accounting for 50% of oligodendroglial tumours, anaplastic subtypes are classified as 
grade III neoplasms, which in contrast to grade II tumours hold a less favourable 
prognosis.  They possess characteristics similar to those of grade II tumours, but in 
addition often contain focal or diffuse features of malignancy (Louis et al. 2007) obvious 
microvascular proliferation and/or necrosis as well as marked mitotic activity (Engelhard 
et al. 2003).  Both subtypes of oligodendroglial tumours may also be found to exhibit 
perinuclear halos along with a branching blood vessel network (Wen and Kesari 2008). 
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1.2.1.4 Mixed gliomas - Oligoastrocytomas 
Oligoastrocytomas are tumours which are composed of two distinct neoplastic cell types, 
which resemble cells found in both oligodendrogliomas and diffuse astrocytomas (Louis et 
al. 2007).  WHO grade II oligoastrocytomas exhibit some cellularity and cytologic atypica 
with occasional mitotic figures.   
In contrast, WHO grade III anaplastic oligoastrocytomas are poorly differentiated tumours 
with histological features of malignancy (Ohgaki and Kleihues 2009).  Anaplastic tumours 
are characterised by the presence of pleomorphic cells, high cellularity and mitotic activity 
with nuclear atypica, necrotic sites and microvascular proliferation (Reifenberger et al. 
2000). 
1.2.1.5 Ependymal Tumours 
Ependymal tumours occur less frequently than astrocytomas and exhibit relatively better 
prognosis. Ependymomas are usually well delineated tumours, subependymoma (WHO 
grade I) lesions are slow growing neoplasms with good prognosis following surgical 
resection (Godfraind 2009). 
WHO grade II lesions (ependymomas) are also slow growing tumours that have four 
histological variants; cellular, papillary, clear cell, and tanycytic ependymoma.  Anaplastic 
ependymomas (WHO grade III) are characterised by accelerated growth, increased 
cellularity and mitotic activity and often exhibit signs of microvascular proliferation with 
pseudopalisading necrosis, all of which are exempt from grade II neoplasms in accordance 
with WHO classification guidelines (Godfraind 2009). 
The WHO criteria as described above, however, are only one component of the array of 
criteria utilised to predict response to therapy and disease outcome.  Other criteria that 
are required to make accurate assessments include: the age of the patient, location of the 
tumour, extent of surgical resection and genetic alterations present (Louis et al. 2007). 
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1.2.2 Diagnosis 
Gliomas often produce no deleterious symptoms until the tumour reaches a certain mass.  
Clinical history is generally short in duration with symptoms developing abruptly due to 
increased intracranial pressure with infiltration of surrounding brain structures and 
compression (Lacob and Dinca 2009, Ohgaki and Kleihues 2009).  Symptoms experienced 
are largely dependent on the location of the tumour and may include: headaches, 
seizures, sensory disturbance, personality changes and visual defects (Lacob and Dinca 
2009). 
Diagnosis of gliomas is achieved based upon findings of neuroradiological imaging, with 
Magnetic Resonance Imaging (MRI) with and without contrast being the current method 
of choice (Chishty et al. 2010).  To assist diagnosis further positron emission topography 
(PET), which uses consumption of radioactively labelled glucose (Lacob and Dinca 2009), 
may be used to distinguish between low and high grade gliomas by assessing whether 
tumours are hypo or hyper-metabolic (Cavaliere et al. 2005).  Nevertheless, the 
aforementioned tests are not utilised in place of histological analysis, and so a tissue 
sample obtained via stereotactic biopsy or from tissue removed during surgery is needed 
for definitive diagnosis. 
1.2.3 Prognosis and treatment 
As previously mentioned, WHO grade I lesions exhibit low proliferative potential and have 
a good possibility of cure following surgical resection without the need for adjuvant 
therapy, whereas grade II and III tumours often recur with the potential to develop into 
more malignant forms.  The most malignant grade IV tumours hold poor prognosis for the 
patient with rapid reoccurrence, evolution of disease state and ultimately fatality (Louis et 
al. 2007).  However, due to the heterogeneity of gliomas, prognosis is often made on a 
case by case basis relying on the age of the patient, location of the tumour, molecular 
profile and how amenable the neoplasm is to surgery and further adjuvant treatments if 
required (Wen and Kesari 2008). 
The first step in the treatment of all glioma types is usually gross surgical resection (Welch 
and Lai 2009) followed by eradication of potential residual cancerous cells irremovable by 
surgery alone with six weeks of radiotherapy treatment concomitant with chemotherapy 
(Yoon et al. 2010).  The most common form of chemotherapy administered is the oral 
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alkylating agent temozolomide (Lim et al. 2011) and following on from 
radiotherapy/chemotherapy an additional six monthly cycles of maintenance by 
treatment with temozolomide may be required (Stupp et al. 2005). 
In spite of the fact that full treatment has the ability to increase significantly the 1-3 
month median survival of even the most aggressive glioma forms, inevitably more needs 
to be done (Yoon et al. 2010).  The inability to extend GBM patient survival beyond 12 
months is due, primarily, to the non-specificity of both radiotherapy and chemotherapy 
coupled with intrinsic resistance of cancerous cells to treatment thus allowing the tumour 
to recur (Hou et al. 2006).  Although treatment with radiotherapy and cytostatic drugs 
dominates first line adjuvant therapy for gliomas at present, targeted intervention is 
becoming increasingly investigated and trialled in an attempt to combat gliomas (Ohgaki 
and Kleihues 2009). 
Due to the poor prognosis of patients diagnosed with malignant glioma, there is a 
requirement for improved treatment strategies. Understanding the molecular 
mechanisms underlying cancer would ultimately help with the development of new 
treatments.  As previously mentioned signalling pathways are often de-regulated in cancer 
and, although some mechanisms of this deregulation are known, much is left to be 
elucidated. 
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1.3 Signal Transduction Pathways 
It is fundamentally important that cells are able to detect and respond to external signals 
from the environment. Central to such responses are the sensing and signalling pathways 
that communicate with cytoplasmic and nuclear targets (Lawrence C.L. et al. 2007).  Signal 
transduction pathways relay information via a variety of stimuli from the cells exterior 
through protein interactions and finally to transcription factors. These transcription 
factors then go on to regulate multiple cellular responses including the expression of 
genes (Bebek and Yang 2007).   
Normal cellular responses and behaviour are controlled by a complex network of highly-
regulated signalling pathways (Downward 2003); consequentially they have received vast 
attention as when this normal regulation is disrupted  a range of disease phenotypes may 
result (Downward 2003, Wilkinson and Millar 2000).   
Of key importance are the mitogen activated protein kinase (MAPK) and mammalian 
target of rapamycin (mTOR) signalling pathways, which are involved in cell growth, 
motility, proliferation and survival (Hsu et al. 2011, Ihermann-Hella et al. 2014). 
Misregulation of both pathways is currently under investigation in connection with 
initiation and progression of numerous cancers, including gliomas (Masui et al. 2011).  
Such deregulation can disrupt the activation and or deactivation of genes enabling cells to 
possess limitless replicative potential, as well as avoidance of cellular death mechanisms 
(Hanahan and Weinberg 2011). 
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1.3.1 mTOR signalling 
mTOR is a serine threonine protein kinase conserved in all eukaryotes which comprises of 
two discrete multi-protein complexes, mTORC1 and mTORC2.  mTOR belongs to the 
phosphoinositide 3-kinase (PI3K) related kinase family and is activated in response to a 
plethora of external signals including cellular stress, growth factors, energy status and the 
availability of nutrients (Laplante and Sabatini 2009a). mTOR consists of two separate 
complexes mTORC1/mTORC2 with the PI3K/Akt/mTOR signal transduction pathway 
serving as a central regulator of cell growth, proliferation, metabolism and survival.  The 
mTORC1 complex comprises of mTOR, Deptor and mLST8 (gβL) and is sensitive to 
rapamycin, whilst mTORC2 is composed of mTOR, Rictor, mLST8, Sin1, Protor-1 and 
Deptor and is largely rapamycin insensitive (Akhavan et al. 2010).  Much of the knowledge 
on mTORC1 function comes from studies utilising the inhibitor rapamycin.  Upon entry to 
cells rapamycin binds to the rapamycin-binding protein FKBP12 via the immunophilin 
FK506. The rapamycin-FKBP12 then binds to the FKBP12-rapamycin-binding domain (FRB) 
inhibiting the function of mTORC1 (Ma and Blenis 2009). 
Engagement of a growth factor with its receptor is the typical route for PI3K activation.  As 
shown in Figure 1.2 activated PI3K then converts its substrate phosphatidylinositol 4,5-
biphosphate (PIP2) into phosphatidylinositol (3,4,5)-triphosphate (PIP3) which brings Akt 
and phosphoinositide-dependent kinase-1 (PDK1) into close proximity.  PDK1 is then able 
to phosphorylate and activate Akt at threonine 308; however, for full Akt activation 
mTORC2 is also required to phosphorylate Akt at serine 473.  Once fully activated Akt can 
activate mTORC1 via inhibitory phosphorylation of tuberous sclerosis complex 2 (TSC2).  
Active mTORC1 can then go on to phosphorylate and activate downstream substrates to 
initiate processes such as cell growth and proliferation (Hay and Sonenberg 2004). 
The best characterised direct downstream targets of mTORC1 are proteins involved in 
controlling the translation of mRNA including S6 kinases (S6Ks) and the 4E-BPs (Hara et al. 
1998).  Other targets of mTORC1 include the transcription factor, hypoxia-inducible factor 
1-alpha (HIF1-α), a regulator of cellular response to hypoxia (Land and Tee 2007), and 
signal transducer and activator of transcription-3 (STAT3) which promotes cell survival 
(Haidinger et al. 2010).  Further mTORC1 targets include Lipin-1 and the transcription 
factor SREBP-1 which both influence signalling events involved in the synthesis of cellular 
lipids (Peterson et al. 2011). 
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Targets of the mTORC2 complex include Akt, which upon activation promotes cell survival.  
mTORC2 also regulates growth via activation of serum and glucocorticoid-induced protein 
kinase 1 (SGK1) and regulates processes involved in cytoskeletal dynamics via protein 
kinase Cα (PKCα) (Huang et al. 2009). 
 
  
Figure 1.2:  mTOR signalling regulation in mammalian cells. Engagement of growth factors including insulin-
like growth factor receptor-1 (IGF-1), platelet derived growth factor receptor (PDGRF) and epidermal growth 
factor receptor (EGFR) are the canonical route of mTOR activation via phosphoinositide 3-kinase (PI3K) 
which is depicted on the diagram by its p85 and p110α subunits.  Active PI3K is able to indirectly activate Akt 
via phosphorylation by phosphoinositide-dependent kinase-1 (PDK1).  Akt then activates mTORC1 by 
inhibitory phosphorylation of tuberous sclerosis complex 2 (TSC2).  Active mTOR then has the ability to 
activate downstream targets to regulate cellular growth.  Adpated from Hay and Sonenberg (2004). 
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Genetic alterations such as loss and gain of function occurring in tumour suppressor and 
proto-oncogenes respectively within the TOR signalling pathway, have been implicated in 
initiation of cellular transformation resulting in cancer.  Specifically in glioblastoma, 
amplification of the cell surface receptor epidermal growth factor receptor (EGFR) occurs 
in approximately 44% of cases (Ohgaki et al. 2004), which is often associated with deletion 
mutations.  One of the most commonly occurring molecular aberrations of EGFR, is the 
truncation of the protein resulting in the loss of exons 2-7, EGFRvIII.  This variant 
comprises 75% of those co-expressing EGFR amplification and results constitutive 
expression of EGFR (Sugawa et al. 1990). This constitutive activation drives activation of 
PI3K/Akt mediated signalling events and in turn activation of mTOR (Yoshimoto et al. 
2008). 
Further, in up to 50% of glioblastoma cases a mutation in the phosphatase and tensin 
homolog (PTEN), which negatively regulates PI3K signalling via PIP3 dephosphorylation, is 
observed.  The mutation results in loss of function of PTEN, thus allowing PI3K/Akt/mTOR 
mediated signalling to persist (Choe et al. 2003). 
 
1.3.2 MAPK Signalling 
Mitogen-activated protein kinases (MAPKs) are serine-threonine protein kinases that 
mediate intracellular signalling associated with numerous cellular activities including cell 
proliferation, differentiation, survival, transformation, migration and apoptosis (Dhillon 
2007, Kim 2010).  MAPK pathways are evolutionary conserved and consist of a three tier 
protein kinase module which is activated sequentially (Figure 1.3).   
MAPK pathways are activated in response to numerous stimuli including growth factors, 
stress and via G-protein coupled receptors (Kyriakis and Avruch 2012). In order for a MAPK 
to be activated, phosphorylation on conserved tyrosine and threonine residues by a 
mitogen-activated protein kinase kinase (MAPKK/MAP2K/MEK) is required.  The MAPKK 
itself is activated by phosphorylation of conserved serine and threonine residues by a 
mitogen-activated protein kinase kinase kinase (MAPKKK/ MAP3K/MEKK).  Additionally to 
phosphorylation of cytoplasmic targets, activation of MAP kinases promotes their nuclear 
translocation and subsequent modulation of transcription factors resulting in altered 
expression of genes (Wilkinson 2000).  
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Figure 1.3: Protein kinase module that makes up the MAPK cascade. A mitogen activated kinase kinase 
kinase kinase (MAPKKKK) is activated in response to external stimulus which then phosphorylates and 
activates a mitogen activated protein kinase kinase kinase (MAPKKK).  Active MAPKKKs phosphorylate 
and activate mitogen activates protein kinase kinases (MAPKKs) on conserved serine and threonine 
residues.  This then leads to activation of the mitogen activated protein kinase (MAPK) which is 
phosphorylated on conserved tyrosine and threonine residues by a MAPKK, resulting in the MAPKs 
translocation to the nucleus* to activate/inhibit target proteins and genes. *phosphorylation is not 
always sufficient for exclusive nuclear translocation of MAPK. Adapted from Roberts et al. (2007). 
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The best studied mammalian MAP kinases are the extracellular signal-regulated kinase 
(ERK) of the ERK-MAPK pathway, c-Jun NH2-terminal kinase (JNK) and p38 of the JNK/p38 
pathways as shown in Figure 1.4.   In general JNK and p38 pathways are activated via 
stress and growth factors, whereas the ERK pathway is usually activated by growth factor 
stimulated cellular surface receptors (Roberts and Der 2007). 
1.3.2.1 ERK MAPK 
The ERK-MAPK pathway, shown in Figure 1.4, is most commonly activated by binding of 
growth factors, such as epidermal growth factor (EGF), to transmembrane receptor 
tyrosine kinases, in this case EGFR, and serves to regulate processes including cellular 
proliferation, differentiation and survival.   
Upon ligand binding to the extracellular domain, the receptors dimerize resulting in 
autophosphorylation on tyrosine residues on the intracellular domain.  This leads to the 
recruitment of adapter proteins, such as growth factor receptor bound protein-2 (Grb2), 
followed by guanine nucleotide exchange factors such as son of sevenless (SOS). Once in 
close proximity to the membrane bound Ras proteins (Schulze et al. 2005, Zarich et al. 
2006), SOS results in the removal of guanine diphosphate (GDP) from Ras which is then 
subsequently activated by guanine triphosphate (GTP) binding.  Once activated, Ras then 
interacts with protein kinase Raf (MAPKKK) which initiates the phosphorylation of the ERK 
cascade (Avruch et al. 2001). 
Cytosolic targets of ERKs include ribosomal S6 kinases (S6Ks) which, once activated, may 
translocate to the nucleus and phosphorylate transcription factors such as c-Fos (a proto-
oncogene) and cAMP response element binding protein (CREB).  In the nucleus ERKs 
phosphorylate numerous other targets such as mitogen and stress activated protein 
kinases (MSKs) and the transcription factor Elk1.  ERK may also directly phosphorylate the 
c-Jun and c-Fos components of the transcription factor AP-1, although there are many 
other nuclear targets including Myc (c-Myc) and nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-KB), which are both frequently deregulated in cancer (Krauss 
2008). 
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1.3.2.2 JNK MAPK 
The JNK MAPK pathway is activated in response to a range of cellular stresses and 
inflammatory cytokines. It may also be stimulated via growth factor mechanisms.  The JNK 
cascade holds important roles in the production of cytokines, metabolism, inflammation 
and apoptosis (Morrison 2012).   
Mammalian cells harbour 3 JNK genes, JNK1, JNK2 and JNK3, which are alternatively 
spliced producing at least 10 isoforms, with JNKs 1 and 2 being ubiquitously expressed.  
After activation of the MAPKKKs (AAK1, MEKK1 and MLK3), JNK kinases are activated by 
the MAPKKs, MKK4 and MKK7, via phosphorylation on conserved threonine and tyrosine 
residues.  The activation of MKK4 is triggered mainly by environmental stress and MKK7 
by cytokines (Davis 2000).  Activated JNK MAPK is then able to phosphorylate 
transcription factors, including Jun, ATF-2, Elk1, p53, STAT1/3, numerous nuclear hormone 
receptors as well as transcription factors regulating the synthesis of ribosomes (Figure 1.4) 
(Krauss 2008). 
1.3.2.3 p38 MAPK 
The p38 MAPK cascade is involved primarily in the cellular response to stress and is 
activated by growth factors and a range of environmental stresses including cytokine 
stimulation, osmotic shock, heat shock and ultraviolet irradiation. Once activated it 
regulates a range of processes including autophagy, apoptosis and proliferation.  
Mammalian p38 MAPKs comprise four isoforms p38α, p38β, p38γ and p38δ, with the 
p38α isoform ubiquitously expressed in most cell types. Activation of upstream MAP3Ks is 
complex and involves phosphorylation by p21 activated kinases (PAK) and binding of Rho 
GTP-binding proteins (Cuadrado and Nebreda 2010).  
As shown in Figure 1.4, p38 MAPK kinases are mainly activated by the MAPKKs, MKK3 and 
MKK6, on conserved Thr-Gly-Tyr residues. Additionally the α isoform may be activated via 
MKK4, which also activates JNK MAPK.  Activated p38 has the ability to phosphorylate 
transcription factors STAT-1, activating transcription factor 2 (ATF-2) and p53 (Thornton 
and Rincon 2009), as well as protein kinases MSK1, MNK, cell cycle control factors such as 
cyclin D1 and death/survival modulators including Bcl-2 and caspases (Cargnello and Roux 
2011). p38 is another kinase that is frequently deregulated in a range of cancers, with the 
up regulation being implicated in promoting proliferation, angiogenesis and metastasis of 
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cancerous cells (Leelahavanichkul et al. 2014, Mao et al. 2010).  However, the role of p38 
in cancer remains controversial as both cell survival, through Bcl2 upregulation, and anti-
proliferative functions, via cell cycle inhibition have been noted.  The inhibition of cell 
cycle progression however could serve to promote cancer cell drug resistance rather than 
to inhibit growth (Liu Liang et al. 2014).   
 
 
 
Figure 1.4: Well characterised MAP Kinase signalling pathways in mammalian cells. A:  Overview of the 
construction of MAP Kinase pathways. B: Ras/Raf/MEK/ERK signalling pathway C: p38 and JNK MAP Kinase 
pathways. Adapted from Roberts et al. (2007). 
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As discussed in the previous sections mTOR and MAPK pathways are both frequently 
deregulated in the initiation and progression of numerous cancer types.  In the case of 
solid tumours, lipid homeostasis is also often perturbed and has been linked to upstream 
oncogenic signalling (Santos CR. and Schulze 2012). 
1.4 Lipids  
Lipids are key constituents of eukaryotic cells; their metabolism is complex and involves 
numerous metabolic reaction steps which produce an array of lipid types. Lipids may be 
broadly classified into neutral and polar lipid subtypes which include fatty acids (FAs), 
triacylglycerols (TAGs), wax esters (WEs), sterol esters (SEs), phospholipids (PLs), lysolipids 
and sphingolipids (SLs) (Nielsen 2009, Rajakumari S et al. 2008).  The major biological 
functions of lipids include roles as structural components of cellular membranes (mainly 
PLs), serving as central energy stores (mainly TAGs and SEs). Furthermore, they have been 
shown to be important signalling molecules.  
The regulation of lipid metabolism and its impact on human disease is under intense 
investigation.  Defects in lipid metabolism have been linked to several disease states 
including Alzheimer’s, cancer, diabetes and Niemann-Pick disease (Di Paolo and Kim 2011, 
Oresic et al. 2008, Zech et al. 2013, Zhang F. and Du 2012).  Therefore an increased 
understanding of the mechanisms underlying regulation of lipid metabolism in 
proliferating tumour cells, through the analysis of signal transduction pathways, could 
allow the identification of novel targets for therapeutic intervention. 
1.4.1 Lipogenesis 
Lipogenesis is defined as the metabolic formation of fat and is the process whereby acetyl 
CoA is converted to fatty acids.  The de novo synthesis of fatty acids (FAs), which mainly 
serve as intermediaries in lipid biosynthesis, begins with the carboxylation of acetyl-CoA 
to malonyl-CoA both of which are utilised by fatty acid synthase (FAS) to synthesise the 
long carbon chains of FAs.  The majority of synthesised FAs are either incorporated into 
TAGs for metabolic energy storage, or assimilated into the membranes as phospholipid 
components (Figure 1.5) (Nelson and Cox 2008). 
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Figure 1.5:  Simplified overview of lipid synthesis from acetyl-CoA. Acetyl CoA (AcCoA) is converted to 
malonyl CoA (MalCoA) or acetoacetyl CoA (AceAcCoA) for fatty acid and sterol synthesis for formation of 
traicylglycerol (TAG) and sterol esters (SEs), respectively.  TAGs and SEs can then be stored as a cellular 
energy reserve in intracellular lipid droplets (LD).  Adapted from Nielsen (2009). 
 
1.4.2 Neutral lipids 
Neutral lipids, comprising TAGs, WEs and SEs are molecules which lack charged groups 
conferring their inability to incorporate into membrane bilayers in significant quantities 
(Athenstaedt and Daum 2006). TAGs and SEs hold central roles in the storage of sterols, 
diacylglycerols and free fatty acids for cellular energy (Hutchins et al. 2008).  As such, 
neutral lipids within cells are stored within cytosolic lipid droplets (LDs) with neutral lipids 
forming the core of the droplet which is surrounded by a monolayer of phospholipids.  
The fatty acids that are encased in LDs can be used for both phospholipid synthesis and 
for cellular energy production via the process of β-oxidation (Athenstaedt and Daum 
2006).   
1.4.2.1 Triacylglycerol and sterol ester synthesis 
The synthesis of TAGs can occur via the glycerol-3-phosphate pathway.  Glycerol-3-
phosphate (G3P) is obtained primarily from glycolysis and is esterified by glycerol-3-
phosphate acyltransferases to produce lysophosphatidic acid (LPA) which is further 
esterified to form phosphatidic acid (PA).  Phosphatidic acid is then dephosphorylated by 
phosphatidic acid phosphorylases (PAPs) to yield 1,2 diacylglycerol (DAG), which can then 
be utilised in the production of TAG or phospholipids (Coleman and Lee 2004).  The 
terminal step of TAG synthesis is the formation of an ester bond between a fatty acid and 
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the hydroxyl group of DAG synthesised by 1,2 diacylglycerol acyltransferase (DGAT) 
(Figure 1.6) (Yen et al. 2005).   
Sterol esters can be synthesised by a acyl-CoA independent reaction whereby 
lecithin:cholesterol acyltransferase (LCAT) catalyses the transfer of a FA from a 
glycerophospholipid to a hydroxyl group of an acceptor sterol.  Secondly sterol esters can 
be produced via an acyl CoA dependent process catalysed by acyl-CoA: cholesterol 
acyltransferase (ACAT) (Athenstaedt and Daum 2006). 
 
 
 
  
Figure 1.6: Key steps facilitating the synthesis of triacylglycerols. A:Glycerol 3-phosphate (G3P) is esterified 
to produce lysophosphatidic acid (LPA).  LPA is further esterified to form phosphatidic acid (PA).  PA is 
dephosphorylated to form 1,2-diacylglycerol (DAG).  B: Triacylglycerol (TAG) is then synthesised from DAG 
by 1,2 diacylglycerol acyltransferase (DGAT). 
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1.4.2.2 Formation of lipid droplets 
Intracellular LDs, as described previously, were long considered to be inert molecules for 
the storage of cellular energy.  Due to recent advances, driven by the pandemic rise of 
lipid dysregulation in human disease, it is now understood that LDs are in fact dynamic 
organelles with diverse functions in the production of both energy and metabolism of 
lipids (Beller et al. 2010).  In spite of such advances the specific functions and molecular 
details of lipid droplet processes are largely unknown with several models proposed for 
their intracellular formation (Beller et al. 2010) (Figure 1.7).  
The most prominent and widely cited model put forward for LD biogenesis is the “lensing” 
model whereby neutral lipids are deposited between endoplasmic reticulum (ER) 
membrane leaflets.  Once a crucial size is accumulated the neutral lipid core formed 
protrudes outwards and the LD is formed, with the surrounding monolayer derived from 
the ER membranes cytosolic leaflet.  The formed LD may completely bud away from the 
ER membrane or remain attached (Martin and Parton 2006) (Figure 1.7A). 
Other models for LD biogenesis that have been proposed include the “bicelle” and 
“vesicle-budding” models, both of which have little direct evidence to support them 
(Wilfling et al. 2013).   
In the bicelle model the notion of neutral lipid accumulation between ER leaflets is mutual 
with that of the lensing model, however rather than the resultant monolayer surrounding 
the neutral lipid core comprising completely of ER cytosolic leaflet both membranes of the 
ER contribute to vesicle formation and the surface monolayer of the final LD (Ploegh 2007) 
(Figure 1.7B).  The major flaw of the bicelle model is that the integrity of the ER 
membrane would be severely compromised by the excision of completed LDs (Walther 
and Farese Jr 2009).   
Conversely the vesicle-budding model proposes that droplets are formed within a small 
bilayer vesicle which remains attached to the membrane of the ER and that these vesicles 
act as a platform for LD synthesis (Figure 1.7C).  Lipids accumulated within the vesicle 
bilayer fill the space between the membranes which squeezes the lumen of the vesicle 
such that it either becomes a small inclusion within the LDs or fuses with the outer leaflet 
of the droplet (Walther and Farese Jr 2009). 
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Figure 1.7: Proposed models of lipid droplet formation at the endoplasmic reticulum. A: The lensing 
model. Neutral lipids are accumulated between the membrane leaflets of the endoplasmic reticulum (ER) 
until a critical size is reached.  Lipid droplets may either remain attached to the ER or “bud” off from the 
membrane. B: The bicelle model.  Lipid droplets comprise of both membranes of the ER C: The vesicle 
budding model.  Droplets are formed within a small bi-layer vesicle, the resultant lipid droplet forms from 
one membrane of the ER, with the membrane contributing to the vesicle potentially forming a small 
inclusion. Adapted from Kohlwein et al. (2013). 
 
In response to cellular biosynthetic requirements, neutral lipids accumulated within LDs 
are mobilised by lipases (lipolysis) to provide substrates for production of lipids for 
membrane synthesis or cellular energy in the form of ATP, yielded via fatty acid oxidation 
(Guo Yi et al. 2009b).  After cytoplasmic activation, oxidation of fatty acids occurs in the 
mitochondria and peroxisomes of cells in a process known as β-oxidation.  This process 
results in the sequential removal of two carbon units with each cycle involving four steps.   
The first is dehydrogenation of and acyl-CoA ester to produce trans-2-enoyl-CoA followed 
by hydration of the double bond.  This is then followed by dehydrogenation of the 
resultant L-3-hydoxy-acyl-CoA to 3-keto-acyl-CoA before finally, thiolytic cleavage of to 
yield an acetyl CoA and acyl-CoA shortened by two carbons (Houten and Wanders 2010).  
Each β-oxidation cycle yields both of the aforementioned thiolytic cleavage products as 
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well as one flavin adenine dinucleotide (FADH2) and one nicotinamide adenine 
dinucleotide (NADH).  The resultant acetyl-CoA may enter the tricarboxylic acid (TCA) cycle 
and is further oxidised producing more FADH2 and NADH which is then transferred, along 
with those produced in β-oxidation, to the electron transport chain yielding ATP (Houten 
and Wanders 2010). 
 
1.4.3 Polar lipids  
Glycerophospholipids (GPLs) are the most abundant lipids present in eukaryotic 
membranes and are derived from phosphatidic acid (PA) (Figure 1.8). The major classes 
present are phosphatidylcholine (PC) phosphatidylethanolamine (PE), phosphatidylinositol 
(PI) and phosphatidylserine (PS).  GPLs are instrumental molecules not only for the 
structural maintenance of biological membranes, but also in mediating cellular regulatory 
functions due to their capacity to be converted into lipid second messengers such as LPA 
and DAG (Vance 2008). 
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Figure 1.8: Major classes of Glycerophospholipids derived from phosphatidic acid. The major classes of 
glycerophospholipids derived from phosphatidic acid (PA) along with their structures. The major 
phospholipids are: phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylethanolamine (PE) and 
phosphatidylcholine (PC).  Shown in red are the hydrophilic head groups (inositol, serine, ethanolamine and 
choline). Taken from Henry et al. (2012). 
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1.4.4 Phospholipid synthesis 
The precursor for the synthesis of all glycerophospholipids is PA which can be generated 
de novo from G3P (as seen with TAG synthesis) or via the phosphorylation of DAG 
(Hermansson et al. 2011, Hishikawa et al. 2014).  The resultant PA can be utilised in the 
synthesis of PLs via two different pathways.  The first involves production of DAG which 
can then be utilised in the synthesis of PE, PC, PS or TAG.  In the second pathway PA is 
utilised to produce PL classes by the creation of CDP-DAG molecules (Henry et al. 2012).  
An overview of the pathways contributing to synthesis of major phospholipid classes is 
depicted in Figure 1.9. 
1.4.4.1 Phosphatidylcholine synthesis 
Phosphatidylcholine (PC) may be produced via two pathways.  In the first pathway PC is 
synthesised via the CDP-choline (Kennedy) pathway.  Firstly choline is phosphorylated to 
phosphocholine by choline kinase before it is further activated using CTP to produce CDP-
choline.  The phosphocholine moiety is then transferred to DAG from CDP-choline to form 
PC.  Secondly PC can be produced as the end product of the CDP-DAG pathway, whereby 
CDP-DAG is initially converted by PS synthase to PS.  The resultant PS is then 
decarboxylated to PE which is in turn methylated sequentially to yield PC (Rajakumari S. et 
al. 2010).   
1.4.4.2 Phosphatidylethanolamine synthesis 
The synthesis of PE via the Kennedy pathway is produced by ethanolamine kinase 
phosphorylating ethanolamine forming phosphoethanolamine.  Phosphoethanolamine is 
then further activated by CTP yielding CDP-ethanolamine with the final step involving 
transfer of ethanolamine to DAG yielding PE.  Via the CDP-DAG pathway, CDP-DAG is 
converted to PS primarily which is then decarboxylated to form PE (Hermansson et al. 
2011).  
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1.4.4.3 Phosphatidylserine synthesis 
Phosphatidylserine is a minor lipid component of cellular membranes. L-serine is an amino 
acid which is actively synthesised and produced in almost all cell types. The synthesis of PS 
occurs via base-exchange from PC or PE by PS synthase.  Phosphatidylserine synthase 1 
(PSS1) replaces the head group of PC with L-serine yielding phosphatidylserine and 
choline, whereas phosphatidylserine synthase 2 (PSS2) catalyses the same reaction 
replaces the head group of PE with L-serine yielding phosphatidylserine and 
ethanolamine. 
1.4.4.4 Phosphatidylinositol synthesis 
A class of GPL that serve as important lipid signalling molecules are phosphatidylinositols.  
PI is formed from PA by the production of CDP-DAG which is condensated with myo-
inositol by PI synthase.  The head group of PI can also be phosphorylated to produce 
phosphatidylinositol phosphates (PIPs).  In addition to roles in maintaining structural 
cellular integrity, PI and its metabolites are involved in the regulation of numerous cellular 
processes including signal transduction, actin cytoskeleton organisation, protein 
anchoring, mRNA export and vesicle mediated membrane trafficking (Gardocki et al. 2005, 
Kim Sung-Kuk et al. 2011). 
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Figure 1.9: Overview of phospholipid biosynthetic pathways. Phospholipid biosynthetic pathways, left: 
CDP-DAG pathway and right: Kennedy pathway.  PA: Phosphatidic acid, PSS1: phosphatidylserine synthase 1, 
PSS2: phosphatidylserine synthase 2, PS: Phosphatidylserine, PE: Phosphatidylethanolamine, PI: 
Phosphatidylinositol, PC: Phosphatidylcholine, DAG: Diacylglycerol, P-ethanolamine: phosphoethanolamine, 
P-choline: phosphocholine, ATP: Adenosine triphosphate, ADP: Adenosine diphosphate.  Adapted from Choi 
Hyeon-Son et al. (2004). 
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1.5 Metabolic switch of cancerous cells 
The uncontrolled potential of cancerous cells to proliferate requires an enhanced nutrient 
supply along with biomass synthesis and subsequently energy consumption.  Aberrant 
metabolism of human cancer cells was first recognised in the 1920s when Otto Warburg 
noted that rapidly proliferating tumour cells consume glucose at an accelerated rate 
compared to non-cancerous cells (Warburg O. 1925, Warburg O 1956).   
Accompanying the high glycolytic characteristic of tumour cells, heightened rates of 
anabolic processes are also displayed resulting in elevated amino acid and lipid synthesis. 
Various types of tumours have been found to undergo increased de novo endogenous 
fatty acid synthesis irrespective of existing extracellular lipid levels (Esechie and Du 2009).  
This phenomenon occurs downstream from oncogenic signalling and is directly linked to 
increased glycolysis associated with solid tumours (Swinnen et al. 2006).   
As depicted in Figure 1.10, in quiescent cells there is a basal rate of glycolysis whereby 
glucose is converted to pyruvate and enters the TCA cycle where it is oxidised.  Alongside 
this process cells are also able to oxidise substrates including fatty acids and amino acids 
from degradation of macromolecules or simply from their environment.  Conversely in 
proliferating cells there is a marked increase in glycolytic flux which generates large 
amounts of ATP within the cytoplasm.  Most of the resultant pyruvate from glycolysis is 
converted via lactate dehydrogenase-A (LDA) to lactate allowing glycolysis to continue.  
Some resultant pyruvate is converted to acetyl-CoA and enters the TCA cycle where it is 
converted to intermediates (DeBerardinis R J. et al. 2008b).  One such intermediate is 
citrate which may be exported from the mitochondria to the cytoplasm and cleaved to 
produce substrates including oxaloacetate and notably acetyl-CoA which is then processed 
by fatty acid synthase (FASN) for the synthesis of lipids (Bauer DE. et al. 2005). 
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  Figure 1.10: Differences in carbon flux between non-proliferating and proliferating cells. In quiescent cells 
(left) there is a basal rate of glycolysis whereas proliferating cells in comparison (right) have a larger 
glycolytic flux which generates cytoplasmic ATP readily (stars).  Most of the resulting pyruvate is converted 
to lactate which, due to NAD+, allows glycolysis to continue. Some of the resulting pyruvate is converted to 
Acetyl-CoA before entry into the TCA cycle.  After entry into the TCA cycle, intermediates, such as citrate is 
formed.  Citrate is one of the requirements for the synthesis of fatty acids and cholesterol which is used to 
generate lipid membranes required for proliferating cells.  Adapted from DeBerardinis RJ. et al. (2008a). 
 
The process of increased glycolysis compared to energy generation by oxidative 
phosphorylation is energetically unfavourable to cells.  For example, the conversion of 
glucose to lactate only produces 2 ATPs per molecule of glucose, whereas oxidative 
phosphorylation (OXPHOS) may generate up to 36 ATPs per glucose molecule.  However 
for cancerous cells which require rapid growth and proliferative potential, this switch 
harbours many advantages.  Firstly, if glycolytic flux is markedly increased then the 
percentage of ATP generated from glycolysis can exceed that of OXPHOS due to its higher 
rate (Pfeiffer et al. 2001).  Secondly the metabolic requirements of cancerous cells extend 
beyond that of mere ATP production and the process of glycolysis also yields 
intermediates for the production of lipids, amino acids and nucleotides (Vander Heiden et 
al. 2009).  Along with this the high lactate production resulting from increased glycolysis 
serves to produce NADPH for anabolic reactions as well as serving to assist cancerous cells 
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in evading immune responses and promoting cellular migration (Hirschhaeuser et al. 
2011). 
More recently it has been shown that cancerous cells residing in solid tumours may have 
dual metabolism for the generation of ATP in a more economical fashion which allows 
effective adaptation to the tumour microenvironment.  This study suggests that once 
cancerous cells consume glucose and produce lactate resulting in lactic acidosis, a 
common feature of solid tumours, the cells switch to OXPHOS to generate ATP in a more 
energetically favourable fashion whilst glucose levels are low (Xie et al. 2014).  It is 
postulated that the Warburg effect has the advantage when glucose supply is sufficient 
for supplying metabolic requirements for rapid proliferation, whereas in non-glycolytic 
circumstances under conditions of lactic acidosis the cancer cells are able to adapt to a 
limited glucose metabolic environment (Xie et al. 2014). 
Although the changes governing the regulation of increased de novo lipogenesis are not 
fully understood, it is postulated that the high rate of de novo lipogenesis occurring in 
rapidly proliferating tumour cells not only creates a supply of phospholipids for membrane 
biogenesis but also a readily available store of energy (Jackowski et al. 2000). 
1.5.1 Pathways involved in the metabolic switch 
Over the last decade a plethora of information has accumulated on the signalling 
components involved in the accelerated glycolytic and lipogenic rates observed in 
cancerous cells. As depicted in Figure 1.11, oncogenic gain of function and loss of tumour 
suppressors may both contribute to stimulating the transcription of genes encoding 
proteins mediating glycolysis. 
For example, as described earlier, PI3K/Akt is deregulated via both EGFR mutation and 
loss of PTEN resulting in constitutive activation. The overexpression of Akt can lead to 
increased LDA fuelling lactate and NAD+ production, increased activity of glucose 
transporter-1 (GLUT-1) which will in turn enhance cellular glucose influx to feed glycolysis 
and phosphofructokinase 2 (PFK2) another positive regulator of glycolysis.  Furthermore 
constitutive activation of Akt suppresses β-oxidation processes supporting anabolic 
metabolism of lipids and therefore proliferation (DeBerardinis RJ. et al. 2006).  
Downstream from enhanced PI3K/Akt signalling, consequent mTOR activation contributes 
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to S6K and HIF-1α up regulation which contribute to enhanced GLUT-1 expression (Buller 
et al. 2008).   
AMP-activated protein kinase (AMPK) is a critical regulator of both glucose and lipid 
metabolism.  Upon activation of AMPK by its major upstream AMPKK, processes that 
generate ATP are enhanced, such as β-oxidation, whilst energy consuming processes 
including fatty acid synthesis are downregulated.  Although often classed as a tumour 
suppressor, AMPK has also been implicated in contributing to promoting cell survival and 
adaptation (Liang and Mills 2013).  Loss of function of LBK1 in many human cancers means 
that the activation of AMPK is perturbed resulting in heightened proliferative potential 
occurring from the inability to supress downstream targets such as mTORC1 and HIF-1α 
(Faubert et al. 2013, Lisi et al. 2014). 
Activation of sterol regulatory element binding proteins (SREBPs) is also implicated in 
facilitating cancer progression.  SREBPs are membrane bound helix-loop-helix leucine 
zipper transcription factors, with three isoforms SREBP-1a, SREBP-1c and SREBP-2 
encoded by SREBPF1 and SREBPF2 found in mammalian cells. SREBP-1a regulates all 
SREBP-responsive genes whereas SREBP-1c and SREBP-2 regulates genes involved in fatty 
acid and cholesterol synthesis, respectively. Control of SREBP isoform activity is controlled 
by the binding protein, SREBP cleavage activating protein (SCAP) (Espenshade and Hughes 
2007, Shao and Espenshade 2014).   
It has been demonstrated that mTOR promotes the activation of SREBP-1a, a master 
regulator of fatty acid synthesis (Porstmann et al. 2008).  The active, cleaved form of 
SREBP-1a translocates to the nucleus where it promotes activation of SREBP responsive 
genes holding roles in the synthesis of cholesterol, FAs and TAGs.  Targets of SREBP-1a/c 
include fatty acid synthase (FASN), acetyl-CoA carboxylase (ACC) and glycerol-3-
phosphate-acyltransferase (GPAT) (Laplante and Sabatini 2009b).   
Additionally, numerous common oncogenes, including c-Myc and H-ras, contribute to 
oncogenic signalling fuelling anabolic reactions.  Specifically the transcription factor c-
Myc, a regulator of cell growth, targets glycolytic enzymes such as well as regulating 
nucleotide, amino acid and carbon metabolism.  
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Tumour suppressors can also aid in regulating cellular metabolism.  For instance, 
activation of p53 results in enhancement of β-oxidation processes as well as favouring 
cellular energy production via OXPHOS.  Due to the loss of p53 in many solid tumours, a 
significant growth advantage is given to cancerous cells as they are able to engage in 
glycolysis with a gain of anti-angiogenic function (Jones and Thompson 2009). 
Links between upregulation of MAPK signalling via the Ras/Raf/MEK/ERK pathway have 
also been implicated in increased expression and activation of FASN via SREBP-1, leading 
to enhanced lipogenesis in cancerous cells (Yang Yu-An et al. 2002).  As with PI3K/Akt 
signalling, ERK pathway activation also causes increased HIF1α levels, which as previously 
described, serves to upregulate the expression of GLUT-1.  It has also been demonstrated 
that ERK is required for nuclear translocation of the glucose metaboliser pyruvate kinase 
M2 (PKM2) which promotes the Warburg effect observed in cancerous cells and also 
serves as a regulator of Myc (Yang W et al. 2012). 
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Figure 1.11:  Overview of metabolic reprogramming occurring via oncogenic signalling. Downstream from growth factor expression, gain of function in proto-oncogenes (green) 
or loss of function in tumour suppressor genes (red) can lead to de-regulated lipid metabolism.  PI3K/Akt/mTOR upregulation activates SREBP-1 transcription factors which drives 
expression of lipid metabolism genes whilst also activating Lipin-1 to drive lipogenesis.  Overactive Ras/Raf/MEK/ERK serves to upregulate HIF-1α, contributing to GLUT-1 activation to 
increase glycolytic flux. PC: Pyruvate carboxylase. LDHA: Lactate dehydrogenase A. 
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Numerous upstream oncogenic signalling components, as described above, have been 
described to fuel the lipogenic phenotype.  However, further understanding and 
dissection of the underlying mechanisms that allow metabolic transformation is still 
required in order to develop targeted therapeutic strategies.  Much of the understanding 
of signalling and lipid biosynthetic regulatory mechanisms has been derived from studies 
utilising the budding yeast Saccharomyces cerevisiae (S. cerevisiae) as a model organism 
(Athenstaedt 2010, Dann and Thomas 2006, Schmidt et al. 2013). It is postulated that 
further studies using simple eukaryotic model organisms will accelerate understanding 
further of the upstream events that regulate lipid biosynthesis. 
1.6 Yeast as a model organism 
Approximately a quarter of a century ago it was predicted that yeast could be utilised as 
the ideal model organism for eukaryotic biology (Botstein D and Fink 1988).  Following on 
from this, studies utilising the budding yeast Saccharomyces cerevisiae (S. cerevisiae) and 
fission yeast Schizosaccharomyces pombe (S. pombe), have enabled major biological 
breakthroughs in understanding a plethora of cellular and molecular processes (Mager 
and Winderickx 2005). Today, yeast are still intensively employed as an excellent 
genetically well-defined model for studying eukaryotic biology. 
The attractiveness for the utilisation of yeast in research stems from their simplistic 
nature, especially with respect to elucidation of genotype/phenotype relationship, ease of 
culture in low cost media and genetic tractability.  In this sense yeast cells hold an 
advantage over their mammalian counterparts as it is easier, in comparison, to identify 
the biochemical function of a gene as well as to study the biological consequences of 
inactivation or overexpression (Botstein D. and Fink 2011, Mager and Winderickx 2005).  
Along with this a more detailed molecular analysis may be carried out when utilising yeast 
than can be undertaken in the clinic or with human primary cell culture (Petranovic et al. 
2010). 
Although phylogenetically distant from the cells of humans and other mammals, a number 
of key processes and regulatory elements are highly evolutionarily conserved.  Therefore 
gene functions, gene/protein interactions and indeed signalling networks can be 
compared with other eukaryotes including those of Homo sapiens (Botstein D. and Fink 
2011, Petranovic et al. 2010).  A comparison of genes in 1997 showed that 30% of known 
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genes involved in human diseases also have orthologues in yeast and that hundreds of 
additional yeast genes exhibit links to such genes (Françoise 1997).  Additionally as the 
fission yeast S. pombe is only distantly related to budding yeast, a valuable 
complementary model system is provided. 
It is therefore not surprising that both MAPK and mTOR pathways are highly conserved 
between yeast and mammalian cells.  In addition, regulation of cellular energy metabolism 
is also highly similar between yeast and mammalian cells with increasing evidence that the 
metabolism of lipids is also conserved (Petranovic et al. 2010).   
1.6.1 mTOR signalling in yeast 
As previously described and depicted in Figure 1.12, mTOR complexes are structurally and 
functionally conserved in yeast and mammalian cells.  Multiple advances in the elucidation 
of cellular growth processes in mammalian cells were initially described utilising yeast, 
including the roles of TOR signalling (Dann and Thomas 2006).  Pioneering work in yeast in 
1991 led to the discovery of the two isoforms of TOR in S. cerevisiae through analysis of 
resistance to the antifungal agent rapamycin (Heitman et al. 1991).   
Since then TOR protein complexes and signalling behaviours have been under intensive 
investigation in the progression of many human cancers and more recently in the 
regulation of lipid metabolism.  As with mammalian cells, the TOR pathway residing in 
yeast cells regulates cell growth in response to cellular stresses and nutrient availability 
(Loewith 2011).  Activation of TOR complexes modulates responses to processes including 
protein synthesis, autophagy, cell cycle and activation of gene transcription (Hay and 
Sonenberg 2004).  
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 Figure 1.12:  Conservation of TOR complex components between mammalian,  S. cerevisiae and S. pombe 
cells. TOR complexes are highly conserved between mammalian and yeast cells.  Homology of key complex 
components including GβL/Lst8/Wat1 and Raptor/Kog1/Mip is indicated by colour. 
 
In S. cerevisiae the TOR complex 1 (TORC1) comprises of either Tor1p or Tor2p along with 
Kog1p, Lst8p and Tco89p and is sensitive to the drug rapamycin.  Conversely TOR complex 
2 (TORC2) is insensitive to rapamycin and comprises of TOR2 accompanied by Avo1p, 
Avo2p, Lst8p, Bit61p, Slm2p, Slm1p and Tsc11p (Loewith et al. 2002).  In budding yeast the 
regulatory mechanisms upstream of TORC1 are not as well described as the downstream 
effects. In favourable conditions with a plentiful nutrient supply, TOR1 inhibits 
transcriptional activators involved in a range of processes including the retrograde 
response (Rtg1, Rtg3) and stress response (Msn2p, Msn4p) (Crespo JL. et al. 2002) by 
sequestering them within the cytoplasm.  Simultaneously, activation of transcription 
factors with roles in the biogenesis of ribosomes (Spf1, Flh1) is initiated (Bandhakavi et al. 
2008). Conversely, under conditions of nitrogen starvation TOR1 activity is inhibited 
resulting in the elevated activity of such transcriptional activators (Rødkær and Færgeman 
2014).  As mTORC1 activates S6Ks in mammalian cells, TOR1 has been found to directly 
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phosphorylate S. cerevisiae Sch9, a regulator of translation initiation and ribosome 
biogenesis (Urban et al. 2007b). 
Analysis of TOR in fission yeast remained largely incomplete until approximately 2009, 
which is remarkable as fission yeast have been found to be more highly conserved to 
mammalian systems in aspects such as cell cycle regulation and response to stress (Cromie 
and Smith 2008, Papadakis and Workman 2004).  In S. pombe there are also two distinct 
TOR homologues, Tor1 and Tor2.  However, it is important to note that budding and 
fission yeast TOR complexes are numbered in opposing ways.  The equivalent to budding 
yeast TORC1 is therefore TORC2 in S. pombe and S. cerevisiae TORC2 is analogous to the 
fission yeast TORC1 complex.   
S. pombe TORC2 consists of Tor1, Ste20, Wat1, Bit61 and Sin1.  TORC1 is comprised of 
Tor2, Wat1, Mip1, Toc1 and Tco89 (Otsubo and Yamamato 2008).  Interestingly it was 
found, in contravention with budding yeast and mammalian systems, that rapamycin 
treatment did not arrest growth in fission yeast but rather inhibited sexual development 
(Weisman 2004).  Regardless, it has been shown that both fission yeast TOR complexes 
contain a conserved domain which could interact with FKBP12-rapamycin (Kawai et al. 
2001, Weisman et al. 2001).  Further to this it is reported that amino acid uptake, which is 
dependent on Tor1 is rapamycin sensitive, being rescued with replacement of wild type 
tor1 containing a defective rapamycin binding allele. (Weisman et al. 2005)  
Upstream of the TOR complexes in fission yeast, functional orthologues of mammalian 
Rheb as well as orthologues of Tsc1/2 components regulate Tor2 activation (Yang W. et al. 
2001).  However, very few direct targets of fission yeast TOR complexes have been 
elucidated.  It is known that Tor1 directly regulates the AGC kinase, Gad8, by 
phosphorylation (Du et al. 2012).  Direct downstream targets of Tor2 include the AGC 
kinase orthologue, Psk1 which is required for phosphorylation of ribosomal protein S6 
(Nakashima et al. 2012a).  Along with this potential interactions with other AGC kinases 
Sck1/2 have also been noted (Nakashima et al. 2012a), thus showing conserved 
mechanisms between mammalian and S. pombe mediated TOR signalling events. 
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1.6.2 MAPK pathways in the budding yeast S. cerevisiae 
In S. cerevisiae five MAP Kinase pathways have been identified.  Four of the MAPK 
pathways present, filamentation-invasion, mating-pheromone response, cell wall integrity 
and high osmolarity growth have been well characterised (Figure 1.13), with the fifth 
believed to hold roles in spore wall assembly (Chen R. and Thorner 2007).  
1.6.2.1 Invasive growth and pheromone response MAPK pathways 
The invasive growth and pheromone response pathways of S. cerevisiae are activated by 
common MAPKKKs and MAPKKs Ste11 and Ste7. The invasive growth pathway is 
stimulated in response to nutrient limitation in haploid cells (Bauer F. and Pretorius 2002) 
resulting in activation of Ras2p.  The MAP kinase of this cascade is Kss1p, which is 
activated via phosphorylation by the MAPKK Ste7p.  This phosphorylation then results in 
activation of the transcription factors Tec1p-Ste12p to control cell adhesion and induce 
expression of target genes including and MUC1 which is a glycoprotein required for 
invasive growth (Chen R. and Thorner 2007). 
The pheromone response pathway mediates cellular response to mating pheromones.  
Stimulation by pheromones results in activation of Fus3 via the MAPKK Ste7.  Once 
activated Fus3 regulates mating specific genes through Ste12 transcription factor 
activation (Chou et al. 2006). 
1.6.2.2 Cell wall integrity pathway 
Activation of the cell wall integrity pathway occurs via Wsc1, Wsc2, Wsc3, Mid2 and Mtl1 
cell surface sensors.  Once activated nucleotide exchange on the Rho1 G-protein is 
stimulated (Levin 2005).  Rho1 in its GTP bound state activates Pkc1 which then activates 
the MAKKK Bck1 which phosphorylates Mkk1/2 MAPKKs (Levin 2005).  Downstream of the 
MAPK Mpk1 transcriptional responses are facilitated via Swi4/6, also known as the SBF 
complex, and Rlm1 which regulates the expression of genes involved in cell wall 
biogenesis (Jung et al. 2002, Truman et al. 2009).  Additionally transcription factors Hsf1, 
Skn7 and Msn2/4 are also regulated downstream of Mpk1 mediating responses to cell 
wall stress (Garcia et al. 2004, Jung and Levin 1999, Li S. et al. 1998). 
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Figure 1.13: MAP Kinase signalling pathways in the budding yeast S. cerevisiae.  A: Pheromone response 
pathway mediates cellular response to mating pheromones for activation of mating specific genes via the 
MAPK Fus3 B: Filamentous growth pathway controls cell adhesion and invasive growth via its MAPK Kss1 C: 
Cell wall integrity pathway MAPK Mpk1, regulates the expression of genes involved in cell wall biogenesis via 
transcription factors such as Swi4/6. Adapted from Thomas and Limper (2007). 
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1.6.3 MAPK pathways in the fission yeast S. pombe 
In the fission yeast S. pombe three distinct MAP Kinase pathways have been identified: the 
pheromone pathway, the stress response pathway and the cellular integrity pathway, 
(Figure 1.14).   
The pheromone MAPK cascade has two pheromone receptors encoded by Mam2 and 
Map3. When pheromones are bound, Ras1 activates the MAPK module which comprises 
Byr2, Byr1 and the MAPK Spk1 (Tamanoi 2011).  Activated Spk1 is responsible for 
regulation of conjugation and sporulation and triggers sexual differentiation via activation 
of the transcription factor Ste11 (Kim Lila et al. 2012). 
The cell integrity pathway in S. pombe serves to regulate processes including construction 
and maintenance of the cell wall, morphogenesis and cytokinesis. The cascade comprises 
the MAPKKK Mkh1, MAPKK Pek1 and MAPK Pmk1 (Madrid et al. 2006). A major 
downstream target of Pmk1 includes the transcription factor Atf1, which is 
phosphorylated by Pmk1 under cell wall damage (Takada et al. 2007). 
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 Figure 1.14: S. pombe MAPK pathways. A: The pheromone response pathway is activated when 
pheromone signals are received.  The activation is relayed to the MAPKKK Byr2 by the upstream Ste20 
Kinase, which then phosphorylates the MAPKK Byr1.  Phosphorylated Byr1 then phosphorylates the MAPK 
Spk1.  Spk1 modulates the expression of transcription factors including Ste11 and Mat1 to regulate sexual 
differentiation, conjugation and sporulation. B: The Cellular integrity pathway is activated under conditions 
of cell wall stress, little is known concerning the targets of this pathway that are related to cell wall 
biogenesis.  It is known that Pmk1 can phosphorylate Atf1, which is a common transcription factor with the 
stress activated protein kinase pathway of S. pombe. 
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1.6.4 Mammalian p38 MAPK orthologues in yeast 
As demonstrated in the previous section, MAPK pathways in S. cerevisiae and S. pombe 
are composed of a three kinase module that is conserved in MAPK cascades of 
mammalian cells.  Mammalian p38 MAPK pathways are structurally and functionally 
conserved in yeast via Hog1 (S. cerevisiae) and Sty1 (S. pombe) stress response pathways 
(Banuett 1998), (Figure 1.15). 
 
 
 
Figure 1.15:  Conservation of eukaryotic p38 pathways. The MAPK pathways of mammalian and yeast cells 
are highly structurally and functionally conserved. Left: mammalian p38 MAP Kinase pathway. Centre: S. 
cerevisiae HOG pathway. Right: S. pombe Sty1 pathway.   
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1.6.4.1 The high osmolarity glycerol (HOG) pathway in S. cerevisiae 
The HOG pathway of S. cerevisiae is activated in response to high osmolarity, citric acid 
and pH (Kapteyn et al. 2001, Lawrence C. L. et al. 2004, Saito and Posas 2012). Upon 
activation an adaptive response of cells is mounted.  Responses include transient cell cycle 
arrest and global readjustment of the expression of genes (Saito and Posas 2012). 
As demonstrated by Figure 1.16, the HOG cascade can be activated via two distinct 
branches, Sln1 and Sho1, both of which converge to a common MAPKK, Pbs2 (O'Rourke et 
al. 2002).   
The Sln1 branch is controlled via a phosphorelay system comprising the Sln1 membrane 
sensor, and proteins Ypd1 and Ssk1 (Kaserer et al. 2009).  After autophosphorylation of 
Sln1 in iso-osmotic conditions, Ypd1 is phosphorylated which then subsequently 
phosphorylates Ssk1 (Chen Ming-Tang and Weiss 2005).  The phosphorylated form of Ssk1 
is unable to bind MAPKKKs Ssk2 and Ssk22.  Once under conditions of hyperosmotic stress 
Ssk1 is dephosphorylated and binds Ssk2/Ssk22 leading to autophosphorylation and in 
turn phosphorylation of the MAPKK Pbs2 (Horie et al. 2008). 
The Sho1 branch is controlled by two transmembrane sensors, Hkr1 and Msb2 which are 
stimulated under hyperosmotic shock (Tatebayashi et al. 2007).  Stimulation of the 
transmembrane sensors promotes Cla4 and Ste20 to bind Cdc42, a membrane bound G-
protein, and become activated.  This activation results in phosphorylation of the MAPKKK 
Ste11, which goes on to activate the MAPKK Pbs2 via phosphorylation (Lamson et al. 
2002). 
Once Pbs2 is active, it goes on to activate the MAPK Hog1 by dual phosphorylation of 
residues which are common to other MAPKs, Thr174 and Ty176 (Maayan et al. 2012).  
Under non-stressed conditions Hog1 is distributed evenly between the nucleus and 
cytoplasm.  Rapid accumulation of Hog1 in the nucleus is observed under conditions of 
hyperosmotic stress allowing Hog1 to control gene expression via DNA binding proteins 
including Msn2/4 and Hot1 (Alepuz et al. 2001).   
Hog1 can also control transcriptional initiation via direct phosphorylation; however 
phosphorylation is not essential for regulating transcription factors which include Hot1.  In 
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this case Hog1 can interact with RNA Polymerase II and other transcriptional machinery 
components recruiting them to the coding regions of genes (Alepuz et al. 2003). 
 
 
 
  
Figure 1.16: The Hog MAPK pathway of S. cerevisiae. The stress activated protein kinase pathway in S. 
cerevisiae is activated by external stresses, including osmotic stress. There are two distinct branches of this 
pathway that converge at the point of the common MAPKK Pbs2.  Active Pbs2 phosphorylates Hog1 on 
conserved tyrosine and threonine residues.  Hog1 is then able to translocate to the nucleus and activate 
transcription factors, including Msn2/4 and Hot1, to drive expression of stress responsive genes.  Hog1 
activity is downregulated by the activity of phosphatases to prevent lethality caused by overexpression of 
Hog1. 
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Due to the inhibitory effect of Hog1 on progression of the cell cycle, constitutive activation 
of Hog1 is lethal to S. cerevisiae cells (Clotet and Posas 2007).  Hog1 kinase activity is 
controlled, in part, by dephosphorylation of the phosphorylated threonine 174 and 
threonine 176 residues.  This is controlled by tyrosine phosphatases Ptp2 and Ptp3 along 
with serine/threonine phosphatases Ptc1, Ptc2 and Ptc3 (Warmka et al. 2001, Wurgler-
Murphy et al. 1997).  Ptp2 dephosphorylates tyrosine in the nucleus whereas Ptp3 
dephosphorylates tyrosine in the cytoplasm (Mattison and Ota 2000, Wurgler-Murphy et 
al. 1997). The serine/threonine phosphatases dephosphorylate the threonine residue with 
Ptc1 holding the greatest role over Ptc2 and Ptc3 (Warmka et al. 2001). 
Phosphorylated Hog1p can also phosphorylate upstream targets such as Ste50 in order to 
down-regulate the HOG cascade (Hao et al. 2008). Phosphorylation of Ste50 acts as a 
negative feedback loop by reducing the affinity of Ste50 to interact with Opy2, which is 
required for Hog1 activation (Yamamoto et al. 2010). 
 
1.6.4.2 Sty1 stress response pathway in S. pombe 
The Sty1 MAPK pathway is also activated in response to a range of external stressors 
including heat stress, oxidative stress, osmotic stress and nutrient stress.  Sty1p is 
activated on the conserved tyrosine and threonine residues by Wis1 (MAPKK), which is 
activated by upstream Wis4 and Win1 (MAPKKK) (Figure 1.17) (Zhou et al. 2010).   
Under moderate oxidative stress conditions Sty1 is regulated by Mak2 and Mak3 histidine 
kinases, along with Mpr1 and Mcs4 (Quinn et al. 2002).  Under high oxidative stress Sty1 
activation is independent of Mak2/3 (Quinn et al. 2002).  As with the Hog1p, 
overexpression of Sty1p is lethal to S. pombe cells, as such, the dual phosphatases Pyp1 
and Pyp2 are key regulators in Sty1p dephosphorylation (Shiozaki and Russell 1996). 
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Figure 1.17: The Sty MAPK pathway of S. pombe. The stress activated protein kinase pathway in S. pombe is 
activated by external stresses including oxidative and osmotic stress. After activation of MAPKKKs the 
pathway converges at the common MAPKK Wis1.  Active Wis1 phosphorylates Sty1 on conserved tyrosine 
and threonine residues.  Sty1 is then able to translocate to the nucleus and activate transcription factors, 
including Aft1 and Pap1, to drive expression of stress responsive genes.   
 
Downstream of Sty1 the regulation of genes in response to stress occurs via Atf1p, a bZIP 
transcription factor.  Although not critical for its function, Atf1 is phosphorylated and 
stabilised by Sty1 (Lawrence C.L. et al. 2007).  Atf1 is important in the cellular response to 
high oxidative stress, whereas activation of the transcription factor Pap1 is required under 
conditions of low oxidative stress (Chen D. et al. 2008).   
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1.6.5 Lipid synthesis in yeast 
As with MAPK signalling, the regulation of lipid metabolism is very well conserved from 
humans to yeast.  S. cerevisiae has proved the model of choice in understanding 
regulatory mechanisms underlying lipid metabolism over the last decade (Henry et al. 
2012). 
S. cerevisiae cells synthesise the same general classes of lipids found in higher eukaryotic 
cells and furthermore the synthesis is via pathways with high structural homology to that 
of mammalian systems (Figure 1.18).  Although largely conserved there are some slight 
differences in both lipid composition and biosynthetic routes, including the fact the yeast 
synthesis ergosterol rather than cholesterol and have simpler fatty acid compositions (van 
Meer et al. 2008).  For polar lipids the route of phospholipid synthesis also differs slightly 
to that of mammalian cells (Carman and Henry 2007). 
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 Figure 1.18: Conservation of the mechanisms of lipid synthesis between mammalian and yeast cells. Lipids are synthesised via conserved mechanisms in mammalian and yeast cells.  
AcetylCoA (AcCoA) is converted to malonyl CoA (MalCoA) via a different mechanism and yeast synthesise ergosterol instead of cholesterol.  However the regulation downstream from 
this including the synthesis of fatty via SREBP like proteins and β-oxidation are largely conserved.  Furthermore, oleaginous yeast species, such as L. starkeyi, have the ability to convert 
citrate to AcCoA (indicated by the purple arrow) due to the presence of ATP citrate lyase activity.  Adapted from Nielsen (2009). 
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 1.6.5.1 Neutral lipids 
As with mammalian systems, synthesis of TAGs in yeast can occur via the glycerol-3-
phosphate pathway.  In S. cerevisiae, analogous to that of mammals, glycerol-3-phosphate 
is acylated by G3P acyltransferase (SCT1) forming LPA which is then acylated by LPA 
acyltransferase (SLC1) to yield PA.  PA is then dephosphorylated by PA phosphohydrolase 
(PAP) releasing DAG.  In the terminal step of TAG synthesis DAG is acylated by either DAG 
acyltransferase (DGA1) or alternatively by phospholipid DAG acyltransferase (LRO1) 
(Beopoulos et al. 2008). 
1.6.5.2 Phospholipids 
Yeast synthesise phospholipids via both the Kennedy pathway and CDP-DAG pathway 
described earlier in Section 1.4.4, which are principally identical to mammalian pathways.  
The Kennedy pathway is the dominant route for both PE and PC synthesis in mammalian 
cells, whereas the CDP-DAG pathway is the dominant route for synthesis in S. cerevisiae.  
However, the components and routes involved for synthesis via each pathway are largely 
conserved (Dowd et al. 2001). 
With respect to PS synthesis, in mammalian cells this occurs via base-exchange facilitated 
by PSS1 and PSS2 which replace the head groups of PE and PC respectively with L-serine.  
In contrast yeast Cho1 facilitates the addition of L-serine to CPD-DAG to form PS (Vance 
and Tasseva 2013). 
At the transcriptional level regarding SREBP proteins, although no orthologues exist in S. 
cerevisiae the proteins Upc2 and Ecm22 are considered functional orthologues.  
Additionally two further SREBP like proteins in S. cerevisiae, Spt23 and Mga2 have been 
identified to have roles in regulating fatty acid synthesis (Nielsen 2009).  Conversely S. 
pombe contains orthologues to mammalian SREBP-1a (Sre1 and Sre2) as well as 
mammalian SCAP (Scp1) (Bien and Espenshade 2010).  Some other key lipid regulatory 
elements conserved between all three systems are listed in Table 1.2. 
In comparison to the plethora of information available regarding S. cerevisiae lipid 
metabolism, very little work has been done to date in the regulation of lipid metabolism in 
the fission yeast species S. pombe (Yazawa et al. 2012).  However, S. pombe is becoming 
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increasingly investigated as a biotechnologically relevant yeast species due to valuable 
lipid products that it is able to produce, such as oleic acid, a ricinoleic acid precursor 
(Yazawa et al. 2012).  Furthermore, phosphatidylinositol (3,4,5)-triphosphate has not yet 
been identified in S. cerevisiae but has been detected in S. pombe.  Also S. pombe has, as 
mentioned previously, been demonstrated to confer greater similarity to mammalian 
systems in aspects of the stress response and cell cycle regulatory mechanisms than S. 
cerevisiae, as such greater insight may be yielded from the study of lipid metabolism in S. 
pombe.  
 
Table 1.2: Key energy/lipid regulatory components conserved between mammalian and yeast cells. Key 
regulatory elements in mammalian and yeast cells for energy production and the synthesis of lipids have 
homologues in both S. cerevisiae and S. pombe yeast species.   
Mammalian S. cerevisiae S. pombe Role 
DGAT Dga1 Dga1 Catalyses terminal step of TAG synthesis. 
PDAT Lro1 Plh1 TAG synthesis 
SREBPs 
Upc2/Ecm22 
SPt23/Mga2 
Sre1/Sre2 
Cholesterol/Ergosterol 
synthesis 
Fatty acid synthesis 
FASN FAS Fas1/2 Catalyses fatty acid synthesis 
AMPK Snf1 Ssp2 Cellular energy homesostasis 
PSS1 Cho1 Pps1 Phosphatidylserine synthase 
 
The oleaginous yeast species Lipomyces starkeyi (L. starkeyi) is a prominent yeast species 
employed in the biotechnology industry for lipid production.  It is extensively employed 
for lipid production as it has the ability to accumulate up to 70% of its dry cell mass as 
lipid, in comparison S. cerevisiae is only able to accumulate approximately 11% of its cell 
mass as lipids. Although little is known on the regulatory mechanisms governing lipid 
metabolism in this non-conventional yeast species, coupled with a lack of molecular tools 
available for its genetic manipulation, it is expected that they will be largely conserved to 
that of S. cerevisiae and S. pombe, as detailed in Table 1.2.   Additionally oleaginous 
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yeasts, in agreement with mammalian cells, contain ATP: citrate lyase activity, and so the 
synthesis of lipids may be more similar to that observed in mammalian cells.  As such, 
oleaginous yeast species, such as L. starkeyi, may prove to be valuable metabolic models 
in deconstructing the regulatory mechanisms involved in lipogenesis.  The usefulness of 
non-conventional yeasts to study human disease has been demonstrated by the 
employment of Yarrowia lipolytica (Y. lipolytica), which has been utilised to investigate 
mitochondrial disorders (Kerscher et al. 2004). 
 
1.7 Aims 
In the last decade, lipid metabolism regulatory pathways have been under intense 
investigation with respect to human disease research.  The mTOR pathway has already 
been identified as a major player in promoting lipid metabolism in cancer by elevation of 
SREBP-1 activity. 
The aim of this thesis is to study the regulation of lipogenesis and to elucidate whether 
the p38 MAP kinase pathway of eukaryotes is involved in the regulation of cellular lipid 
homeostasis. Saccharomyces cerevisiae and Schizosaccharomyces pombe are ideal model 
organisms in which to study the regulation of lipid accumulation.  Due to the similarity of 
major signalling pathways including p38 MAP Kinase, with the Hog1 and Sty1 pathways in 
yeast, coupled with conservation of the regulation of lipid metabolism, it is hoped that 
yeast will help further knowledge of the regulation of lipid accumulation accompanying 
solid tumours.  A further aim was to develop the oleaginous yeast species L. starkeyi as a 
complementary model organism for investigating the regulation of lipid accumulation. 
Chapter 3 describes the development of suitable methodology for determination of lipid 
accumulation profiles and lipid quantitation in oleaginous and non-oleaginous budding 
and fission yeast species.  Chapter 4 studies the involvement of the Hog1 and Sty1 MAP 
kinase signal transduction pathways in the regulation of lipid accumulation.  Finally, 
chapter 5 assesses the suitability of utilising the oleaginous yeast species L. starkeyi as a 
potential model organism which could subsequently be used as a metabolic model for 
cancer. 
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Data within this thesis describes how the regulation of lipid accumulation is impacted 
through the deletion of components within the MAP Kinase pathway.  The influence of 
MAPK mediated signalling events on lipogenesis may allow further insight not only into 
the regulation of lipid metabolism, but also anti-lipogenic targets which may be 
modulated in the treatment of highly lipogenic tumour types. 
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Chapter II Materials and Methods 
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2. Materials and methods 
2.1 Yeast strains 
Details of the yeast species and strains utilised are detailed in Table 2.1. 
All strains were maintained on agar plates, either yeast extract peptone dextrose (YPD) (S. 
cerevisiae) or yeast extract sucrose (YES) (S. pombe), containing 2% agar. Antibiotics were 
added to agar as appropriate (100 µg/ml G418 from 1000x stock in water). For genes 
deleted by incorporation of sequences encoding amino acids, strains were maintained on 
defined medium agar plates, either yeast nitrogen base (YNB) (S. cerevisiae) or Edinburgh 
minimal medium (EMM) (S. pombe) lacking the appropriate amino acids. See Section 2.1.1 
for media composition. 
Table 2.1: Yeast species and strains utilised in the present study. Strain information for wild type and 
deletion (Δ) yeast species and strains used in the present study. NBRP: National BioResource Project (Japan). 
Euroscarf: European Saccharomyces cerevisiae Archive for Functional Analysis (Germany). 
 Yeast species Strain Genotype Reference 
S. cerevisiae wild 
type 
BY4741a 
(derivative 
of S288C) 
MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
Brachmann et al. 
(1998) 
S. pombe wild type NJ1 
h+ura4-D18 leu1-32 ade6-M210 his7-
366 
Lawrence et al. 
(2007) 
S. pombe wild type NJ2 
h-ura4-D18 leu1-32 ade6-M210 his7-
366 
Lawrence et al. 
(2007) 
L. starkeyi wild 
type NCYC2710 No details available. 
Lodder & Kreger-
van Rij (1952) 
S. cerevisiae hog1Δ  BY23209 MATα hog1::URA3 leu2 his3 trp1 ura3 NBRP of the MEXT, Japan 
S. cerevisiae 
msn2/4Δ  BYP23752 
MATa msn2::HIS3 msn4::URA3 ade2-1 
his3-11,15 leu2-3,112 trp1-1 ura3-1 
can1-100 
NBRP of the 
MEXT, Japan 
S. cerevisiae sho1Δ  Y06116 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; sho1::kanMX4 
Euroscarf, 
Germany 
S. cerevisiae fat1Δ  BYP5648 
MATa fat1::HIS3 ade2-1 leu2-1,112 
ura3-1 trp1-1 his3-11,15 can1-100 
ssd1-d2 rad3-535 
NBRP of the 
MEXT, Japan 
S. cerevisiae tor1Δ  Y06864 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; tor1::kanMX4 
Euroscarf 
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S. cerevisiae pbs2Δ  Y07101 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; pbs2::kanMX4 
Euroscarf 
S. cerevisiae dga1Δ  Y02501 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; dga1::kanMX4 
Euroscarf 
S. cerevisiae 
ste11Δ  Y05271 
BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; ste11::kanMX4 
Euroscarf 
S. cerevisiae lro1Δ  Y05383 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; lro1::kanMX4 
Euroscarf 
S. cerevisiae 
tco89Δ  Y02072 
BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; tco89::kanMX4 
Euroscarf 
S. cerevisiae hot1Δ  Y06957 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0YMR172w::kanMX4 
Euroscarf 
S. cerevisiae 
ecm22Δ Y05137 
BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0YLR228c::kanMX4 
Euroscarf 
S. cerevisiae upc2Δ  Y03572 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0YDR213w::kanMX4 
Euroscarf 
S. cerevisiae 
spt23Δ  Y04869 
BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YKL020c::kanMX4 
Euroscarf 
S. cerevisiae 
mga2Δ  Y05968 
BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YIR033w::kanMX4 
Euroscarf 
S. cerevisiae pip2Δ Y01660 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YOR363c::kanMX4 
Euroscarf 
S. cerevisiae oaf1Δ Y00355 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YAL051w::kanMX4 
Euroscarf 
S. cerevisiae fld1Δ Y05313 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YLR404w::kanMX4 
Euroscarf 
S. cerevisiae ino2Δ Y04057 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YDR123c::kanMX4 
Euroscarf 
S. cerevisiae ino4Δ Y06258 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; YOL108c::kanMX4 
Euroscarf 
S. cerevisiae opi1Δ Y00943 BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0;; YHL020c::kanMX4 
Euroscarf 
S. cerevisiae avo2Δ Y06201 
BY4741; MATa; his3Δ1; leu2Δ0; 
met15Δ0; ura3Δ0; 
YMR068w::kanMX4 
Euroscarf 
S. cerevisiae W303 
wild type W303-1a 
MATa ade2-1 leu2-3,112 his3-1 ura3-
52 trp1-100 can1-100 
J. Rine 
S. cerevisiae 
ecm22Δ JRY7180 W303-1a ecm22Δ::TRP1 
J. Rine  
S. cerevisiae JRY7181 W303-1a ecm22Δ::TRP1 upc2Δ::HIS3 J. Rine  
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ecm22Δupc2Δ 
S. pombe wis1Δ FY19955 h- leu1 ura4 wis1::his7+ spc1-12myc-ura4+ 
NBRP of the 
MEXT, Japan 
S. pombe sty1Δ FY19932 h- leu1 ura4 spc1::ura4+ NBRP of the MEXT, Japan 
S. pombe sty1 
kinase dead FY20578 h- LU spc1-kinaseDead 
NBRP of the 
MEXT, Japan 
S. pombe pap1Δ FY9748 h- leu1 ura4 pap1::ura4+ NBRP of the MEXT, Japan 
S. pombe atf1Δ FY13438 h- ade6-M216 leu1 ura4-D18 gad7::ura4+ 
NBRP of the 
MEXT, Japan 
S. pombe ptl3Δ BG_H1649 ptl3Δ:kanMX4 ade6-M210 URA4-d18 leu1-32 
Bioneer 
corporation 
S. pombe dga1Δ BG_H4437 dga1Δ:kanMX4 ade6-M210 URA4-d18 leu1-32 
Bioneer 
corporation 
S. pombe sre1Δ ----- h
−, his3-Δ1,leu1-32, ura4 Δ 18, ade6-
M210; sre1::KanMX6 
P. Epenshade  
2005 
S. pombe sre2Δ ------- h
−, his3-Δ1,leu1-32, ura4 Δ 18, ade6-
M210; sre2::KanMX6 
P. Epenshade 
2005 
S. pombe scp1Δ ------- h
−, his3-Δ1,leu1-32, ura4 Δ 18, ade6-
M210; scp1::KanMX6 
P. Epenshade 
2005 
 
2.1.1 Growth Media 
All growth media, including agar for strain maintenance, were prepared in distilled water 
before autoclaving for 15 minutes at 121 oC and 15 pounds per square inch (psi) of 
pressure.  Unless otherwise stated all strains were cultured in an orbital shaking incubator 
at 30 oC, duplicate. 
Lipomyces starkeyi (L. starkeyi), Saccharomyces cerevisiae (S. cerevisiae) and 
Schizosaccharomyces pombe (S. pombe) strains utilised in this study, listed in Table 2.1, 
were pre-cultured in appropriate complex media. Either YPD [2% glucose, 1% peptone, 1% 
yeast extract] (S. cerevisiae and L. starkeyi) or YES [3% glucose, 0.5% yeast extract, 0.005% 
amino acids leucine, lysine, adenine, histidine and uracil] (S. pombe) (ForMedium™, UK) 
were used. 
Limiting growth media were prepared according to Rolph, Moreton and Harwood (1989).  
Nitrogen limiting media (NLM) contained: 0.7% KH2PO4, 0.2% Na2HPO4,  0.15% 
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MgSO4.7H2O, 0.01% CaCl2.2H2O, 0.0008% FeCl3.6H2O, 0.0001% ZnSO4.7H2O 0.15% yeast 
extract, 0.05% NH4Cl,  3% glucose.  Carbon limiting media (CLM) was as NLM except that 
NH4Cl and glucose were added at 0.3% and 1% respectively. 
Defined minimal medium was either Yeast Nitrogen Base (YNB) (S. cerevisiae and L. 
starkeyi) [0.67% yeast nitrogen base without amino acids (ForMedium™, UK), 2% glucose 
and 0.002% of appropriate amino acids except for threonine, uracil, tyrosine, lysine at 
0.001% and 0.005% leucine] or Edinburgh Minimal Media (EMM) (S. pombe) [1.2% EMM 
without added dextrose and amino acids (ForMedium™ UK), 2% glucose and 0.0225% 
appropriate amino acids].   
Unless otherwise stated all experiments for S. cerevisiae were undertaken utilising the 
wild type strain BY4741a and S. pombe utilising wild type strain NJ1 or NJ2.  NJ1 and NJ2 
comprise the same genotype, only differing by mating type (h+/ h-). 
For Escherichia coli (E. coli), (genotype: fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17), Luria Broth (LB) [10% tryptone, 5% 
yeast extract, 0.5% NaCl] was utilised for shake flask growth. Cultures were grown at 37 oC 
with shaking, 200 rpm.  For selection of cells containing vectors and plasmids in liquid 
culture, LB was supplemented with 100 µg/ml Ampicillin.  LB containing 2% agar and 100 
µg/ml Ampicillin was utilised after cell transformation for selection of cells containing 
vectors and plasmids. 
2.1.2 Growth curves and doubling times 
Mid-exponential cultures of S. cerevisiae, S. pombe and L. starkeyi were diluted in the 
appropriate media and allowed to grow for 15 hours (or until stationary phase was 
achieved) at 30 oC, duplicate.  Growth of all three yeast species was monitored at hourly 
intervals using a spectrophotometer at a wavelength of 595 nm.  For growth curves 
conducted in limiting and defined minimal media, cells were pre-cultured in appropriate 
complex medium (YPD or YES) at 30 oC, duplicate overnight, before resuspending to a 
density of ~2.0 x 106 cells/ml for S. cerevisiae and S. pombe and ~4.0 x 106 cells/ml for L. 
starkeyi (OD595 approximately 0.1).  Cell counts were conducted using a haemocytometer 
to determine cell number at a given absorbance reading.  
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2.2 Extraction of cellular lipids for gravimetric analyses 
Extraction of cellular lipids was carried out using a modified Bligh and Dyer method 
described by (Rolph et al. 1989).  Cultures of 50 ml volume were harvested by 
centrifugation for 2 minutes at 492 x g.  The resultant cell pellet was resuspended in 10 ml 
of media and transferred to 10 ml of methanol, pre-warmed to 70 oC (Fisher, UK).  
Samples were heated for 30 mins at 70 oC, cooled and 20 ml chloroform (Fisher, UK) was 
added giving a chloroform/methanol ratio of 2:1 (v/v).  A 10 ml aliquot of 5% NaCl (w/v) 
was then added to the extraction mixture prior to stirring for 1 hr at room temperature, 
allowing a two phase system to develop.  The lower chloroform phases were removed 
using a glass pipette into pre-weighed aluminium boats.  Lipid extracts were then 
evaporated to complete dryness under nitrogen gas (N2) at 40 oC.  Aluminium boats were 
allowed to equilibrate before weighing and recording mass differences on an Ohaus 
Pioneer precision balance with an accuracy of 0.001g.  Lipid mass data was expressed as 
mg of lipid per 50 ml of culture harvested. 
2.2.1 FAME analysis Gas Chromatography 
Fatty acid methyl esters (FAMES) were prepared from total lipid extracts, as described by 
Rolph and Goad (1991).   Lipid samples were extracted as per Section 2.2. Aliquots of 200 
µl lipid extract dissolved in chloroform were spiked with 40 µg of diheptadecyl 
phosphatidylcholine in chloroform as the internal standard.  The mixture was evaporated 
to complete dryness under N2 at 40 oC, and mixed with 2 ml of methylating solution (2.5% 
(v/v) H2SO4 in anhydrous methanol) before heating at 70 oC for 2 hours. The methylated 
sample was then cooled and mixed with 5ml 5% (w/v) NaCl solution and stored at 4 oC.   
Prior to FAME extraction, 2 ml petroleum ether was added, and quickly vortex mixed 
three times at highest speed setting, creating a top layer of petroleum ether containing 
FAMEs which was extracted using Pasteur pipettes into a tapered glass tube. This was 
repeated twice more, extracting into the same tube. The extracted solution was 
evaporated to complete dryness under N2 at 40 oC, and 50 µl petroleum ether added to 
the dried sample using a Hamilton syringe.  The sample was kept at 4 oC prior to GC 
analysis. 1µl of sample was loaded into the GC sampler (ATI unicam 610 series). The oven 
was ramped to 250 oC over a 30 minute period from 50 oC. FAMES were identified by 
comparison with the relative retention times of authentic standards. The area under the 
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peaks and retention times were calculated using Azur software at the following settings: 
PW: 50, TH: 125, WA: 25. 
2.2.2 Thin Layer Chromatography (TLC) of extracted yeast lipids 
Aliquots (50 µl) of each prepared lipid sample and standards were applied to TLC plates 
(Analtech) in 1 cm bands using microcapillary pipettes.  Standards utilised were 
triacylglycerols (TAGs), oleic acid (for FFAs), sterol esters (SEs), and cholesterol (for sterols) 
at a stock concentration of 5 mg/ml (Sigma Aldrich, UK).  The solvent system consisted of 
petroleum ether/diethyl ether/glacial acetic acid (80/20/2, v/v) (Thermo Fisher Scientific, 
UK).  
After equilibration of the tank for 1 hour, the plate was run for 40 minutes until the 
solvent front was 1 cm from the top of the plate.  Lipid classes on the completed TLC plate 
were visualised utilising iodine vapour (Sigma Aldrich, UK).  Strength of resultant lipid 
classes on the TLC plate was assessed semi-quantitatively by visual inspection.   
2.3 Nile red 96-well plate assay  
A modified version of the screening method described by Sitepu et al. (2012) was used. 
Briefly, cells were harvested by centrifugation at 492 x g for 2 mins.  The resultant cell 
pellet was washed twice in phosphate buffered saline (PBS) [8% NaCl, 0.2% KCl, 1.44% 
Na2HPO4, 0.24% KH2PO4] (Fisher, UK), in order to remove the high background 
fluorescence of the medium, before being resuspended in (PBS) at a density of 2 x 107 
cells/ml (S. cerevisiae and S. pombe) and 4 x 107 cells/ml (L. starkeyi) (OD595~1.0).  The 
optical density at 595 nm was recorded again after final resuspension and ~5 x 106 (S. 
cerevisiae and S. pombe) or ~10 x 106 (L. starkeyi) cells were plated into the wells of a 
black, clear bottomed 96-well plate (Krystal 2000, Porvair Sciences) in triplicate. A 25µl 
volume of DMSO/PBS (1:1 v/v) solution was added to each well before addition of a final 
concentration 5 µg/ml Nile red in acetone.  The wavelengths excitation 485 nm and 
emission 535 nm were utilised to determine the amount of neutral lipid in yeast cell 
suspensions.  Conversely wavelengths excitation 535 nm and emission 590 nm were 
utilised to determine the amount of polar lipid. 
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The number of plate reader cycles for each wavelength was previously optimised by 
reading samples plated out onto separate plates on a kinetic reading for 20 mins, with a 
60 second interval.  The cycle before saturation point of the Nile red dye was determined 
for the three yeast species for each wavelength and subsequently used for further screens 
in all cases.   
Plates were read immediately after addition of Nile red firstly for polar lipids and then for 
neutral lipids using the determined kinetic cycle on a Tecan Genios Pro platereader using 
the top 50% mirror setting.  The gain settings for each wavelength of individual 
experiments was set to optimal and recorded after the initial screen before setting the 
gain manually to the same values for further screens within the triplicate.  
Data was corrected against PBS containing 1/10 volume DMSO/PBS (1:1 v/v) and 5 µg/ml 
Nile red in acetone and further corrected for optical density of each sample. In order to 
plot data together for triplicates, all data was adjusted to the screen with the highest 
background fluorescence by multiplying relative fluorescence averages for each sample by 
the determined ratio. To determine total lipid levels, fluorescence RFU values from neutral 
and polar lipids were combined. 
2.3.1 Methylene blue viability staining of yeast cells 
Methylene blue stains non-viable cells dark blue but is de-colourised by mitochondrial 
dehydrogenase activity of viable yeast cells and was used to determine the viability of 
yeast cells.  Citrate methylene blue [0.01% (w/v) methylene blue (Sigma, UK) 2% sodium 
citrate] was added to an equal volume of cell culture and mixed by vortexing.  After 
incubation at room temperature for 5 minutes samples were viewed on a Zeiss Axio 
upright microscope, using the bright phase setting at 100x magnification.  Yeast cells that 
were stained blue were counted as non-viable whilst unstained cells were counted as 
viable. Percentage viability was determined by the following equation: 
% Viability = (Total cells counted – total blue cells counted) / total cells counted x 100 
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2.3.2 Nile red fluorescence microscopy 
Cells for microscopy were stained by addition of a final concentration of 5 µg/ml Nile red 
in acetone per 250 µl of yeast culture before incubation for 5 minutes in the dark at room 
temperature.  Stained cultures were then centrifuged for 2 mins at 492 x g before washing 
twice in phosphate buffered saline (PBS) (Fisher, UK).  Cells were resuspended in 10% (v/v) 
formalin and fixed for 15 mins in the dark at room temperature before centrifugation and 
a further 2 washes with PBS.  Cell pellets were resuspended in SlowFade (Invitrogen, UK) 
to prevent loss of cellular fluorescence exhibited when viewing cells with 590 nm 
emission. 
Nile red stained cells were viewed on a Zeiss Axio upright microscope using an AxioCam 
MRm camera at 100 x magnification.  Excitation and emission wavelengths utilised for 
visualisation of neutral and polar lipids were 485nm/535nm and 535nm/590nm, 
respectively. 
2.4 Yeast genomic DNA extraction 
Genomic DNA extractions were carried out according to Lõoke et al. (2011). Aliquots 
(200µl) of exponentially growing culture (~2.4 x 107 cells/ml S. cerevisiae and S. pombe 
and ~1.6 x107 cells/ml L. starkeyi), were harvested and centrifuged at 14 000 x g for 2 
minutes before being resuspended in 100 µl 0.2M LiAc, 1% SDS solution and incubated for 
5 minutes at 70 oC.  An equal volume of 96-100% EtOH was added and samples vortexed 
before centrifuging at 16 000 x g for 3 minutes.  The resultant pellet was then washed 
with 70% EtOH and allowed to air dry for 3 minutes before being resuspended in 50 µl of 
sterile water.  
2.4.1 Polymerase chain reaction 
Primers utilised in this study are listed in Table 2.2.  All primers were synthesised by 
integrated DNA technologies (IDT, UK). 
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2.4.1.1 Amplification of p38 orthologues 
Primers CLL001-002 and CLL021-022 (Table 2.2) were used to amplify S. cerevisiae hog1, 
CLL005-006 and CLL026-27 (Table 2.2) for L. starkeyi p38 orthologue and CLL023-024 
(Table 2.2) for S. pombe sty1.  Each PCR reaction contained 0.25µM of each primer (IDT), 
200µM dNTP mix, 1mM MgCl2, 1x GoTaq Flexi buffer and 1.25units of GoTaq Flexi 
Polymerase (Promega).  PCR parameters used for amplification were: 
1. Initial denaturation – 94oC, 5 minutes 
2. Denaturation – 94oC, 1 minute 
3. Annealing – 45oC, 1 minute                 30 cycles 
4. Extension – 72oC, 1 minute 
5. Final Extension – 72oC, 7 minutes 
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Table 2.2: Table of primers designed and utilised for PCR reactions. 
 Primer Sequence Restriction sites 
CLL001 SC hog1 F 5'- TGG TAC GGA TCC GAC CAC TAA CGA GGA AAT C -3' BamHI 
CLL002 SC hog1 R 5'- GGC ATT CCA TGG GGA ACT CAT TAG CGT ACT G -3' BamHI 
CLL003 conserved 
hog1/sty1 F 
5'- CAT GGA GGA TCC GAC ACA GAT ATT CGG TAC AG -3' BamHI 
CLL004 conserved 
hog1/sty1 R 
5'- CGC AAT CCA TGG CTG AGT ACA TCA TAA CAC GC -3' BamHI 
CLL005 LS MAPK F 5’ TTG TAC GGA TCC ATG GCA GAA TTT ATT CGT ACA C 3’ BamHI 
CLL006 LS MAPK R 5’ GGC ATT CCA TGG TTA GGA TTG CAG TTC ATT ATC C 3’ BamHI 
CLL007 SP sty1 F 5'- TTG TAC GGA TCC ATG GCC GAT TTC ATC AGG TAT -3' BamHI 
CLL008 SP sty1 R 5'- GGC ATT CCA TGG TTA TTC CGG TGA AAC TAC TCC -3' BamHI 
CLL009 LS deletion G418 F 5'- CTT CTA CGG CTC GCT CTG TCC CAT CCA TCA ACA CAG TAT CTG TCT GCT CAG CAA CCG TCG TCA 
GTG CTA TTT AGT GAT CTG CTA ACA CCA CGG ATC CCC GGG TTA ATT AA -3' 
NA 
CLL010 LS deletion G418 R 5'- AGT AGC AGG GTT TAG CTG CCC ACC TTT CCG TGA CGT AGC AGT TGA GAC CTT CCG GCA ATT 
TCT TCT TCT TTT TCT CTC CGG CCG GCC TCT GAA TTC GAG CTC GTT TAA AC -3' 
NA 
CLL015 LS deletion URA F 5'- CTT CTA CGG CTC GCT CTG TCC CAT CCA TCA ACA CAG TAT CTG TCT GCT CAG CAA CCG TCG TCA 
GTG CTA TTT AGT GAT CTG CTA ACA CCA CGC CAG GGT TTT CCC AGT CAC GAC -3 
NA 
CLL016 LS deletion URA R 5'- AGT AGC AGG GTT TAG CTG CCC ACC TTT CCG TGA CGTAGC AGT TGA GAC CTT CCG GCA ATT TCT 
TCT TCT TTT TCT CTC CGG CCG GCC TCT AGC GGA TAA CAA TTT CAC ACA GGA -3' 
NA 
CLL021 SC hog1 + 1kb 
promoter F 
5' TTG TAC TCT AGA TGG CTG GCT CCA GAT AC 3' XbaI 
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CLL022 SC hog1 R 5' GGC ATT GAG CTC TTA CTG TTG GAA CTC ATT AGC  3' SacI 
CLL026 LS MAPK + 1Kb 
promoter 5' TTG TAC TCT AGA GTT CCA AGT GCA AGT GAA TTC 3' 
XbaI 
CLL028  LS MAPK R 5' GGC ATT GAG CTC TTA TTC CGG TGA AAC TAC TCC 3' SacI 
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2.4.1.2 Amplification of deletion cassettes by PCR 
PCR was performed using Phusion polymerase (Fisher, UK) with 200 µM dNTPs, 2.5 mM 
MgCl2, 1 x HF buffer and 2 µM each of forward and reverse primers (CLL009-010: G418 and 
CLL015-016: URA) with the following PCR parameters: 
1. Initial denaturation – 94oC, 5 minutes 
2. Denaturation – 94oC, 1 minute 
3. Annealing – 55oC, 1 minute                 35 cycles 
4. Extension – 72oC, 2 minutes 
5. Final Extension – 72oC, 3 minutes 
The products of ten PCR reactions were pooled prior to extraction using phenol 
chloroform isoamyl alcohol (25:24:1) (Fisher, UK) and ethanol precipitation. 
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2.5 Cloning for yeast phenotype recovery and heterologous protein 
expression 
Details of plasmids used in this study are given in Table 2.3.  Corresponding plasmid maps 
are shown in Appendix I. 
 
Table 2.3: Plasmids utilised in the present study Plasmids constructed for complementation in S. cerevisiae 
and heterologous protein expression in L. starkeyi.  
 Plasmid 
name 
Base vector Selectable 
markers/promo
ter 
Construction Source 
CLLp001 pRS315 Amp/LEU2 
gene under its 
own promoter 
HOG1 + 1Kb upstream of ATG 
cloned into XbaI and SacI sites of 
pRS315 
This 
study 
CLLp002 pRS315 Amp/LEU2 
gene under its 
own promoter 
MAPK + 1Kb upstream of ATG 
cloned into XbaI and SacI sites of 
pRS315 
This 
study 
CLLp004 pRS313 Amp/HIS3 
gene under its 
own promoter 
HOG1+ 1Kb upstream of ATG 
cloned into XbaI and SacI sites of 
pRS313 
This 
study 
CLLp006 pFA6a-
KanMX6 
Amp/KanMX n/a Lab stock 
CLLp008 pFA6a-
natMX6 
Amp/NatMX n/a Lab stock 
 
For routine transformation of vectors and of ligation products to obtain constructed 
plasmids Escherichia coli (E. coli) DH5α cells were utilised.  Briefly for transformation of E. 
coli, 100 µl of cells were incubated on ice with 100 ng of plasmid DNA for 30 minutes.  
Cells were then heat shocked for 90 seconds at 42 oC before placing back onto ice for 2 
minutes before addition of 1 ml room temperature LB.  Cells were incubated with shaking 
at 37 oC, 200 rpm for 1 hour before plating out onto LB plates containing 100 µg/ml 
Ampicillin. 
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S. cerevisiae HOG1 (under the control of its own promoter) was initially cloned into 
pRS315 (CLLp001), a pBluescript based centromere vector containing the yeast selectable 
marker LEU2.  The HOG1 open reading frame was amplified from S. cerevisiae genomic 
DNA utilising primers CLL021 and CLL022.  Both purified PCR product and vector were 
digested with XbaI and SacI (Thermo Scientific) before ligation and transformation into E. 
coli DH5α cells.  Resultant colonies were screened for insert using primers CLL021 and 
CLL022 by colony PCR.  Positive colonies were cultured overnight in LB medium at 37oC, 
200 rpm before extracting plasmid DNA using a GeneJET plasmid mini prep kit (Thermo 
Scientific). 
For cloning of S. cerevisiae HOG1 into pRS313, CLLp001 was digested with XbaI and SacI 
before running on a 0.8% agarose gel for 30 minutes at 100V.  Gel extraction was 
performed using GeneJET gel extraction kit (Thermo Scientific) before ligation with 
digested pRS313 (XbaI and SacI). 
L. starkeyi MAPK plus 1 kb upstream of the ATG was cloned into pRS315 on SacI and XbaI 
sites in the same way as S. cerevisiae HOG1 using primers CLL026 and CLL028 to amplify 
the insert.   
PCR parameters for all inserts and colony PCR screens were as described in Section 
2.3.1.1. 
2.5.1 Plasmid transformation in S. cerevisiae  
Preparation and transformation of S. cerevisiae competent cells was carried out according 
to Knop et al. (1999).  Mid exponentially growing cells were harvested by centrifugation at 
492 x g for 5 minutes and washed once with 0.5 volumes of sterile water and once with 
0.2 volumes of SORB [100mM LiAc, 10mM Tris-HCl pH 8, 1mM EDTA/NaOH pH 8.0, 1M 
sorbitol] adjusted to pH 8 with dilute acetic acid.   
SORB was removed by aspiration and cells resuspended in 360 µl SORB per 50 ml culture 
and 1 mg/ml salmon sperm carrier DNA added (Invitrogen, UK).  50 µl of prepared 
competent cells were added to 4 µg plasmid DNA and mixed well before addition of a six-
fold volume of PEG [100mM LiAc, 10mM Tris-HCl pH 8, 1mM EDTA/NaOH  pH 8, 40% PEG 
4000 (Fisher, UK)].  The suspension was incubated for 30 minutes at room temperature, 
mixing throughout.  10% DMSO was added before heat shocking the cells at 42 oC for 15 
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minutes.  Cells were pelleted by centrifugation for 2 minutes at 300 x g, the supernatant 
removed and cells resuspended in 200 µl of liquid medium before plating onto selective 
medium (YNB lacking the appropriate amino acid). 
2.5.2 Plasmid transformation in S. pombe  
S. pombe transformations were carried out as described in the modified acetate 
procedure of Moreno et al. (1998). 1 x 107 cells/ml of mid exponentially growing cells 
were harvested at 492 x g for 2 minutes and washed once in water before being 
resuspended at 1 x 109 cells/ml in 0.1M lithium acetate (pH 4.9).  Cells were divided into 
100 µl aliquots and incubated for 1 hour at room temperature.  1 µg of plasmid DNA and 
50 µg salmon sperm carrier DNA (Invitrogen, UK) was added to the cells before mixing 
thoroughly and addition of a 3.6 fold volume of 50% PEG and 10% DMSO.  The reaction 
mixture was then subjected to heat shock at 42 oC for 15 minutes before centrifuging at 
300 x g for 2 minutes. Cells were resuspended in 200 µl of liquid medium before plating 
onto selective medium. 
2.5.2.1 Sensitivity testing S. cerevisiae and S. pombe  
Cultures were grown in YPD/YES or YNB/EMM medium lacking the relevant amino acid 
supplement at 30 oC, duplicate for 2 days. Cell densities of cultures were adjusted to ~2 x 
107 (OD595 ~1.0) before making a 1:10 serial dilution generating aliquots with optical 
densities down to 0.0001.  10 µl of each serial dilution (corresponding to 200 000, 20 000, 
2 000, 200, 20 and 4 cells respectively) were then spotted onto the relevant solid medium 
and solid medium containing the stress inducing agent, either sodium chloride or 
hydrogen peroxide.  Plates were left face up at room temperature to allow absorption of 
the culture before inversion of the plates and incubation at 30 oC for 2-3 days. 
2.5.2.2 Sensitivity testing L. starkeyi  
Cultures were grown in YPD medium at 30 oC, duplicate. Cell densities of cultures were 
adjusted to ~2 x 107 (OD595 ~0.5) before making a 1:10 dilution series generating aliquots 
with optical densities down to 0.0001.  10 µl of each serial dilution (corresponding to 200 
000, 20 000, 2 000, 200, 20 and 4 cells respectively) were then spotted onto the relevant 
solid medium and solid medium containing various stress inducing agents, such as sodium 
chloride and hydrogen peroxide.  Plates were incubated at 30 oC for 1 week. 
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2.6 SDS-PAGE and Western blotting 
2.6.1 Denatured protein extraction 
Denatured protein extractions were carried out as described by Lawrence et al. (2007).  
Cells were harvested at 492 g before resuspension in 1 ml of 0.3M NaOH.  150 µl of 
trichloroacetic acid 55% (w/v) was added before vortexing and incubation on ice for 10 
minutes.  Samples were centrifuged at 4 oC at 17000 x g for 10 minutes before removal of 
the supernatant by aspiration.  The pellet was then resuspended in 30 µl SDS sample 
buffer [50 mm Tris-Cl (pH 6.8), 2% SDS (w/v), 0.1% bromophenol blue, 10% (v/v) glycerol, 
10 mm dithiothreitol] per Abs 0.1595 of cells.  Proteins were denatured at 100 oC for 10 
minutes and spun briefly prior to loading onto pre-cast 12% TGX polyacrylamide gels 
(Biorad, UK).  Gels were run using Tris/Glycine/SDS buffer [25 mM Tris, 192 mM glycine, 
0.1% SDS] at a constant 20 mA per gel.   
2.6.2 Phos-tag gels of protein extracts 
Protein extractions were carried out as described in Section 2.5.1.  12% polyacrylamide 
gels were prepared with 200 µM manganese chloride (MnCl2) and 5.0 mmol/L Phos-tag 
(Wako chemicals Ltd), added.  Gels were run at a constant 20 mA per gel and washed for 
10 minutes in transfer buffer containing 1.0 mM EDTA before protein transfer was 
performed as described in Section 2.5.3.  
2.6.3 Western blotting 
For Western blotting proteins were transferred to polyvinylidene fluoride (PVDF) 
membrane (Millipore, UK) by electroblotting for 1 hour at constant voltage, 100 V.  
Membranes were blocked for 1 hour in 10% milk solution (Marvel) before washing 3 times 
in Tris buffered saline tween (TBST) [50 mM Tris HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 
20] for 10 minutes each.  Primary antibodies were applied at 1:1000 dilution in TBST and 
incubated overnight on a shaking platform at 4 oC.  Membranes were then washed 3 times 
in TBST as described above before application of the secondary antibody diluted 1:10000 
in TBST.  PVDF membranes were incubated for 45 minutes at room temperature in 
secondary antibody before a further three 10 minute washes prior to detection.   
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For detection a 1:1 ratio of Enhanced chemiluminescence (ECL) prime solutions (GE 
Healthcare) were incubated with membranes for 5 minutes.  The membrane was then 
exposed to X-ray film (Fisher, UK) in the dark for 1 minute before placing into developer 
solution (Sigma, UK) for 30 seconds.  X-ray films were then rinsed in distilled water and 
fixed with fixer solution (Sigma, UK).   
Antibodies utilised in the present study were:  primary antibody α-Hog1p to detect total 
amounts of Hog1p (Santa Cruz Biotechnology). Primary antibody α-P-p38 to detect dually 
phosphorylated Hog1p (Cell Signalling Technology).  ECL Rabbit IgG, HRP-linked secondary 
antibody (from donkey) (GE Healthcare). 
 
2.7 Statistical analysis 
All data is displayed as means of triplicate experiments +/- SD.  Where relevant, statistical 
analyses were performed by means of one way ANOVA with Tukey post hoc comparisons 
using GraphPad Prism 5.0 software.  A significant result was determined to have a p value 
of <0.05. 
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Chapter III Development of methodology to evaluate 
lipid accumulation in both oleaginous and non-
oleaginous yeast species 
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3.1 Introduction  
As outlined previously in Section 1.4, lipids are important molecules that play a wide range 
of roles supporting living processes within both prokaryotic and eukaryotic cells.  They 
may be broadly classified into neutral and polar lipid subtypes. Unlike their more dynamic 
polar counterparts (e.g. phospholipids) that support a range of cellular functions, neutral 
lipids (mainly triacylglycerols (TAGs) and sterol esters (SEs)) are almost exclusively 
synthesised to facilitate the storage of cellular energy within phospholipid and protein 
monolayer vesicles known as lipid droplets (LDs) (Hutchins et al. 2008). 
In humans, the ectopic production of triacylglycerols has been shown to be a 
characteristic feature of several prominent pathological states of global significance, 
including cancer (Di Paolo and Kim 2011, Zhang F. and Du 2012). The understanding of the 
mechanisms involved in the regulation of ectopic lipid metabolism constitutes an 
interesting focus for the development of future therapeutic strategies. The study 
described within this thesis utilises several yeast paradigms of human disease to further 
knowledge of the aforementioned regulatory strategies. 
The currently utilised methods to quantify lipids such as gravimetric, gas or liquid 
chromatography are time consuming and laborious, often involving several steps from 
extraction to determination of lipid amounts (Bligh and Dyer 1959, Folch et al. 1957, 
Santamauro et al. 2014, Shahidi 2001).  Therefore, screening large numbers of samples is 
complex requiring the need for multiple extractions, which often necessitate the use of 
large quantities of environmentally challenging organic solvents (Poli et al. 2014).  
Increased throughput methods allowing rapid screening of multiple samples, such as Nile 
red, have been developed but lack specificity and sensitivity with regards to identification 
of molecular species and limits of detection. 
In this chapter it has been demonstrated that gravimetric analyses were difficult to 
perform with the low lipid producing non-oleaginous species S. cerevisiae.  Furthermore 
the gravimetric, gas chromatography (GC) and thin layer chromatography (TLC) methods 
were time consuming and labour intensive and so not conducive to analysing large 
numbers of samples, as is required by the present study.  It has also been shown in this 
chapter that total Nile red fluorescence was a reliable measure of total lipid in L. starkeyi 
when compared to gravimetric analyses undertaken. Additionally, it has been 
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demonstrated that utilising different excitation and emission wavelengths of Nile red can 
separate fluorescence due neutral and polar lipid types. 
Furthermore use of Nile red may be utilised in an assay screening format to distinguish 
between neutral and polar lipid phenotypes in the non-oleaginous budding yeast, S. 
cerevisiae and, for the first time, the non-oleaginous fission yeast S. pombe. 
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3.2 Results 
3.2.1 Lipomyces starkeyi growth and characterisation of lipid accumulation 
It is widely reported in the literature that oleaginous yeast species accumulate large 
quantities of neutral lipids when grown under nitrogen-limiting conditions. Meanwhile, 
growth under carbon-limiting conditions is characterised by relatively little neutral lipid 
production.  This lipid accumulation occurs maximally when the cells enter the stationary 
phase of growth (Ratledge 1982, Seip et al. 2013). 
L. starkeyi is one of several species of yeast which can accumulate up to 70% of its dry cell 
mass as lipid (Tapia et al. 2012) and, as such, it is an excellent model to validate methods 
for monitoring lipid accumulation. 
Preliminary evaluation of L. starkeyi growth to determine where stationary phase occurs 
in limiting medium was conducted by inoculation of single colonies into nitrogen limiting 
media (NLM) and carbon limiting media (CLM).  Growth was then monitored via optical 
density and cell number over a period of 120 hours (hrs).  The growth of this yeast species 
was found to be extremely slow in both limiting media with an initial lag phase of 
approximately 60 hrs before stationary phase was achieved at ~90 hrs, as indicated by 
plateaued growth, (Figures 3.1, 3.2 and Table 3.1).  
Nitrogen limiting cultures typically entered the stationary phase of growth at an optical 
density (595 nm) of 10, whereas cells grown in CLM accumulated less cell mass, entering 
stationary phase with an optical density of 2.4.  Although the exponential doubling time of 
this species is ~4 hrs, due to the long lag phase an increased culturing period would be 
required before stationary phase samples could be obtained, which would impact on time 
taken to execute experiments.   
To determine if time taken for L. starkeyi to reach stationary phase could be reduced by 
pre-culturing in complex medium, colonies were inoculated in rich medium (YPD). 
Exponentially growing cells, as determined from Figure 3.3, were then transferred to 
limiting medium at a density of ~4.0 x 106 cells/ml (corresponding to an OD595 0.1).  Cell 
growth was then monitored by optical density until plateaued growth, indicating 
stationary phase, was observed.   
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Figure 3.1: Growth analysis of L. starkeyi in nitrogen limiting medium (NLM). In order to determine 
stationary phase.  L. starkeyi colonies were inoculated directly into the medium and cultures were allowed 
to grow with shaking at 180rpm, 30oC.  Readings were taken as appropriate until stationary phase was 
reached, as indicated by plateaued growth.  Growth curves were conducted in duplicate with blue and red 
lines denoting growth pattern observed from two distinct colonies. 
  
Figure 3.2: Growth analysis of L. starkeyi in carbon limiting medium (CLM). In order to determine 
stationary phase. L. starkeyi colonies were inoculated directly into the medium and cultures were allowed to 
grow with shaking at 180rpm, 30oC.  Readings were taken as seen appropriate until stationary phase was 
reached, as indicated by plateaued growth. Growth curves were conducted in duplicate with blue and red 
lines denoting growth pattern observed from two distinct colonies. 
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Figure 3.3:  Growth of L. starkeyi in YPD medium. Cultures were diluted in YPD medium to a density of 4 x 
106 cells/ml.  Cultures were incubated with shaking at duplicate, 30oC and optical density readings taken 
each hour to determine the exponential growth phase of L. starkeyi. Growth curves were conducted in 
duplicate with blue and red lines denoting growth pattern observed from two distinct colonies. 
  
 
As shown in Figures 3.4 and 3.5, the time required for L. starkeyi to enter early stationary 
phase of growth was reduced from ~110hrs to ~40hrs in NLM and from ~85-110 hrs to ~17 
hrs in CLM by firstly acquiring cell mass in rich medium (Table 1).  Optical density 
measurements obtained by this method on entry of the cells into stationary phase were 
concurrent with cultures from direct inoculation.  As previously described, NLM cultures 
entered early stationary phase at an optical density of approximately 10, and CLM cultures 
at an optical density of 2.5. 
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 Figure 3.4: Growth analysis of L. starkeyi whereby cell mass was accumulated in YPD before re-suspension 
in nitrogen limiting medium (NLM) in order to determine stationary phase.  Cells from log phase YPD 
cultures were resuspended in limiting medium to give a starting optical density half that of the original YPD 
culture.  Cultures were allowed to grow, with shaking at 180rpm, 30oC and readings taken as appropriate 
until stationary phase was reached, as indicated by plateaued growth. Growth curves were conducted in 
duplicate with blue and red lines denoting growth pattern observed from two distinct colonies. 
 
Figure 3.5: Growth analysis of L. starkeyi whereby cell mass was accumulated in YPD before re-suspension 
in carbon limiting medium (CLM) in order to determine stationary phase. Cells from log phase YPD cultures 
were resuspended in limiting medium to give a starting optical density half that of the original YPD culture.  
Cultures were allowed to grow, with shaking at 180rpm 30oC and readings taken as appropriate until 
stationary phase was reached, as indicated by plateaued growth. Growth curves were conducted in 
duplicate with blue and red lines denoting growth pattern observed from two distinct colonies.  
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 Table 3.1:  Time (hrs) taken to reach stationary phase of growth for L. starkeyi. Comparison of cultures 
inoculated directly into limiting medium (NLM/CLM) and for L. starkeyi grown in rich medium before re-
suspension of cellular mass in limiting medium (YNLM/YCLM). 
Culture NLM YNLM CLM YCLM 
Time to stationary phase ~110 hours ~40 hours ~85-110 hours ~17 hours 
Difference in time taken to reach 
stationary phase (hrs) 70 hours 68-93 hours 
 
In order to elucidate whether the re-suspension of YPD pre-cultured cells into limiting 
medium affected lipid production in L. starkeyi, samples were taken for lipid extractions 
during exponential and stationary phases of growth, as determined from the growth 
curves.  The amount of lipid was then quantified via the gravimetric method detailed in 
Chapter 2, Section 2.2.  As Figure 3.6 shows, the ability of L. starkeyi to accumulate lipid in 
both limiting media, by utilising the method whereby cell mass is firstly accumulated in 
YPD, was not affected.   
For carbon limiting cultures, consistently low levels of lipid mass ranging between 1 mg 
and 3 mg per 50 ml culture were obtained from both directly inoculated and resuspended 
cultures irrespective of the phase of growth.  For cells inoculated directly in NLM lipid 
masses of 9 mg and 13 mg per 50 ml culture were obtained at 96 hrs and 17 mg per 50 ml 
culture was obtained for both 120 hr cultures.  Cells pre-cultured in YPD before re-
suspension in NLM accumulated raw lipid masses of 4 mg and 6 mg per 50 ml culture at 48 
hrs and 16 mg and 17mg per 50 ml culture for stationary phase at 72 hrs. 
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Figure 3.6: Graph showing total mass of lipids accumulated is not affected between direct inoculation and 
re-suspension from YPD pre-cultures. Total cellular lipids were analysed utilising the gravimetric method. 
Data is presented as the average lipid mass of extractions carried out in duplicate. CLM: carbon limiting 
medium, YCLM: carbon limiting cultures from YPD pre-cultures, NLM: nitrogen limiting medium, YNLM: 
nitrogen limiting cultures from YPD pre-cultures.  
 
As a result, re-suspending L. starkeyi cells into limiting medium from YPD pre-cultures was 
the optimum culturing method allowing cell mass production and lipid accumulation. The 
technique did not affect the amount of lipids that are accumulated by this yeast species in 
stationary phase and drastically reduced the time in which stationary phase of growth was 
achieved.  
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3.2.2 Detailed growth and lipid accumulation of L. starkeyi 
Having identified the optimum method for determining lipid accumulation in L. starkeyi, a 
full growth and lipid characterisation of the wild type strain was conducted.  Growth of 
the cultures was monitored every 2 hrs, (Figure 3.7), and lipid extractions were conducted 
in duplicate every 24 hrs up to 144 hrs, (Figure 3.8).  These time points were chosen so 
that data on the amount of lipid accumulated could be obtained for each growth phase 
from early exponential to late stationary phase. 
 
 
 
  
Figure 3.7: Detailed growth analyses of L. starkeyi after re-suspension of YPD pre-culture into limiting 
medium. After re-suspension in either nitrogen limiting (NLM) or carbon limiting (CLM) media, cultures were 
allowed to grow with shaking at duplicate, 30oC.  Optical density readings were taken 5 times per day at 
regularly spaced intervals to construct the curve.  
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It is important to note that the time taken to reach stationary phase has increased 2 fold 
for L. starkeyi in both nitrogen and carbon limiting medium compared to the initial 
characterisation detailed in Section 3.2.1.  This was due to the larger culture volumes that 
were required in order to harvest 50ml samples for lipid extractions at each point of the 
time course. This highlights that growth curves should be conducted alongside 
experiments where the culture volume has been subsequently altered. 
As shown in Figure 3.8 similar levels of lipid were observed in exponential phase cultures 
for both NLM and CLM at 24 and 48 hrs.  At 72 hrs lipid accumulation began to increase in 
NLM cultures until late stationary phase at 144 hrs.  Raw lipid amounts and final adjusted 
lipid amounts were consistent within each duplicate. 
 
Figure 3.8: Characterisation of L. starkeyi lipid accumulation in nitrogen limiting (NLM) and carbon limiting 
media (CLM). Every 24 hrs samples were harvested from the cultures used to construct the growth curve in 
Figure 3.7.  Lipid extractions were carried out as detailed in the Section 2.2.  Raw lipid mass was normalised 
to account for differences in cell number, all data adjusted to an OD595 of 10, and the adjusted data plotted.  
Data presented as means of duplicate experiments.  
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By combining the two data sets, lipid accumulation relative to growth phase of the L. 
starkeyi species was determined.  As depicted in Figure 3.9, under nitrogen limiting 
conditions, lipid begins to accumulate in mid exponential phase (~72 hrs) with a mass of 
15.3 mg/50ml culture and then increases 6.3 fold to 96.7 mg/50 ml culture in mid-
stationary phase (~120 hrs).  After this point, at late stationary phase (~144 hrs), where 
the cells would no longer be dividing, there is a 1.3 fold decrease in total lipid amount to 
74.2 mg/50 ml culture. From this it is concluded that the methodology utilised is 
appropriate for the gravimetric measurement of lipid from L. starkeyi.  
After optimisation in L. starkeyi this methodology was used to determine if it was also 
appropriate for use in S. cerevisiae and S. pombe for monitoring lipid accumulation. 
 
 
 
Figure 3.9: Characterisation of lipid accumulation in nitrogen limiting media (NLM) relative to growth 
phase of L. starkeyi. As depicted by the graph in log phase (exponential growth ~48-72hrs) limited amounts 
of lipid are produced.  A sharp increase is seen in late exponential/early stationary phase (~96 hrs) and a 
slight further increase in mid stationary phase (~120 hrs).  After this point the amount of total lipid 
decreases in late stationary phase (~144 hrs).  Lipid data are presented as mean mg mass of duplicate 50ml 
cultures. 
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3.3 Characterisation of growth and lipid accumulation in S. cerevisiae 
Due to the availability of tools allowing genetic modification and the high conservation of 
many signalling pathways to that of mammalian cells, S. cerevisiae is an excellent model 
organism for use in elucidating components involved in lipid accumulation.  
S. cerevisiae also accumulates lipid as it enters stationary phase as a result of nutrient 
limitation. However, as a non-oleaginous yeast it accumulates approximately 11% total 
lipid (Sitepu et al. 2012) compared to L. starkeyi which accumulates approximately 70% of 
total lipid in stationary phase.  The previously devised methodology was applied in the 
elucidation of whether the gravimetric method could be applied to the non-oleaginous 
yeast S. cerevisiae.  In order to assess when cells enter stationary phase growth, where 
maximal lipid accumulation would occur, S. cerevisiae cultures were monitored and 
optical density readings taken over the course of 2 days.   
Upon inoculating S. cerevisiae directly into limiting medium, and monitoring growth for 
the 48 hr period, limited growth was observed (data not shown). Therefore, as in Section 
3.2.1, cell mass was firstly accumulated in rich medium before transferring mid 
exponentially growing cells (8 x 106 cells/ml) into limiting media.  Exponentially growing 
cells (7 hrs) were transferred to limiting media as determined by monitoring growth of S. 
cerevisiae in YPD, Figure 3.10.  Exponential growth was shown to begin ~5 hrs after 
inoculation into YPD.   Growth of S. cerevisiae after re-suspension in limiting medium is 
detailed in Figure 3.11. 
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Figure 3.10:  Growth of S. cerevisiae in YPD medium Cultures were diluted in YPD medium to a density of 2 
x 106 cells/ml.  Cultures were incubated with shaking at duplicate, 30oC and optical density readings taken 
each hour to determine the exponential growth phase of S. cerevisiae. Growth curves were conducted in 
duplicate with blue and red lines denoting growth pattern observed from two distinct colonies.  
 
      
Figure 3.11: Growth analysis of S. cerevisiae whereby cell mass was accumulated in YPD before re-
suspension in limiting medium in order to determine stationary phase.  Cells from log phase YPD cultures 
were resuspended in either nitrogen limiting (NLM) or carbon limiting (CLM) media to give a starting optical 
density half that of the original YPD culture.  Cultures were allowed to grow, with shaking at 180rpm, 30oC 
and readings taken as appropriate until stationary phase was reached, as indicated by plateaued growth.  
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As Figure 3.11 shows S. cerevisiae stationary phase was achieved within approximately 15 
hrs of inoculation in both CLM and NLM. 
Following on from the data derived from initial growth experiments, a more detailed 
analysis of S. cerevisiae was undertaken; along with this the lipid accumulation was also 
investigated.  Growth and lipid analyses were conducted, as previously described in 
Section 3.2, using wild type S. cerevisiae.  Growth of the cultures was monitored via 
optical density; (Figure 3.12), and lipid extractions carried out at 0, 15, 23, 39 and 67 hrs to 
align with and a range of points in stationary phase (15 hrs onwards), (Figure 3.13).  These 
time points were chosen so that samples could be obtained largely from the stationary 
phase of growth, where maximal lipid accumulation was expected to occur in order to 
allow the assessment of the suitability of gravimetric measurement. 
 
Figure 3.12: Growth analyses of S. cerevisiae after re-suspension of YPD pre-culture into limiting medium.  
After re-suspension in either nitrogen limiting (NLM) or carbon limiting (CLM) media, cultures were allowed 
to grow with shaking at 180rpm, 30oC.  Optical density readings were taken hourly each day to construct the 
curve.  As the growth curve shows cultures are reaching early stationary phase at ~20 hrs follow by mid 
stationary ~40 hrs and late stationary at ~60 hrs. 
 
 
86 
Lipid extractions from 50 ml of culture, analysed by gravimetric means, yielded little lipid 
mass over the full course of growth analysed (minimum 0.2 mg and maximum 1.7mg). This 
was not accurately measurable by using the methodology for L. starkeyi and weighing on 
an analytical balance.  As shown by the raw lipid mass data, the amount of lipid measured 
did not exceed 2 mg total weight per 50 ml culture, (Figure 3.13).  The amount of lipid 
increased 4.5 fold from 0 to 15 hrs (0.22 mg to 1 mg/50 ml culture), with a further 
increase of 1.4 fold from 15 to 23 hrs (1 mg to 1.4 mg/50 ml culture).  Although due to 
high error in measurements from 0 and 15 hr samples it was deemed that the gravimetric 
method is inappropriate for use with S. cerevisiae. 
 
 
 Figure 3.13: Characterisation of S. cerevisiae lipid accumulation in nitrogen limiting (NLM) and carbon 
limiting (CLM) media.  At the time points indicated on the graph samples were harvested from the cultures 
used to construct the growth curve in Figure 11.  Raw lipid mass data is plotted (see Figure 13 for adjusted 
lipid mass).  As the graph shows there little lipid produced by S. cerevisiae of the course of different growth 
phases, with the maximum being ~1.7 mg.  As the amounts are so small it is difficult to accurately quantify 
lipid mass by standard weight measurement (as indicated by the error observed at 0 and 15 hrs).  Data are 
presented as means of triplicates ± SD per 50ml culture. o indicates an outlier was present within the 
triplicate. 
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3.3.2 Growth characterisation of S. pombe in limiting medium 
As with S. cerevisiae there are also numerous genetic tools that can be utilised to 
deconstruct the regulation of lipid accumulation in S. pombe.  S. pombe was cultured in 
complex medium (YES) prior to re-suspension in NLM and CLM.  Growth curves were 
conducted by transferring exponentially growing cells from YES into NLM and CLM at a 
density of 8 x 106 cells/ml.  Growth was then monitored via optical density (OD) at 595nm 
for 48 hrs. The results are shown in Figure 3.14.  
 
 
 
 Figure 3.14: Growth analysis of S. pombe whereby cell mass was accumulated in YES before re-suspension 
in limiting medium in order to determine stationary phase. Cells from log phase YPD cultures were 
resuspended in in either nitrogen limiting (NLM) or carbon limiting (CLM) media to give a starting optical 
density half that of the original YES culture.  Cultures were allowed to grow, with shaking at 180rpm, 30oC 
and readings taken as appropriate until stationary phase was reached, as indicated by plateaued growth. 
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As shown by the growth curve, S. pombe growth in limiting medium was analogous to that 
of S. cerevisiae producing a slow growth phenotype, with growth plateauing within 15-20 
hrs post re-suspension in limiting medium (Figure 3.14).  Based on the gravimetric results 
obtained with S. cerevisiae it was postulated that a measurable amount of lipid would not 
be obtained by gravimetric means in S. pombe, as it is also a non-oleaginous yeast species. 
3.3.3 Growth analysis of the three yeast species in minimal medium 
Following on from the experiments conducted within this chapter it was found that 
growth in limiting medium potentially causes an autophagic, mitophagic and stress 
response in both S. cerevisiae and S. pombe (Crespo J. L. and Hall 2002, Mukaiyama et al. 
2009).  As a result, growth and lipid accumulation was monitored using defined minimal 
medium instead.  L. starkeyi and S. cerevisiae were cultured in yeast nitrogen base (YNB) 
and S. pombe in Edinburgh minimal medium (EMM) supplemented with relevant amino 
acids.  This strategy was based on data from several published papers that employed 
minimal medium in lipid accumulation analyses (Park et al. 2009, Shin et al. 2012) and 
investigated responses of lipid production to genetic manipulation (Kamisaka et al. 2006, 
Shi et al. 2012).   
Furthermore, these defined media were chosen as others  have utilised YNB and EMM to 
investigate the stress response via MAP Kinase and mTOR pathways as well as the 
activation of these pathways in response to external stimuli (Berlanga et al. 2010, Maayan 
et al. 2012, Valbuena et al. 2012). Figures 3.15, 3.16 and 3.17 show detailed growth of L. 
starkeyi, S. cerevisiae and S. pombe, in minimal medium. 
   
3.3.3.1 Growth of L. starkeyi in yeast nitrogen base medium 
Growth curves were conducted for wild type L. starkeyi by firstly accumulating cell mass in 
YPD before transferring exponentially growing cells to YNB medium, giving a cell density of 
4 x 106 cells/ml.  Growth was monitored via optical density for a period of 72 hrs until 
stationary phase was reached (Figure 3.15). 
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Figure 3.15:  Growth curve of L. starkeyi  in YNB medium. Cells from log phase YPD cultures were 
resuspended in minimal medium to give a starting optical density half that of the original YPD culture, 0.1.  
Cultures were allowed to grow, with shaking at 180rpm 30oC and readings taken as seen appropriate until 
stationary phase was reached, as indicated by plateaued growth. Growth curves were conducted in 
duplicate with blue and red lines denoting growth pattern observed from two distinct colonies.  
 
As shown by Figure 3.15, L. starkeyi cells remained in lag phase for 15 hrs post re-
suspension in YNB medium before exponential growth is observed.  Cells then entered 
early stationary phase after approximately 48 hrs. 
 
3.3.3.2 Growth of S. cerevisiae in yeast nitrogen base medium 
Growth curves were conducted for wild type S. cerevisiae by firstly accumulating cell mass 
in YPD before transferring mid exponentially growing cells to give a cell density of 2 x 106 
cells/ml in YNB medium.  Growth was monitored via optical density for a period of 21 hrs, 
(Figure 3.16), until growth plateaued, indicative of cells in stationary phase. 
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 Figure 3.16:  Growth curve of S. cerevisiae in YNB medium. Cells from log phase YPD cultures were 
resuspended in minimal medium to give a starting optical density half that of the original YPD culture, 0.1.  
Cultures were allowed to grow, with shaking at 180rpm, 30oC and readings taken as appropriate until 
stationary phase was reached, as indicated by plateaued growth. Growth curves were conducted in 
duplicate with blue and red lines denoting growth pattern observed from two distinct colonies.  
 
As depicted by Figure 3.16, the lag phase of S. cerevisiae continued for 5 hrs after re-
suspension of cells in YNB medium before exponential phase of growth was entered.  
Early stationary phase occurred at approximately 12 hrs post re-suspension. 
 
3.3.3.3 Growth of S. pombe in Edinburgh minimal medium 
Growth curves were conducted for wild type S. pombe utilising the same procedure as 
that given for S. cerevisiae (Section 3.3.3.2) Growth was monitored via optical density for a 
period of 32 hours until stationary phase was reached (Figure 3.17). 
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Figure 3.17:  Growth curve of S. pombe in Edinburgh minimal media (EMM) medium.  Cells from log phase 
YES cultures were resuspended in minimal medium to give a starting optical density half that of the original 
YES culture, 0.1.  Cultures were allowed to grow, with shaking at 180rpm 30oC and readings taken as seen 
appropriate until stationary phase was reached, as indicated by plateaued growth. Growth curves were 
conducted in duplicate with blue and red lines denoting growth pattern observed from two distinct colonies.  
 
As shown by Figure 3.17, S. pombe cells remained in lag phase for 8 hrs post re-suspension 
in EMM medium before exponential growth was observed.  Cells then entered early 
stationary phase after approximately 20 hrs. 
Having determined the growth phases for all three yeast species in minimal medium, a 
lipid accumulation profile of each yeast species was then required to identify optimal time 
points for assessing the accumulation of lipids.  This was accomplished utilising a Nile red 
microplate assay. 
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3.4 Development of a Nile red screening method for accumulation of lipids 
Following the results of gravimetric analyses conducted in the non-oleaginous yeast S. 
cerevisiae, other methodologies were trialled to identify a suitable method to detect and 
quantify lipid accumulation in low lipid yeasts.  Thin layer and gas chromatographic 
methods were initially employed as qualitative and quantitative techniques respectively to 
investigate the accumulation of neutral lipids in wild type S. cerevisiae.  Nevertheless, 
these methods were deemed inappropriate for the current investigation as the 
methodology proved to be time consuming and labour intensive. This study demanded an 
increased throughput method of semi-quantitative analysis due to the numerous deletion 
strains that would require screening in order to distinguish phenotypes. 
Nile red (9-diethylamino-5H-benzo[a]phenoxazine-5-one), is a lipophilic dye that has been 
used extensively to visualise lipids in a range of organisms.  In a study by Sitepu et al. 
(2012), Nile red was utilised to quantify lipids in numerous oleaginous species and was 
also demonstrated to have the ability determine lipid content in non-oleaginous yeast 
species, including S. cerevisiae (Sitepu et al. 2012).  
 
3.4.1 Optimisation of Nile red methodology 
Based on the gravimetric data obtained for S. cerevisiae and the labour intensive, low 
throughput nature of gas and thin layer chromatography, Nile red was trialled in a 
modified microplate assay.   The Nile red assay used was adapted from a method by 
Sitepu et al. (2012) with a number of modifications.  To undertake screening, Krystal 2000 
96-well plates were chosen over plates utilised in the previous study (Costar microplates 
product #3370), due to the plates consisting of individually moulded wells.  
Although Nile red has varying fluorescence properties in a range of media types (Sitepu et 
al. 2012), the fluorescence properties of spent culture media may differ.   As such, all cells 
were washed twice in phosphate buffered saline (PBS) to reduce background fluorescence 
resulting from culture medium; this was carried out for all three yeast species. In addition, 
fluorescence data obtained was corrected against not only cell density but additionally 
background fluorescence resulting from PBS.  This improved the accuracy of the method 
by eliminating fluorescence occurring from the background medium, PBS in this case, thus 
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ensuring that RFU values obtained are a measure of fluorescence pertaining to cellular 
lipid content alone. 
 
3.4.1.2 The Nile red fluorescence method showed comparable trends to the 
gravimetric measurement of total lipids in the oleaginous yeast, L. starkeyi 
To develop and optimise the use of the Nile red method for high throughput screening of 
lipid content in yeast, we first validated the method using the oleaginous yeast L. starkeyi.  
As lipids accumulated in oleaginous yeast species have the ability to be determined 
gravimetrically, the sum of relative fluorescence intensities from each wavelength 
obtained over a range of growth points of L. starkeyi were compared to absolute lipid 
content determined gravimetrically. Figure 3.18 shows the results. The time points chosen 
were the same as those utilised in the initial lipid characterisation of L. starkeyi in Section 
3.2.2. 
As shown in Figure 3.18, the same trend of lipid accumulation was observed for both 
gravimetric and fluorescence determination of total lipids with increasing amounts of lipid 
until the point of late stationary phase (96 hrs) before a decrease at 120 and 144 hrs. This 
data demonstrated the Nile red method gave trends equivalent to the well-established 
gravimetric method, and so was appropriate to use for further studies. 
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Figure 3.18: Comparison of total lipid determination by Nile red and gravimetric assessment in L. starkeyi 
cells. Cells were harvested at 24 hourly intervals until 144 hrs post resuspension in YNB.  For Nile red cells 
were washed twice in PBS before adjusting to a cell density of 4 x 107 cells/ml.  10 x 106 cells were 
transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red 
were added to each sample.  Plates were screened using the wavelengths: excitation 485 nm, emission 535 
nm (neutral lipids) and excitation 535 nm, emission 590 nm (polar lipids). Total lipids were extracted and 
measured by gravimetric means as describe in Section 2.2.  Results of gravimetric analyses were compared 
to combined relative fluorescence values obtained for both neutral and polar lipids.  All values are 
normalised to a cell density of 4 x 107 cells, corresponding to OD595 of 1.0.  Data are shown as means of 
triplicate experiments ± SD.  
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3.4.2 Nile red for use as a selective lipophilic dye 
One feature of the Nile Red dye, identified by Greenspan et al. (1985), but seldom used 
experimentally, is that it can select between different lipid subtypes present within cells.  
Depending on the hydrophobicity of the lipid type with which Nile red is associated, a shift 
in the emission spectra from red to yellow is observed (Diaz et al. 2008).   
Polar lipids, such as phospholipids (PLs), are stained red and mainly found to be present in 
cellular membranes.  Conversely neutral lipids, such as TAGs and SEs, found to be present 
in intracellular lipid droplets, are stained yellow (Greenspan et al. 1985).   
To determine the specificity of Nile red at the two emission wavelengths, fluorescence 
microscopy was used to visualize neutral and polar lipids within cells (Figure 3.19).  
Samples of L. starkeyi cultures were taken at mid stationary phase (72 hrs) and stained 
with Nile red, before being visualised. Polar, membranous lipids and those associated with 
intracellular lipid droplets could be readily distinguished via fluorescence microscopy using 
the two wavelengths described. (Figure 3.19). 
Characteristic of a number of oleaginous yeast species, a large lipid filled vacuole (neutral 
lipids visualised at an emission wavelength of 535 nm) was observed in L. starkeyi cells 
viewed during stationary phase (Certik et al. 1999).  This can be distinguished easily from 
the more polar membranous structures (polar lipids, visualised at an emission wavelength 
of 590 nm). 
To determine if Nile red could distinguish between polar and neutral lipids in the non-
oleaginous yeast, S. cerevisiae and S. pombe, cells were stained and viewed using 
fluorescent microscopy. Samples for S. cerevisiae were harvested at mid stationary phase 
(18 hrs) for Nile red staining.  Viewed under yellow-gold fluorescence the stationary phase 
Nile red stained cells exhibited discrete fluorescent bodies, of varying sizes, throughout 
the cytoplasm of the cell. This pattern of fluorescence was similar across the population of 
S. cerevisiae cells observed and indicated the presence of intracellular lipid droplets. 
However, under red fluorescence the cells showed consistent staining across the cell, with 
limited appearance of fluorescent bodies within the cytoplasm. 
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As with S. cerevisiae, fluorescence microscopy of Nile red stained S. pombe cells in 
stationary phase (24 hrs) at 535 nm showed varying numbers of distinct fluorescent 
bodies throughout the cytoplasm of the cell, indicative of intracellular neutral lipid 
droplets. At 590 nm, there was consistent staining across the cell suggesting staining of 
the polar lipids in the cell membrane with some appearance of polar lipid monolayer 
surrounding the lipid droplets. 
Green fluorescence observed in colour images results from the merging of images 
containing both red and yellow fluorescence. 
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Figure 3.19:  Fluorescence microscopy highlighting emission properties of Nile Red stained yeast cells. S. cerevisiae, S. pombe and L. starkeyi stationary phase cells were stained with 
Nile Red and visualised for both polar (590 nm emission) and neutral (535 nm emission) lipids.  Scale bar 5µM. 
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 Nile red, via microscopic means, appears to have the ability to distinguish between the 
two main subtypes of lipids present in cells.  Can it also be used to distinguish the levels of 
each class of lipids? 
 
3.4.2.2 Using dual wavelengths, the Nile red fluorescence method can distinguish 
levels of neutral and polar lipids in L. starkeyi 
To further test the ability of Nile red to distinguish between neutral and polar lipid pools, 
the dual wavelengths for Nile red fluorescence were used to assess amounts of 
fluorescence pertaining to cellular lipid amounts during growth. Figures 3.20 and 3.21, 
show fluorescence intensity values obtained for L. starkeyi when screened for lipid 
molecules at each emission wavelength, neutral and polar lipids, across the growth series.  
As expected for neutral lipids, fluorescence intensity increased gradually yet sharply at 
each time point from 48 hrs until cells approached stationary phase at 72 – 96 hrs, before 
a marked decrease was observed at 144 hrs. 
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Figure 3.20: Neutral lipid fluorescence intensity of Nile red stained L. starkeyi over a range of growth 
phases. Cells were harvested at 24 hourly intervals until 144 hrs post resuspension in YNB.  For Nile red 
analysis, cells were washed twice in PBS before adjusting to a cell density of 4 x 107 cells/ml.  10 x 106 cells 
were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile 
red were added to each sample.  Fluorescence intensity was measured using an excitation wavelength of 
485 nm and an emission wavelength of 535 nm. All values are normalised to a cell density of 4 x 107 cells, 
corresponding to OD595 of 1.0.  Data are shown as means of triplicate experiments ± SD. 
 
As expected for more polar lipids (Figure 3.21) after an initial increase post 48 hrs, 
fluorescence levels remained relatively constant until late stationary phase (Becker and 
Lester 1977). 
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Figure 3.21: Polar lipid fluorescence intensity of Nile red stained L. starkeyi over a range of growth phases. 
Cells were harvested at 24 hourly intervals until 144 hrs post resuspension in YNB.  For Nile red analysis, 
cells were washed twice in PBS before adjusting to a cell density of 4 x 107 cells/ml.  10 x 106 cells were 
transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red 
were added to each sample.  Fluorescence intensity was measured using an excitation wavelength of 535 
nm and an emission wavelength of 590 nm. All values are normalised to a cell density of 4 x 107 cells, 
corresponding to OD595 of 1.0.  Data are shown as means of triplicate experiments ± SD. 
 
These results indicated the dual wavelength Nile red method was a viable increased 
throughput screening method for determination of neutral and polar lipid content in 
oleaginous yeast cells.  
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3.5 Determination of lipid content in the non-oleaginous budding yeast, S. 
cerevisiae using the Nile red fluorescence assay 
As previously demonstrated in Section 3.3, the low lipid content of S. cerevisiae cells 
means accurate measurement by gravimetric means was difficult, therefore alternative 
methods are required. 
Growth phases on which to conduct Nile red screening were determined from the growth 
curve described in Section 3.3.3.2 (Figure 3.16) and reflected each growth phase of S. 
cerevisiae cells in YNB, ranging from exponential through to late stationary phase. 
Figure 3.22 shows neutral and Figure 3.23 polar lipid levels.  Fluorescence levels pertaining 
to cellular lipid content increased over time from exponential growth leading into mid 
stationary phase (18 hrs) before decreasing at late stationary phase, (48hrs) in a similar 
manner to that observed for L. starkeyi. 
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Figure 3.22: Neutral lipid fluorescence intensity of Nile red stained S. cerevisiae over a range of growth 
phases. Cells were harvested at 8, 18, 24, 48 and 72 hrs post resuspension in YNB.  For Nile red analysis cells 
were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred 
to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added 
to each sample.  Fluorescence intensity was measured using an excitation wavelength of 485 nm and an 
emission wavelength of 535 nm. All values are normalised to a cell density of 2 x 107 cells, corresponding to 
OD595 of 1.0.  Data are shown as means of triplicate experiments ± SD. 
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Figure 3.23: Polar lipid fluorescence intensity of Nile red stained S. cerevisiae over a range of growth 
phases. Cells were harvested at 8, 18, 24, 48 and 72 hrs post resuspension in YNB.  For Nile red analysis cells 
were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred 
to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added 
to each sample.  Fluorescence intensity was measured using an excitation wavelength of 535 nm and an 
emission wavelength of 590 nm. All values are normalised to a cell density of 2 x 107 cells, corresponding to 
OD595 of 1.0.  Data are shown as means of triplicate experiments ± SD. 
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3.5.1 The dual wavelength Nile red fluorescence assay can distinguish between polar 
and neutral lipid phenotypes in S. cerevisiae deletion strains 
In order to test the sensitivity and selectivity of the dual wavelength Nile red method, a 
screen was undertaken with S. cerevisiae gene deletions known to produce a neutral lipid 
phenotype at stationary phase.  The deletions used were dga1, lro1 and fat1. The genes 
DGA1 and IRO1 encode enzymes involved in triacylglycerol synthesis with Dga1p 
(Diacylglycerol acyl transferase) catalysing the terminal step by acylating diacylglycerol 
using acyl-CoA as an acyl donor (Oelkers Peter et al. 2002). Lro1p is an acyltransferase that 
catalyses diacylglycerol esterification utilising phospholipid as the acyl donor (Oelkers P. et 
al. 2000).  In S. cerevisiae, Dga1p and Lro1p catalyse 96% of TAG synthesis (Sandager et al. 
2002), and so cells deleted for these genes would be expected to display a decreased 
neutral lipid phenotype compared with wild type cells.  FAT1 encodes a protein, which 
functions as a fatty acid transporter and a very long chain acyl-CoA synthetase (Choi J. Y. 
and Martin 1999); its deletion could be expected to result in an increased intracellular 
(neutral) lipid phenotype (Watkins et al. 1998).  
Growth curves were carried out for all strains to ensure growth was similar between the 
mutant and wild type cells. No observed growth defects were seen with the deletions 
tested apart from a slightly increased lag phase coupled with a greater cell mass for the 
fat1Δ, as shown in Figures 3.24, 3.25 and 3.26. 
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 Figure 3.24: Growth curves of S. cerevisiae wild type and dga1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
Figure 3.25: Growth curves of S. cerevisiae wild type and lro1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
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 Figure 3.26: Growth curves of S. cerevisiae wild type and fat1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
The Nile red assay was carried out in stationary phase wild type and deletion cells to infer 
phenotype, along with cells about to exit lag phase as an additional low lipid control.  
Figures 3.27 and 3.28 show the results of the neutral lipid and polar lipid fluorescence 
intensity of wild type and deletion strains, respectively, in both early exponential and 
stationary phases of growth. Figure 3.27 shows stationary phase cells deficient in DGA1 
exhibited a significant reduction in fluorescence attributable to neutral lipids compared to 
that of wild type cells with a 1.4 fold decrease.  Cells lacking lro1 showed a slight decrease 
in neutral lipids in stationary phase, although to a lesser extent than that of the dga1∆, 
which failed to reach significance.  Cells deleted for FAT1 on the other hand, as expected, 
exhibited a significant increase compared to wild type cells of 1.2 fold. 
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Figure 3.27: Neutral lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and deletions 
known to produce a neutral lipid phenotype.  Cells were harvested at 5 and 18 hrs post resuspension in 
YNB for early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 485 nm, emission 535 nm.  Data shown as means of triplicates 
±SD.  Significance indicated between early exponential and stationary phases ***p≤0.001 and difference in 
stationary phases between cells indicated by solid black lines ƗƗp≤0.01, ƗƗƗ p≤0.001.  Data analysed by one 
way ANOVA with Tukey post hoc test. 
 
Conversely, when yeast samples were screened using the wavelength to identify more 
polar lipid classes no significant difference was observed (Figure 3.28).   
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Figure 3.28: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and deletions 
known to produce a neutral lipid phenotype.  Cells were harvested at 5 and 18 hrs post resuspension in 
YNB for early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 535 nm, emission 590 nm.  Data shown as means of triplicates 
±SD.  Significance indicated between exponential and stationary phases ***p≤0.001.  Data analysed by one 
way ANOVA with Tukey post hoc test. 
 
These results demonstrated that the dual wavelength Nile red fluorescence method was 
sensitive enough to detect differences between polar and neutral lipids in S. cerevisiae, a 
non-oleaginous yeast.  
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3.5.1.1 Nile Red screening in S. cerevisiae utilising deletion strains known to regulate 
polar lipid production 
In order to further test the sensitivity of the dual wavelength capabilities of Nile red, 
transcription factor mutants known to be involved in the regulation of phospholipid 
metabolism ino2∆, ino4∆ and opi1∆ were screened for both polar and neutral lipids.  
Ino2p and Ino4p are basic helix-loop-helix transcription factors, which are required in 
response to inositol depletion for de-repression of phospholipid biosynthetic genes.  
Opi1p is a negative regulator of the Ino2p/Ino4p complex and therefore negatively 
regulates transcription of phospholipid biosynthetic genes.  Growth curves were 
conducted to ensure that all strains were in a comparable phase of growth before 
screening via Nile red, (Figures 3.29, 3.30 and 3.31). 
As shown in Figures 3.29 and 3.30, both the ino2Δ and ino4Δ strains reached a lower cell 
density than wild type cells.  However, time taken to exit lag phase (5hrs) and enter early 
stationary phase (12 hrs) were consistent between the deletion strains and wild type cells.  
The opi1Δ had comparable growth phases whilst also reaching a cell density equivalent to 
that of wild type cells (Figure 3.31). 
 
 
 
110 
  
Figure 3.29: Growth curves of S. cerevisiae wild type and ino2∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
Figure 3.30: Growth curves of S. cerevisiae wild type and ino4∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
0 5 10 15 20 25
0
1
2
3
4
Wild type 1
Wild type 2
ino2∆ 1
ino2∆ 2
Time hrs
O
D
59
5n
m
0 5 10 15 20 25
0
1
2
3
4
Wild type 1
Wild type 2
ino4∆ 1
ino4∆ 2
Time hrs
O
D
59
5n
m
111 
   
Figure 3.31: Growth curves of S. cerevisiae wild type and opi1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
 
Figures 3.32 and 3.33 show results of neutral and polar lipid fluorescence obtained from 
the Nile red assay.  For cells deficient in INO2 and INO4 increases of 2.7 and 2.6 fold 
respectively, were observed for neutral lipids.  Cells deleted for OPI1 displayed a neutral 
lipid phenotype comparable to that of wild type cells. 
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Figure 3.32: Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and deletion 
strains involved in phospholipid biosynthesis. Cells were harvested at 5 and 18 hrs post resuspension in 
YNB for early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 485 nm, emission 535 nm.  Data shown as means of triplicates 
±SD.  Significance indicated between early exponential and stationary phases ***p≤0.001 and difference in 
stationary phases between cells indicated by solid black lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA 
with Tukey post hoc test. 
 
In the case of the screen conducted to infer more polar lipid species significant increases 
were also seen for the ino2Δ and ino4Δ of 2.6 and 2.5 fold, respectively.  Concurrent with 
neutral lipid status, the opi1Δ did not significantly differ in fluorescence level from that of 
the wild type strain (Figure 3.33). 
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Figure 3.33: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and deletion 
strains involved in phospholipid biosynthesis.   Cells were harvested at 5 and 18 hrs post resuspension in 
YNB for early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 535 nm, emission 590 nm. Data shown as means of triplicates 
±SD.  Significance indicated between early exponential and stationary phases ***p≤0.001 and difference in 
stationary phases between cells indicated by solid black lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA 
with Tukey post hoc test. 
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3.5.1.2 Nile red screening of S. cerevisiae mutants involved in lipid droplet 
morphology and β-oxidation 
Other S. cerevisiae deletion strains involved in lipid droplet morphology, fld1∆ and 
transcription factors involved in β-oxidation, oaf1∆ and pip2∆, were also screened via Nile 
red to elucidate whether a phenotype could be shown.  Growth curves of the deletion 
strains were conducted, Figures 3.34, 3.35 and 3.36, alongside S. cerevisiae wild type 
cultures to ensure that no growth defects were present and to ensure cells were in a 
comparable growth phase prior to screening.  As shown in Figures 3.34, 3.35 and 3.36 
exponential growth routinely began 5 hrs post re-suspension in YNB medium before cells 
reached early stationary phase after 12 hrs of incubation. 
 
 
    Figure 
3.34: Growth curves of S. cerevisiae wild type and fld1∆ under normal conditions in yeast nitrogen base 
medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, at 
30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
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Figure 3.35: Growth curves of S. cerevisiae wild type and oaf1∆ under normal conditions in yeast nitrogen 
base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
    
Figure 3.36: Growth curves of S. cerevisiae wild type and pip2∆ under normal conditions in yeast nitrogen 
base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC. Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
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As shown in Figure 3.37, at stationary phase, the amounts of neutral lipid in all three 
deletion strains did not differ significantly from that of the wild type.  The fld1Δ exhibited 
a slight increase whilst deletion of OAF1 and PIP2 resulted in decreases of 1.1 fold. 
 
 
 
Figure 3.37: Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and deletion 
strains involved in lipid droplet morphology and β-oxidation.  Cells were harvested at 5 and 18 hrs post 
resuspension in YNB for early exponential and stationary phase samples respectively.  Cells were washed 
twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells 
of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each 
sample.  Plates were screened using the wavelengths: excitation 485 nm, emission 535 nm.  Data shown as 
means of triplicates ±SD.  Significance indicated between early exponential and stationary phases 
***p≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test. 
 
For polar lipids in stationary phase deletion strains did not display a significantly different 
phenotype from that of wild type cells (Figure 3.38). 
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Figure 3.38: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and deletion 
strains involved in lipid droplet morphology and β-oxidation.   Cells were harvested at 5 and 18 hrs post 
resuspension in YNB for early exponential and stationary phase samples respectively.  Cells were washed 
twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells 
of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each 
sample.  Plates were screened using the wavelengths: excitation 535 nm, emission 590 nm.  Data shown as 
means of triplicates ±SD.  Significance indicated between early exponential and stationary phases 
***p≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test. 
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3.5.1.3 Nile red screening of S. cerevisiae SREBP-like transcription factors 
Although S. cerevisiae cells do not contain SREBP orthologues, the proteins Upc2 and 
Ecm22 are classified as functional orthologues to mammalian SREBP-2. Upc2 and Ecm22 
are involved in the production of ergosterol, a component of yeast cellular membranes 
(Valachovic et al. 2006), whereas SREBP-2 in mammalian systems is involved in regulation 
of cholesterol synthesis.  Similarly, as the S. cerevisiae proteins Spt23 and Mga2 function 
in the regulation of fatty acid synthesis and therefore TAG synthesis, they are functionally 
related to mammalian SREBP-1 (Rice et al. 2010).   
Nile red screening was conducted for single deletion strains of genes encoding each SREBP 
like proteins to assess if a phenotype could be detected.  Growth curves were conducted 
prior to screening to ensure no growth defects were present and additionally that 
screening was conducted at comparable growth phases. 
As shown by Figures 3.39 and 3.40, no growth defects were observed for ecm22Δ or 
upc2Δ with growth rates comparable to that of wild type cells. 
 
Figure 3.39: Growth curves of S. cerevisiae wild type and ecm22∆ under normal conditions in yeast 
nitrogen base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with 
shaking, 180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
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Figure 3.40: Growth curves of S. cerevisiae wild type and upc2∆ under normal conditions in yeast nitrogen 
base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 180rpm, 
at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
As depicted in Figures 3.41 and 3.42, growth profiles consistent to that of wild type cells 
were also obtained from the spt23 and mga2 single deletion strains. 
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Figure 3.41: Growth curves of S. cerevisiae wild type and spt23∆ under normal conditions in yeast 
nitrogen base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) 
showing growth patterns observed for two distinct colonies of the same strain. 
  
Figure 3.42: Growth curves of S. cerevisiae wild type and mga2∆ under normal conditions in yeast 
nitrogen base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) 
showing growth patterns observed for two distinct colonies of the same strain. 
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When single deletions were screened using the wavelength to infer neutral lipid status the 
deletion of ECM22 and UPC2 resulted in 1.1 fold and 1.2 fold decreases respectively.  Cells 
deleted for SPT23 showed a 1.2 fold reduction in fluorescence attributable to neutral 
lipids, with the mga2Δ giving the largest decrease of 1.3 fold compared to wild type cells 
(Figure 3.43). 
 
 
 
Figure 3.43: Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and SREBP like 
component deletions. Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential 
and stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density 
of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 485 nm, emission 535 nm.  Data shown as means of triplicates ±SD.  Significance 
indicated between early exponential and stationary phases ***p≤0.001 and difference in stationary phases 
between cells indicated by solid black lines ƗƗp≤0.01. Data analysed by one way ANOVA with Tukey post hoc 
test. 
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Nile red screening using the wavelength to identify more polar lipids showed no significant 
differences compared to wild type cells.  Cells deleted for ECM22 and UPC2 resulted in a 
1.1 fold decrease and cells deficient in MGA2 and SPT23 exhibited a 1.2 fold decrease in 
fluorescence intensity (Figure 3.44). 
 
 
 
Figure 3.44: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and SREBP like 
component deletions.   Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential 
and stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density 
of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 535 nm, emission 590 nm.  Data shown as means of triplicates ±SD.  Significance 
indicated between early exponential and stationary phases ***p≤0.001. Data analysed by one way ANOVA 
with Tukey post hoc test. 
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3.5.1.4 ecm22/upc2 double deletion is viable in the W303 S. cerevisiae genetic 
background 
Although deletion of single SREBP like components results in viable cells, double mutants 
of SREBP functional orthologues ECM22/UPC2 or SPT23/MGA2 are non-viable in the 
S288C background.  However, the double deletion of ECM22/UPC2 is viable in the W303 
genetic background of S. cerevisiae.   
This is due to W303 cells having functional HAP1, whereas the S288C cells contain a 
mutated HAP1 allele (Davies and Rine 2006).  Nile red screening was conducted to 
elucidate whether the double deletion of ECM22 and UPC2 would result in the detection 
of a more severe phenotype than was observed with the single deletions in Section 
3.5.1.3. 
Growth curves were conducted for W303 wild type cells along with cells containing the 
single deletion of ecm22 and double deletion of ecm22/upc2.  As shown by Figures 3.45 
and 3.46, no growth defects were observed from either mutant strain. 
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Figure 3.45: Growth curves of S. cerevisiae wild type and ecm22∆ (W303 background) under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and 
incubated with shaking, 180rpm, at 30oC.  Optical density readings were taken hourly until mid to late 
stationary phase was reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both 
WT and deletion strain) showing growth patterns observed for two distinct colonies of the same strain. 
  
Figure 3.46: Growth curves of S. cerevisiae wild type and ecm22∆upc2Δ (W303 background) under normal 
conditions in yeast nitrogen base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and 
incubated with shaking, 180rpm, at 30oC.  Optical density readings were taken hourly until mid to late 
stationary phase was reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both 
WT and deletion strain) showing growth patterns observed for two distinct colonies of the same strain. 
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As previously demonstrated with the deletion of ECM22 in the S288C background, the 
levels of neutral lipids were not significantly different to that of wild type cells in the 
W303 genetic background. The double deletion of ecm22 and upc2 resulted in a 1.2 fold 
decrease in the levels of fluorescence pertaining to neutral lipids, although this failed to 
reach significance (Figure 3.47). 
 
 
  
Figure 3.47: Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and SREBP like 
component deletions in the W303 genetic background. Cells were harvested at 5 and 18 hrs post 
resuspension in YNB for early exponential and stationary phase samples respectively.  Cells were washed 
twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells 
of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each 
sample.  Plates were screened using the wavelengths: excitation 485 nm, emission 535 nm.  Data shown as 
means of triplicates ±SD.  Significance indicated between exponential and stationary phases ***p≤0.001.  
Data analysed by one way ANOVA with Tukey post hoc test. 
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 After analysis of fluorescence values for more polar lipid classes, again no significant 
difference was observed for the single deletion or double deletion strains (Figure 3.48). 
 
 
 
 
Figure 3.48: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and SREBP like 
component deletions in the W303 genetic background. Cells were harvested at 5 and 18 hrs post 
resuspension in YNB for early exponential and stationary phase samples respectively.  Cells were washed 
twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells 
of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each 
sample.  Plates were screened using the wavelengths: excitation 535 nm, emission 590 nm.  Data shown as 
means of triplicates ±SD.  Significance indicated between exponential and stationary phases ***p≤0.001.  
Data analysed by one way ANOVA with Tukey post hoc test. 
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3.6 Determination of lipid content in the non-oleaginous fission yeast, S. 
pombe using the Nile red fluorescence assay 
At present, a published rapid screening method for lipid accumulation in S. pombe has yet 
to be developed and validated.  Such platforms would aid in the rapid identification of 
superior culture conditions and relevant metabolism regulatory components, which can 
then be investigated more in depth. 
Little research has been undertaken on lipid accumulation in the fission yeast, S. pombe. 
Due to the importance of S. pombe in the study of human diseases, we tested whether the 
dual wavelength Nile red assay could be used to examine the lipid content of S. pombe 
cells.   
As Limited previous work has been published which describes lipid accumulation in S. 
pombe cells, growth phases in which to undertake a time course for Nile red screening of 
total lipid amounts were established from the growth curve shown in Section 3.3.3.3., 
Figure 3.17.  Interestingly, unlike L. starkeyi and S. cerevisiae, we found a higher lipid 
content existed in S. pombe exponentially growing cells (8 hrs) compared to those in 
stationary phase (24 hrs) (Figures 3.49 and 3.50).  As such, an exponentially growing 
culture of S. pombe could not be used as a low lipid control for screening stationary phase 
samples.  
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Figure 3.49: Neutral lipid fluorescence intensity of Nile red stained S. pombe over a range of growth 
phases. Cells were harvested at 8, 18, 24, 48 and 72 hrs post resuspension in EMM.  For Nile red cells were 
washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to 
the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to 
each sample.  Fluorescence intensity was measured using an excitation wavelength of 485 nm and an 
emission wavelength of 535 nm. All values are normalised to a cell density of 2 x 107 cells, corresponding to 
OD595 of 1.0.  Data are shown as means of triplicate experiments ± SD. 
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Figure 3.50: Polar lipid fluorescence intensity of Nile red stained S. pombe over a range of growth phases. 
Cells were harvested at 8, 18, 24, 48 and 72 hrs post resuspension in EMM.  For Nile red cells were washed 
twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells 
of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each 
sample.  Fluorescence intensity was measured using an excitation wavelength of 535 nm and an emission 
wavelength of 590 nm. All values are normalised to a cell density of 2 x 107 cells, corresponding to OD595 of 
1.0.  Data are shown as means of triplicate experiments ± SD. 
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3.6.1 The dual wavelength Nile red fluorescence assay can distinguish between polar 
and neutral lipids in S. pombe deletion strains 
To assess whether the Nile red assay could be applied to S. pombe to deliver reliable lipid 
phenotype data, screening was conducted utilising S. pombe deletion strains expected to 
deliver a predominantly neutral lipid phenotype.  The S. pombe dga1∆ mutant, analogous 
to its S. cerevisiae counterpart, is expected to show a significant decrease in neutral but 
not polar lipid amount. The deletion of PTL3, a predicted triacylglycerol lipase, is expected 
to demonstrate an increased quantity of neutral lipid.  Growth curves of deletion strains 
alongside wild type cultures were conducted prior to screening, Figures 3.51 and 3.52, in 
order to ensure the mutant strains did not display any growth defects and that samples 
for Nile red screening were obtained with cells in comparable phases of growth.  
 
  
Figure 3.51: Growth curves of S. pombe wild type and dga1∆ under normal conditions in yeast Edinburgh 
minimal medium (EMM). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Experiments were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
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  Figure 3.52: Growth curves of S. pombe wild type and ptl3∆ under normal conditions in yeast Edinburgh 
minimal medium (EMM). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Experiments were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
Unlike S. cerevisiae, a low lipid exponentially growing control could not be employed for S. 
pombe screening; as such S. pombe mutant cells were screened once early stationary 
phase had been achieved at 24 hrs and compared against wild type cells for both neutral 
lipids, Figure 3.53 and polar lipids, Figure 3.54.   
Cells deleted for DGA1 exhibited a 1.5 fold decrease in fluorescence attributed to neutral 
lipids when compared to the wild type, similar to the impact on neutral lipid amounts of 
the dga1 deletion in S. cerevisiae.  Cells lacking PTL3 displayed a 1.4 fold increase in 
neutral lipid fluorescence compared to wild type (Figure 3.53). 
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Figure 3.53: Neutral lipid fluorescence intensity of Nile red stained S. pombe wild type, dga1Δ and ptl3Δ 
mutants. Cells were harvested 24 hrs post resuspension in EMM.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 485 nm, emission 535 nm. Data shown as means of triplicates 
±SD.  Significance indicated between strains indicated by solid black lines Ɨ <0.05, ƗƗp≤0.01.  Data analysed by 
one way ANOVA with Tukey post hoc test. 
 
 
As expected for polar lipids no significant difference in fluorescence was observed in the 
dga1 mutant. However, a significant increase of fluorescence pertaining to polar lipid 
amounts was observed in cells deficient in PTL3 (Figure 3.54). 
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 Figure 3.54: Polar lipid fluorescence intensity of Nile red stained S. pombe wild type, dga1Δ and ptl3Δ 
mutants.  Cells were harvested 24 hrs post resuspension in EMM.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 535nm, emission 590 nm. Data shown as means of triplicates 
±SD.  Significance indicated between strains indicated by solid black lines Ɨ <0.05, ƗƗp≤0.01.  Data analysed by 
one way ANOVA with Tukey post hoc test. 
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3.6.1.2 Nile red screening of S. pombe SREBP transcription factor homologues 
S. pombe, unlike S. cerevisiae, contains orthologues to human SREBP-1a, Sre1 and Sre2, 
along with mammalian SCAP, Scp1. Sre1 is proteolytically cleaved in response to low sterol 
conditions and is dependent on interaction with Scp1, concurrent with the route of 
activation of its mammalian counterpart.  The less well described Sre2 however, does not 
bind Scp1 and is constitutively cleaved (Bien and Espenshade 2010, Hughes Adam L. et al. 
2005). 
Growth curves of wild type S. pombe were conducted prior to Nile red screening to ensure 
mutant cells had comparable growth rate to that of wild type (Figures 3.55, 3.56 and 
3.57). 
 
  
Figure 3.55: Growth curves of S. pombe wild type and sre1∆ under normal conditions in yeast Edinburgh 
minimal medium (EMM). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) 
showing growth patterns observed for two distinct colonies of the same strain. 
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Figure 3.56: Growth curves of S. pombe wild type and sre2∆ under normal conditions in yeast Edinburgh 
minimal medium (EMM). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) 
showing growth patterns observed for two distinct colonies of the same strain. 
  
Figure 3.57: Growth curves of S. pombe wild type and scp1∆ under normal conditions in yeast Edinburgh 
minimal medium (EMM). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
180rpm, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was reached. 
Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) 
showing growth patterns observed for two distinct colonies of the same strain. 
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 Data obtained from the neutral lipid screen indicated that levels of lipids in all SREBP 
component deletion strains did not differ significantly from that of wild type cells (Figure 
3.58). 
 
 
 
Figure 3.58: Neutral lipid fluorescence intensity of Nile Red stained S. pombe wild type and SREBP 
component deletions sre1, sre2 and scp1.   Cells were harvested 24 hrs post resuspension in EMM.  Cells 
were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred 
to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added 
to each sample.  Plates were screened using the wavelengths: excitation 485nm, emission 535 nm. Data 
shown as means of triplicates ±SD. Data analysed by one way ANOVA with Tukey post hoc test. 
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 For more polar lipid classes, no significant differences in fluorescence were observed for 
sre1, sre2 or scp1 deletion strains compared to wild type cells (Figure 3.59). 
 
 
  
Figure 3.59: Polar lipid fluorescence intensity of Nile Red stained S. pombe wild type and SREBP 
component deletions sre1, sre2 and scp. Cells were harvested 24 hrs post resuspension in EMM.  Cells were 
washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to 
the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to 
each sample.  Plates were screened using the wavelengths: excitation 535nm, emission 590 nm. Data shown 
as means of triplicates ±SD. Data analysed by one way ANOVA with Tukey post hoc test. 
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3.7 Discussion 
In this study the aim was to develop suitable methodology to assess lipid content in the 
oleaginous yeast species L. starkeyi as well as the non-oleaginous yeasts S. cerevisiae and 
S. pombe. 
For oleaginous yeasts, such as L. starkeyi, cells are cultured in nitrogen limiting medium in 
order to achieve maximal lipid production via the assimilation of the excess carbon source 
(Tanimura et al. 2014).  In this chapter, nitrogen limiting media (NLM) was utilised for lipid 
production and carbon limiting media (CLM) utilised as a medium that would produce cells 
to act as a low lipid controls (Wild et al. 2010).  It was shown that the growth of L. starkeyi 
inoculated directly into limiting medium took an approximately 90-100 hrs to reach 
stationary phase in limiting media (Table 3.1).  To reduce the time taken for cells to reach 
stationary phase, YPD pre-cultures were subsequently used as inoculum for nitrogen and 
carbon limiting culture conditions which did not have an effect of lipid production 
compared to direct inoculation (Figure 3.6).   
Gravimetric assessment of the lipid accumulation profile of L. starkeyi in a range of growth 
phases showed that in NLM, lipid began to accumulate at 72 hrs and sharply increased at 
96-120 hrs (Figure 3.8).  The sharp increase observed at 96 hrs is consistent with cells 
entering early stationary phase of growth (Figure 3.7).  The maximal lipid accumulation for 
this time course occurred at 120 hrs which is concurrent with cells in mid stationary 
phase, a reduction in lipid mass was then observed at 144hrs (Figure 3.8). The observed 
reduction is suggested to be as a consequence of lipase activity and subsequent β-
oxidation (Beopoulos et al. 2011). 
After optimisation in L. starkeyi, the methodology for culturing and assessing lipid 
accumulation was transferred to the non-oleaginous yeasts S. cerevisiae and S. pombe.  
Upon culturing cells in limiting medium a poor growth rate was observed for both species 
which could be attributed to an autophagic and/or mitophagic response (Crespo J. L. and 
Hall 2002, Mukaiyama et al. 2009). Further to this, both nitrogen and carbon limitation 
exert stress on both S. cerevisiae and S. pombe (Aoki Y. et al. 2011, Smith et al. 2002, Zuin 
et al. 2010a) which could have affected further work as it would have been difficult to 
separate the cellular response to stress from that of lipid accumulation.   
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Additionally, lipid amounts could not be accurately assessed in S. cerevisiae via gravimetric 
means (Figure 3.13).  This is as a consequence of this species only being able to 
accumulate approximately 11% of its total mass as lipid (Sitepu et al. 2012). 
The culture medium was changed from nitrogen and carbon limiting to a defined minimal 
medium, YNB for L. starkeyi and S. cerevisiae and EMM for S. pombe.  By culturing in YNB, 
using 2% glucose as the carbon source, de novo lipid formation could be followed which is 
analogous to the route of lipid production in cancerous cells. Additionally, defined minimal 
medium has been utilised in studies investigating both lipid production and the stress 
response in S. cerevisiae (Kamisaka et al. 2007, Marques et al. 2006, Ruiz-Roig et al. 2012). 
Along with this a limiting nutrient source would occur as a natural consequence of growth 
rather than being limited throughout the culturing process, allowing a more accurate 
assessment of lipid production. 
The use of gas chromatography in order analyse fatty acid composition of wild type cells 
was trialled initially after gravimetric means were deemed inappropriate.  Although GC 
analysis proved to display enough sensitivity for low lipid quantification in S. cerevisiae, 
the labour intensive and low throughput nature of this analytical technology meant that it 
was time consuming and logistically incompatible with screening a large number of 
deletion strains.  Moreover, it also meant that further work utilising a separate column 
and use of a solvent system would be required to infer the phospholipid status of the 
samples by liquid chromatography.  Similarly analysis of samples by thin layer 
chromatography was equally labour and time intensive, whilst also being limited to 
sample space available on TLC plates.  Further, after development and visualisation of the 
plates, assessment of lipid amounts would have been subjective unless plates were 
analysed via densitometry. 
The Nile red assay for analysis of lipid amounts was adapted from a method by Sitepu et 
al. (2012).  In optimisation of the methodology, a number of modifications were made to 
the method.  Firstly Krystal 2000 plates were employed instead of Costar plates utilised in 
the study by Sitepu et al. (2012).  As the wells of Krystal 2000 plates are individually 
moulded, each well is separate from the next, whereas Costar plates comprise of a single 
sheet of plastic running along the bottom of the plate.  Plates comprising of individually 
moulded wells serve to increase the specificity of well fluorescence readings by avoidance 
of lateral piping of light underneath the wells. 
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Dual wavelengths were also utilised in the present study to distinguish polar and neutral 
lipid classes simultaneously, which has been seldom used in lipid analyses utilising Nile red 
assays.  As described previously in this chapter, cells were washed in PBS twice prior to 
screening to reduce background fluorescence from spent culture medium.  This is 
especially important with culture media such as YNB as it produces high levels of 
background fluorescence in the presence of Nile red. 
Finally, as with the previous study, fluorescence data was corrected for cell density but 
then was also further corrected for background fluorescence resulting from Nile red in 
PBS.  This further improved the accuracy of the method by eliminating fluorescence 
occurring from the background medium, PBS in this case, thus ensuring any changes in 
RFU values were the result of cellular lipid content alone. 
The method was initially validated using the biotechnologically relevant oleaginous yeast, 
Lipomyces starkeyi.  Lipid accumulation in yeast is affected by altering culture conditions.  
In this study 2% glucose is utilized as the carbon source in YNB medium for monitoring de 
novo lipid formation (Kamisaka et al. 2006). In L. starkeyi, the same trend of lipid 
accumulation was observed for both gravimetric and fluorescence determination of total 
lipids (Figure 3.18). As the cells enter stationary phase and exhaust the available nitrogen, 
lipids are stored for cellular energy resulting in maximum lipid accumulation (Beopoulos et 
al. 2011).  
In late stationary phase a decrease in lipids is seen, which may occur as a consequence of 
triacylglycerol depletion as the acyl chains are released for β oxidation in a similar manner 
to that suggested by (Beopoulos et al. 2011).  It is important to note that as cells approach 
mid stationary phase of growth, 72 hrs onwards, there was less total lipid detected by 
gravimetric analysis than Nile red.  This is suggested to result from a common problem 
encountered with lipids extracted using the method of Bligh and Dyer whereby significant 
underestimates of lipid content, mainly neutral lipids, occurs in samples comprising in 
excess of 2% lipid content (Iverson et al. 2001).  This data also suggested that Nile red is a 
more reliable and repeatable means of assessing cellular lipid due to the reduced standard 
deviation compared to the results of the gravimetric analyses (Figure 3.18).   
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Excitation of Nile red at two different wavelengths enables the microscopic detection of 
polar and neutral lipids. Fluorescence microscopy of Nile red stained L. starkeyi cells 
allowed visualization of specific structures related to neutral and polar lipids (Figure 3.19). 
Limited overlap in fluorescence signal was observed between the two wavelengths, 
indicating the selectivity of Nile red dye for neutral and polar lipids.  This study also 
demonstrated that Nile red assays only utilising the wavelength for more polar lipids (590 
nm), as described by Sitepu et al. (2012), would mainly detect lipids within membranous 
structures rather than the intracellular lipid content of the cells. Further to this our data 
indicated the dual wavelength Nile red method may be a viable microplate screening 
method for determining neutral and polar lipid content of oleaginous yeast cells.  
It has also been demonstrated that the Nile red method is sensitive and specific enough to 
determine polar and neutral lipid levels within the non-oleaginous yeast, S. cerevisiae.  
Using neutral lipid mutants, it has been presented that the optimized Nile red 
fluorescence assay confers similar sensitivity to more advanced methodologies, such as 
gas chromatography, when a severe lipid phenotype results (Figures 3.27 and 3.28).  
The validation mutant set for S. cerevisiae Nile red screening comprised of cells deficient 
in DGA1, LRO1 and FAT1.  Diacylglycerol acyltransferases in S. cerevisiae are encoded by 
DGA1 in S. cerevisiae, a functional mammalian DGAT2 homologue, and LRO1, which is 
homologous to mammalian LCAT.  Both contribute substantially to the synthesis of neutral 
storage lipids by acylation of DAG to produce the end product TAG.  Using the Nile red 
method, the data showed that cells deficient for DGA1 exhibited a 1.4 fold decrease in 
neutral lipids compared to wild type cells (Figure 3.27).  This supports findings by Oelkers 
et al.., who demonstrated a decrease (1.9 fold) in the amount of triacylglycerol synthesis 
via metabolic labelling (Oelkers Peter et al. 2002). Also consistent with the findings of 
Oelkers et al. (2002), cells lacking LRO1 showed a slight decrease in neutral lipids in 
stationary phase, (Figure 3.27), which may indicate that Dga1 activity is greater in 
stationary phase.   
The phenotypic differences between cells deleted for DGA1 and LRO1 may be explained 
by their activity in different growth phases.  It has been demonstrated that Lro1 is more 
active in the synthesis of TAG in exponentially growing cells (Athenstaedt 2011) and so 
would not be expected to display a severe phenotype at stationary phase.  Conversely, 
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Dga1 may be more active during later phases of growth and so may contribute to TAG 
formation more significantly in stationary phase cells (Oelkers Peter et al. 2002). 
The FAT1 gene of S. cerevisiae encodes an acyl-CoA synthetase required for activation of 
very long chain fatty acids (VLCFA). Work undertaken by Watkins et al. (1998) 
demonstrated that the fat1Δ accumulated markedly increased VLCFA when compared to 
wild type cells (Watkins et al. 1998).  When cells deleted for FAT1 were screened using 
Nile red they exhibited a significant increase in neutral lipids compared to wild type cells 
(Figure 3.27). Therefore, the observed increase could be as a result of its accumulation of 
hydrophobic very long chain fatty acids (Watkins et al. 1998). 
For polar lipids, although slight changes in fluorescence values were observed in the 
deletion strains (Figure 3.28), this is believed to be due to amounts of the phospholipid 
monolayer encasing the lipid droplets (Grillitsch et al. 2011). These results demonstrated 
that the dual wavelength Nile red fluorescence method was able to detect changes to 
neutral lipids from that of polar lipids in S. cerevisiae, a non-oleaginous yeast. 
For screening conducted utilising components known to be involved in phospholipid 
synthesis, an increased neutral lipid phenotype was observed for deletions in INO2 (2.7 
fold) and INO4 (2.6 fold). This is suggested to be as a result of these strains harbouring 
“supersized” lipid droplets, which may increase fluorescence signal when using the 
wavelength for more neutral lipid subtypes (Wang et al. 2014).  It was recently reported 
that components involved in β-oxidation, including Oaf1 and Pip2, are downregulated in 
INO2 and INO4 deletion strains, which would serve to increase the free fatty acid content 
of the cell.  From looking at combined SE and TAG contents determined by gas 
chromatography in a study by Chumnanpuen et al. (2013), a 2.1 fold and 2 fold increase in 
neutral lipids resulted from deletion of INO2 and INO4 respectively (Chumnanpuen et al. 
2013). These results are consistent with the data in this study using the Nile red method 
(Figure 3.32).  
Interestingly an increase in phospholipid levels was also seen in both the ino2Δ and the 
ino4Δ (Figure 3.33).   It is therefore suggested that these deletions, in normal culture 
conditions, may have up-regulated phospholipid synthesis via the CDP-DAG pathway, 
which has been described as being independent from the Ino2, Ino4, Opi1 regulatory 
circuit (Su and Dowhan 2006).  Alternatively, the inability of these mutants to de-repress 
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enzymes which convert phosphatidylethanolamine (PE) to phosphatidylcholine (PC) may 
provide a further explanation.  It was demonstrated that although mutations of INO2 and 
INO4 resulted in reduced cellular PC, increased levels of PE, phosphatidylinositol and the 
phospholipid intermediates phosphatidylmonomethylethanolamine (PMME) and 
phosphatidyldimethylethanolamine (PDME) along with neutral lipids were observed 
compared to wild type cells (Fei Weihua et al. 2011, Loewy and Henry 1984).  This 
demonstrated that the levels of polar lipids observed by Nile red in the present study may 
have resulted from increased levels of other polar lipid classes (Figure 3.33). 
In the case of the opiΔ, it is expected that an increased level of phospholipids would result 
as Opi1 functions to repress transcriptional activity of Ino2/Ino4. Previous analysis by Klig 
et al. (1985) of phospholipid fractions in cells deleted for OPI1 in YNB medium, 
demonstrated that levels of PI were increased 1.5 fold but both PS and PC levels were 
decreased 1.7 and 1.2 fold respectively (Klig et al. 1985). No significantly different 
phenotype from that of wild type cells was observed via Nile red screening for the opi1Δ in 
the present study (Figure 3.33).  This, taken together with the work of Klig et al. (1985) 
suggested that the phospholipid phenotype does not severely affect the overall levels of 
the phospholipid pool.   
In the screening of deletion strains involved in lipid droplet morphology and β-oxidation, 
no significant lipid phenotypes were determined using the Nile red assay (Figures 3.37 and 
3.38).  Fld1p is a functional homologue of mammalian seipin.  It has been described that 
cells lacking FLD1 contain “supersized” lipid droplets which demonstrate enhanced fusion 
activity compared to LDs in wild type cells (Fei W. et al. 2008).  Although this would be 
expected to increase fluorescence intensity pertaining to neutral lipids, it is suggested that 
as cells lacking FLD1 contain fewer lipid droplets (Fei W. et al. 2008).  Therefore, the 
fluorescence intensity yielded from Nile red may be equivalent to that of wild type cells 
which contain an increased number of smaller LDs in comparison. In order to verify this 
fluorescence microscopy of Nile red stained wild type cells and those lacking FLD1 could 
be employed. 
Oaf1p and Pip2p are both components involved in β-oxidation.  They are paralogues of 
each other and form a heterodimer to induce transcription of β-oxidation genes. Strains 
lacking components in β-oxidation processes may be expected to have increase neutral 
lipids in comparison to wild type cells, as components of β-oxidation serve to regulate the 
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breakdown of cellular fatty acids.  It must be remembered that both growth phase and 
access to key nutrients also impact upon fatty acid catabolism.  No significant differences 
were observed for neutral or polar lipid classes using Nile red screening (Figures 3.37 and 
3.38). However, the Nile red method may not be sensitive enough to detect significance 
when only a slight lipid phenotype results.   
Alternately, Oaf1 and Pip2 are paralogues of each other, meaning the phenotype of a 
single deletion may be rescued by activity of the other.  It has been demonstrated that in 
the absence of Pip2, Oaf1 can homodimerise to induce gene expression of some oleate 
responsive genes (Trzcinska-Danielewicz et al. 2008).  It has also been shown that 
expression of key peroxisomal β-oxidation genes are identical in cells lacking OAF1 and 
PIP2 to wild type cells growing in glucose medium.  Although these observations support 
the Nile red data in the present study, it is not known what contribution TAGs and SEs are 
making to the neutral lipid pool.  This could be further investigated by analysis of samples 
utilising gas chromatography. 
The SREBP-like proteins of S. cerevisiae are key activators of genes which encode enzymes 
such as Erg2 and Erg3 in the late stages of ergosterol synthesis. They regulate 
transcription by binding of the sterol binding element in the promoters of target genes.  
Under normal culture conditions Ecm22p is more abundant at the ERG promoter regions. 
In contrast when sterols are depleted, Ecm22p decreases and is replaced at the ERG 
promoters by Upc2p (Davies et al. 2005).  However, no significantly different phenotypes 
of cells lacking ECM22 or UPC2 were observed by the Nile red assay when compared to 
wild type cells (Figures 3.43 and 3.44). This result can be explained as Upc2 and Ecm22 are 
paralogues of each other, therefore deletion of one may result in the phenotype being 
rescued by the other. This is supported by the description that induction of ERG genes 
catalysing the final steps of ergosterol synthesis can be mediated by both Ecm22 and Upc2 
(Davies et al. 2005).   
For Mga2 and Spt23, which are involved in the regulation of fatty acid synthesis and 
regulate the expression of the FA desaturase OLE1, no significant lipid phenotype was 
observed for cells lacking SPT23.  As with Ecm22 and Upc2, the deletion of Spt23 may be 
compensated by the presence of Mga2.  It has been demonstrated that under normoxic 
growth conditions in glucose medium that Spt23 and Mga2 perform overlapping functions 
with little differences in OLE1 expression (Chellappa et al. 2001).  In cells lacking MGA2 a 
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significantly reduced lipid phenotype was observed.  This suggests that Mga2p is one of 
the dominant transcription factors for driving expression of lipid biosynthetic genes.   
It has been further demonstrated that Mga2 function becomes critical for the expression 
of OLE1 when there is an increased demand for de novo lipid synthesis (Surma et al. 
2013).  Additionally, it has been shown that Mga2 holds an additional role in the 
stabilisation of the OLE1 transcript, therefore in the absence of Mga2 OLE1 stability is 
perturbed which may result disturbed translation efficiency (Kandasamy et al. 2004).  
Taken together, the observations made in previous studies support the observations in 
the present study, whereby cells deficient for MGA2 displayed a decreased neutral lipid 
phenotype compared to cells deleted for SPT23 (Figure 3.43). 
If the SREBP-like proteins are compensating for each other, it would be expected that a 
double deletion would show a further phenotype.  In the W303 S. cerevisiae genetic 
background, the ecm22Δ did not result in a significantly altered neutral nor polar lipid 
phenotype.  In cells lacking both ECM22 and UPC2 a slight reduction in the neutral lipid 
pool occurred, although this was not found to be significantly different from that of wild 
type cells (Figure3.47).  This could be due to the presence of functional Hap1, which is 
both a transcriptional repressor and activator of ERG genes.  As ERG gene transcription is 
activated by Hap1 in aerobic conditions (Hickman MJ. and Winston 2007) this suggests 
that Hap1 could compensate, to some level, for the loss of ECM22 and UPC2 in the W303 
genetic background. 
In addition to S. cerevisiae, the use of the Nile red fluorescence assay in the fission yeast, 
S. pombe has also been examined. As described previously little work has been 
undertaken on lipid accumulation in this yeast species, but due to its potential importance 
in human disease research the study was extended to fission yeast.   
Unlike L. starkeyi and S. cerevisiae, the fission yeast S. pombe does not gradually 
accumulate lipid over time. Instead, maximal levels of lipid are seen during exponential 
growth with lower levels as cell progress into stationary phase (Figures 3.49 and 3.50). It 
has been previously demonstrated that S. pombe accumulates greater levels of certain 
lipid species in exponential phase, including TAG, PE and PS, than is seen in S. cerevisiae 
cells (Shui et al. 2010). Two observations could explain why the total lipid content of S. 
pombe would be significantly more during exponential growth than in stationary phase. 
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Firstly, as S. pombe has a polarized manner of growth, dividing via medial fission, 
increased levels of sterols are present at the tips during exponential growth before 
accumulating at the completed septum closer to cell division (Wachtler et al. 2003). 
Secondly, intracellular lipid droplets in S. pombe are increased in the G2 phase of the cell 
cycle (Long et al. 2012).  As a result of this, when quantifying the lipid in S. pombe cells, an 
exponentially growing low lipid control could not be used. Instead, as we were interested 
in lipid accumulation as a result of assimilation of carbon, stationary phase cultures only 
were analysed and compared to wild type cultures. 
The microscopy data demonstrated that in S. pombe, using the dual wavelengths of Nile 
red, neutral and polar lipids may be distinguished (Figure 3.19). The S. pombe validation 
set for high throughput screening via Nile red contained cells deficient for dga1 and ptl3. 
Dga1 in S. pombe is analogous to S. cerevisiae Dga1 and is responsible for the majority of 
TAG synthesis along with Plh1 (Lro1 homologue). Similar to the impact on neutral lipid 
amounts of the DGA1 deletion in S. cerevisiae, S. pombe cells deleted for dga1 also 
showed a 1.5 fold decrease in neutral lipids (Figure 3.53). This is suggested to be due to 
the inability of substantial TAG formation via esterification of DAG (Zhang Qian et al. 
2003). As in S. cerevisiae the activity of S. pombe Plh1 has been found to be higher in 
logarithmic phase cells (Zhang Qian et al. 2003), showing a conserved mechanism of TAG 
synthesis between Lro1/Plh1.  The phenotype observed by Nile red, for cells deficient in 
dga1 also supports the hypothesis that S. pombe Dga1p may function to produce TAG 
mainly in stationary phase cells (Zhang Qian et al. 2003).   
S. pombe contains three intracellular lipases; Ptl1, Ptl2 and Ptl3, with Ptl2 and Ptl3 
conferring significant homology to S. cerevisiae lipases Tgl3, Tgl4 and Tgl5.  It has been 
demonstrated upon deletion of triacylglycerol lipases in S. cerevisiae that intracellular TAG 
levels are increased (Athenstaedt and Daum 2005), and so it was expected an increased 
neutral lipid phenotype would have been observed in cells deleted for TAG lipases in S. 
pombe. The results for cells lacking ptl3 (1.4 fold increase in neutral lipid), yielded data 
consistent with more recently published gas chromatography data where a 1.7 fold 
increase in average cellular TAG amounts was observed upon deletion of ptl3 in S. pombe 
(Yazawa et al. 2012).  This increase is observed as cells have a reduced ability to mobilise 
TAG stored in LDs when lipase activity is reduced (Figure 3.53). 
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For polar lipids, a significant change was only observed in the ptl3 mutant (Figure 3.54). 
This result could be due to the level of increased neutral lipid observed, which in turn 
would mean more polar lipids due to the phospholipid monolayers encasing the droplets 
(Grillitsch et al. 2011).  Alternatively, Ptl3p may also have a role in regulating phospholipid 
levels in addition to maintaining neutral lipid homeostasis, which has been shown with S. 
cerevisiae Tgl3 and Tgl5 (Rajakumari S. and Daum 2010a). A further possibility may be 
that, due to the deletion of ptl3, increased phospholipid synthesis/remodelling results, 
which has also been demonstrated to occur in S. cerevisiae triacylglycerol deleted strains 
(Mora et al. 2012, Rajakumari S. and Daum 2010b). 
Nile red screening of S. pombe SREBP (sre1, sre2) and SCAP (scp1) deletions did not reveal 
significantly different lipid phenotypes to that of wild type cells (Figures 3.58 and 3.59).  As 
the cleaved active form of Sre1 regulates transcription of genes in response to low oxygen 
and sterol levels (Hughes B. and Espenshade 2008), it is possible that cultures contained 
either sufficient levels of sterols or a sufficient oxygen supply to synthesise sterols without 
requiring the presence of active Sre1 (Hughes A. L. et al. 2008).  In cells lacking Scp1, Sre1 
activity is abolished and so it is suggested that oxygen levels within the cultures were 
sufficient to not require Sre1 activity via cleavage by Scp1 (Hughes A. L. et al. 2008). In the 
case of the less well characterised Sre2, which is constitutively cleaved irrespective of 
oxygen levels (Cheung and Espenshade 2013), it is suggested that the presence of Sre1 
and Scp1 would be sufficient to maintain lipid homeostasis if a decrease in sterols 
occurred. 
It has been established by utilising the dual emission properties of Nile red in a microplate 
assay that more informative phenotypic data may be obtained on lipid content of both 
oleaginous and non-oleaginous yeast cells.  Knowledge of the effect of cellular 
components impacting neutral and polar lipid levels is of particular importance in human 
diseases, such as cancer, in order to understand the regulation of lipid metabolism and 
how components involved could be modulated for subsequent phenotype amelioration. 
Unlike most non-conventional yeast species, including L. starkeyi, genetic tools are 
available for use with S. cerevisiae and S. pombe. Additionally due to their extensive 
characterisation, both S. cerevisiae and S. pombe serve as excellent model organisms in 
eukaryotic biology. This coupled with a plethora of available genetically modified strains 
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means that novel lipogenic regulatory elements can be identified to provide further 
insight into aberrant metabolism in human disease processes.   
For the first time, it has been shown, that a Nile red assay can be applied to the fission 
yeast S. pombe. This is of particular importance due to growing interest and research in 
the area of S. pombe lipid metabolism. 
This method is however, not without its limitations especially with regards to dye 
bleaching when observing red emission and that neutral and polar fluorescence cannot be 
directly compared due to differences in optimal gain parameters.  This is due to the gain 
for each wavelength comprising of different optimal values.  The gain adjusts the voltage 
across the photomultiplier tube of the plate reader making it either more or less 
responsive to the intensity of the signal generated by the sample and so samples with a 
higher intensity of fluorescence will have a lower optimal gain setting.  Therefore neutral 
and polar lipids can be compared within each class but not directly to one another.  The 
method is also limited to general pools of lipids, therefore further analysis to determine 
changes in molecular species, which may not impact on overall lipid levels, would need to 
be conducted by other means.   
However, the rapid nature, reproducibility and potential scalability of this methodology 
means that interesting yeast strains, species and indeed culture conditions, that have 
significant impact on lipid amounts, can be readily segregated for further analysis by 
modern hyphenated chromatographic technologies, including liquid chromatography-
mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS). The 
employment of Nile red ultimately means avoidance of time consuming, labour intensive 
analyses of samples that may not yield a lipid phenotype. 
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Chapter IV: The role of Mitogen Activated Protein 
Kinase signalling in lipogenesis 
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4.1 Introduction 
As previously described in Chapter 1, upstream signalling has been found to contribute to 
the initiation of lipogenesis in solid tumours, resulting from oncogenic gain of function and 
loss of tumour suppressors.  These aberrations serve to fuel a heightened glycolytic rate 
resulting in increased production and accumulation of cellular lipids which drive cellular 
proliferation.  It has been well documented in mammalian models that the mTOR pathway 
has significant involvement in the regulation of lipid metabolism (Soliman 2011). However, 
a potential role for the p38 MAP Kinase pathway in lipogenesis has not yet been subject to 
in depth investigation. 
The yeasts S. cerevisiae and S. pombe have been utilised extensively as eukaryotic model 
organisms in order to increase understanding of key cellular and molecular processes 
(Botstein D and Fink 1988). Although phylogenetically distant from mammalian cells, 
numerous processes, regulatory elements and key pathways are highly conserved.  Both 
mTOR complexes and signalling are conserved between mammalian and yeast systems. 
Additionally the p38 MAPK pathway is structurally and functionally conserved to the yeast 
Hog1 and Sty1 pathways of S. cerevisiae and S. pombe respectively (Bahn 2008). 
The HOG pathway in S. cerevisiae responds to a wide range of external stimuli including 
high osmolarity, pH, endoplasmic reticulum (ER) stress, cell wall stress and citric acid 
stress (Bicknell et al. 2010, Garcia et al. 2009, Hohmann 2002, Kapteyn et al. 2001, 
Lawrence C. L. et al. 2004).  Hog1p may be activated via two distinct signalling branches 
which both converge at the point of the common MAPKK Pbs2 (O'Rourke et al. 2002).  
Pbs2 phosphorylates Hog1p dually on conserved Thr174 and Tyr176 residues (Maayan et 
al. 2012).  The response of Hog1 to phosphorylation can vary widely and is dependent on 
the stimulus to which it is responding.  Under osmotic stress, activation of Hog1 precedes 
a rapid nuclear translocation where it may induce DNA transcription through recruitment 
of DNA binding proteins (Msn2/4) or interaction with RNA Polymerase II (Alepuz et al. 
2001).  Conversely under conditions of cell wall stress, Hog1 remains in the cytoplasm, 
indicating that it additionally activates cytoplasmic targets to regulate cellular processes 
(Garcia et al. 2004). 
 
 
151 
Msn2/4 are zinc finger transcription factors that operate downstream of Hog1 and are 
involved in the regulation of the general stress response (Alepuz et al. 2001).  Msn2/4 are 
responsible for the regulation of ~200 genes in response to a number of stresses which 
include osmotic stress, glucose limitation, oxidative stress and heat shock (Martinez-
Pastor et al. 1996).  Msn2/4 can be localised either in the cytoplasm or nucleus.  Under 
normal conditions, Msn2/4 are tethered in the cytoplasm, a localisation that is in part 
regulated by Tor1 (Beck and Hall 1999).  Upon exposure of the cells to stress Msn2/4 
become hyperphosphorylated before translocating to the nucleus to induce the 
expression of target genes.  After activation and translocation to the nucleus, Msn2/4 are 
observed to shuttle between the nucleus and cytoplasm, a periodic behaviour of the 
proteins that corresponds to an intermediate level of stress (Jacquet et al. 2003). 
The fission yeast species S. pombe also contains a conserved MAPK pathway to that of the 
mammalian p38 pathway (Bahn 2008).  The Sty1 pathway, as in S. cerevisiae, is also 
activated under a range of stress conditions.  Sty1p is activated by its upstream MAPKK 
Wis1 on residues conserved in p38 and Hog1 (Zhou et al. 2010).  The downstream targets 
of Sty1 are less well characterised than those of Hog1 in S. cerevisiae, the most well 
understood being the transcription factors Pap1, which is required under low levels of 
stress, and Atf1 which is required in high levels of stress (Chen D. et al. 2008). 
The work presented within this chapter describes deletions of components within the high 
osmolarity glycerol (HOG) MAPK pathway in S. cerevisiae and their effect on the 
production of both neutral and polar lipids in stationary phase.  Further to this the study 
was extended to look at regulation of lipid accumulation via the Sty1 pathway in S. pombe. 
In this chapter it has been demonstrated that Hog1p may play a key role in neutral lipid 
synthesis and additionally may hold a role in the synthesis of phospholipids.  It has been 
further demonstrated that downstream targets of Hog1p, Msn2/4 may also be involved in 
the regulation of neutral lipid homeostasis.  Additionally, the role of the MAPK pathway in 
accumulation of lipid appears to be conserved in S. pombe. 
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4.2 Results 
4.2.1 S. cerevisiae TOR1 component deletions display an altered lipid phenotype to 
that of wild type cells 
The mTOR pathway has been shown to be involved in regulating lipid biosynthesis in 
mammalian cells, and displays high homology to yeast Tor proteins.  As mammalian 
mTORC1 has been shown to play a definite role in lipid synthesis, deletion of S. cerevisiae 
Tor1 components, tco89∆ and tor1∆ were screened using the Nile red assay along with a 
component of the Tor2 complex avo2Δ, as a negative control.   
The role of mTORC2 in lipogenesis is less clear than that of mTORC1 in mammalian cells.  It 
has been suggested that the role of mTORC2 may be more subtle than that of mTORC1, 
although it has been observed that mTORC2 signalling drives lipogenesis in hepatic tissues 
(Hagiwara et al. 2012).  This highlights that mTOR2 activity, in respect to lipid metabolism 
in mammals, may likely be cell type specific.  In S. cerevisiae it has been reported that Tor2 
is involved in ceramide and sphingolipids synthesis, through the essential protein 
component Avo3 (Aronova et al. 2008). The Tor2 component Avo2 is involved, as in higher 
eukaryotes, in regulating the actin cytoskeleton during progression of the cell cycle, and so 
is not expected to exhibit an altered lipid phenotype.  As previously described, the Tor1 
protein complex regulates cellular growth in response to nutrient availability.  Additionally 
one of the subunits of Tor1, Tco89, has been implicated in degradation of vacuole proteins 
including fructose 1,6-biphosphatase (FBPase) (Alibhoy and Chiang 2011).  Nile red 
screening was carried out on yeast TOR protein component deletions to assess whether a 
distinguishable lipid phenotype resulted before going onto screening components of the 
HOG MAPK pathway. 
Growth curves were conducted prior to screening to ensure deletion strains did not 
convey any growth defects and to ensure that cells were harvested at comparable growth 
phases.  As shown by Figures 4.1, 4.2 and 4.3 exponential growth began ~4 hrs post 
resuspension in YNB medium before stationary phase of growth was reached at ~ 12hrs in 
all cases. 
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Figure 4.1: Growth curve of S. cerevisiae wild type and avo2∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
  
Figure 4.2: Growth curve of S. cerevisiae wild type and tco89∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
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Figure 4.3: Growth curve of S. cerevisiae wild type and tor1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
 
Samples were harvested at 5 hrs and 18 hrs post resuspension in YNB for early 
exponential and mid stationary phases respectively, before processing and screening using 
the Nile red assay as described in Chapter 2, Section 2.3. 
The results of both neutral and polar lipid accumulation, Figures 4.4 and 4.5 respectively, 
showed no significant difference between the strains when in early exponential stages of 
growth.   
In stationary phase no significant difference was detected for neutral lipids in the avo2∆ 
compared to wild type cells.  The deletion of TCO89 resulted in a 1.1 fold increase in 
neutral lipids compared to wild type, although this failed to reach significance.  For the 
tor1∆ a significant decrease in neutral lipids was observed, with a 1.3 fold decrease 
compared to the wild type strain (Figure 4.4). 
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Figure 4.4: Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and TOR 
component mutants.   Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential 
and stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density 
of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 485nm, emission 535nm.  Data shown as means of triplicates ±SD.  Significance 
indicated between exponential and stationary phases ***p≤0.001 and difference in stationary phases 
between cells indicated by solid black lines Ɨ p≤0.05.  Data analysed by one way ANOVA with Tukey post hoc 
test. 
 
Compared with wild type cells, the screen conducted for more polar lipid subtypes 
showed a decrease in polar lipids for the avo2Δ, an increase for tco89Δ and a 1.2 fold 
decrease for the tor1Δ.  However these differences were not significantly different from 
the levels observed in wild type cells (Figure 4.5). 
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Figure 4.5: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and TOR 
component mutants.   Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential 
and stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density 
of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 535nm, emission 590nm. Data shown as means of triplicates ±SD.  Significance 
indicated between exponential and stationary phases **p≤0.01 ***p≤0.001.  Data analysed by one way 
ANOVA with Tukey post hoc test. 
 
These results demonstrated that the Nile red method was able to detect a neutral lipid 
specific phenotype in cells deleted for TOR1, highlighting that possible phenotypes arising 
from MAPK component deletions may be confidently elucidated. 
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4.2.2 Neutral and polar lipid accumulation in S. cerevisiae hog1∆ cells is reduced in 
stationary phase 
The PI3K/Akt/mTOR and MAP Kinase pathways are central to numerous signalling 
cascades and are involved in regulating a plethora of cellular processes.  Along with this, 
their normal regulation is frequently disrupted in many cancer types.   
Both mTOR and ERK MAPK signalling contributes to the initiation of increased lipid 
synthesis in cancer (Laplante and Sabatini 2009b, Yang W et al. 2012). Therefore it is 
postulated that the p38 MAPK pathway may also play a role in cancer related lipid 
synthesis due to its frequent upregulation. The S. cerevisiae MAPK Hog1p has been 
extensively characterised and demonstrated to be well conserved to mammalian p38 MAP 
kinase. As such, to determine if the HOG MAPK pathway in S. cerevisiae has a role in lipid 
accumulation, neutral and polar lipid levels were examined in a HOG1 deletion strain using 
the Nile red method.  
Firstly, growth curves were conducted to ensure samples from both wild type and hog1∆ 
strains had comparable growth phases for both exponential and stationary phases, with 
early exponential samples acting as the low lipid control.  As shown in Figure 4.6, 
exponential growth routinely began for both wild type and hog1Δ cells at ~5hrs post 
resuspension in YNB before stationary phase was achieved at ~12hrs. 
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Figure 4.6: Growth curves of S. cerevisiae wild type and hog1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells/ml (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
 
Samples were harvested at 5 hrs and 18 hrs post resuspension in YNB, representing early 
exponential and stationary phases of growth, before screening using the Nile red assay. 
Results showed that accumulation of both neutral and polar lipids in stationary phase was 
decreased significantly in the hog1∆ strain compared to wild type. For neutral lipids the 
hog1∆ mutant showed a 1.4 fold decrease and for polar lipids a significant decrease of 1.7 
fold was observed (Figures 4.7 and 4.8). 
 
 
 
 
0 5 10 15 20 25
0.0
0.5
1.0
1.5
2.0
2.5
Wild type 1
Wild type 2
hog1∆ 1
hog1∆ 2
Time (hrs)
O
D
59
5n
m
159 
   
Figure 4.7:  Neutral lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and hog1∆ 
cultures.  Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential and stationary 
phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 
cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 
v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the wavelengths: 
excitation 485nm, emission 535nm.  Data shown as means of triplicates ± SD.  Significance indicated 
between wild type and hog1∆ cultures **p≤0.01 ***p≤0.001 and change from exponential to stationary 
phase indicated by solid black lines ƗƗp≤0.01.  Data analysed by one way ANOVA with Tukey post hoc test.  
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Figure 4.8: Polar lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and hog1∆ cultures. 
Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential and stationary phase 
samples respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 
x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 
5µg/ml Nile red were added to each sample.  Plates were screened using the wavelengths: excitation 
535nm, emission 590nm.  Data shown as means of triplicates ± SD.  Significance indicated between wild type 
and hog1∆ cultures ***p≤0.001 and change from exponential to stationary phase indicated by solid black 
lines ƗƗƗ≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test.   
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 4.2.3 Transformation with pRS315 impacts on lipid accumulation in S. cerevisiae 
In order to confirm that deletion of HOG1 attenuated lipid accumulation, a 
complementation experiment was performed, whereby HOG1 was introduced into the 
deletion strain using a single copy plasmid pRS315HOG1 (CLLp001) under the control of its 
own promoter.   
To assess whether complementation had been successful wild type and hog1∆ strains 
transformed either with pRS315 or pRS315 containing HOG1 were spotted onto YNB agar, 
minus leucine and YNB agar minus leucine supplemented with 0.4 M NaCl was utilised to 
determine if sensitivity of the hog1∆ to NaCl had been recovered.  As shown in Figure 4.9, 
NaCl sensitivity of hog1∆ cells was rescued upon transformation with pRS315 expressing 
HOG1. 
 
  
Figure 4.9:  Spot plates of S. cerevisiae wild type and hog1∆ with pRS315 and pRS315::HOG1 exposed to 
osmotic stress. Control plates (YNB) and osmotic stress plates, YNB supplemented with 0.4M NaCl. Starting 
cell densities were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate to 2.3 x 102 cells/ml. 
 
Transformed cells were then assessed using the Nile red method to determine their lipid 
phenotype in stationary phase.  Cells were resuspended at a cell density of 2 x 106 cells/ml 
in YNB minus leucine, and allowed to grow until early exponential at 5 hrs and stationary 
phase, 18 hrs, as described previously. 
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As demonstrated in Figure 4.10, cells deleted for HOG1 containing the empty vector 
pRS315, exhibited an increase in fluorescence intensity, reaching levels comparable to 
wild type in both exponential and stationary phases of growth. This suggested an increase 
in neutral lipids within the yeast cells transformed with the empty vector.   
 
  
Figure 4.10: Neutral lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and hog1Δ 
containing pRS315 and pRS315HOG1  Cells were harvested at 5 and 18 hrs post resuspension in YNB for 
early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 485nm, emission 535nm.  Fluorescence intensities of wild type 
cells containing pRS315 and pRS315HOG1 compared to hog1∆ cells containing pRS315 and pRS315HOG1. 
Data displayed as means of duplicate experiments.   
 
For more polar lipids, Figure 4.11, levels of fluorescence remained lower than that of wild 
type in hog1 deleted cells regardless of whether they were transformed with vector 
pRS315 or pRS315HOG1. 
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Figure 4.11: Polar lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and hog1Δ 
containing pRS315 and pRS315HOG1  Cells were harvested at 5 and 18 hrs post resuspension in YNB for 
early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 535nm, emission 590nm.  Fluorescence intensities of wild type 
cells containing pRS315 and pRS315HOG1 compared to hog1∆ cells containing pRS315 and pRS315HOG1. 
Data displayed as means of duplicate experiments.   
 
As a result of the data derived from the Nile red assay, both wild type and hog1∆ strains 
were re-transformed with pRS315 and pRS315HOG1.  Again the stress sensitive 
phenotype of cells deleted for hog1 was recovered following transformation with 
pRS315HOG1 on solid medium.   
Consistent with the previous Nile red data obtained, cells deleted for HOG1 containing 
empty pRS315 displayed an increased neutral lipid phenotype in stationary phase which 
on this occasion exceeded levels seen in wild type cells.  Conversely in exponential phase 
the levels of fluorescence remained similar across all strains screened (Figure 4.12).  
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Figure 4.12: Neutral lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and hog1Δ 
containing pRS315 and pRS315HOG1  Cells were harvested at 5 and 18 hrs post resuspension in YNB for 
early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 485nm, emission 535nm.  Fluorescence intensities of wild type 
cells containing pRS315 and pRS315HOG1 compared to hog1∆ cells containing pRS315 and pRS315HOG1. 
Data displayed as means of duplicate experiments.   
 
When screening was conducted for more polar lipids, again a decreased level of 
fluorescence was observed for the hog1∆ containing pRS315HOG1.  In contrast to the 
previous experiment an increased level of fluorescence, which reached levels comparable 
to wild type, was seen in hog1 deleted cells containing pRS315 (Figure 4.13).   
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Figure 4.13: Polar lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and hog1Δ 
containing pRS315 and pRS315HOG1  Cells were harvested at 5 and 18 hrs post resuspension in YNB for 
early exponential and stationary phase samples respectively.  Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 535nm, emission 590nm.  Fluorescence intensities of wild type 
cells containing pRS315 and pRS315HOG1 compared to hog1∆ cells containing pRS315 and pRS315HOG1. 
Data displayed as means of duplicate experiments.   
 
The data derived from these two individual sets of transformations utilising pRS315 was 
inconsistent.  It is suggested that utilisation of pRS315 may have affected the lipid 
phenotype.  Due to this, HOG1 was cloned into another single copy vector, pRS313, which 
contains HIS3 as the selectable marker. 
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4.2.4 Complementation of HOG1 restores lipid accumulation to wild type levels 
As previously described in Section 4.2.2, to ascertain that complementation had been 
successful wild type and hog1∆ strains were transformed with plasmid pRS313 and 
pRS313 containing HOG1 (CLLp004).  These cells were spotted onto YNB agar, minus 
histidine and YNB agar minus histidine supplemented with 0.4 M NaCl.  As demonstrated 
by Figure 4.14, NaCl sensitivity of hog1∆ cells was abolished upon transformation with 
pRS313 expressing HOG1 (CLLp004) and not with the pRS313 vector alone. 
 
 
  
Figure 4.14: Spot plates of S. cerevisiae wild type and hog1∆ with pRS315 and pRS315::HOG1 exposed to 
osmotic stress. Control plates (YNB) and osmotic stress plates, YNB supplemented with 0.4M NaCl. Starting 
cell densities were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate down to 2.3 x 102 
cells/ml. 
 
Protein extracts from wild type cells containing pRS313 and hog1Δ cells containing pRS313 
and pRS313HOG1 were analysed by Western blotting using α-Hog1 antibody.  This was 
carried out to ensure that HOG1 expression was absent for the hog1Δ and that expression 
had been successfully restored in hog1Δ cells containing pRS313HOG1.  As demonstrated 
by Figure 4.15 a band was observed corresponding to Hog1p at 50 kDa for wild type cells 
containing pRS313.  A band corresponding to the 50 kDa Hog1p was also observed for the 
hog1Δ containing pRS313HOG1 and no band was observed in HOG1 deleted cells 
containing empty vector. 
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Figure 4.15:  Western blot showing restoration of Hog1p expression in HOG1 deleted cells. TCA extracted 
protein samples were prepared from wild type and HOG1 deleted cells containing pRS313 and HOG1 
deleted cells containing pRS313HOG1.  Proteins on Western blot were reacted with antibody specific for 
Hog1 to confirm complementation of Hog1 in the hog1Δ. 
 
To determine if the hog1∆ lipid accumulation phenotype had been recovered, 
transformed cells were transferred to YNB medium lacking histidine before resuspending 
at a cell density of 2 x 106 cells/ml in YNB minus histidine.  Cultures were allowed to 
growth before harvesting as described in Section 4.2.3. 
Figures 4.16 and 4.17 show the results of neutral and polar lipid fluorescence intensity of 
wild type and hog1∆ strains transformed with either empty vector, pRS313, or 
pRS313HOG1 in both exponential and stationary phases of growth.  Consistent with data 
shown in Section 4.2.2, the hog1∆ strain transformed with the empty vector displayed a 
significant reduction in fluorescence attributed to neutral lipids with a 1.6 fold decrease 
compared to wild type cells.   
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Upon transformation with pRS313HOG1 levels of fluorescence attributable to neutral 
lipids was restored to that of wild type, increasing 1.7 fold from that of the hog1∆.  Wild 
type cells transformed with pRS313HOG1 did not exhibit any significant difference in 
fluorescence intensity when compared to wild type cells. 
 
  
Figure 4.16:  Neutral lipid fluorescence intensity of Nile red stained retransformed S. cerevisiae wild type 
pRS313 and wild type pRS313::HOG1 compared to hog1∆ pRS313 and hog1 pRS313::HOG1.  Cells were 
harvested at 5 and 18 hrs post resuspension in YNB for early exponential and stationary phase samples 
respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 
cells were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml 
Nile red were added to each sample.  Plates were screened using the wavelengths: excitation 485nm, 
emission 535nm. Data shown as means of triplicates ±SD.  Significance indicated between exponential and 
stationary phases * p<0.05 ***p≤0.001 and difference in stationary phases between cells indicated by solid 
black lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test. 
 
When screened utilising the wavelength attributed to more polar lipid types (Figure 4.17), 
a significant reduction of 1.4 fold was observed in hog1∆ cells compared to wild type 
consistent with results from section 4.2.2.  This was then restored with a 1.4 fold increase 
upon transformation with pRS313HOG1 to wild type levels.  Again, no significant 
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difference to that of wild type was observed for wild type cells transformed with 
pRS313HOG1. 
 
  
Figure 4.17: Polar lipid fluorescence intensity of Nile Red stained retransformed S. cerevisiae wild type 
pRS313 and wild type pRS313::HOG1 compared to hog1∆ pRS313 and hog1 pRS313::HOG1.  Cells were 
harvested at 5 and 18 hrs post resuspension in YNB for early exponential and stationary phase samples 
respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 
cells were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml 
Nile red were added to each sample.  Plates were screened using the wavelengths: excitation 535nm, 
emission 590nm.  Data shown as means of triplicates ±SD.  Significance indicated between exponential and 
stationary phases ***p≤0.001 and difference in stationary phases between cells indicated by solid black 
lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test. 
 
These results show hog1 deleted cells display an altered lipid accumulation phenotype; 
and suggested the involvement of Hog1p in the regulation of lipid accumulation.  
To further investigate this Nile red screening was conducted on other deletions within the 
HOG MAPK pathway to elucidate whether other components of the pathway are involved 
in regulating the accumulation of lipids.  
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4.2.5 Deletions upstream of HOG1 MAP Kinase do not display altered lipid 
phenotypes 
In order to elucidate whether the accumulation of lipids is regulated by components 
upstream of the MAPK Hog1, Nile red screening was conducted on single deletion mutants 
of upstream components of the MAPK cascade sho1∆, ste11∆ and pbs2∆ (see Chapter 1, 
Figure 1.16).  Growth curves were conducted for each strain to ensure samples from wild 
type and deletion strains were in the same phase of growth for the assay (Figures 4.18, 
4.19 and 4.20).   
As shown in the growth curves, for all deletion strains and wild type cells, exponential 
phase growth typically began 5 hrs post resuspension in YNB medium before early 
stationary phase was reached at 12 hrs in both wild type and deletion strains.   
 
  
Figure 4.18:  Growth curve of S. cerevisiae wild type and sho1∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
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Figure 4.19: Growth curve of S. cerevisiae wild type and ste11∆ under normal conditions in yeast nitrogen 
base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
  
Figure 4.20: Growth curve of S. cerevisiae wild type and pbs2∆ under normal conditions in yeast nitrogen 
base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
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 Samples from wild type, sho1∆, ste11∆, and pbs2∆ cultures were harvested and screened 
using Nile red as described in Section 4.2.1.  The hog1∆ was also included as a control for 
low lipid accumulation in stationary phase. 
Figures 4.19 and 4.20 show neutral and polar lipid fluorescence intensities of wild type 
and MAP kinase deletion strains in both early exponential and mid stationary phases of 
growth.  Deletions in the upstream components of the HOG pathway had no effect on the 
accumulation of neutral or polar lipids, with all displaying comparable levels and no 
significant changes to that of the wild type strain.  As previously demonstrated in Section 
4.2.2, cells containing the hog1 deletion displayed significantly attenuated lipid 
accumulation with a 1.7 fold decrease in neutral lipids and 1.4 fold decrease in polar lipids 
compared to wild type. 
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Figure 4.21: Neutral lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and MAP Kinase 
pathway mutants.   Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential and 
stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 
x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 485nm, emission 535nm.  Data shown as means of triplicates ±SD.  Significance 
indicated between exponential and stationary phases *p<0.05 ***p≤0.001 and difference in stationary 
phases between cells indicated by solid black lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA with Tukey 
post hoc test. 
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Figure 4.22: Polar lipid fluorescence intensity of Nile Red stained S. cerevisiae wild type and MAP Kinase 
pathway mutants.   Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential and 
stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 
x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 435nm, emission 590nm. Data shown as means of triplicates ±SD.  Significance 
indicated between exponential and stationary phases ***p≤0.001 and difference in stationary phases 
between cells indicated by solid black lines Ɨ p<0.05.  Data analysed by one way ANOVA with Tukey post hoc 
test. 
 
This data demonstrated that components upstream of Hog1p in the MAPK cascade did not 
appear to be involved in the regulation of lipid accumulation.  As such, the study was 
extended to screen components of the HOG pathway downstream from the MAPK Hog1p 
to elucidate if altered lipid phenotypes were displayed. 
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4.2.6 Neutral lipid accumulation is attenuated on deletion of Msn2/4, a downstream 
target of Hog1p 
As the results from Section 4.2.5 show, lipid accumulation is only significantly reduced at 
the point of the MAPK Hog1p. To further characterise the role of this pathway in lipid 
regulation the Nile red assay was performed on a number of downstream targets of 
Hog1p to assess whether the transcription factors Msn2/4 and Hot1 contributed to the 
accumulation of lipids.  Growth curves are shown in Figures 4.23 and 4.24, and the Nile 
Red assays were conducted as described previously, using hog1∆ cells as a low lipid 
control for stationary phase cultures. 
As demonstrated by Figures 4.23 and 4.24, after an initial lag phase of 5 hrs the deletion 
strains and wild type cells entered exponential growth until early stationary phase is 
achieved at 12 hrs. 
 
  
Figure 4.23: Growth curve of S. cerevisiae wild type and msn2/4∆ under normal conditions in yeast 
nitrogen base medium (YNB).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
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Figure 4.24: Growth curve of S. cerevisiae wild type and hot1∆ under normal conditions in yeast nitrogen 
base medium (YNB). Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until mid to late stationary phase was 
reached. Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion 
strain) showing growth patterns observed for two distinct colonies of the same strain. 
 
Analysis of the Nile red fluorescence data for neutral lipids showed hot1∆ cells had wild 
type levels of neutral lipids. However, in the msn2/4∆ strain a significant decrease of 1.6 
fold in neutral lipids compared to wild type was observed (Figure 4.25).  
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Figure 4.25: Neutral lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and 
transcription factor mutants. Cells were harvested at 5 and 18 hrs post resuspension in YNB for early 
exponential and stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to 
a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in 
triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened 
using the wavelengths: excitation 485nm, emission 535nm. Data shown as means of triplicates ±SD.  
Significance indicated between exponential and stationary phases ***p≤0.001 and difference in stationary 
phases between cells indicated by solid black lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA with Tukey 
post hoc test. 
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 For polar lipids again hot1∆ cells showed no significant difference from wild type.  For the 
msn2/4∆ strain, there was no significant difference in polar lipids compared with the wild 
type strain, with only a slight decrease in fluorescence of 1.1 fold (Figure 4.26). 
 
 
  
Figure 4.26: Polar lipid fluorescence intensity of Nile red stained S. cerevisiae wild type and transcription 
factor mutants. Cells were harvested at 5 and 18 hrs post resuspension in YNB for early exponential and 
stationary phase samples respectively.  Cells were washed twice in PBS before adjusting to a cell density of 2 
x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well plates in triplicate.  25µl 
PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were screened using the 
wavelengths: excitation 535nm, emission 590nm. Data shown as means of triplicates ±SD.  Significance 
indicated between exponential and stationary phases ***p≤0.001 and difference in stationary phases 
between cells indicated by solid black lines ƗƗƗ p≤0.001.  Data analysed by one way ANOVA with Tukey post 
hoc test. 
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4.2.7 Stress sensitivity of HOG pathway deletion strains does not align with observed 
lipid accumulation phenotypes 
As the (HOG) MAPK pathway is involved in the response of cells to conditions of osmotic 
stress, a stress experiment was conducted for all tested deletion strains of the MAPK 
pathway.  This was undertaken to assess whether the lipid phenotypes of cells deleted for 
HOG1 and MSN2/4 could potentially have resulted as a consequence of the stress 
response. 
Figure 4.27 shows that cells lacking SHO1 and STE11 were no more sensitive to salt stress 
than wild type cells.  Cells lacking HOG1 and PBS2, when compared to wild type, showed 
limited growth in the presence of NaCl indicating similar stress sensitivities.  In the case of 
the msn2/4 deletion strain, cells displayed slight sensitivity to salt stress compared to wild 
type but markedly increased growth compared to cells deleted for HOG1 and PBS2.  This 
data indicated that stress sensitivity of the deletion strains did not align with the lipid 
accumulation phenotypes observed in the Nile red screen. 
  
Figure 4.27: Spot plates of S. cerevisiae wild type, sho1∆, ste11Δ, pbs2Δ, hog1Δ msn2/4Δ and hot1Δ. 
Control plates (YNB) and osmotic stress plates, YNB supplemented with 0.4M NaCl. Starting cell densities 
were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate down to 2.3 x 102 cells/ml. 
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4.2.8 Lipid accumulation is not delayed in cells deleted for HOG1 
It is known that Hog1p plays a crucial role in cell cycle control as well as in the resting exit 
status of cells (Escoté et al. 2011).  Therefore it is important to determine whether the 
lipid phenotype observed in the hog1 delete was the result of delayed accumulation 
either from delayed cell cycle progression in G1 (which has been shown to occur in HOG1 
deleted cells under stress) or from delayed resting exit resulting from resuspension of cells 
into YNB medium.   
To determine if lipid accumulation was reduced or rather delayed in the hog1Δ, a time 
course was conducted and lipid levels determined in wild type and hog1Δ cells.  Samples 
were harvested at 5, 8, 12, 18, 24, 48 and 72 hrs post resuspension so that lipid 
accumulation at each stage of growth could be assessed via the Nile red fluorescence 
method. The 72 hr time point was chosen as this is the stage where a reduction in lipids is 
expected to be observed due to β-oxidation (Beopoulos et al. 2011). 
As shown in Figure 4.28, wild type cells began to gradually accumulate neutral lipids as 
growth progresses, with maximum levels reached after 24hrs, as cells enter stationary 
phase. From 48 hrs onwards, a decrease in neutral lipids was then observed. Initial neutral 
lipid levels in the hog1Δ are comparable to those found in wild type cells. However, as the 
growth curve progressed hog1∆ cells failed to accumulate neutral lipids at the level seen 
in wild type cells. In stationary phase (after 12 hrs) significant decreases in lipid 
accumulation, of between 1.3 and 1.6 fold were observed at each time point in the hog1Δ 
compared to wild type, consistent with previous stationary phase data derived for the 
hog1Δ in this chapter. 
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Figure 4.28: Nile Red neutral lipid fluorescence intensity over time of S. cerevisiae wild type and hog1Δ. 
Cells were harvested at 5, 8, 12, 18, 24, 48 and 72 hours post resuspension in YNB.  Cells were washed twice 
in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of 
black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  
Plates were screened using the wavelengths: excitation 485nm, emission 535nm.  Cultures were incubated 
for the time course at 30oC, 180rpm in YNB medium until the time points illustrated on the graph.  
Significant differences between wild type and the hog1Δ at each stage of the time course indicated by 
***p≤0.001, *p≤0.05.  Data analysed by one way ANOVA with Tukey post hoc test. 
 
For polar lipids again the hog1Δ failed to accumulate lipid to a comparable level of the 
wild type strain after the early exponential phase 5 hr time point.  Significant decreases of 
between 1.2 and 1.4 fold were observed at each point after 8 hours and thereafter until 
late stationary phase at 24 hrs, consistent with previous polar lipid related fluorescence 
data obtained for hog1Δ cells in this chapter.  As expected with the 48 and 72 hr time 
points, a decrease in both neutral and phospholipids was observed in both wild type and 
hog1 deleted cells (Figure 4.29). 
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Figure 4.29: Nile Red polar lipid fluorescence intensity over time of S. cerevisiae wild type and hog1Δ.  
Cells were harvested at 5, 8, 12, 18, 24, 48 and 72 hours post resuspension in YNB.  Cells were washed twice 
in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of 
black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  
Plates were screened using the wavelengths: excitation 535nm, emission 590nm.  Cultures were incubated 
for the time course at 30oC, 180rpm in YNB medium until the time points illustrated on the graph.  
Significant differences between wild type and the hog1Δ at each stage of the time course indicated by 
***p≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test. 
 
This data demonstrated that the attenuated lipid accumulation phenotype seen when 
screening cells in mid stationary phase, 18 hrs, was not as a result of delayed 
accumulation in cells lacking HOG1. 
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4.2.9 Hog1p is dually phosphorylated as cells begin to accumulate lipid 
To determine whether Hog1 is dually phosphorylated and activated at the initiation of 
lipid accumulation processes, which would imply a role for Hog1p in regulating lipid levels, 
protein samples were prepared from wild type cells at hourly time intervals from early 
exponential phase (5 hrs) until late exponential phase (9/10 hrs).  The resultant Western 
blot was probed with antibodies to detect the dual phosphorylation status, α-P-p38 and 
total levels of Hog1p, α-Hog1. 
As shown by Figure 4.30, Hog1p was phosphorylated at lag phase (5 hrs) and early 
exponential phase (7 hrs), which aligned with the transition of cells from lag to the 
exponential phase of growth.   
Phosphorylation did not occur at the 8 hr time period, aligning with exponential growth, 
before becoming apparent again at 9 hrs. The dual phosphorylation of Hog1p at 9 hrs 
aligned with cells in late exponential/early stationary phase of growth and after the point 
at which wild type S. cerevisiae began to accumulate lipid, as demonstrated in Figure 4.28 
(8-12 hrs).  After 10 hrs phosphorylation of Hog1p was once again not observed.   
 
  
Figure 4.30: Western blots of S. cerevisiae Hog1 phosphorylation status in wild type cells over time. Time 
in hours indicates time protein sample was harvested post resuspension in YNB medium.  α-P-p38: 
phosphorylated Hog1p.  α-hog1: total Hog1 protein levels.  
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To further dissect the phosphorylation status of Hog1p, protein samples were harvested 
at half hourly intervals from 6 hrs until 9.5 hrs.  As shown in Figure 4.31, phosphorylation 
of Hog1p was again observed at 7 hrs consistent with Figure 4.30.  After this point Hog1p 
phosphorylation was again reduced until being observed again at 9 and 9.5 hrs.   
 
 
  
 
Figure 4.31: Western blots of S. cerevisiae Hog1 phosphorylation status in wild type cells at half hourly 
intervals. Time in hours indicates time protein sample was harvested post resuspension in YNB medium.  α-
P-p38: phosphorylated Hog1p.  α-hog1: total Hog1 protein levels.  
 
 
From this it can be concluded that Hog1p was dually phosphorylated between 9 and 9.5 
hrs post resuspension in YNB and that this phosphorylation aligned with the point at 
which cells entered the late exponential/early stationary phase of growth, as well as 
aligning with increased cellular lipid accumulation in S. cerevisiae. 
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4.2.9.1 Nutrient limitation as an activator of Hog1p 
It has been previously reported that Hog1p is dually phosphorylated in response to 
nitrogen limitation (-N) (Aoki Y. et al. 2011b).  Nutrient limitation is a natural consequence 
of growth as yeast cells enter late exponential/early stationary phase.  In this study by 
Aoki et al.  (2011) dual phosphorylation of Hog1p was observed at 3 hrs post resuspension 
of cells from YPD medium to YNB plus NaCl and YNB – N. 
To determine whether the phosphorylation observed in Figures 4.30 and 4.31 could be as 
a result of nutrient limitation the experiment was repeated with some adaptations.  Firstly 
YNB pre-cultures were employed instead of YPD, cells were resuspended either into 
complete YNB medium or YNB minus carbon source (-C) to assess the effect of carbon 
limitation.  Further to this YNB –N and lacking amino acids was employed as it was unclear 
from the study by Aoki et al. (2011) whether YNB –N contained amino acids. Samples were 
harvested at 3 hrs post resuspension and the resulting protein samples were analysed 
with antibodies to detect the dually phosphorylated Hog1p and total Hog1p protein levels, 
as with the previous experiment. 
As shown by Figure 4.32, 3 hrs post resuspension in YNB complete medium low levels of 
Hog1p phosphorylation were observed.  Phosphorylation was increased in cells subjected 
to treatment with 0.4M NaCl, as expected and consistent with the observation by Aoki et 
al.  (2011). However, no phosphorylation was observed when cells were transferred from 
YNB to medium lacking nitrogen plus amino acids, nitrogen or carbon sources. 
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Figure 4.32: Western blots of S. cerevisiae Hog1 phosphorylation status under nutrient starvation. YNB: 
Yeast nitrogen base complete medium, +NaCl: Yeast nitrogen base complete medium supplemented with 
0.4M NaCl, -N and aa: Yeast nitrogen base medium minus nitrogen and amino acid source, -N: Yeast 
nitrogen base medium minus nitrogen source, -C: Yeast nitrogen base medium minus carbon source.  α-P-
p38: phosphorylated Hog1p.  α-hog1: total Hog1 protein levels.  
 
This suggested that nutrient starvation, both nitrogen and carbon, did not result in the 
dual phosphorylation of Hog1p at 3 hrs post resuspension in starvation medium.   
 
 
 
 
 
 
α-P-p38
α-Hog1
50kDa
50kDa
S. cerevisiae wt 3hrs
YN
B
+ 
N
aC
l
-N
 a
nd
 a
a
-N -C
187 
4.2.9.2 Observed phosphorylation of Hog1p appears to be Pbs2 dependant 
As described previously, Hog1p is dually phosphorylated in response to stress on Thr174 
and Ty176 residues by its upstream MAPKK Pbs2.  However, lipid accumulation data 
suggests that Pbs2 was not involved at the lipogenic switch. To assess whether Hog1p 
phosphorylation observed in Figures 4.30 and 4.31 was Pbs2 dependant, protein samples 
were harvested from the pbs2 deletion strain at 6 hrs and half hourly intervals thereafter, 
before probing the resultant Western blot with antibodies to detect phosphorylated and 
total levels of Hog1p.  As shown by Figure 4.33, no phosphorylation was found to be 
present at any point during the time course.  
 
  
Figure 4.33: Western blots of S. cerevisiae Hog1 phosphorylation status in pbs2Δ cells at half hourly 
intervals. Time in hours indicates time protein sample was harvested post resuspension in YNB medium.  α-
P-p38: phosphorylated Hog1p.  α-hog1: total Hog1 protein levels.  
 
Therefore, the results of the time course conducted with the pbs2Δ suggested that the 
phosphorylation observed in Figures 4.30 and 4.31 was dependent on the MAPKK Pbs2.   
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4.2.9.3 Potential Pbs2-independent phosphorylation of Hog1  
To further investigate the phosphorylation status of Hog1p in both wild type and pbs2Δ 
cells, a Phos-tag gel of protein samples utilised in Section 4.2.9 was undertaken (Figure 
3.3.4. Phosphorylated proteins are bound within an SDS-PAGE gel by Phos-tag, as such the 
migration speed of proteins which are phosphorylated is decreased compared to non-
phosphorylated proteins. 
As demonstrated by Figure 4.34, at 7.5 hrs where little dual phosphorylation was 
observed, bands for both wild type and the pbs2Δ appeared to migrate to an equivalent 
level.  At 8.5 hrs, where very little dual phosphorylation of Hog1p was detected in Figure 
4.31, an upshift of the hog1 band was observed both in wild type and pbs2Δ samples.  This 
is indicative of protein phosphorylation and suggested that Hog1p is further 
phosphorylated at this point, independently of Pbs2.  At 9 hrs there appeared to be an 
additional upshift of the wild type sample, which is suggested to be as a result of Hog1p 
dual phosphorylation by Pbs2. 
 
  
Figure 4.34: Phos-tag Western blot of S. cerevisiae Hog1 in wild type and pbs2Δ cells. Time in hours 
indicates time protein sample was harvested post resuspension in YNB medium. α-hog1: total Hog1 protein 
levels.  
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The results of the Phos-tag gel suggested that Hog1p was additionally phosphorylated in a 
Pbs2 independent manner at 8.5 hrs.  This 8.5 hr time point precedes the point where S. 
cerevisiae displays a marked increase in accumulated lipids post resuspension in YNB, as 
shown previously by Figure 4.28 (8 to 12 hrs). 
 
4.3 Regulation of lipid synthesis by Hog1 
It has been demonstrated in this chapter that Hog1p appears to play a role in the 
accumulation of lipids in S. cerevisiae along with its downstream target Msn2/4.  Utilising 
bioinformatics, potential targets of Hog1 and Msn2/4 that are involved in the regulation of 
lipid homeostasis were identified. 
4.3.1 Potential MAPK phosphorylation sites on lipid regulatory proteins 
Hog1 phosphorylates target proteins on conserved serine and threonine resides which are 
followed by a proline residue. Selected key lipid regulatory proteins were identified via 
bioinformatics analysis to contain potential MAPK phosphorylation sites. 
Dga1p, a major protein involved in TAG synthesis, can be localised to the ER or present on 
lipid droplets within the cytoplasm.  After analysis of the protein sequence via UniProt, it 
was found that Dga1p has four potential MAPK phosphorylation sites within the N 
terminus of the protein sequence (Figure 4.35). 
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Figure 4.35:  The protein sequence of Dga1p contains potential MAPK phosphorylation sites. Identification 
of potential MAPK phosphorylation sites within the N terminus of Dga1p.  Phosphorylation sites are 
indicated on the graphical diagram in red and yellow within the protein sequence.  Phosphorylation sites 
were determined from data curated by Uniprot and Saccharomyces genome database. 
 
 
Lro1p, another contributor to TAG synthesis by an acyl-CoA independent pathway, 
contains two potential MAPK sites at residues 475 and 586 (Figure 4.36). 
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Figure 4.36:  The protein sequence of Lro1p contains potential MAPK phosphorylation sites. 
Phosphorylation sites are indicated on the graphical diagram in red and yellow within the protein sequence.  
Phosphorylation sites were determined from data curated by Uniprot and Saccharomyces genome database. 
 
 
With regards to the regulation of phospholipids, one potential MAPK site was found at 
position 157 in the protein sequence of Cho1, an outer mitochondrial membrane protein 
involved in the synthesis of PS (Figure 4.37).   
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Figure 4.37: The protein sequence of Cho1p contains potential MAPK phosphorylation sites. 
Phosphorylation sites are indicated on the graphical diagram in red and yellow within the protein sequence.  
Phosphorylation sites were determined from data curated by Uniprot and Saccharomyces genome database. 
 
 
Further to this, a further 6 potential MAPK sites were identified within sequence of the ER 
protein Cho2, which catalyses the first step in the phosphatidylethanolamine to 
phosphatidylcholine conversion (Figure 4.38). 
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Figure 4.38:  The protein sequence of Cho2p contains potential MAPK phosphorylation sites. Potential 
phosphorylation sites are indicated on the graphical diagram in red and yellow within the protein sequence.  
Phosphorylation sites were determined from data curated by Uniprot and Saccharomyces genome database. 
 
Potential MAPK phosphorylation sites were also found in all four of the SREBP-like 
proteins of S. cerevisiae Mga2, Spt23, Ecm22 and Upc2.  All are intracellular membrane 
proteins which translocate to the nucleus upon requirement and are involved in the 
transcription of lipid regulatory genes.   
In the protein sequences of Ecm22 and Upc2 multiple potential MAPK sites were found 
throughout the protein sequences (Figures 4.39 and 4.40).  Of those identified in the 
sequence of Ecm22p amino acids 431, 445 and 464 have been assigned as phosphoserines 
via multidimensional chromatography analysis (Albuquerque et al. 2008).   
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Figure 4.39: The protein sequence of Ecm22p contains potential MAPK phosphorylation sites. 
Phosphorylation sites that have been assigned phosphoserine status are indicated on the graphical diagram 
in red and yellow within the protein sequence.  Phosphorylation sites were determined from data curated 
by Uniprot and Saccharomyces genome database. 
 
Similarly for Upc2 amino acid residues 122, 519 and 522 have been assigned 
phosphothreonine and phosphoserine sites (Figure 4.40). Additionally, residues 520-523 
have been assigned as a MAPK/ERK site (Albuquerque et al. 2008), demonstrating a 
potential interaction of MAPKs and SREBP-like proteins. 
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Figure 4.40: The protein sequence of Upc2p contains potential MAPK phosphorylation sites. 
Phosphorylation sites that have been assigned phosphoserine or phosphothreonine status are indicated on 
the graphical diagram in red and yellow within the protein sequence.  Phosphorylation sites were 
determined from data curated by Uniprot and Saccharomyces genome database. 
 
In Spt23 and Mga2 the potential MAPK sites are highlighted in Figures 4.41 and 4.42 
respectively.  Out of all of the phosphorylation sites present within the protein sequences 
of Spt23 and Upc2, only residue 468 of Spt23 has been assigned as a phosphoserine by 
quantitative mass spectrometry (Holt et al. 2009).   
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Figure 4.41: The protein sequence of Spt23p contains potential MAPK phosphorylation sites. 
Phosphorylation site that has been assigned phosphoserine is indicated on the graphical diagram in red and 
yellow within the protein sequence.  Phosphorylation sites were determined from data curated by Uniprot 
and Saccharomyces genome database. 
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Figure 4.42: The protein sequence of Mga2p contains potential MAPK phosphorylation sites. 
Phosphorylation sites are indicated on the graphical diagram and in red and yellow within the protein 
sequence.  Phosphorylation sites were determined from data curated by Uniprot and Saccharomyces 
genome database. 
 
 
 
 
 
198 
 4.3.2 Msn2/4 as a regulator of SREBP-like protein activity 
Hog1p has a number of downstream targets including the transcription factors Msn2/4. 
This study has demonstrated a neutral lipid phenotype associated with deletion of these 
genes.  SREBP-like proteins are important in the transcriptional regulation of lipid 
homeostasis, as such bioinformatics analyses were undertaken to elucidate whether 
SREBP-like proteins are potential transcriptional targets of Msn2/4. 
Msn2/4 bind to stress response elements (STRE) within the promoter regions of target 
genes in order to regulate their expression.  STRE elements identified that are bound by 
Msn2/4 are 5’-CCCCT-3’ and 5’-AGGGG-3’ (Grably et al. 2002).  It was found that both 
ECM22 contained a full STRE element within its promoter region at position -238, whereas 
UPC2 contained PDS elements (Figure 4.43). 
 
 
  
Figure 4.43:  The promoter regions of ECM22 and UPC2 contain STRE and PDS elements. Promoter regions, 
1000 bp upstream of the ORF were analysed for the presence of STRE and PDS elements.  Sequence 
positions within the promoter are indicated STRE (red), PDS CCCT (blue) and PDS AGGG (green). 
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 On analysis of the promoter regions of SPT23 and MGA2, it was found that MGA2 
contained a full STRE element at position -62, and SPT23 contained PDS elements (Figure 
4.44). 
 
 
  
Figure 4.44: The promoter regions of SPT23and MGA2 contain STRE and PDS elements. Promoter regions, 
1000 bp upstream of the ORF were analysed for the presence of STRE and PDS elements.  Sequence 
positions within the promoter are indicated STRE (red), PDS CCCT (blue) and PDS AGGG (green). 
 
From analyses of the bioinformatics data collated it is suggested that the MAPK pathway 
of S. cerevisiae may regulate components important in the metabolism of lipids. 
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4.4 Lipid phenotypes observed in S. cerevisiae are conserved in the fission 
yeast S. pombe at the level of the MAPK 
The fission yeast S. pombe has been used extensively as a model eukaryote in human 
disease research and additionally has been found to be more similar to human cells in cell 
cycle regulation and stress responses.  As S. pombe cells are as divergent from S. 
cerevisiae as they are mammalian cells, the study was extended to elucidate whether the 
Sty1 MAPK pathway of S. pombe was also involved in regulating lipid homeostasis.  A 
strain containing a deletion of the upstream MAPKK, wis1 was screened along with a sty1 
deletion strain and a Sty1 Kinase dead mutant which is able to be phosphorylated and 
translocate to the nucleus.  However, once in the nucleus the kinase dead mutant is 
unable to activate its downstream targets (Reiter et al. 2008).  Deletions in two of the 
main downstream targets of Sty1p in the stress response, atf1 and pap1 were also 
screened to elucidate whether downstream members of this stress response pathway 
were involved in the regulation of lipid accumulation. 
4.4.1 Lipid accumulation is attenuated upon deletion of sty1 and its upstream 
MAPKK wis1 
The S. pombe MAPK protein Sty1p has been well characterised and is well conserved to 
both S. cerevisiae Hog1p and the mammalian p38 MAP Kinase. To determine if the Sty1 
MAPK pathway in S. cerevisiae has a role in lipid accumulation, neutral and polar lipid 
levels were examined in wis1 and sty1 deletion strains along with a sty1-KD mutant using 
the Nile red assay.  
Growth curves were conducted to ensure samples from wild type, wis1∆, sty1∆ and sty1-
KD strains had comparable growth phases.  As shown in Figure 4.45, cells deleted for wis1 
had a longer lag phase than wild type cells.  Wild type cells typically entered exponential 
growth 10 hrs post resuspension in EMM, whereas wis1 deleted cells lag for 
approximately a further 3 hrs before entering the exponential phase.  Although the wis1Δ 
entered stationary phase at a similar cell density and at the same point as wild type cells, 
at 24 hrs, it is important to note that up until stationary phase cells lacking wis1 failed to 
reach an equivalent cell density to that of wild type cells. 
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Figure 4.45: Growth curve of S. pombe wild type and wis1∆ under normal conditions in Edinburgh minimal 
medium (EMM).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, duplicate, at 
30oC.  Optical density readings were taken hourly until stationary phase was reached. Growth curves were 
conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing growth patterns 
observed for two distinct colonies of the same strain. 
 
In cells lacking sty1, Figure 4.46, exponential growth began at an equivalent time point to 
wild type cells at 10 hrs.  Although the sty1Δ also failed to reach an equivalent cell density 
until the point of stationary phase at 24 hrs, the growth defect observed was not as severe 
as that of the wis1Δ strain. 
The sty1-kinase dead mutant displayed a similar growth pattern to that of cells deleted for 
sty1, although reached a lower cell density during exponential growth until stationary 
phase was achieved at 24 hrs (Figure 4.47). 
0 5 10 15 20 25 30
0
1
2
3
4
Wild type 1
Wild type 2
wis1∆ 1
wis1∆ 2
Time hrs
O
D
59
5n
m
202 
  
Figure 4.46: Growth curve of S. pombe wild type and sty1∆ under normal conditions in Edinburgh minimal 
medium (EMM).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, duplicate, at 
30oC.  Optical density readings were taken hourly until stationary phase was reached. Growth curves were 
conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing growth patterns 
observed for two distinct colonies of the same strain. 
  
Figure 4.47: Growth curve of S. pombe wild type and Sty1 kinase dead mutant under normal conditions in 
Edinburgh minimal medium (EMM).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with 
shaking, duplicate, at 30oC.  Optical density readings were taken hourly until stationary phase was reached. 
Growth curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) 
showing growth patterns observed for two distinct colonies of the same strain. 
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The results of Nile red screening to infer the neutral lipid status at early stationary phase 
demonstrated that neutral lipid accumulation was significantly perturbed in both the wis1 
and sty1 deletion strains. The wis1Δ exhibited a 2 fold decrease and the sty1Δ a 1.9 fold 
decrease compared to wild type cells.  The sty1-KD mutant also accumulated significantly 
lower levels of neutral lipids, 1.3 fold decrease, compared to the wild type strain although 
the phenotype observed was not as severe as in the sty1 deletion strain (Figure 4.48). 
 
 
  
Figure 4.48: Neutral lipid fluorescence intensity of Nile red stained S. pombe wild type and MAPK pathway 
mutants. Cells were harvested at 24 hrs post resuspension in EMM. Cells were washed twice in PBS before 
adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were transferred to the wells of black 96-well 
plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red were added to each sample.  Plates were 
screened using the wavelengths: excitation 485nm, emission 535nm. Data shown as means of triplicates 
±SD.  Significance between strains is indicated by solid black lines Ɨ p<0.05, ƗƗƗ p≤0.001.  Data analysed by one 
way ANOVA with Tukey post hoc test. 
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For screening to identify more polar lipid subtypes accumulation was similarly attenuated 
in both the wis1 and sty1 deletion strains with both displaying a 1.8 fold decrease.  
Although a reduction of 1.3 fold was observed for the sty1-KD mutant, this failed to reach 
significance when compared to wild type cells (Figure 4.49). 
 
 
 
  
Figure 4.49: Polar lipid fluorescence intensity of Nile red stained S. pombe wild type and MAPK pathway 
mutants. Cells were harvested at 24 hours post resuspension in EMM for early stationary phase samples.  
Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells were 
transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile red 
were added to each sample.  Plates were screened using the wavelengths: excitation 535nm, emission 
590nm. Data shown as means of triplicates ±SD.  Significance between strains is indicated by solid black lines 
ƗƗƗ p≤0.001.  Data analysed by one way ANOVA with Tukey post hoc test. 
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4.4.1.1 Viability of S. pombe MAPK deletions at stationary phase 
It is reported that Sty1p is required for entry into stationary phase and mutants in Sty1 
MAPK pathway lose viability at stationary phase (Shieh et al. 1998). As such, viability of 
cells deleted for wis1 and sty1 were determined at the 24hr time point by methylene blue 
on duplicate cultures.  
Figure 4.50 shows the results of cell viability in early stationary phase, determined from 
methylene blue staining.  Wild type cells had an average of 98% viability at the 24hr 
stationary phase time point.  Samples from cultures of the sty1 deleted strain had 
percentage viability within 10% of that of wild type cells at 91.5% (93% and 90%).  
However, the viability of cultures where cells were deleted for wis1 was less clear.  The 
average viability of these samples was 86% with one sample being found 81% viable and 
the other 91% viable. 
 
 
  
Figure 4.50: Percentage viability of wis1 and sty1 deleted cells compared to cells from wild type cultures. 
Samples were harvested at the 24 hr time point utilised for Nile red screening.  Methylene blue stain was 
added to cultures at a 1:1 ratio and incubated for 5 minutes at room temperature.  Cells were counted on a 
haemocytometer.  Cells stained blue were counted as non-viable cells.  Average percentage viability is 
displayed as means from duplicate cultures. 
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4.4.2 The stress response of S. pombe aligns with altered lipid phenotypes 
As the (Sty1) MAPK pathway is involved in the response of cells to conditions of stress, a 
stress experiment was conducted of upstream components of the MAPK pathway.  This 
was undertaken to assess whether the lipid phenotypes of cells deleted for wis1 and sty1 
could potentially have resulted as a consequence of the stress response. 
It has been previously shown that strains deleted for wis1 and sty1 are sensitive to 
oxidative stress (H202).  Figure 4.51 shows that cells lacking wis1 and sty1 were more 
sensitive to oxidative stress when compared to wild type. It is further demonstrated that 
the sty1-KD mutant displayed increased resistance compared to the sty1Δ in the presence 
of oxidative stress.  From this it can be concluded that the stress sensitivity of these 
mutants did align with the lipid phenotypes observed.  This is in contrast to S. cerevisiae, 
where it was shown that the stress response of deletion mutants did not align with the 
observed lipid phenotypes. 
 
 
  
Figure 4.51: Spot plates of S. pombe wild type, wis1∆, sty1Δ and Sty1-KD. Control plates (EMM) and 
oxidative stress plates, EMM supplemented with 1mM hydrogen peroxide (H2O2). Starting cell densities 
were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate down to 2.3 x 102 cells/ml. 
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4.4.3 Atf1 and Pap1, downstream targets of Sty1, do not play a significant role in 
lipid accumulation 
To characterise whether the lipid accumulation phenotypes extend downstream of the 
MAPK Sty1, the Nile red assay was performed on downstream targets of Sty1p to assess 
whether the transcription factors Aft1 and Pap1 contributed to the accumulation of lipids.  
Growth curves were conducted to ensure cells were in a comparable phase of growth 
before performing Nile red (Figures 4.52 and 4.53). 
As demonstrated by Figures 4.52 and 4.53, after an initial lag phase of 10 hrs the deletion 
strains and wild type cells entered exponential growth, until early stationary phase was 
achieved at 24 hrs. 
 
 
 Figure 4.52: Growth curve of S. pombe wild type and aft1Δ under normal conditions in Edinburgh minimal 
medium (EMM).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, duplicate, at 
30oC.  Optical density readings were taken hourly until stationary phase was reached. Growth curves were 
conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing growth patterns 
observed for two distinct colonies of the same strain. 
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Figure 4.53: Growth curve of S. pombe wild type and pap1Δ under normal conditions in Edinburgh 
minimal medium (EMM).  Cultures were diluted to 2 x 106 cells (OD595 ~0.1) and incubated with shaking, 
duplicate, at 30oC.  Optical density readings were taken hourly until stationary phase was reached. Growth 
curves were conducted in duplicate (culture 1 and culture 2 for both WT and deletion strain) showing 
growth patterns observed for two distinct colonies of the same strain. 
 
 
Figure 4.54 shows the results of the Nile red assay to assess neutral lipid status.  Although 
changes failed to reach significance when compared to wild type, the atf1Δ displayed a 1.2 
fold decrease and pap1Δ cells a 1.1 fold decrease in fluorescence intensity. 
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Figure 4.54: Neutral lipid fluorescence intensity of Nile red stained S. pombe wild type and transcription 
factor mutants. Cells were harvested at 24 hours post resuspension in EMM for early stationary phase 
samples.  Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells 
were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile 
red were added to each sample.  Plates were screened using the wavelengths: excitation 485nm, emission 
535nm. Data shown as means of triplicates ±SD. Data analysed by one way ANOVA with Tukey post hoc test. 
 
In cells lacking aft1 and pap1 significant differences were detected when samples were 
screened using the wavelength attributed to more polar lipids by Nile red. (Figure 4.55). 
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Figure 4.55: Polar lipid fluorescence intensity of Nile red stained S. pombe wild type and transcription 
factor mutants. Cells were harvested at 24 hours post resuspension in EMM for early stationary phase 
samples.  Cells were washed twice in PBS before adjusting to a cell density of 2 x 107 cells/ml.  5 x 106 cells 
were transferred to the wells of black 96-well plates in triplicate.  25µl PBS/DMSO (1:1 v/v) and 5µg/ml Nile 
red were added to each sample.  Plates were screened using the wavelengths: excitation 535nm, emission 
590nm. Data shown as means of triplicates ±SD. Data analysed by one way ANOVA with Tukey post hoc test. 
 
 
This data suggests that the downstream Sty1 targets, Atf1 and Pap1, did not hold a 
significant role in the regulation of lipid accumulation in S. pombe. 
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4.4.4 Potential MAPK sites on S. pombe lipid regulatory proteins is conserved to that 
of S. cerevisiae 
To elucidate whether the potential MAPK sites identified for S. cerevisiae were conserved 
in S. pombe, Uniprot was utilised to search for potential MAPK sites with S. pombe protein 
sequences.  After analysis of the protein sequences via UniProt, it was found that Dga1p 
has one potential MAPK phosphorylation sites within the N terminus of the protein 
sequence, Figure 4.56. 
 
  
Figure 4.56: The protein sequence of Dga1p contains a potential MAPK phosphorylation site. Identification 
of a potential MAPK phosphorylation site within the N terminus of Dga1p.  Phosphorylation sites are 
indicated on the graphical diagram and in yellow within the protein sequence.  Phosphorylation sites were 
determined from data curated by Uniprot and PomBase genome database. 
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The Lro1p homologue in S. pombe, Plh1 was found to contain two potential 
phosphorylation sites within the N terminus of the protein sequence (Figure 4.57). 
 
 
 
 
  
Figure 4.57: The protein sequence of Plh1p contains potential MAPK phosphorylation sites. Identification 
of potential MAPK phosphorylation sites within the N terminus of Plh1p.  Phosphorylation sites are indicated 
on the graphical diagram and in yellow within the protein sequence.  Phosphorylation sites were determined 
from data curated by Uniprot and PomBase genome database. 
 
 
 
 
 
213 
S. pombe Pps1p (Cho1p homologue) was found to contain 4 potential phosphorylation 
sites (Figure 4.58). 
 
 
 
 
  
Figure 4.58: The protein sequence of Pps1p contains potential MAPK phosphorylation sites. Identification 
of potential MAPK phosphorylation sites within the protein sequence of Pps1p.  Phosphorylation sites are 
indicated on the graphical diagram and in yellow within the protein sequence.  Phosphorylation sites were 
determined from data curated by Uniprot and PomBase genome database. 
 
 
The SREBP homologues of S. pombe were found to contain multiple potential MAPK 
phosphorylation sites throughout their protein sequences.  The N terminus of Sre1p was 
found to be more enriched with sites than the C terminal region (Figure 4.59). 
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Figure 4.59: The protein sequence of Sre1p contains potential MAPK phosphorylation sites. Identification 
of potential MAPK phosphorylation sites within the protein sequence of Sre1p.  Phosphorylation sites are 
indicated on the graphical diagram and in yellow within the protein sequence.  Phosphorylation sites were 
determined from data curated by Uniprot and PomBase genome database. 
 
As shown by Figure 4.60, the protein sequence of Sre2p also contained multiple potential 
MAPK sites, although not as many in comparison to Sre1 (19 sites versus 12 sites). 
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Figure 4.60: The protein sequence of Sre2p contains potential MAPK phosphorylation sites Identification 
of potential MAPK phosphorylation sites within the protein sequence of Sre2p.  Phosphorylation sites are 
indicated on the graphical diagram and in yellow within the protein sequence.  Phosphorylation sites were 
determined from data curated by Uniprot and PomBase genome database. 
 
From analysis of the protein sequences indicating potential MAPK phosphorylation sites, it 
may be suggested that the potential targets of Hog1p in the regulation of lipid 
accumulation are similarly conserved in S. pombe. 
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4.5 Discussion 
In this chapter the aim was to elucidate whether the p38 MAP Kinase pathway, which is 
also commonly de-regulated in cancer and highly conserved in yeast, could play a role in 
mediating cancer-related de novo lipogenesis.  Nile red screening was initially conducted 
on deletions from the TOR pathway, as mTORC1 has been demonstrated to be a key 
upstream regulator of the synthesis of lipid in mammalian cells.  mTORC1 signalling, 
driven by Akt, results in upregulation of SREBP-1 activity contributing to the synthesis of 
lipids (Laplante and Sabatini 2009b).  In a study by Portsmann et al. (2008) it was found 
that inhibition of mTORC1, blocked Akt induced nuclear localisation of SREBP-1, indicating 
that SREBP activation is dependent on mTORC1 activity (Porstmann et al. 2008). 
The Nile red screening conducted on S. cerevisiae Tor component deletions showed that 
levels of lipid, particularly neutral lipids, were reduced in the tor1 deletion strain (Figures 
4.44 and 4.45).  This highlighted a role for Tor1p in lipid synthesis in S. cerevisiae, which is 
consistent with the observation in mammalian cells that mTORC1 regulates the synthesis 
of lipids (Porstmann et al. 2008).  Although not significant, an increased neutral lipid 
phenotype was also observed when the Tor1 complex was deleted for Tco89 (Figure 4.44).  
Tco89p has been shown to be involved in the packaging of enzymes/proteins into 
vacuoles for subsequent degradation.  One such enzyme is fructose 1,6-biphosphatase 
(FBPase), a key enzyme of the gluconeogenic pathway. It has been described that Tco89p 
presence is essential for vacuole import and degradation of FBPase (Yan and Kang 2010). 
Therefore inefficient degradation of FBPase may contribute to increased lipid 
accumulation through production of glycolytic intermediates (Ros and Schulze 2013).  
Tor2p has not been demonstrated to play a significant role in the synthesis of lipids. The 
results of the Nile red assay confirmed this, demonstrating that deletion of AVO2 did not 
result in a significantly different lipid phenotype from that of wild type cells (Figures 4.44 
and 4.45). 
Using the Nile red assay it was established that neutral and phospholipid phenotypes 
could be distinguished between when screening deletions of Tor components based on 
the fluorescence values obtained of the deletion strains compared to wild type cells.   
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To assess whether the HOG MAPK pathway of S. cerevisiae was also involved in regulation 
of lipid homeostasis, wild type and hog1Δ strains were screened via Nile red.  The Nile red 
screening of the MAP kinase from the HOG pathway in S. cerevisiae revealed a decreased 
neutral and phospholipid phenotype of the hog1Δ compared to wild type (Figures 4.7 and 
4.8).  Upon complementation of hog1 deleted cells with pRS315HOG1 the stress sensitive 
phenotype of the hog1Δ to NaCl was recovered to that of wild type levels (Figure 4.9). 
However, upon transferring transformed cells to culture in order to assess if the lipid 
phenotype could be restored the Nile red data was inconsistent.  In the case of the hog1Δ 
transformed with empty vector, pRS315, a significantly increased lipid phenotype was 
observed (Figures 4.10 and 4.11).  As inconsistencies persisted, even after re-
transformation of the cells (Figures 4.12 and 4.13), it was suggested that the lipid 
phenotype was the result of the pRS315 leucine based vector.  This was further supported 
by the work of Kamisaka et al. (2007), in which a similar phenomenon occurred in the S. 
cerevisiae snf2Δ strain.  When cells deleted for snf2 were transformed with an empty 
leucine vector they displayed significantly increased lipid accumulation of ~1.3 fold, which 
was not seen in cells transformed with an empty vector containing the URA3 marker.  The 
phenotype observed with the empty LEU2 vector could also be replicated by adding large 
amounts of leucine to the growth medium of snf2Δ cultures.  It was found that the 
exogenous leucine initially acted to increase cellular weight prior to accumulation of lipid 
and so confirmed that leucine biosynthesis, as a consequence of LEU2 expression from 
pRS315, caused enhanced lipid accumulation (Kamisaka et al. 2007).   
The impact of leucine expression on lipid accumulation may be explained via two 
mechanisms.  Firstly it is suggested that excessive leucine expression may impact on and 
subsequently upregulate TOR signalling, as TOR serves as a nutrient and amino acid sensor 
(Gran and Cameron-Smith 2011).  Secondly, expression of leucine may serve to increase 
levels of glutamate production in S. cerevisiae (Kohlhaw 2003) which may serve to 
stimulate lipid accumulation via glycolysis (Dang 2012, Pellerin and Magistretti 1994). 
The pRS315 vector was subsequently replaced with pRS313, which contains histidine as 
the selectable marker.  There is no literature to suggest that the expression of HIS3 would 
affect the lipid phenotype of the cell.  After transformation of wild type and hog1Δ cells 
with pRS313 and pRS313HOG1, the stress phenotype of the hog1Δ strain was recovered 
to that of wild type levels (Figure 4.14).  After transferring to culture, the results of the 
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Nile red screen showed that the lipid phenotype of the hog1Δ strain containing the empty 
vector remained low compared to that of wild type cells (Figures 4.16 and 4.17).  Wild 
type cells which were transformed with pRS313HOG1, displayed levels of lipid comparable 
to that of wild type cells containing pRS313.  This is likely due to feedback mechanisms in 
wild type cells transformed with pRS313HOG1 to ensure Hog1p is not overexpressed, 
which results in lethality of S. cerevisiae cells (Wurgler-Murphy et al. 1997). This confirmed 
that the reduction in lipids compared to wild type cells was as a consequence of the loss 
of Hog1, and suggested that Hog1 function is required for cellular lipid homeostasis in S. 
cerevisiae.  In addition, from this data, it can also be concluded that expression of HIS3 
does not impact on lipid accumulation in S. cerevisiae. 
The Nile red data for components of the MAPK pathway upstream of Hog1 demonstrated 
that deletions in SHO1, STE11, and PBS2 did not produce a significant change in neutral 
levels of lipid nor phospholipids (Figures 4.21 and 4.22).  This suggested that upstream 
components of the HOG pathway did not play a key role in the accumulation of lipids in S. 
cerevisiae.  Pbs2p is required for dual phosphorylation and thus activation of Hog1p. As 
the levels of lipid in the pbs2Δ appeared unaffected it is unlikely that Pbs2p holds a major 
role in regulating lipid accumulation.   
It has been reported recently, via a large scale lipidomic study which utilised monitoring 
mass spectrometry for sphingolipid/phospholipid analysis coupled with GC-MS for sterol 
analysis, that both pbs2 and hog1 deleted cells have increased levels of sphingolipids and 
ceramides, which are both minor lipid components of cell walls and membranes (da 
Silveira Dos Santos et al. 2014).   However, the samples in the aforementioned study were 
harvested in early exponential phase. As an absence of HOG1 results in a delayed resting 
exit compared to wild type cells (Escoté et al. 2011), this means that wild type and mutant 
cells may not have been harvested at comparable points and the hog1Δ may have induced 
an accumulation of such lipid classes due to delayed active exponential division.  Similarly, 
resting exit delays have also been observed in cells lacking PBS2 (Escoté et al. 2011).  
Furthermore, as ceramide and sphingolipids represent a relatively minor proportion of 
cellular lipid, any increase of these lipid classes would likely be beyond the limits of 
detection of the Nile red assay employed by the present study. 
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Of the downstream targets of Hog1p, the hot1 deletion strain did not display an altered 
lipid accumulation phenotype for neutral or phospholipids; this suggested that the 
transcription factor Hot1p was not involved in regulation of lipid homeostasis (Figures 
4.25 and 4.26).  Conversely, a neutral lipid phenotype was seen in the msn2/4Δ and 
suggested that Msn2/4p was involved in neutral lipid accumulation, potentially through 
Hog1p mediated signalling (Figure 4.25).  No significantly altered phospholipid phenotype 
was observed in the msn2/4 mutant, which demonstrated that synthesis of neutral lipids 
by the HOG pathway may proceed via the transcription factors Msn2/4 (Figure 4.26). This 
implied that Msn2 and Msn4 may specifically regulate the production of neutral lipids.  It 
is unknown whether Msn2/4 are directly activated by Hog1 to drive the accumulation of 
neutral lipid species, however, as Msn2/4 shuttle between the cytoplasm and nucleus it is 
possible that Hog1 could activate Msn2/4 localised within the cytoplasm.  
It is well characterised that HOG1 deleted cells are sensitive to osmotic stress conditions 
(Kim Sungjoon and Shah 2007). The data presented in Section 4.2.7 proposed that the lipid 
phenotypes observed in both the hog1Δ and msn2/4Δ were not a consequence of the 
stress response (Figure 4.27).  Specifically, the msn2/4Δ was not sensitive to osmotic 
stress when compared with wild type, yet exhibited a significant reduction in the amount 
of neutral lipids accumulated.  Additionally when cells were deleted for pbs2, they 
exhibited equal osmotic stress sensitivity to cells that were deleted for HOG1, yet were 
able to accumulate wild type levels of lipid.  This suggested that regulation of lipid 
accumulation via the Hog1 pathway in S. cerevisiae was independent from the stress 
response. 
It is reported that HOG1 deleted cells do not lose viability in stationary phase (Escoté et al. 
2011).  However, as cells lacking HOG1 display a delay in exiting from the resting state 
compared to wild type cells, a delayed lipid accumulation response was ruled out by 
conducting a time course of lipid accumulation across all growth phases.  This data 
demonstrated that lipid accumulation was not delayed in the hog1Δ strain. At each point 
from 8hrs post resuspension until late stationary phase, the hog1Δ failed to accumulate 
lipid in amounts comparable to that of wild type cells.  Although cells deficient for HOG1 
failed to accumulate equivalent levels of lipid to that of wild type cells, the general trend 
of increased lipid amounts into stationary phase before a decrease at late stationary 
phase was conserved (Figures 4.28 and 4.29). 
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Activation of Hog1 via the canonical route requires dual phosphorylation on Threonine-
174 and Tyrosine-176 residues by Pbs2 (Alonso et al. 2007).  Dually phosphorylated Hog1p 
was present at 6 and 7 hrs post resuspension in YNB medium (Figure 4.31).  It is suggested 
that this is due to cells undergoing the transition from lag phase into exponential phase, as 
growth phase-dependent activation of Hog1 has been documented (Escoté et al. 2011).  S. 
cerevisiae showed a marked increase in the accumulation of lipid after 8 hrs post 
resuspension in YNB (Figure 4.28), indicating that if Hog1 activation is required for lipid 
accumulation it may occur between 8 and 12 hrs.   
The dually phosphorylated form of Hog1 was observed at 9 hrs by Western blot analysis; 
as such this activation may be concomitant with the point of the lipogenic switch (Figure 
4.31).  However, it is also possible that this activation is attributed to the cells response to 
a change in growth phase or nutrient limitation at the onset of stationary phase.  This is 
suggested as Pbs2 did not appear to be involved in the accumulation of lipid. This idea is 
further supported as it has been documented in both S. cerevisiae and S. pombe that 
nutrient limitation induces dual phosphorylation of both Hog1p and Sty1p (Aoki 
Yoshimasa et al. 2011a, Smith et al. 2002, Zuin et al. 2010a). 
Data within this chapter suggested that nutrient starvation, both nitrogen and carbon, did 
not result in the dual phosphorylation of Hog1p, as phosphorylation of Hog1 was not 
detected under starvation conditions (Figure 4.32).  However, it is possible that, due to 
the rapid and often transient nature of Hog1p phosphorylation that the response was 
missed in the present study. It has been reported more recently that glucose limitation, 
and additionally glucose stimulation, results in activation of Hog1p which is Snf1 
dependent (Piao et al. 2012).  The role and phosphorylation status of Hog1p preceding 
entry into stationary phase, where lipid accumulation begins to occur, is not well defined. 
Due to these inconsistencies a definitive conclusion on the effect of nutrient starvation 
and onset of stationary phase on the activation of Hog1p cannot be reached.  
Furthermore, the experiment conducted by Aoki et al. (2011), to assess the effect on 
Hog1p phosphorylation under nitrogen starvation is synthetic and did not allow for 
assessment of phosphorylation as a natural consequence of nutrient depletion during the 
course of normal growth conditions. 
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It is reported in the literature that the upstream MAPKK Pbs2p is the only known route for 
activation of Hog1p.  The localisation of Hog1p in response to phosphorylation by Pbs2p 
can vary significantly and is dependent on the type of stress (Bicknell et al. 2010).  
Although Hog1p, activated by osmotic stress, rapidly translocates to the nucleus to 
enhance transcription of target genes, it has been described that Hog1 can activate 
several responses on differing time frames.  For example, rapid non-transcriptional 
responses of Hog1p within the cytoplasm have been suggested prior to the transcriptional 
responses modulated by nuclear translocation (Geijer et al. 2013).  Upon cell wall stress 
Hog1p is activated by dual phosphorylation and instead of being imported to the nucleus, 
remains in the cytoplasm where it is still able to regulate gene expression (Garcia et al. 
2004).  This highlights a Hog1 response that is distinct from that of osmotic stress. 
Additionally, a further differential response pattern of Hog1 has been identified following 
ER stress.  Under conditions of ER stress, Hog1p is phosphorylated and translocates to the 
nucleus to activate nuclear targets. Phosphorylated Hog1p can then re-enter the 
cytoplasm, highlighting the potential for further activation of cytoplasmic targets (Bicknell 
et al. 2010).  
To further dissect the phosphorylation status of Hog1p during the lipogenic switch, further 
analysis was undertaken using Phos-tag. A Phos-tag gel, which helps determine 
phosphorylation patterns of proteins (Ha et al. 2014, Lee Yong Jae et al. 2012) was 
employed to determine whether there was any evidence of Pbs2 independent Hog1p 
phosphorylation.  The results of the Phos-tag gel in this chapter suggested that Hog1p was 
phosphorylated independently of Pbs2 at 8.5hrs (Figure 4.34). No dual phosphorylation of 
Hog1 was detected at this time point using the α-P-p38 antibody.  This suggested that 
Hog1p may have been phosphorylated on sites other than those previously characterised.   
Recent evidence has suggested that Hog1p is able to autophosphorylate, independently of 
Pbs2, in response to severe osmotic stress (Maayan et al. 2012). However this 
phosphorylation was detected using the antibody specific to the dual phosphorylation 
status of Hog1p.  Due to this the possibility of autophosphorylation on a single tyrosine or 
threonine residue in response to nutrient limitation, or crosstalk from neighbouring 
pathways, resulting in Hog1p activation in a Pbs2 independent manner cannot be ruled 
out.  Taken together this highlighted that the regulation of lipid accumulation by the HOG 
pathway in S. cerevisiae could function independently of the classical route of Hog1p 
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activation as well as being distinct from osmotic and nutrient stress responses.  In order to 
confirm Pbs2 independent phosphorylation of residues on Hog1, mass spectrometry (MS) 
of purified Hog1p at different stages of the time course could be employed. Further 
approaches include MS, such as stable isotope labelling by amino acids in cell culture 
(SILAC), which allows simultaneous quantification of all phosphorylation events.  
Furthermore employment of selective reaction monitoring MS (SRM-MS) phosphorylation 
kinetics of individual sites may also be determined (Reiter et al. 2012).    
It was demonstrated in this study that activation of Hog1p is important for lipid 
accumulation in S. cerevisiae; potential targets of Hog1 were inferred by bioinformatics 
analysis and included key components in both neutral and polar lipid synthesis.  It is 
known that phosphorylation can result in a number of outcomes for the target protein 
including direct/indirect activation or inhibition of protein activity, a change in the 
subcellular localisation of the protein as well as affecting protein stability. 
It is suggested that Hog1p may interact either directly or indirectly with a number of 
proteins involved in lipid accumulation.  As Dga1 catalyses the terminal step in TAG 
formation it was speculated that the similar decrease observed for neutral lipids may 
indicate an interaction between Hog1 and Dga1.  The consensus sequence which Hog1 
recognises is highly conserved, (a serine or threonine residue followed by a proline 
residue) (Roux and Blenis 2004).  Upon analysis of the protein sequence of Dga1, potential 
MAP kinase binding sites were found, indicating the possibility that Hog1 could 
phosphorylate Dga1 to regulated neutral lipid accumulation (Figure 4.35).   
Two of the identified potential MAPK sites were at the N terminus of the protein, S17 and 
T53.  It has been identified in a study by Lui et al. (2011) that the C terminus of Dga1 may 
have a more important role in maintenance of the enzyme activity.  However, upon 
deletion of residues 1-62 (N1) of the proteins N terminus a significant reduction in the 
amount of TAG detected by Nile red screening was observed.  Similarly when residues 1-
33 (N2) of the N terminus were disrupted TAG levels were also reduced, although not to 
the extent seen with the N1 disruption (Liu Qin et al. 2011b).  As two of the potential 
MAPK sites fall within these regions of the N terminus it may be postulated that the loss of 
activity in these N terminal mutants could be as a result of Hog1p being unable to 
phosphorylate Dga1p at these sites.   
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In order to determine if Dga1 is phosphorylated, a genomically tagged Dga1 strain could 
be utilised in a protein time course and a Phos-tag experiment conducted to see if an 
upshift in the molecular weight of Dga1 occurs.  This experiment could then be conducted 
in cells deleted for HOG1, whereby it could be determined if any phosphorylation events 
of Dga1 appear to be Hog1 specific.  Further to this, in order to confirm a Hog1/Dga1 
interaction at the point of phosphorylation an immunoprecipitation experiment could be 
performed to see if Hog1 is bound to Dga1.   
Two additional potential MAPK sites were found to be located at the C terminus of Lro1p, 
however these residues are present at the portion of the protein that is predicted to be 
embedded in the lumen of the ER (Figure 4.36).  As such, this suggested that these sites 
would not be accessible for phosphorylation by Hog1. 
A number of potential MAPK sites have been identified within the protein sequences of all 
four S. cerevisiae SREBP-like proteins (Figures 4.39, 4.40, 4.41 and 4.42).  It is possible that 
Hog1p may activate SREBP-like proteins via phosphorylation in the cytoplasm to promote 
their cleavage and nuclear translocation.  This concept is supported by evidence that the 
mammalian p38 MAPK directly phosphorylates aiding activation of SREBP-1a in vitro in 
hepatic cells, linking stress response pathways with cellular metabolism and supporting 
sterol independent activation of SREBPs (Kotzka et al. 2012).  
Known and extensively studied targets of Hog1p are the transcription factors Msn2 and 
Msn4.  Data presented within this chapter suggests that these transcription factors are 
involved in the regulation of neutral lipid accumulation in S. cerevisiae (Figure 4.25).  As 
referred to previously, Msn2/4 are localised to the cytoplasm and translocate to the 
nucleus under conditions of stress, before undergoing periodical nucleocytoplasmic 
shuttling (Jacquet et al. 2003).  Activation of Hog1 may activate Msn2/4 resulting in their 
relocation to the nucleus for gene transcription, however, it should also be noted that not 
all Msn2/4 dependent genes require active Hog1 for their regulation. 
As previously described, Msn2/4p bind to conserved sequences known as STREs within 
gene promoters, in order to drive transcription (Grably et al. 2002).  A complete STRE 
element (5’CCCCT3’) has been identified in the promoter regions of both MGA2 and 
ECM22 (Figure 4.43).  Additionally, PDS elements (both 5’CCCT3’ and 5’AGGG3’) which 
may also be bound by Msn2/4 have been identified in the promoter regions of SPT23, 
224 
MGA2, UPC2 and ECM22 (Figures 4.43 and 4.44) (Grably et al. 2002, Orzechowski 
Westholm et al. 2012).  This suggests that Msn2/4 may drive the synthesis of neutral lipids 
via a SREBP dependent mechanism.   
It is not yet known whether Msn2, Msn4 or even both proteins function in the regulation 
of lipid accumulation.  Data within this chapter has shown that the double deletion results 
in a significantly altered neutral, but not polar, lipid phenotype (Figure 4.25).  In order to 
elucidate whether one or both components are required each would need to be 
complemented in turn to assess the impact of the expression of each protein on lipid 
levels compared to wild type cells.  Furthermore, to identify whether binding the 
promoters of SREBP like proteins is required, further work could seek to mutate STRE and 
PDS elements present in the promoter regions of SREBP like proteins to evaluate whether 
the lipid phenotype is altered.  Additionally chromatin immunoprecipitation (ChIP) could 
be conducted utilising genomically tagged Msn2/4 strains to identify whether they are 
bound to the promoter regions of SREBP-like proteins.   
With respect to the altered phospholipid phenotype of hog1Δ cells, it is not known 
whether this is as a consequence of Hog1 regulating accumulation of phospholipids or due 
to cells deleted for HOG1 bearing altered membrane permeability to that of wild type cells 
(Escoté et al. 2011).  Potential MAPK binding sites have been identified in Cho1 and Cho2 
protein sequences, which regulate the synthesis of phospholipids (Figures 4.37 and 4.38).  
However, altered membrane permeability cannot be ruled out as a contributor to the 
reduced phospholipid phenotype of the HOG1 deletion strain.  Although the polar lipid 
phenotype was recovered in the hog1Δ following transformation with pRS313HOG1, it is 
not clear whether the more permeable membrane of HOG1 deleted cells would also be 
restored. To distinguish altered membrane permeability from requirement in lipid 
accumulation, strains of S. cerevisiae other than hog1Δ which display altered membrane 
permeability, such as ERG mutants (Iwaki et al. 2008) and potentially stressed wild type 
cells (Davey and Hexley 2011), could be screened for polar lipids via Nile red.   
The scope of potential Hog1 targets is vast due to its ability to regulate both cytoplasmic 
and nuclear targets along with differing dynamics and localisation which is dependent on 
the stimulus.  Therefore it is possible that Hog1 could regulate both cytoplasmic (Dga1, 
Cho1, Cho2, SREBPs) targets as well as nuclear targets (including Msn2/4) in order to drive 
transcription of lipid regulatory genes.  It is also suggested that Hog1 may have a mode of 
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activation and localisation dynamic that is distinct to that observed in osmotic and cell 
wall stress.  This could be subsequently dissected by analysis of a HOG1 GFP tagged strain 
over the range of growth phases where it is suggested Hog1 activity is required for lipid 
accumulation. 
For a more in depth investigation, to identify key regulatory components in the 
accumulation of lipids which is specific to the HOG pathway, microarray analyses could be 
performed.  In this case, wild type cells would be analysed, along with the hog1Δ and 
msn2/4Δ strains before, during and after lipid accumulation is observed.  This would 
provide comprehensive information of genes that are activated and repressed during the 
lipogenic phase along with which components are dependent on the presence of 
functional Hog1 and Msn2/4.  
The data within this chapter demonstrates that lipid accumulation is similarly perturbed in 
mutants within the Sty1 MAPK pathway of S. pombe.  As demonstrated with the deletion 
of HOG1, deletion of sty1 also results in attenuated neutral and polar lipid accumulation 
(Figures 4.48 and 4.49).  In a study by Grimard et al. (2008) it was demonstrated via Nile 
red microscopy that cells deleted for sty1 had increased lipid levels compared to wild type 
cells (Grimard et al. 2008).  This is in contravention with results obtained in the present 
study.  However, as the microscopy data presented by Grimard et al. (2008) shows sty1Δ 
cells that do not appear to be elongated, it is suggested that the cells were utilised in 
exponential phase growth.  As shown in Chapter 3, S. pombe accumulates increased levels 
of lipids in exponential phase and as such, the sty1Δ may accumulate comparable levels in 
early exponential phase.  In order to investigate this, a time course of lipid accumulation 
should be conducted for wild type S. pombe compared to cells lacking sty1.  
Interestingly the upstream MAPKK of Sty1, Wis1, also displays an altered neutral and polar 
lipid phenotype (Figures 4.48 and 4.49).  This observation may mean that, unlike the HOG 
pathway in S. cerevisiae, lipid accumulation could be regulated further upstream of the 
MAPK in S. pombe.  However, the wis1Δ displayed a significant growth defect in 
comparison to wild type and sty1Δ cells, along with markedly decreased cell viability 
(Figures 4.45 and 4.50). As such, altered viability coupled with the growth defect cannot 
be ruled out as contributing factors to the lipid phenotype observed.   
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The results of screening with the sty1-KD mutant revealed a significantly altered neutral, 
but not polar, lipid phenotype compared to wild type cells (Figures 4.48 and 4.49).  
However, the reduction in neutral lipids observed was found not to be as severe as in the 
sty1 deletion strain, 1.9 fold (sty1Δ) vs 1.3 fold (sty1-KD) (Figure 4.48).  As previously 
described, the kinase dead mutant can be dually phosphorylated by Wis1 and can 
translocate to the nucleus. Along with phosphorylation of target proteins, Sty1 also has a 
role in the recruitment of RNA Polymerase II to the promoters of genes to activate 
transcription (Reiter et al. 2008).  However, the kinase dead mutant is unable to 
phosphorylate downstream targets nor is it able to bind promoters of stress induced 
genes without its kinase activity (Reiter et al. 2008).  The limited reduction in neutral lipids 
observed in the sty1-KD mutant compared to sty1Δ suggests that Sty1 has limited 
importance in the expression of lipid regulatory genes. However, recruitment of Sty1 to 
promoters may be required for some target genes as the level of lipid seen is sty1-KD does 
not reach that of wild type cells.  Although Sty1-KD is unable to be recruited to the 
promoters of genes involved in the stress response, it may be possible that the Sty1-KD 
mutant is able to bind promoter regions of other genes.  It has been demonstrated that in 
S. cerevisiae a hog1-KD mutant can be recruited to gene promoters, although at a reduced 
efficiency to wild type cells (Reiter et al. 2008), as such it may be informative to assess 
lipid accumulation in a hog1-KD mutant.  Once downstream target genes of Sty1 that may 
play a role in lipid accumulation have been identified, binding at the promoter regions of 
both sty1 and sty1-KD would need to be confirmed by chromatin immunoprecipitation 
(ChIP). 
As lipid accumulation in the sty1-KD mutant is less severely perturbed compared to sty1Δ, 
it suggests that phosphorylation of Sty1 targets is not required for the response to lipid 
accumulation.  Therefore, lipogenic targets which may be activated via the Sty1 pathway 
may only require interaction with Sty1 for their activity.  It is possible that the interaction 
of Sty1 with a target protein could serve to change its subcellular localisation or stabilise it 
to some extent, preventing its degradation.  It has been demonstrated that physical 
interactions occur between translation factors and Sty1, which could aid protein synthesis 
(Asp et al. 2008).  As, such, the association of sty1-KD with lipid regulatory proteins could 
result in a small increase in protein levels and therefore lipid accumulation. It is further 
suggested that if Sty1 was able to phosphorylate such a target protein, rather than just 
interact, much higher levels of the target protein would result therefore increasing the 
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accumulation of lipids.  This is supported by data in S. pombe that the levels of Aft1p are 
not only regulated by Sty1 phosphorylation but also by its interaction with Pcr1 (Lawrence 
C.L. et al. 2007). 
An alternative possibility is that Sty1 may bind an inhibitor of a target lipogenic protein in 
the nucleus.  Under normal conditions Sty1 would phosphorylate the inhibitory protein, 
therefore removing its inhibitory effect on the target protein.  In the sty1-KD mutant this 
removal of inhibition would be unable to happen.  However, the inhibitory effect may be 
“diluted” to some extent by interaction of Sty1-KD. 
In contrast to S. cerevisiae, the stress response of Sty1 pathway S. pombe mutants aligned 
with the lipid accumulation phenotypes observed (Figure 4.51).  Consistent with 
previously published observations, deletions of wis1 and sty1 resulted in reduced 
sensitivity to oxidative stress when compared to wild type cells (Rodríguez-Gabriel and 
Russell 2005). The sty1-KD mutant showed similar stress sensitivity to sty1 deleted cells 
(Reiter et al. 2008).    
No significant lipid phenotypes were observed upon deletion of the Sty1 downstream 
targets aft1 and pap1, suggesting that Aft1 and Pap1 are not involved in the regulation of 
lipid accumulation (Figures 4.54 and 4.55).  Potential cytoplasmic lipid regulatory targets 
of Sty1 were identified by bioinformatics analyses, the proteins identified which harbour 
potential MAPK sites, are conserved with those identified in S. cerevisiae. However, as 
with S. cerevisiae further investigation of cytoplasmic and downstream targets of the Sty1 
pathway would need to be conducted, especially in order to elucidate the involvement of 
downstream targets in regulating lipid accumulation.  It is suggested that once the point at 
which Sty1 is required for lipid accumulation is deduced, microarray analyses could be 
performed in both wild type, sty1Δ and sty1-KD strains to identify potential targets of the 
Sty1 pathway that are required for lipid accumulation based on their levels of expression 
compared to wild type cells. 
Data within this chapter has demonstrated a novel role for the HOG and Sty1 MAPK 
pathways within yeast in regulating cellular neutral and polar lipid accumulation.  For S. 
cerevisiae this role converges at the point of the MAPK, whereas regulation may occur 
further upstream at the level of the MAPKK in S. pombe.  Although the major downstream 
targets of Sty1, Aft1 and Pap1, appeared to have no significant role in lipid accumulation, 
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downstream targets of Hog1p, Msn2/4 are suggested to play a role in the accumulation of 
neutral lipids.  This suggests that regulation of lipid accumulation may also extend to 
downstream targets in S. pombe.  Furthermore, a potential Pbs2 independent mechanism 
of Hog1 phosphorylation in S. cerevisiae has been suggested to occur preceding the point 
where increased cellular lipid accumulation occurs.  This demonstrates that the role of the 
MAPK pathway in the regulation of lipid accumulation may be distinct to that observed 
under osmotic stress conditions. 
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Chapter V Lipomyces starkeyi as a metabolic model 
for lipogenesis  
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5.1 Introduction 
Lipomyces starkeyi is one of many species of oleaginous yeasts that are intensively 
employed in the biotechnology industry for the production of biofuels due to its ability to 
accumulate up to 70% of their dry cells mass as lipids (Lin et al. 2011). 
It is suggested that L. starkeyi would serve as a favourable model organism for research 
into lipogenesis, not only owing to its lipid production, but also as it converts citrate to 
oxaloacetate and acetyl CoA via ATP-citrate lyase, a phenomenon not observed in the 
budding yeast S. cerevisiae.  The presence and activity of ATP-citrate lyase is typically what 
distinguishes oleaginous species from non-oleaginous yeasts (Ratledge C. 2002, Walker 
1998). 
The utilisation of the genetically well characterised species S. cerevisiae and S. pombe, 
along with development of L. starkeyi as a model organism, may enable a better 
understanding of the mechanisms underlying eukaryotic lipid accumulation. 
The major drawback for the use of oleaginous yeast species as model organisms for 
human disease is that the plethora of genetic tools, accompanying the well characterised 
models S. cerevisiae and S. pombe, are not available for L. starkeyi.  The oleaginous yeast 
Yarrowia lipolytica is one of the most studied non-conventional yeast with a range of 
molecular tools available (Nicaud 2012). In addition, the usefulness of utilising non-
conventional yeast species for human disease research is further supported by the use of 
Y. lipolytica in research on mitochondrial disorders (Kerscher et al. 2004). 
Genetic techniques available in S. cerevisiae and S. pombe include the ability to transform 
cells, in order to create null strains by homologous recombination and cloning of genes for 
genetic complementation (Forsburg 2001).  Furthermore, protein-protein and protein-
DNA interactions can be readily elucidated via co-immunoprecipitation and chromatin 
immunoprecipitation (ChIP) techniques (Ezhkova and Tansey 2006, Geva and Sharan 
2011).  
The employment of L. starkeyi in biotechnology has fuelled interest into the development 
of molecular platforms, especially with regards to creation of null strains and protein 
overexpression (Calvey et al. 2014).  Such platforms would enable L. starkeyi to be 
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engineered metabolically in order to enhance lipid production and improve the economic 
viability of biofuels derived from micro-organisms (Calvey et al. 2014). 
The draft assembly of the L. starkeyi genome was published in 2011 by the Department of 
Energy (DOE) and Joint Genome Institute (JGI) after the course of initial work conducted in 
this chapter.  However, very little work had been done on annotation and no work had 
been completed on the proteome (Liu Hongwei et al. 2011a). 
In this chapter it has been demonstrated that L. starkeyi displayed a growth phenotype 
similar to that of S. cerevisiae when exposed to both osmotic and oxidative stress.  Along 
with this, successful amplification and cloning of the MAPK homologue in L. starkeyi has 
been demonstrated for the first time.  It has also been shown that the antibody 
recognising the dually phosphorylated MAPK in S. cerevisiae could potentially be utilised 
in L. starkeyi.  Additionally, it has been highlighted that alternative strategies from those 
utilised in S. cerevisiae and S. pombe are required for genetic transformation of both 
plasmids and integrating cassettes into L. starkeyi.  Finally, from bioinformatics analysis, it 
has been demonstrated that L. starkeyi appears to have a conserved MAPK pathway to 
that of S. cerevisiae and S. pombe. 
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5.2 Results 
From the data shown in Chapter 4, it is proposed that the Hog1/Sty1 MAPK pathways are 
involved in the regulation of lipid accumulation.  This suggests that the MAPK homologue 
in L. starkeyi may also have a similar role in mediating lipogenesis. 
5.2.1 Characterisation of the stress response of wild type L. starkeyi 
One of the main roles of the MAPK pathway in yeast is the regulation of the stress 
response. There is limited information on the genome of L. starkeyi. Furthermore there 
has been no characterisation conducted of this yeast species with regards to the stress 
response.  Enhancing the knowledge of yeast physiological response is not only important 
to identify the role of L. starkeyi in the response to stress, but it is also important in 
biotechnology for subsequent industrial exploitation of yeast (Walker 2011).  Yeasts are 
subjected to numerous stressors not only in the laboratory environment, but also when 
grown in industrial fermenters (Walker 1998), utilised in both the brewing industry and for 
production of biofuel. As this study is interested specifically in MAPK pathways, 
experiments were conducted to see if wild type L. starkeyi had similar stress sensitivity to 
S. cerevisiae and S. pombe wild type cells.  Two types of cellular stressors, osmotic (NaCl) 
and oxidative (H2O2), were used as they are known to elicit a stress response via MAPK 
pathways in budding and fission yeast (Asp et al. 2008).   
Osmotic stress results in the efflux (hyperosmotic) or influx (hypo osmotic) of water into 
the cell. Hyperosmotic stress is characterised by cell shrinkage, whereas hypo osmotic 
stress results in swelling of the cells.  In response to osmotic stress yeast cells initiate a 
complex adaptive response resulting in temporary arrest of the cell cycle, altered 
transcriptional and translation and synthesis of the osmolyte glycerol.  The 
osmoadaptation of yeasts is highly dependent on the activation of the stress-activated 
protein kinase (SAPK) pathway (de Nadal E. et al. 2002).  
Oxidative stress results in the accumulation of reactive oxygen species, which can result in 
damage to proteins and lipids along with DNA damage and mutations (Ikner and Shiozaki 
2005).  In response to oxidative stress yeast S. cerevisiae and S. pombe Hog1/Sty1 
pathways mediate a response to upregulate or repress transcription of genes in order to 
mediate antioxidant defence (Farrugia and Balzan 2012). 
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By comparison of L. starkeyi with the well characterised yeast species S. cerevisiae and S. 
pombe, establishment of whether the response of L. starkeyi to stress is conserved can be 
assessed. As demonstrated by Figure 5.1, wild type S. cerevisiae was able to grow at all 
concentrations of osmotic stress tested, with growth only being slightly reduced at the 
maximum NaCl concentration of 1.0 M.  Conversely, S. pombe was unable to grow under 
osmotic stress conditions beyond a concentration of 0.4 M.  In the case of L. starkeyi 
reduced growth was observed at a NaCl concentrations of 0.4 M-0.6 M (Figure 5.1). 
In response to oxidative stress S. cerevisiae exhibited reduced growth at 6mM H2O2 with 
growth being abolished at a concentration of 8mM.  Wild type S. pombe was found to be 
display reduced growth on plates containing 2mM H2O2 with no growth observed at 4mM. 
In response to oxidative stress, L. starkeyi growth was perturbed at a concentration of 
4mM (Figure 5.2).  From the stress experiments it can be concluded that L. starkeyi, for 
both osmotic and oxidative stressors, has a response which is intermediate compared to 
the responses displayed by S. cerevisiae and S. pombe. 
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Figure 5.1: Spot plates of wild type S. cerevisiae, S. pombe and L. starkeyi showing response to osmotic stress. Control plates (YPD/YES) and osmotic stress plates, 
YPD/YES supplemented with NaCl. Starting cell densities were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate down to 2.3 x 102 cells/ml. 
 
 
  
Figure 5.2: Spot plates of wild type S. cerevisiae, S. pombe and L. starkeyi showing response to oxidative stress. Control plates (YPD/YES) and oxidative stress plates, 
YPD/YES supplemented with H2O2. Starting cell densities were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate down to 2.3 x 102 cells/ml. 
YPD/YES 0.4M NaCl 0.6M NaCl 0.8M NaCl 1.0M NaCl0.2M NaCl
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As previously described the stress response of S. cerevisiae and S. pombe is largely 
regulated by Hog1 and Sty1 MAPK pathways which are well conserved both structurally 
and functionally to the p38 MAP kinase of mammalian cells.   
By alignment of MAPK protein sequences from yeast species compared to mammalian 
p38, the percentage similarity was calculated using Clustal Omega from the European 
Bioinformatics Institute (EBI). Table 5.1 depicts the percentage similarity of the 
mammalian p38 protein sequence to corresponding MAP Kinases present in yeast. It is 
demonstrated that S. cerevisiae and S. pombe MAPK homologues display 50.28% AND 
53.16% similarity respectively to that of mammalian p38.  Further to this, the oleaginous 
yeast species Y. lipolytica p38 homologue also displays 50.14% similarity.  This highlights 
that oleaginous yeasts may be valuable in studying the role of the MAPK pathway. 
 
 
Table 5.1:  Percentage identity showing similarities between mammalian p38 and yeast p38 MAPK 
homologue protein sequences. Percentage identity matrix was compiled by multiple sequence alignment 
using Clustal Omega from the European Bioinformatics institute (EBI). 
 
 
 
The phylogenetic relationship inferred from protein sequence alignments demonstrates 
that all yeast MAPK homologues are equally as divergent from mammalian p38 (Figure 
5.3).  Further, the MAP kinases of S. pombe and Y. lipolytica have been grouped as the 
MAPK sequences are more evolutionarily conserved between them than of the other 
groups. 
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Figure 5.3: Phylogram indicating evolutionary relationships based on MAPK protein sequence alignments.  
Phylogenetic tree generated from protein sequence alignments by Clustal Omega from the European 
Bioinformatics Institute.  
 
5.3. Amplification of the L. starkeyi p38 homologue by the polymerase 
chain reaction 
As the S. cerevisiae (Hog1) and S. pombe (Sty1) MAP kinase proteins are well conserved 
and characterised (80% similar, Table 5.1) (Dinér et al. 2011, Sansó et al. 2011), 
amplification of the L. starkeyi MAPK open reading frame from genomic DNA was 
attempted.  If successful amplification is achieved this would facilitate the creation of a 
MAPK null strain along with cloning of the gene for heterologous expression studies.    
Before conducting any amplification of the gene by PCR, samples of L. starkeyi genomic 
DNA were extracted as detailed in Chapter 2 and run on a 0.8% agarose gel (Figure 5.4).  
Using an established genomic yeast DNA extraction technique detailed in Section 2.3, DNA 
was purified from L. starkeyi cultures, utilising S. pombe and S. cerevisiae as positive 
controls. 
As the agarose gel in Figure 5.4 shows, two distinct bands were observed in lanes 1 and 2 
corresponding to genomic DNA from S. cerevisiae and S. pombe at ~1.0 and ~1.5 kb 
respectively.  Smearing on the gel also indicates the presence of genomic DNA as genomic 
DNA contains fragments of DNA comprising different molecular weights. Similar bands 
were obtained in lane 3 for the L. starkeyi sample indicating that the genomic DNA 
extraction had been successful.  
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Figure 5.4: Agarose gel showing successful extraction and presence of genomic DNA from L. starkeyi.  Lane 
1: S. cerevisiae. Lane 2: S. pombe. Lane 3: L. starkeyi.  DNA bands can be seen for all three species at 
approximately 1.5Kb, 1.0Kb and 250bp. 
 
Following successful genomic DNA extraction, DNA sequence data from the well 
characterised yeast species S. cerevisiae and S. pombe was analysed. Conserved regions 
were identified by aligning the nucleotide sequences utilising the Kalign multiple sequence 
alignment tool from EBI.  With no genomic sequence information available at the time for 
L. starkeyi, primers specific to HOG1 (CLL001/002) and primers against a conserved region 
found in the genes HOG1 and sty1 (CLL003/004) were designed. The primers specific to 
HOG1 were utilised to act as a positive control for the PCR reaction and the conserved 
primers to attempt amplification of the L. starkeyi p38 homologue. This was based on the 
assumption that similar regions between the three yeast species would be conserved.  
Figure 5.5 shows the aligned sequences and where the primers were designed to.   
 
 
1.5 kb -
1.0 kb -
250 bp -
1           2          3
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Figure 5.5: Sequence data showing rationale behind conserved MAP Kinase primers.  Primers specific to 
HOG1 are highlighted in pink (CLL001/002), Section A: forward primers and Section B: reverse primers.  
Highlighted in blue are the conserved primers designed to amplify S. pombe sty1 and L. starkeyi MAPK 
homologues (as no sequence information was available at the time) (CLL003/004).  The conserved primers 
were designed to regions of the HOG1 and sty1 nucleotide sequences that were well conserved, as indicated 
by the asterisks (*) which show where the sequences between the two species are identical. 
 
 
 
 
 
 
 
 
 
hog1            ATGACCACTAACGAGGAATTCATTAGGACACAGATATTCGGTACAGTTTTCGAGATCACA 60 
sty1            ATGGC---------AGAATTTATTCGTACACAAATATTCGGTACATGTTTTGAAATTACC 51 
                *** *          ***** *** * ***** ************  *** ** ** **  
 
hog1            AATAGATACAATGATTTAAACCCCGTTGGGATGGGGGCATTTGGGTTGGTTTGCTCAGCC 120 
sty1            ACTAGATATAGCGACTTACAGCCGATTGGCATGGGCGCCTTTGGCCTCGTTTGTTCAGCG 111 
                * ****** *  ** *** * **  **** ***** ** *****  * ***** *****  
ORF 
 
hog1            GAAAAAATGCTGGTTTTTGATCCTAAGAAGAGAATCACTGCGGCGGATGCCTTGGCTCAT 897 
sty1            GAAAAAATGCTTGTCTTTGATCCTCGTAAGCGTATTAGTGCTGCTGATGCTTTGGCTCAT 888 
                *********** ** *********   *** * ** * *** ** ***** ********* 
 
hog1            CCTTATTCGGCTCCTTACCACGATCCAACGGATGAACCAGTAGCCGATGCCAAGTTC--G 955 
sty1            AACTATCTTGCTCCATACCATGATCCTACTGATGAGCCTGTTGCTGATG--AAGTTTTTG 946 
                   ***   ***** ***** ***** ** ***** ** ** ** ****  *****   * 
 
hog1            ATTGG-CACTTTAATGACGCTGATCTGCCTGTCGATACCTGGCGTGTTATGATGTACTCA 1014 
sty1            ACTGGTCATTCCAA-GATAATGATTTACCTGTGGAGACTTGGAAGGTCATGATGTACTCC 1005 
                * *** ** *  ** **   **** * ***** ** ** ***   ** ***********  
 
hog1            GAAATCCTAGACTTCCATAAGATTGGTGGCAGTGATGGACAGATTGATATATCTGCCACG 1074 
sty1            GAGGTTTT-----------------GT-------------------------------CG 1017 
                **  *  *                 **                               ** 
 
hog1            TTTGATGACCAAGTTGCTGCAGCCACCGCTGCCGCGGCGCAGGCACAGGCTCAGGCTCAG 1134 
sty1            TTT----------------------------------------CACA------------- 1024 
                ***                                        ****              
 
hog1            GCTCAAGTTCAGTTAAACATGGCTGCGCATTCGCATAATGGCGCTGGCACTACTGGAAAT 1194 
sty1            ----------------ACATGG------------ATAATG-------------------- 1036 
                                ******            ******                     
 
hog1            GATCACTCAGATATAGCTGGTGGAAACAAAGTCAGCGATCATGTAGCTGCAAATGACACC 1254 
sty1            --------------------------------------------AACTGCAA-------- 1044 
                                                            * ******         
 
hog1            ATTACGGACTACGGTAACCAGGCCATACAGTACGCTAATGAGTTCCAACAGTAA 1308 
sty1            ------------------------------------------TCCTAA------ 1050 
                                                          * * **       
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Following PCR amplification with the standard annealing temperature of 45 oC, S. 
cerevisiae HOG1 was successfully amplified using both specific (~1.3 kb) (lane 2) and 
conserved primers (~1 kb) (lane 6).  No amplification products were observed for S. pombe 
or L. starkeyi (lanes 3-4 and 7-8 respectively) (Figure 5.6).   The expected size of S. pombe 
sty1 is ~1.0 kb with the expected size of L. starkeyi MAPK being ~1.4 kb. 
 
 
  
Figure 5.6: Agarose gel showing amplification products obtained from all three yeast species using specific 
and conserved primers.  Lane 1: negative control, lane 2: SC with HOG1 primers (positive control), lanes 3 
and 4: S. pombe and L. starkeyi with HOG1 primers, lane. Lane 5: negative control, lane 6: S. cerevisiae with 
conserved primers, lanes 7 and 8: S. pombe and L. starkeyi with conserved primers. 
 
As no PCR products were observed for S. pombe or L. starkeyi, the experiment was 
repeated utilising a lower annealing temperature of 42 oC, as decreasing the annealing 
temperature results in less specific primer binding.  This again produced amplification of 
HOG1 in the positive control but gave no amplification products from either S. pombe or L. 
starkeyi.  The annealing temperature was then dropped further to 40 oC, again only 
amplification was observed for HOG1 positive control (data not shown).   
A ramp PCR was then carried out using the conserved primers with an annealing 
temperature of 40 oC, 41 oC and 42 oC for 10 cycles each, the resultant agarose gel again 
showed only successful amplification of HOG1 from S. cerevisiae using the conserved 
primers. 
After dropping the annealing temperature further to 35 oC, amplification products were 
again observed corresponding to S. cerevisiae HOG1 (lane 1).  Bands were also observed 
for S. pombe and L. starkeyi (lanes 2 and 3 respectively), however, due to the size of the 
1.5 kb -
1.0 kb -
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bands these were deemed the result of non-specific amplification due to the low 
annealing temperature used and that products of the expected size were absent (Figure 
5.7).  
 
  
Figure 5.7: Agarose gel showing successful amplification of S. cerevisiae HOG1 using conserved primers. 
Lane 1: S. cerevisiae HOG1, Lanes 2 and 3: non-specific amplification products from S. pombe and L. starkeyi 
respectively. Lanes 4, 5 and 6 negative controls containing no Taq polymerase for S. cerevisiae, S. pombe and 
L. starkeyi respectively. 
 
It was determined from these results that amplification of the L. starkeyi MAP Kinase 
utilising primers conserved to S. cerevisiae and S. pombe was not a viable approach.  At 
the time it was known that the genome of L. starkeyi was undergoing sequencing, 
however, numerous scaffolds had yet to be annotated.  As such, amplification of the ORF 
was conducted once annotated information became available.  
 
1.5 kb -
1.0 kb -
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In 2011 92% of the L. starkeyi genome, which was partially annotated, became available 
having been sequenced in collaboration with the Department of Energy and Joint Genome 
Institute’s Fungal Genomics Program (JGI).  The nucleotide sequence for the L. starkeyi 
p38 MAPK homologue was obtained and aligned from the ATG codon, to those of S. 
cerevisiae HOG1 and S. pombe sty1 using the Kalign alignment tool from European 
Bioinformatics Institute (EBI) to show sequence similarity (Appendix I, Figure A8). The 
alignment showed that the nucleotide sequence was ~80% conserved between L. starkeyi 
and the other two yeast species (81.09% similarity to HOG1 and 80.33% similarity to sty1).  
Primers were then designed specifically to the ORF of L. starkeyi MAPK and PCR carried 
out for L. starkeyi p38 homologue (primers CLL005/006) using PCR parameters described 
in Chapter 2.  S. cerevisiae HOG1 (primers CLL001/002) and S. pombe sty1 (primers 
CLL007/008) were utilised as positive controls for the PCR reaction.   
Figure 5.8 shows successful amplification of S. cerevisiae HOG1 (lane 1, ~1.3 kb), S. pombe 
sty1 (lane 2, ~1.0 kb) and a putative L. starkeyi MAPK gene, (lane 3 ~1.4 kb).  This is the 
first time that a MAPK gene has been shown to be amplified from the yeast species L. 
starkeyi. 
 
  
Figure 5.8: Agarose gel showing successful amplification of HOG1 (lane1), sty1 (lane 2) and the p38 MAPK 
homologue of L. starkeyi (lane 3).   Bands were observed at ~1.3Kb, ~1.0Kb and ~1.4Kb respectively 
corresponding to the expected sizes of S. cerevisiae, S. pombe and L. starkeyi respectively. 
 
 
1.5 kb -
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5.4 Use of α-P-p38 and α-Hog1 antibodies for the detection of L. starkeyi 
MAPK protein 
Proteomic analysis in 2010 highlighted that most proteins in mammalian cells are 
phosphorylated (Olsen et al. 2010).  Phosphorylation can produce a wide range of 
biological effects serving to regulate a plethora of cellular processes.  Phosphorylation 
events can serve to activate a protein, either directly, or by removing its association with 
an inhibitory complex. In other cases phosphorylation can inhibit the activity of a protein 
by mechanisms including masking of the active domain.  Furthermore phosphorylation can 
also occur where the subcellular localisation of a protein can be altered.  Additionally 
phosphorylation may not affect protein activity but produce a binding site to facilitate 
protein-protein interactions (Nishi et al. 2014).  Phosphorylation is an important 
regulatory mechanism for MAPKs and is important for them to become activate.  Active 
MAPKs are then able to activate/inhibit other proteins along with expression of genes 
under various cellular conditions including stress. 
Due to the high conservation of mammalian p38 and yeast homologues, the dually 
phosphorylated status of Hog1 and Sty1 proteins can be detected with the same α-P-p38 
antibody used for dually phosphorylated mammalian p38 (Bell Michal and Engelberg 
2003). Similarly the α-Hog1p antibody utilised in this study is also utilised in the detection 
of total S. pombe Sty1p (Hartmuth and Petersen 2009). 
Due to the high level of conservation of the MAPK across species, it was postulated that 
the L. starkeyi MAPK will also be conserved at the protein level. As such, an alignment of 
the three yeast species protein sequences was undertaken using the Clustal 2.1 alignment 
tool from EBI. This identified high levels of conservation between the three yeast species 
(Figure 5.9).   
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Figure 5.9: Sequence alignment showing conservation of p38 homologues for all three yeast species at the 
protein level.  Colours that are the same indicate either identical or similar amino acids between all 3 yeast 
species. Carried out using Clustal 2.1 programme for multiple sequence alignment (MSA).  (MSA infers 
sequence homology and therefore evolutionary relationships).  Letters that are the same show identical 
amino acid sequences between the three species of yeast. Same colours but differing sequence refers to 
amino acids that have similar properties.  Red: small, hydrophobic. Blue: Acidic.  Magenta: Basic. Green: 
Hydroxyl + sulfhydryl + amine + G. *amino acids the same : indicates a conserved substitution and . a semi 
conserved substitution. 
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In addition to the visual alignment (Figure 5.9), the percentage identity between the 
protein sequences was also determined (Table 5.2).The MAPK protein sequence of L. 
starkeyi was found to be 82.05% similar to Hog1 and 83.95% similar to Sty1.  The 
percentage conservation of L. starkeyi relative to S. cerevisiae and S. pombe is greater 
than the level of conservation seen between Hog1 and Sty1 sequences, which are 
80.52% similar to one another.  Additionally the percentage identity between 
mammalian p38 and L. starkeyi protein sequences was determined to be 51.14% which 
is greater than the homology between mammalian p38 and S. cerevisiae Hog1p 
(50.28%), but not as homologous as S. pombe Sty1p (53.16%) (data not shown). This 
indicates that antibodies available to detect dually phosphorylated MAPK and total 
MAPK levels may also work for L. starkeyi MAPK. 
 
Table 5.2: Percentage identity of S. cerevisiae, S. pombe and L. starkeyi protein sequences. Percentage 
identity matrix was compiled by multiple protein sequence alignment using Clustal Omega from the 
European Bioinformatics institute (EBI). 
 
 
 
The protein sequences of S. cerevisiae, S. pombe and L. starkeyi were further inspected to 
identify the residues recognised by the α-P-p38 antibody, along with the epitope 
recognised by the Hog1p antibody. 
As shown in Figure 5.10 the Thr174 and Tyr176 phosphorylation sites (indicated in yellow) 
of S. cerevisiae and S. pombe are present at conserved regions within the protein 
sequence of L. starkeyi.  This suggests that the P-p38 antibody should recognise these 
sites if they become dually phosphorylated. 
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Figure 5.10: Conservation of phosphorylation sites recognised by α-P-p38 antibody. Protein sequence 
alignment for S. cerevisiae Hog1, S. pombe Sty1 and a putative L. starkeyi MAPK were aligned using Clustal 
Omega from EBI.  Yellow highlights show conserved Thr174 and Tyr176 residues. Conservation of the 
recognition motif of the antibody T-G-Y is indicated by the red box. 
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In the case of the antibody used to detect total Hog1 and Sty1 protein levels, the C 
terminal sequence that is recognised by the antibody was aligned to the corresponding 
region of the L. starkeyi protein sequence. 
Figure 5.11 shows percentage identity of the C terminus alignment and highlights high 
levels of conservation between the sequences of S. cerevisiae, S. pombe and L. starkeyi. 
Although there are regions of sequence where the L. starkeyi sequence does not 
correspond to the other sequences, these are mostly regions where S. cerevisiae and S. 
pombe also differ, for example at position 260. Overall the degree of confirmation of the 
region recognised by the Hog1/Sty1 antibody is high, suggesting the Hog1 antibody should 
recognise the MAPK protein in L. starkeyi.   
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Figure 5.11: Percentage identity and conservation of epitope region recognised by α-Hog1 in S. cerevisiae and S. pombe compared to the corresponding region of L. starkeyi protein 
sequence. Similarity index and degree of conservation were derived from Jalview after protein sequence alignment using Clustal Omega from EBI.  The strength of the colour on the 
sequence indicates the degree of similarity between protein sequences only, ranging from dark blue: >80% down to white: <40%.  Regions where L. starkeyi sequence is not conserved to 
those of S. cerevisiae or S. pombe is indicated by red boxes. Degree of confirmation is shown below the sequence in yellow with the height of boxes corresponding to the similarity of the 
sequence. 
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To determine whether the antibodies utilised for detection of phosphorylated and total S. 
cerevisiae Hog1p and S. pombe Sty1p could also recognise the putative L. starkeyi MAPK, a 
stress experiment was conducted utilising S. cerevisiae as a positive control. 
Wild type S. cerevisiae and L. starkeyi cultures were exposed to osmotic stress in YPD 
culture, utilising 0.4M NaCl.  Samples were harvested at 10 minutes after exposure to 
stress, as it is known that S. cerevisiae Hog1p will be activated under this condition (de 
Nadal Eulalia et al. 2004).  As L. starkeyi has a slower growth rate than S. cerevisiae and 
the response to stress in liquid culture is unknown for this species, further samples were 
harvested at 20 minutes.  Protein was extracted from cells and a Western blot performed 
as described in Section 2.51 and 2.53. 
As shown in Figure 5.12, with the α-P-p38 antibody no band was observed in non-stressed 
S. cerevisiae and a band corresponding to phosphorylated Hog1p was observed at 50 kDa.  
Bands were also observed for stressed L. starkeyi at both 10 and 20 minutes consistent 
with size of the L. starkeyi MAPK at ~40 kDa.  However, a band at the same position was 
also observed for non-stressed L. starkeyi. 
Using the Hog1 antibody to detect total Hog1 protein, bands at 50 kDa were observed for 
S. cerevisiae corresponding to the Hog1 protein, however, no bands were observed for L. 
starkeyi (Figure 5.12). 
 
 
 
 
 
 
 
 
 
249 
   
Figure 5.12:  Western blot of S. cerevisiae and L. starkeyi under non-stressed and stressed conditions. S. 
cerevisiae non-stressed is indicated by – and stressed S. cerevisiae exposed to 0.4 M NaCl for 10 mins +.  L. 
starkeyi 0: non stressed, 10: exposed to 0.4 M NaCl for 10 mins 20: exposed to 0.4 M Nacl for 20 mins.  
Phosphorylated was detected using α-P-p38 and total protein with α-Hog1. 
 
These results suggest that the antibody used to detect the dually phosphorylated MAPK 
may recognise the active form of the putative L. starkeyi MAPK protein as bands were 
observed at the expected size for L. starkeyi MAPK.  As no bands were observed when 
utilising the antibody to detect total MAPK protein, it is concluded that the antibody is 
unable detect the putative L. starkeyi MAPK. 
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5.5 Genomic gene deletion using homologous recombination in L. starkeyi 
In order to characterise the role of the putative L. starkeyi MAPK in the stress response 
and the accumulation of cellular lipids, experiments were conducted in order to produce a 
MAPK null strain. 
Prior to April 2014 there was no published information or methodologies for the 
transformation and integration of DNA into the genome of L. starkeyi.  As such, an S. 
pombe methodology was first utilised, as described by Bahler et al. (1998), as this yeast 
species appears to be more similar at the nucleotide level to L. starkeyi than S. cerevisiae. 
This methodology was used as a platform in order to optimise the DNA transformation 
methodology in L. starkeyi.  Specific deletion primers (CLL009/010) were designed to the 
KanMX module of pFA6a-KanMX6 (Bahler et al. 1998) vector.  These primers contained 
flanking regions corresponding to 100 bp upstream and downstream of the L. starkeyi 
open reading frame.  Kanamycin was utilised as the selectable marker as it is a commonly 
used antibiotic marker for gene disruption in yeast. 
The deletion primers used in this study are 4 nmol Ultramer Oligos with standard desalting 
(CLL009/010).  The primer concentration required to produce sufficient transforming DNA, 
according to Bahler et al. (1998), is high (1.2 µM).  Due to this, PCR reactions were 
conducted to assess the lowest concentration of primers that could be utilised to generate 
the required MAPK deletion cassette.  Following PCR DNA bands were observed at ~1.6 kb 
(~1.4 kb KanMX and 200 bp flanking region), corresponding to the expected size of the 
deletion cassette (Figure 5.13).  
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Figure 5.13: Agarose gel showing amplification of the MAPK homologue deletion cassette for L. starkeyi. 
Lane 1: Plasmid, PFA6a-kanMX6, lane 2:  reaction using 1.2 µM, lane 3: using 0.8 µM, lane 4: using 0.4 µM of 
primers and lane 5: no Taq control.  As the agarose gel shows, PCR product is still generated using a third of 
the recommended primer concentration. 
 
It was determined, following successful amplification of the deletion cassette, that a 
primer concentration of 0.4 µM could be used (lane 4) rather than 1.2 or 0.8 µM (lanes 2 
and 3). This is a more cost effective option whilst the methodology is being optimised for 
deleting the putative L. starkeyi p38 homologue. 
 
5.5.1 Yeast transformation utilising S. pombe methodology 
Initial transformation experiments were carried out using a method for S. pombe, the 
lithium acetate (LiAc) method described by Bahler et al. (1998). Cells (5.2 x 108) from an 
exponentially growing culture (2.6 x 107cells/ml) were used for each transformation.  
Cultures were centrifuged at 492 g for 2 minutes before washing cells with an equal 
amount of sterile water.  Cells were then resuspended in 1ml 0.1 M LiAc/TE, centrifuged 
for 2 minutes at 1500 rpm before resuspending in 200µl 0.1 M LiAc/TE giving an 
approximate cell number of 5.2 x 1010.  Cells were mixed with 2 µg salmon sperm DNA and 
~10-20 µg transforming DNA (with the appropriate volume of sterile water was added for 
the control) and incubated at room temperature for 10 minutes before adding 260 µl 
40%PEG/LiAc/TE, mixing and incubating at 30oC for 1 hour.  43 µl DMSO was then added 
and the cells heat shocked for 5 minutes at 42oC before centrifugation at 1500 rpm for 2 
mins.  The cell pellet was washed in sterile water, before being resuspended in 2 ml of rich 
medium, YPD, and incubated overnight with shaking at 30 oC before plating out on YPD 
5.0 kb -
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agar supplemented with 400 µg/ml of G418 sulphate.  After 2 weeks incubation at 30 oC 
no colonies were formed on the selection plates. Although this initial transformation 
experiment was unsuccessful, this was used as the basis to develop a modified 
transformation protocol for L. starkeyi. 
5.5.1.1 Optimisation of G418 concentration 
A number of conditions were identified that may influence the efficiency of yeast 
transformation, including concentration of the selection antibiotic, amount of 
transforming DNA, transforming solutions and time of heat shock.   
The first was the concentration of the drug used for selection, in this case the antibiotic 
G418. For S. pombe a concentration of 200-400 µg/ml of G418 is used for selection of 
KanMX transformed cells. There is no published information on the expression of the 
KanMX gene in L. starkeyi or the G418 concentration at which growth of transformants 
may be seen. As such the concentration of G418 was reviewed and a lower concentration 
of 100 µg/ml G418 was used.  Following a repeat of the S. pombe transformation method, 
no yeast colonies were observed on plates containing the reduced antibiotic 
concentration after a 2 week incubation period. 
5.5.1.2 Assessment of URA3 as a suitable selectable marker 
In order to determine if the kanamycin selective marker was the limiting factor in the 
transformations, cells were transformed with pKS-URA (Bahler et al. 1998), a non- 
integrating plasmid containing uracil (URA) as the selective marker. A non-integrating 
plasmid was utilised to assess whether the previous transformation was unsuccessful due 
to failed integration of the cassette. The protocol detailed above was repeated and cells 
plated out onto yeast nitrogen base (YNB) agar -URA.  After less than one week of 
incubation, yeast colonies were observed on all plates, including the control.  From this it 
was inferred that L. starkeyi does not require external sources of uracil for growth and as 
a result URA cannot be used as a selectable marker. As such, the KanMX cassette 
continued to be utilised for further transformation protocols.    
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5.5.1.3 Optimisation of chemical transformation reagents 
In order to determine the effect of transforming DNA concentration the method was 
further optimised by increasing the concentration of the transforming DNA deletion 
cassette from 10 ng to 20 ng. This would increase the amount of transforming DNA 
available to be taken up by the yeast cell and potentially increase the DNA cassette 
transported to the nucleus of the cell, thereby increasing the chance of homologous 
recombination.  However, this modification resulted in no visible growth following 2 
weeks incubation at 30 oC.   
As a chemical transformation protocol is being employed, reagents and their proportions 
are one of the critical factors for yielding good transformation efficiencies.  It is widely 
documented that the presence of polyethylene glycol (PEG) is critical for transformation 
of yeast cells (Ito et al. 1983, Kawai S. et al. 2010).  It has been suggested that the role of 
PEG in transformation is to disrupt the membrane as well being essential for the 
attachment of DNA.  Therefore too high a PEG concentration could be detrimental to 
yeast cells and too low a concentration not able to permeabilise the membrane 
sufficiently to allow transformation.  As such, PEG was prepared fresh without autoclaving 
before use in each transformation protocol, as evaporation of water during autoclaving 
can increase its final concentration (Gietz and Schiestl 2007).   
It has been reported that LiAc is important for passage of DNA into the cell (Kawai S. et al. 
2010). As no colonies were observed when utilising fresh PEG, other solutions required for 
chemical transformation (LiAc and TE) were also prepared fresh and filter sterilised 
instead of autoclaving.  Further to this half of the control sample, containing no 
transforming DNA, was plated onto YPD agar to ensure that the transformation procedure 
was not lethal to the cells.  After 3 days of incubation at 30 oC colonies were present on 
the YPD control plate showing that the transformation procedure was not lethal and cells 
were still viable.  
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5.5.1.4 Effect of extending heat shock 
The act of heat shocking cells after the addition of carrier DNA, transforming DNA and 
chemical solutions is executed in order to decrease membrane fluidity via the release of 
lipids, which in turn open up the “pores” created by the chemical solutions used.  Heat 
shock also promotes passage of DNA into the cell and although the optimum time for cells 
to be exposed to heat-shock varies with yeast species (Gietz and Schiestl 2007) between 5 
and 15 mins at 42 oC is generally utilised for most strains (Knop et al. 1999). 
No published data on the temperature sensitivity at 42 oC of L. starkeyi is available; 
therefore a cell viability experiment at this temperature was undertaken. Samples of L. 
starkeyi cells were harvested and exposed to 42 oC heat for 15, 30, 45 and 60 minutes 
before plating out onto YPD agar.  After one week of incubation at 30 oC yeast colonies 
were observed on all plates, with little reduction in viability after a heat shock of 60 
minutes compared to non-heat shocked control cells. 
Based on the above data, the L. starkeyi transformation was repeated using fresh 
transformation chemicals with heat shock at 42 oC for 50 minutes and selection on YPD 
agar supplemented with 100 µg/ml G418.  A longer heat shock was utilised based on the 
transformation of oleaginous yeast by (Chen D.C. et al. 1997). 
After 2 weeks of incubation at 30 oC, a single colony was observed on one of the 
experimental plates (the control plate remained free of growth), suggesting genomic 
integration of the KanMX deletion cassette. To confirm a stable integration into the 
genome, cells transferred to YPD alone before colonies were transferred back to YPD agar 
supplemented with 100 µg/ml G418.  To determine if the KanMX gene had integrated and 
displaced the L. starkeyi genomic MAPK, the cells were tested for both phenotype and 
genotype. If the L. starkeyi MAPK holds a role similar to that in S. cerevisiae and S. pombe, 
the gene deletion would be expected to show sensitivity to H2O2 at a lower concentration 
compared to that of wild type cells. To determine stress sensitivity, cells were patched 
onto YPD supplemented with 6 mM and 4 mM hydrogen peroxide.   
Colonies were found to be more sensitive to 6mM and 4mM H2O2, indicated by inhibition 
of growth on YPD/H2O2 plates in comparison to the wild type strain.  To determine 
whether this stress sensitivity was due to deletion of the MAPK a genomic DNA extraction 
was undertaken, as detailed in section 2.3, and a PCR carried out utilising primers specific 
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to the ORF of the L. starkeyi MAPK (CLL005/006).  The resultant PCR products were 
compared to that amplified from wild type L. starkeyi genomic DNA on a 0.8% agarose gel.  
The agarose gel showed a clear band in the test strain at the same position as the wild 
type sample (~1.4 Kb) corresponding to the MAPK of L. starkeyi.  If KanMX had integrated 
and displaced L. starkeyi MAPK, no PCR product at 1.4 Kb would have been expected. As 
the colony produced from the transformation was found to not contain the desired 
deletion it was concluded that either: the transforming DNA had randomly  integrated into 
the genome allowing growth on G418 or that upon plating out the cells mutations had 
arisen as a result of a stress response, giving rise to cells with some resistance to G418. 
5.5.1.5 S. cerevisiae transformation method 
As S. pombe methodology was unsuccessful, alternative transformation protocols were 
tested.  The transformation method utilised for S. cerevisiae was also tested with L. 
starkeyi, as described in Chapter 2.   As with previously utilised methods, no L. starkeyi 
colonies were observed on G418 plates after a 2 week incubation period. 
5.5.1.6 Yarrowia lipolytica transformation method 
As neither the S. pombe nor S. cerevisiae transformation methods produced successful 
transformants in L. starkeyi, a transformation protocol for the oleaginous yeast species Y. 
lipolytica was next utilised.  The transformation method used was a modified one-step 
method, carried out according to Chen et al. (1997), where transformation efficiency was 
reported to be ~1 x 104 for integrative vectors (Chen D.C. et al. 1997). Liquid cultures were 
harvested and cells resuspended in 100 µl one step buffer [45% PEG4000, 0.1 M LiAc pH 
6.0, 25 µg carrier DNA, 100 mM dithiothreitol].  10-20 ng of transforming DNA was then 
added before thoroughly vortexing and incubating at 39 oC for 60 minutes.  Cells were 
then spread directly onto a well dried YPD plate supplemented with 100 µg/ml G418 and 
incubated at 30 oC.  No growth of L. starkeyi was observed following a 2 week incubation 
period. 
5.5.1.7 Bahler-Chen hybrid method 
As no colonies were observed using the method of Chen et al. (1997)   further 
transformations were carried out using the previously described modified method of 
Bahler et al. (1998) (fresh solutions, reduced G418 plate concentration and increased 
DNA) along with some of the principles of the method by Chen et al. (1997).  The 
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principles taken from the latter paper which were then incorporated into the modified 
Bahler protocol were: no washing of cells in water as there is a suggestion that competent 
cells may be osmosensitive, longer heat shock (60 minutes) at a lower temperature (39 
oC), well dried selective plates as wet plates were found to critically affect the efficiency of 
transformations and finally increased the concentration of PEG4000 (45% rather than 
40%).  This protocol produced a single colony on one experimental plate (the control 
plate, YPD supplemented with 100 µg/ml G418, remained free of growth).  Upon PCR of 
the resultant colony, the band corresponding to L. starkeyi MAPK was found to still be 
present. 
5.5.1.8 Lipomyces transformation protocol published by Calvey et al. 2014 
In April 2014, an optimised transformation method for L. starkeyi, using native promoters 
and terminators, was published (Calvey et al. 2014).  This protocol recommended: 
harvesting cells at 3 x 107 cells/ml before addition of 86 mM LiAc, 240 µl 50% PEG, 30 µg 
ssDNA and 15 µl transforming DNA.   Incubation at 30 oC for 3 hrs and 5 minute heat shock 
at 42 oC, before removal of supernatant, addition of YPD and further incubation at 30 oC 
for 4 hrs.  After 4 hrs of recovery at 30 oC cells were plated onto 30 µg/ml clonNAT (Calvey 
et al. 2014). 
The main differences between protocols tested in the present study and the published 
optimised method were: use of cells at a density of 3 x 107 cells/ml, 30 oC incubation for 3 
hrs, 5 minute heat shock at 42 oC, the further 4 hr recovery period and utilisation of 
nourseothricin (clonNAT) as a selectable marker.  Increased cell number utilised may serve 
to enhance transformation efficiency by increasing the number of cells available for DNA 
uptake.  Additionally it is reported by Calvey et al. (2014) that L. starkeyi has a low 
tolerance to extensive high temperature exposure, which may have affected previous 
transformation experiments utilising a longer heat shock at 42 oC.  Furthermore, as this 
species of yeast has a reduced rate of growth compared to S. cerevisiae and S. pombe the 
longer incubation period before heat shock and subsequent recovery period may serve to 
allow more efficient transformation. 
Transformation was carried out as detailed by Calvey et al. (2014) and plates incubated at 
30 oC for 1 week.  After 1 week, no colonies were observed.  Following on from this, the 
standard protocol was repeated along with additional reactions whereby 10% DMSO was 
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added prior to heat shock and cells were allowed a final recovery overnight before plating 
onto selective medium.  After 1 week of incubation at 30 oC no colonies resulted from 
utilisation of the standard protocol or additional reactions containing DMSO nor those 
that were subjected to an overnight recovery. 
 
5.6 Cloning of L. starkeyi MAPK for heterologous protein expression 
As the method development for the transformation of L. starkeyi did not result in 
production of a MAPK null strain, the MAPK gene from L. starkeyi was amplified by PCR 
and cloned into pRS315 for heterologous expression studies in S. cerevisiae. If the MAPK 
of L. starkeyi has a similar role to that of HOG1 in S. cerevisiae it might be expected that 
the stress sensitive phenotype of the hog1Δ would be recovered.  The L. starkeyi MAPK 
ORF plus promoter region (1 kb upstream) was amplified by PCR using primers 
CLL026/028. The resulting PCR product was then digested along with pRS315 using XbaI 
and SacI restriction enzymes, before ligation and transformation into E. coli DH5α.  
Resultant colonies were screened by colony PCR before mini-prep and digestion of 
positive colonies. 
Digestion of mini-prepped plasmids with XbaI and SacI produced fragments at 6.0 kb, 
corresponding to pRS315, and 2.4 kb corresponding to the L. starkeyi MAPK ORF plus 1 kb 
of upstream sequence (Figure 5.14). 
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Figure 5.14: Agarose gel of digested pRS315 and pRS315LSMAPK. 0.8% agarose gel. Lane 1: Digested 
vector, pRS315 using XbaI and SacI restriction enzymes, lanes 2 and 3: Digested pRS315LSMAPK using XbaI 
and SacI restriction enzymes showing 6.0 kb band corresponding to pRS315 and ~2.4 kb band corresponding 
to putative L. starkeyi MAPK plus 1 kb promoter region. 
 
pRS315 and pRS315LSMAPK were then transformed into S. cerevisiae wild type and cells 
deleted for HOG1, as described in Chapter 2.  Transformants were transferred to YNB 
medium lacking leucine to select for cells containing empty vector and the constructed 
plasmid.  To test if L. starkeyi MAPK recovered the osmotic stress sensitive phenotype of 
the hog1Δ, cells were transferred to YNB agar and YNB agar plus 0.4 M NaCl. 
As shown in Figure 5.15, the phenotype of cells lacking HOG1 subjected to osmotic stress 
was not recovered upon transformation with pRS315LSMAPK. 
 
 
 
 
 
2.4 kb-
6.0 kb-
1 32
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Figure 5.15: Spot plates of S. cerevisiae wild type and hog1Δ transformed with pRS315 and 
pRS315LSMAPK. Control plates (YNB) and osmotic stress plates, YNB supplemented with 0.4 M NaCl. 
Starting cell densities were ~2.3 x 107 cells/ml before being serially diluted 1:10 across the plate down to 2.3 
x 102 cells/ml. 
 
5.7 Identification of components of the MAPK pathway in L. starkeyi using 
bioinformatics tools 
A p38/Hog1/Sty1 homologue has been identified in L. starkeyi suggesting that L. starkeyi 
may have a functional MAPK pathway, analogous to those of S. cerevisiae and S. pombe. 
BLAST protein-protein searches were performed on the JGI database utilising protein 
sequences of S. cerevisiae and S. pombe MAPK components.  The results, shown in Table 
5.3 indicate that L. starkeyi contains homologues of all components of the HOG and Sty1 
pathways.  The MAPKKK identified, protein 42041, showed 33% similarity to that of S. 
cerevisiae Ste11 and 35% similarity to Win1 in S. pombe.  The MAPKK, protein: 4347, was 
also found to be ~62% identical to Pbs2 and Wis1.  As demonstrated earlier the MAPK, 
protein 106427, is ~82/83% similar to Hog1 and Sty1 proteins. 
 
 
 
 
 
 
YNB YNB + 0.4M NaCl
wt pRS315
wt pRS315MAPK
hog1Δ pRS315
hog1Δ pRS315MAPK
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 Table 5.3: MAPK components of L. starkeyi are conserved with those in S. cerevisiae and S. pombe. 
Components of the S. cerevisiae HOG pathway and S. pombe Sty1 pathway compared to homologues 
identified via sequences searches.  Sequences were obtained from the L. starkeyi JGI genome portal using 
BLAST protein searches.  Protein ID is given for L. starkeyi and percentage similarity of MAPKKKs, MAPKKs 
and MAPKs to S. cerevisiae shown in bold. 
 
 
L. starkeyi also contains MAPK targets including an Msn2/4 like protein (protein 2854) 
which shares 57% homology to Msn2/4 of S. cerevisiae.   Furthermore Aft1 and Pap1 like 
proteins (6160/5850) were also found which confer 27% and 24% similarity respectively. 
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5.8 Discussion 
In this study the aim was to develop molecular techniques in the oleaginous yeast species 
L. starkeyi for use as a metabolic model to study the regulation of lipogenesis.  This was 
required to assess whether the role of this yeast MAPK was similar to that of S. cerevisiae 
and S. pombe in the regulation of both the stress response and lipid accumulation. 
As described in Chapter 1, the MAPK pathway is important in the response of cells to 
various stresses including osmotic and oxidative stress.  In order to characterise the MAPK 
of L. starkeyi the responses of L. starkeyi to stresses was determined for comparison with 
those known for S. cerevisiae and S. pombe. 
Results of the spot plates determined that L. starkeyi had a response to osmotic and 
oxidative stress in between those displayed by S. cerevisiae and S. pombe, most 
resembling that of S. cerevisiae (Figures 5.1 and 5.2).  Although L. starkeyi did not grow as 
well as S. cerevisiae at higher levels of stress, this could be due to the reduced growth rate 
of L. starkeyi compared to S. cerevisiae.  This could potentially be determined by repeating 
the experiment at a reduced growth temperature for S. cerevisiae.  
Amplification of L. starkeyi MAPK from genomic DNA using conserved primers was not 
successful (Figure 5.6).  This suggested the L. starkeyi nucleotide sequence was not well 
conserved to that of S. cerevisiae and S. pombe. No amplified products were yielded for S. 
pombe whilst utilising the conserved primers.  This demonstrated that amplification of the 
MAPK genes using a conserved primer approach was not viable as no specific products for 
L. starkeyi were yielded (Figure 5.6).  Amplified DNA products were observed once the 
annealing temperature had been dropped to 35 oC (Figure 5.7).  However, during PCR 
conducted below the optimal annealing temperature, the primers hybridize non-
specifically to the template strand due to weak interactions caused by the lower annealing 
temperature.  This results in amplification of non-specific products by Taq polymerase 
(Bell D. A. and DeMarini 1991).  Due to this it is suggested that most of the bands 
observed for S. pombe and L. starkeyi in this case were likely due to non-specific binding 
of primers to template genomic DNA. 
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A further approach that could be utilised with conserved primers to amplify L. starkeyi 
MAPK, would be a touch down PCR program. With a touch down program, the annealing 
temperature starts 10 degrees higher than the optimal annealing temperature of the 
primers. The annealing temperature is then decreased by 1 degree per cycle for 10 cycles, 
followed by a further 10-15 cycles at the optimal annealing temperature. It is suggested 
that this approach may have been a more viable means of obtaining specific products 
from conserved PCR as it has been shown to reduce the amount of non-specific product 
yield (Korbie and Mattick 2008). 
After obtaining sequence data from the Joint Genome Institute (JGI), the MAPK 
homologue gene in L. starkeyi was amplified successfully utilising a standard PCR program.  
This is the first time that amplification of the L. starkeyi MAPK ORF has been 
demonstrated (Figure 5.8). On subsequent alignment of all three nucleotide sequences it 
was found that regions at the beginning and end of the open reading frame of L. starkeyi 
MAPK were not well conserved to those of S. cerevisiae and S. pombe (Appendix I, Figure 
A8). As such, the low level conservation of the nucleotide sequences at the extremities of 
the ORF explains why the conserved primer PCR was unsuccessful for amplification of the 
L. starkeyi MAPK.   
Upon alignment of the protein sequences from the three yeast species utilised it was 
found that the MAPK protein sequence of L. starkeyi was highly homologous to both S. 
cerevisiae and S. pombe (Figure 5.9).  
The antibody used to detect total Hog1p detected total Hog1p for S. cerevisiae samples 
but did not produce any bands for L. starkeyi (Figure 5.12).  This was not expected as the C 
terminal epitope recognised by the antibody is highly conserved between L. starkeyi, S. 
cerevisiae and S. pombe (Figure 5.11).  This could suggest that residues of the L. starkeyi 
sequence that differ from both S. cerevisiae and S. pombe, such as residues 260, 270, 300 
and 350, could be pivotal to recognition of the epitope by the antibody.  Alternately the 
conformation of L. starkeyi MAPK may differ from that of S. cerevisiae and S. pombe, and 
so the epitope may be masked by differential folding of L. starkeyi MAPK. 
Protein analysis also suggests that the commercially available P-p38 antibody would 
recognise the dually phosphorylated form of L. starkeyi MAPK due to the conserved 
residues being analogous to those in Hog1 and Sty1 (Figure 5.10). Western blot analysis of 
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L. starkeyi protein extracts utilising the α-P-p38 antibody suggested that the antibody may 
recognise dually phosphorylated L. starkeyi MAPK.  However, no band was observed for 
stressed S. cerevisiae whereas bands were observed in the non-stressed samples where, 
following evidence from other yeast MAPK, dual phosphorylation would not be expected 
(Figure 5.12).  This could be due to non-specific bands, or could demonstrate there is a 
basal level of MAPK dual phosphorylation in L. starkeyi. As sections of the nucleotide 
sequence are significantly different in L. starkeyi than in S. cerevisiae and S. pombe, due to 
the high conservation observed at the protein level, this suggests that the codon usage is 
different.  This would explain the differences in nucleotide sequence yet similar protein 
sequence observed. 
In order to determine if the band present in the L. starkeyi samples are as a result of 
phosphorylation, alkaline phosphatase treatment of native protein extracts could be 
employed.  Alkaline phosphatase treatment would remove phosphorylation on amino acid 
residues of the protein, as such if the bands observed were due to phosphorylation they 
would be absent following treatment with alkaline phosphatase. 
Transformations conducted to produce an L. starkeyi MAPK null strain, which would serve 
to characterise the role of the MAPK homologue in both the stress response and lipid 
accumulation, were unsuccessful.  In initial experiments conducted utilising S. pombe 
methodology, no colonies resulted from transformations. After identification of a number 
of factors which may influence transformation efficiency, modifications to the protocol 
were made to see if successful integration resulted. Lowering the concentration of G418 
did not result in efficient colony formation after transformation.  As the toxicity of G418 to 
L. starkeyi cells is unknown, a toxicity assay should be performed in order to identify the 
minimum inhibitory concentration of G418 before further employment of KanMX as a 
selectable marker. Furthermore, as there is no published information on the expression of 
KanMX from an S. pombe based vector in L. starkeyi, it was equally possible that it might 
not be expressed in L. starkeyi. 
It was also determined that L. starkeyi is able to grow without an exogenous source of 
uracil.  In order to overcome this and utilise uracil as a selectable marker a URA- mutant 
could be developed from wild type cells.  This could be achieved by spreading mature 
cultures into 5-FOA plates which is toxic to cells that are able to metabolise uracil. 
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As it has been suggested that DNA attached to the cell wall enters the cells during 
transformation (Kawai S. et al. 2010), the concentration of transforming DNA was 
increased as this may increase the chance of DNA attachment/entry into the cell and 
subsequent integration. However, it is not known whether the failure to transform L. 
starkeyi was as a result of the transforming DNA being unable to enter the cell or failure to 
integrate into the genome.  In order to elucidate the fate of the transforming DNA, a GFP 
tagged DNA cassette could be utilised for transformation and assessment of DNA entry 
into the cell assessed via fluorescence microscopy. 
A published protocol for L. starkeyi by Calvey et al. (2014) was reported to yield 
transformation efficiencies of >8000 transformants/µg DNA for the integrative vector 
used. Although modifications were made, such as addition of DMSO and an overnight 
recovery period, viable transformants were not yielded. Addition of DMSO to 
transformation mixtures was conducted prior to heat shock as it has been reported to 
affect the permeability of cell membranes facilitating DNA uptake (Murata et al. 2003).  
The recovery period was also increased as extended recovery periods were reported to 
improve the efficiency of transformation (Calvey et al. 2014). However, the method was 
not reproducible in the present study utilising a deletion cassette.  The integrative vector 
used contained native L. starkeyi promoters and terminators for nourseothricin 
expression. In this study the NAT deletion module was produced using an S. pombe vector, 
which contained S. pombe transcriptional regulatory elements (Bahler et al. 1998). As 
such, it is possible that there was no transcription of the S. pombe selection marker in L. 
starkeyi. Therefore, the deletion cassette may have integrated into the genome, but it was 
unable to growth on the selection antibiotic.    
As described earlier within this chapter, the protein sequences of L. starkeyi and S. 
cerevisiae are well conserved. Therefore, to study the role of the L. starkeyi MAPK protein, 
it was cloned and expressed in an S. cerevisiae cells deleted for HOG1. Recovery of the 
osmostress phenotype associated with the deletion of HOG1 by the L. starkeyi MAPK 
would suggest it had a similar role in the osmostress response of the cell. Heterologous 
expression of mammalian MAPK proteins in S. cerevisiae has demonstrated the ability of 
p38 and JNK to recover osmosensitivity of HOG1 deleted cells (Galcheva-Gargova et al. 
1994, Saito and Posas 2012).  On transforming S. cerevisiae hog1Δ with pRS315LSMAPK it 
was observed that L. starkeyi MAPK did not recover the osmotic stress sensitivity of the 
265 
cells (Figure 5.15).  This could suggest that L. starkeyi MAPK does not hold a similar role to 
that of S. cerevisiae Hog1.   
However, it is possible as the promoter region of L. starkeyi was utilised for transcription 
of the L. starkeyi MAPK within pRS315, that it was not recognised by the transcriptional 
machinery of S. cerevisiae meaning that the gene would not be transcribed.  There are a 
number of transcription factors that regulate the expression of HOG1 under various 
conditions including Hap1, Skn7 and Med2 (MacIsaac et al. 2006, Venters et al. 2011).  
Therefore for heterologous expression it was assumed that L. starkeyi would contain such 
transcription factor homologues.   Upon analysis of the promoter regions of L. starkeyi and 
S. cerevisiae (1kb upstream of the ATG), they were found not to be well conserved 
exhibiting only 43.97% similarity (Appendix I, Figure A9).  In order to overcome this, the 
employment of inducible promoters could be used to express L. starkeyi MAPK in S. 
cerevisiae. Alternately L. starkeyi MAPK could be cloned and placed under the control of 
the HOG1 promoter. 
It was demonstrated in Section 5.3.1 that the nucleotide sequence of L. starkeyi MAPK 
was 1.4 kb in length and in Section 5.4 that the mass of the protein is approximately 40 
kDa.  In contrast, the S. pombe sty1 nucleotide sequence is 1.0 kb and protein 40 kDa and 
S. cerevisiae 1.3 kb and 50 kDa respectively. This demonstrated that the translated 
genomic DNA sequence for the L. starkeyi MAPK did not match with the identified size of 
the protein.  Upon analysing the 3-frame translation of the L. starkeyi MAPK sequence via 
the genome portal of JGI it was discovered that the sequence contains 6 introns ranging 
between 47 and 65 base pairs long (Appendix I, Figure A10).  
It has been demonstrated that another oleaginous yeast species, Y. lipolytica, has an 
intron rich genome (Mekouar et al. 2010).  However no introns were identified within the 
sequence of its p38 homologue.  After removal of the introns, the cDNA of L. starkeyi 
MAPK was found to be a similar length to S. pombe sty1 at ~1.0 Kb (Appendix I, Figure 
A11).  After analysing S. pombe and S. cerevisiae sty1 and HOG1 sequences via PomBase 
and the Saccharomyces genome database neither sequence contained introns.  This 
suggested that the L. starkeyi MAPK may be transcribed in the hog1Δ strain, but the 
introns may not be spliced to form mature mRNA.  This is supported by S. cerevisiae 
harbouring very simple splicing machinery, as there are only 5% of genes which contain 
introns in S. cerevisiae (Juneau et al. 2006). In order to confirm that the MAPK of L. 
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starkeyi was not expressed a Northern blot could be performed utilising the hog1Δ 
expressing HOG1 as a positive control.  If L. starkeyi MAPK is not found to be expressed it 
could be cloned utilising processed mRNA reverse transcribed to cDNA before 
transformation into the S. cerevisiae hog1Δ strain.  
As a potential MAP kinase has been identified for L. starkeyi, it would be required to be 
part of a pathway in order to function.  In order to identify if the potential MAPK identified 
had conserved upstream regulators and downstream targets, bioinformatics analyses 
were performed using the Lipomyces genome portal, JGI.  After BLAST analysis of S. 
cerevisiae and S. pombe MAPK components using the Lipomyces genome database 
provided by JGI, MAPK protein homologues were identified in L. starkeyi which produced 
a potential MAPK cascade (Figure 5.16).  All components from the MAPKKK to 
transcription factors were found to have homologues in L. starkeyi with the MAPKKs and 
MAPKs conferring the greatest similarity when compared to S. cerevisiae and S. pombe.   
For downstream targets, homologues of S. pombe Aft1/Pap1 were identified but were 
found to only be 27% and 24% similar.  In comparison for Msn2/4, homologues were 
identified that conferred 57% similarity, which may suggest that L. starkeyi is more 
conserved at the transcription factor level to S. cerevisiae than S. pombe. 
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Figure 5.16:  Potential MAPK cascade identified for L. starkeyi via bioinformatics. Left: S. cerevisiae HOG 
pathway.  Centre: S. pombe Sty1 pathway. Right: potential MAPK pathway.  The L. starkeyi MAPK pathway 
was constructed from searching the Lipomyces genome portal database, JGI using protein-protein BLAST.  
Searches were conducted utilising the protein sequences of MAPK components from both S. cerevisiae and 
S. pombe. L. starkeyi proteins are named based on their protein identification number obtained from JGI, 
TFs: Transcription factors.  Protein identification; 42041: MAPKKK (Pbs2 homologue), 4347: MAPKK, 106427: 
MAPK, 2854: Msn2/4 homologue, 6160: Atf1 homologue. 
 
In this chapter it has been demonstrated that the stress response of L. starkeyi was more 
similar to that of S. cerevisiae than S. pombe, suggesting that the role of the MAPK 
pathway in L. starkeyi may be conserved to this yeast species.   
It has been further demonstrated that although the nucleotide sequence of the identified 
MAPK homologue in L. starkeyi is not well conserved, there is a high degree of 
conservation at the protein level.  Further, it was been highlighted that further work is 
required on the development of molecular tools for L. starkeyi, for both transformation 
and detection of proteins utilising antibodies.   
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Finally it was shown that L. starkeyi may have a potentially functional MAPK pathway, 
from the identification of MAPK components that are homologous to those present in 
both S. cerevisiae and S. pombe.  In conclusion, once reliable molecular tools are 
developed and optimised, it is expected that L. starkeyi would serve as an excellent 
complementary model organism for investigating the regulation of lipid accumulation via 
the MAPK pathway. 
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Chapter VI Discussion 
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6.1 Discussion Summary 
Since the observation by Otto Warburg in the 1920s that cancerous cells have an altered 
metabolic state, the regulation of tumour metabolism has become an increasingly 
important area of research.  Although increased de novo lipogenesis in solid tumours has 
been well described, there are still many questions remaining on the impact of complex 
upstream signalling networks on the metabolism of lipids.  As such, a greater 
understanding of signalling processes residing upstream of lipid regulatory proteins will 
ultimately aid in the development and implementation of novel therapeutic strategies.  
Due to the complex nature of mammalian systems, yeast have been increasingly utilised 
to study the regulation of lipid accumulation.  This has aided the understanding of 
fundamental metabolic processes which are applicable to mammalian cells. 
This study has focused on the regulation of lipid accumulation via the stress induced MAP 
kinase pathway, which is structurally and functionally conserved within yeast.  A Nile red 
method for assessing levels of both polar and neutral lipid pools has been developed and 
has allowed characterisation of lipid phenotypes in yeast cells.  This method has been 
used to demonstrate that the MAP kinase pathway plays a key role in the regulation of 
neutral and polar lipid accumulation.  This regulation is conserved both in the budding 
yeast, S. cerevisiae, and the fission yeast, S. pombe, at the point of the central MAPK.  The 
investigation has been further extended to study the use of the non-conventional yeast 
species, L. starkeyi, as a model organism.  Use of this oleaginous lipid -accumulating yeast 
may, in future, further enhance our understanding of the role of MAP kinase and other 
pathways in the regulation of lipid accumulation. Ultimately, this may lead to the 
identification of novel targets for improved treatment of tumour-associated lipid 
formation.  
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6.2 Assessment of neutral and polar lipid classes utilising Nile red 
As there is much unknown about the regulation of lipid accumulation an increased 
throughput methodology would allow components that are involved to be quickly and 
easily identified.  Identification of novel regulatory components would increase 
understanding of the underlying mechanism of lipid accumulation, which would lead to an 
enhanced understanding of diseases including cancer.  This would then lead onto 
facilitating the development of improved treatment strategies.  
As described in Chapter 3, currently employed methodologies for the assessment of 
cellular lipids are often labour intensive and time consuming, involving several steps and 
often necessitate the use of large amounts of organic solvents.  Further to this, the 
lipidologist must take precautions to ensure extracted lipids are not oxidised either by 
contaminants, such as plasticisers from plastics, or enzymes and oxygen.  It is generally 
accepted that there is no single method of extraction that is capable of obtaining 100% 
lipid yield.  Inherent problems with commonly used extraction methods, including those 
developed by Bligh and Dyer (1959) along with Folch et al. (1957), include inefficient cell 
wall breakage along with underestimates of neutral lipids in extracts comprising more 
than 2% lipid (Iverson et al. 2001).   
Gas chromatography and liquid chromatography coupled with mass spectrometry are 
commonly utilised sensitive techniques to evaluate cellular lipids (Yang Kui and Han 2011).  
These techniques not only allow for assessment of cellular lipid amounts, but also allow 
comprehensive analysis of different lipid classes present.  Due to the rapid growth of 
lipidomic research the development of higher throughput methodologies is being trialled.  
Direct infusion techniques, which do not comprise of a prior chromatographic separation, 
allow simultaneous analysis of multiple lipids in high throughput format.  However, they 
have previously been shown to lack the ability to distinguish all lipid molecules present (Li 
Min et al. 2013).  As such, for a more quantitative and comprehensive analysis of the 
lipidome, use of chromatographic separation is essential and therefore is more time 
consuming (Li Min et al. 2013).  Furthermore, two separation protocols are often required 
in order to analyse both neutral and polar lipids which has sparked interest in the 
development of one step systems to analyse major components of both neutral and polar 
lipid pools simultaneously (Shui et al. 2010). 
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Although this highlights significant progress in the development of high throughput lipid 
analyses by more sophisticated means, such as GC and LC, the preparation of samples is 
still considered laborious and time consuming and does not allow for in situ measurement 
of cellular lipid content. 
As such, screening large numbers of samples is complex and highlights the need for 
increased throughput methodology in order to identify key components which may then 
be promoted for further in-depth analyses.  The Nile red fluorescence assay developed in 
this study (Chapter 3) allows for rapid identification of neutral and polar lipid levels in situ, 
abolishing the requirement for multiple extractions of samples which may not yield an 
informative phenotype.   
Other dyes for assessing lipid status of cells have been described that could potentially be 
utilised in high throughput screening, including BODIPY, Sudan Black, LD540 and Oil Red O, 
which all have advantages and disadvantages in their application.  However, the non-
fluorescent dye Sudan Black, does not provide accurate assessment of lipid content, often 
producing false positive absorbance readings (Li Shi Lin et al. 2012).  Oil red O allows 
fluorescent detection of neutral lipid within cells but not polar lipids and has not been 
utilised as extensively in yeast as Nile red. The fluorescent dye BODIPY can also be used to 
detect neutral lipids and has been found to have greater specificity in its detection of 
neutral lipid droplets. The major disadvantages of BODIPY are that it cannot be used to 
infer polar lipid status and its higher cost in comparison to Nile red. LD540, a fluorescent 
dye based on the BODIPY fluorophore shows a significant reduction in photo bleaching 
compared to Nile red, although under intense illumination lipid droplet fusion may be 
propagated by LD540 (Radulovic et al. 2013). 
Whilst all lipophilic dyes will have their merits, Nile red is one of the most established and 
widely utilised.  Nile red has been extensively employed in the biotechnological field as a 
fast, efficient lipid detection and quantification tool to identify high lipid producing 
microalgae and yeast species in the production of biofuels (Chen Wei et al. 2009, Diaz et 
al. 2008, Ren et al. 2013). Further to this Nile red has also been used to screen for the 
production of microbial biosurfactants (Castro et al. 2005) and has been additionally 
applied to detection of polyhydroxyalkanoates (PHAs).  PHAs are a class of polymer 
produced by stressed microorganisms which may be used in the production of 
environmentally friendly alternatives to plastics (Zuriani et al. 2013). 
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The dual wavelength capability of Nile red has made it particularly attractive for use in the 
current study, allowing for analysis of neutral and polar lipid levels simultaneously with a 
single dye (Diaz et al. 2008).   It has been demonstrated, for the first time, that a Nile red 
assay can be applied to the fission yeast S. pombe. This is of particular importance due to 
growing interest and research in the area of S. pombe lipid metabolism, not only for 
modelling mammalian lipid accumulation but also to facilitate use as a potentially relevant 
tool in the biotechnology industry.   
As described in Chapter 3, the method is not without its limitations, namely rapid 
bleaching of red emission, neutral and polar lipid fluorescence values cannot be directly 
compared and that the assay is limited to general pools of lipids.  Knowing more about the 
levels of individual molecular species is important to dissect the specific contribution of 
components in the metabolism of lipids.  For example, to determine whether deletion 
strains differ from wild type cells in the PC composition of the polar lipid pool, rather than 
PS or PE.  Therefore further analysis to determine changes in molecular species would 
need to be conducted by other means, such as gas/liquid chromatography.   
However, as discussed in Chapter 3, the increased throughput nature of the Nile red assay 
allows for rapid identification of components that have a significant impact on the 
accumulation of lipids.  Incorporation of the dual wavelength feature also ensures that 
information pertaining to carbon flux for polar lipids is not overlooked.  By exploiting the 
dual wavelength capability of Nile red in this study, two components of the MAPK 
signalling pathway have been identified that have not been previously implicated in lipid 
biosynthesis, with one having a potential role in both neutral and polar lipid homeostasis.  
This emphasises the usefulness of employing both neutral and polar wavelengths when 
screening yeast gene deletions to assess involvement in lipogenesis.   
Nile red has been extensively used both for microscopic and assay based fluorescence 
studies for the assessment of lipid status in numerous systems aside from yeast including 
Caenorhabditis elegans (Lemieux et al. 2011) (Soukas et al. 2013), Drosophila (Reis et al. 
2010) (Liu Z. and Huang 2013), bacteria (Zuriani et al. 2013), zebrafish (Flynn et al. 2009) 
(Tingaud-Sequeira et al. 2011) and microalgae (Chen Wei et al. 2009, Ren et al. 2013).  
Nile red has also been utilised in staining of mammalian cells such as macrophages 
(Greenspan et al. 1985) and cell lines which include MCF-7 (breast cancer), HepG2 
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(hepatic cancer) (Drabsch et al. 2010, Yao et al. 2011).  As such, it is possible to further 
develop this methodology for differential wavelength screening in a variety of model 
systems which are inclusive of mammalian cells. 
6.3 Use of yeast as a model organism for lipogenesis 
Previous published data and this thesis have proven that yeast systems are an excellent 
model system for deconstructing the regulation of lipid metabolism (Henry et al. 2012).  
Although differences exist, especially at the enzyme level, between lipid metabolism in 
yeast and mammalian cells the mechanisms involved in lipid accumulation are largely 
conserved (as described in Chapter 1).  Additionally the growth of yeast in the presence of 
glucose is similar to that of the Warburg effect observed in cancerous cells (Vander Heiden 
et al. 2009).  There are also potentially strong similarities with respect to regulation of 
metabolism by oncogene homologues found in yeast, as highlighted in a review by Diaz-
Ruiz et al. (2011).  Furthermore the present study has also shown that deletion of the 
mTORC1 homologue results in a reduced lipid phenotype (Figure 4.4 and 4.5), which is 
consistent with the role of mTORC1 as a positive regulator of lipid synthesis in mammalian 
systems. 
Much of the research conducted in yeast lipid metabolism has centred on employment of 
the budding yeast species S. cerevisiae.  S. cerevisiae has been extensively characterised 
owing to it being the first eukaryotic organism to have its entire genome sequenced.  The 
conservation highlighted earlier, coupled with the simplified lipidome and ease of genetic 
manipulation compared to mammalian cells (Santos AXS. and Riezman 2012) placed S. 
cerevisiae as a superior model yeast for investigating the regulation of metabolic 
processes.   
As previously described in Chapters 1 and 3, the regulation of lipid metabolism is 
becoming increasingly investigated due to potential exploitation in the biotechnology 
industry.  Furthermore, S. pombe may prove to be a good complementary organism due 
to its higher degree of conservation to mammalian cells, as described previously in 
Chapter 1.  Additionally S. pombe may be superior model for investigation of de novo lipid 
formation owing to the high rate of de novo lipid synthesis exhibited in exponential phase 
growth (Figure 3.49 and 3.50).   
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Oleaginous yeasts have been primarily employed in the biotechnology industry for 
production of useful products such as biofuels, biosurfactants and cocoa butter 
substitutes, reviewed in (Gon et al. 2014). It is suggested that oleaginous species, 
including L. starkeyi may prove useful as model organisms for understanding metabolic 
processes in human disease.  It has been described previously that oleaginous species, 
such as L. starkeyi, may be more similar to humans with respect to metabolism, as they 
contain ATP citrate lyase (Boulton and Ratledge 1981). Furthermore, the present study has 
demonstrated that the MAPK of L. starkeyi contains introns (Appendix I, Figure A10).  The 
human homologue also contains introns, yet S. cerevisiae/S. pombe Hog1/Sty1 do not 
further highlighting that L. starkeyi may be a superior model for analysis of lipid 
accumulation via the MAPK pathway.   
The major current disadvantage in utilisation of L. starkeyi is the lack of robust molecular 
tools available for genetic manipulation along with the potential requirement for the 
development of antibodies.  However, if the genetic tools are developed the need for 
antibodies for protein detection would be circumvented by the ability to genomically tag 
cellular components for detection.  It is suggested that, until reliable molecular tools are 
available, Y. lipolytica could be utilised to offer insight into the impact of the MAPK 
pathway on lipid accumulation.  Although less well characterised than S. cerevisiae and S. 
pombe, Y. lipolytica has been sequenced, utilised for human mitochondrial disorder 
research and has a number of molecular tools already developed.  As an oleaginous yeast 
species it is also expected to contain ATP citrate lyase activity and furthermore contains a 
Hog1 homologue (Nikolaou et al. 2009).   
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6.4 The role of Hog1p in the regulation of lipogenesis 
The data presented in Chapter 4 confirmed the involvement of the stress activated MAPK 
pathway in the accumulation of lipids.  In S. cerevisiae, lipid signalling converges at the 
MAPK Hog1, with upstream members of the HOG pathway, Sho1, Ste11 and Pbs2, not 
playing a significant role in the accumulation of neutral or polar lipids.  If Pbs2 was directly 
involved, a similar level of reduction in lipid accumulation, as seen in HOG1 deficient cells, 
would be expected. As such, it is suggested that the regulation of Hog1 in the process of 
lipid accumulation is distinct from that of the canonical pathway, Figure 6.1.   
 
 
 
  
Figure 6.1: Pbs2 independent activation of Hog1. From Nile red screening conducted in chapter 3, Pbs2 did 
not appear to be involved in the accumulation of cellular lipids nor did a direct target of Hog1, Hot1p.  Phos-
tag suggested that a Pbs2 independent activation occurred preceding the point of increased lipid 
accumulation.  This suggested that lipid accumulation via Hog1p did not occur as a result of activation via 
the canonical pathway. 
 
 
 
Ste11
Pbs2
Msn2/4 Hot1
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Hog1Hog1
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Although there is no published data suggesting a direct activator of Hog1 other than Pbs2, 
evidence in chapter 4 suggested that Hog1 can be activated via a Pbs2 independent 
mechanism and this may have resulted from phosphorylation on previously undescribed 
residues (Figure 4.34).  However, Pbs2 dependent phosphorylation of Hog1 was observed 
in S. cerevisiae in late exponential phase of growth which suggested it may play a role in 
activating Hog1, which is distinct from its initial activation (Figures 4.30, 4.31 and 4.33).   
One potential Pbs2 independent mode of Hog1 activation in the response of S. cerevisiae 
to accumulate lipid is autophosphorylation.  Hog1 autophosphorylation has been 
demonstrated to occur on both tyrosine and threonine residues under severe osmotic 
stress (Maayan et al. 2012).  This highlighted the possibility that Hog1p could similarly be 
autophosphorylated on currently undescribed residues.  Another possibility is the 
interconnection of other pathways upstream converging at the point of Hog1.  Upstream 
signalling components that have been described to potentially influence Hog1 signalling 
by indirect or direct means include Tor and Sch9. 
Analysis of the yeast phosphoproteome gave additional insight that Tor complex 1 is 
involved in the modulation of a range of glycolytic genes, not only at the transcriptional 
level but also at the post-translational level (Loewith 2011).  It has been demonstrated in 
Chapter 4 that Tor1 is involved in regulating the accumulation of neutral lipids, as TOR1 
deficient cells exhibit a significant decrease of 1.3 fold in the neutral lipid pool compared 
to wild type (Figure 4.4).  One of the major targets of Tor1 containing complex, TORC1, is 
the AGC protein kinase Sch9 (Urban et al. 2007a).  Similarly in cells deleted for SCH9, it has 
been shown that the levels of TAGs and other neutral lipids were markedly reduced 
compared to wild type cells (Wei et al. 2009).  This suggests that Tor1, Sch9 and Hog1 may 
be interconnected in the signalling mechanisms that regulate the accumulation of lipids. 
This is further supported by data in Chapter 4, where the neutral lipid decrease observed 
in HOG1 deleted cells is 1.7 fold (Figure 4.21). The increased reduction in cells deleted for 
HOG1 compared to tor1Δ cells, suggests Tor1 may feed into Hog1, which may hold the 
central role in regulating lipogenesis 
Taken together, with data from the present study a two phase lipid accumulation 
regulatory mechanism is proposed, comprising of both Pbs2 independent and Pbs2 
dependent Hog1 activation.  This two phase mechanism facilitates the accumulation of 
278 
 
cellular lipids in S. cerevisiae over the course of growth from exponential to stationary 
phase.  
In phase one (Figure 6.2) where cells are growing exponentially, potential Pbs2 
independent Hog1 phosphorylation was observed 7.5hrs post resuspension in YNB (Figure 
4.34).  As described in Chapter 4, this was the point preceded by a marked increase in lipid 
accumulation in mid exponentially growing cells.  In conditions where nutrient supply is 
favourable, as in exponential phase, Sch9 is phosphorylated and activated by Tor1 (Urban 
et al. 2007a).  In addition, it has been suggested that Sch9 is activated in a Tor1 
independent manner via ceramide signalling (Teixeira et al. 2013). Not only has Sch9 been 
shown to interact with Hog1 in vitro, Hog1 has also been shown to be a phosphorylation 
target of Sch9, further supporting the model of a potential Sch9 dependent Hog1 
activation facilitating the accumulation of cellular lipids (Pascual-Ahuir and Proft 2007, 
Teixeira et al. 2013). Additionally, Sch9 is functionally related to PKA and has been 
demonstrated to share a number of phosphorylation targets, which include Hog1 (Zhu et 
al. 2000). 
It is likely that at this point that the majority of Hog1 is present in the cytoplasm and is 
involved in the regulation of lipid regulatory proteins. It is expected that there are other 
potential downstream targets of Hog1 that could either be directly or indirectly activated 
by Hog1.  Data in Chapter 3 showed that cells lacking DGA1 had a ~1.4 fold reduction in 
neutral lipids compared to wild type cells (Figure 3.27).  A similar reduction of ~1.6 fold in 
neutral lipid accumulation is observed in HOG1 deleted cells, suggesting that Hog1 may 
interact directly with proteins involved in lipid accumulation.  As Dga1 catalyses the 
terminal step in TAG formation is was speculated that this similar decrease may indicate 
an interaction between Hog1 and Dga1.   
Upon analysis of the protein sequence of Dga1, potential MAP Kinase binding sites were 
found, indicating the possibility that Hog1 could phosphorylate Dga1 to regulated neutral 
lipid accumulation (Figure 4.35).  Two of the identified potential MAPK sites in Dga1 were 
at the N terminus of the protein, S17, which has been assigned as a phosphoserine (Li X. et 
al. 2007), and T53, which sit on the cytoplasmic side of the ER membrane. 
Phosphorylation of these sites by Hog1 may result in activation of Dga1 and cause an 
increase in TAG levels within the cell.   
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Other potential targets of Hog1 include the lipid associated SREBP-like transcription 
factors Ecm22, Upc2, Spt23 and Mga2, which are involved in regulating the transcription 
of lipid biosynthetic genes. The inactive membrane bound SREBP-like proteins of S. 
cerevisiae require cleavage from the membrane in order to be activated and transported 
to the nucleus to facilitate transcription of lipid regulatory genes.  Bioinformatics data 
presented within Chapter 4 depicts that several potential MAPK phosphorylation sites 
exist within the protein sequences of all four SREBP-like proteins.  This suggests that 
Hog1p may promote activation and nuclear translocation of SREBP-like proteins via direct 
phosphorylation to support neutral lipid regulation.  This concept is supported by 
evidence that the mammalian p38 MAPK directly phosphorylates SREBP-1a in hepatic 
cells, linking stress response pathways with cellular metabolism and supporting sterol 
independent activation of SREBPs (Kotzka et al. 2012).  The proposal of SREBP-like protein 
activation via Hog1 is further supported by the suggestion of Hickmann et al. (2011) where 
it was proposed that Hog1 may interact with and activate Upc2 under conditions of 
hypoxia (Hickman M J. et al. 2011).    
For more polar lipids the role of the HOG pathway as a potential regulator is unclear.  
Hog1 may not be involved in phospholipid synthesis as altered membrane permeability 
suggests that this could be the cause of reduced phospholipids.  However, phospholipid 
regulatory elements, Cho1 and Cho2, contain potential MAPK sites (Figures 4.37 and 4.38) 
and so further investigation on the role of Hog1 in polar lipid accumulation is required. 
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Figure 6.2: Phase one of the proposed Saccharomyces cerevisiae model, Pbs2 independent regulation of lipid homeostasis by Hog1. Under conditions where nutrients are available, the TORC1 is 
active, this in turn can activate the protein kinase Sch9 and inhibit the phosphatase Sit4. It is possible that Sch9 can be activated directly by an unknown mechanism, related to the lipogenic switch. Activated Sch9 
inhibits Rim15 and the transcription factors Msn2/4 by retaining them in the cytoplasm, preventing nuclear accumulation. It is postulated that Sch9 may also phosphorylate Hog1 on a previously uncharacterised 
amino acid residue. Hog1 may also autophosphorylate itself through an unknown mechanism. Once phosphorylated, Hog1 is retained in the cytoplasm where it can potentially interact with a number of targets 
including lipid regulatory proteins including Cho1, Cho2, Dga1, Ecm22, Upc2, Mga2 and Spt23. The SREBP like proteins, Ecm22, Upc2, Mga2 and Spt23 may then translocate to the nucleus, where they can activate 
transcription of a number of lipogenic genes. 
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In phase 2 of the model proposed by this study, Figure 6.3, where nutrient supply 
becomes decreased, Pbs2 dependent dual phosphorylation of Hog1 is observed (9 hrs 
post resuspension YNB) (Figures 4.30 and 4.31).  This dual phosphorylation of Hog1 has 
been previously demonstrated following nutrient limitation (Aoki Y. et al. 2011); however, 
data in Chapter 4 does not support this (Figure 4.32). It is suggested that phosphorylation 
of Hog1 may occur at a much earlier time point than the 3 hrs analysed in this thesis, 
therefore it cannot be discounted that it is involved in phase 2 activation. Dual 
phosphorylation of Hog1 has been linked to its translocation and accumulation in the 
nucleus (Ferrigno et al. 1998, Reiser et al. 1999). Previous studies have indicated a role for 
Sch9 in regulating cellular stress responses (Pascual-Ahuir and Proft 2007, Wei et al. 
2009). As such, the regulation of downstream HOG pathway components could be 
modulated by two mechanisms.  When nutrient supplies are decreased Tor1 is inhibited, 
which in turn leads to decreased phosphorylation of Sch9.  A decrease in Sch9 activity 
leads to de-repression of Rim15, which is then able to translocate to the nucleus and 
activate the transcription factors Msn2/4 (Lee et al. 2013).  
Additionally Sit4 phosphatase activity is increased in response to Tor inhibition which 
could serve to negatively regulate Hog1p.  This is supported by the observation that Hog1 
dual phosphorylation is increased in cells deleted for SIT4 (Teixeira et al. 2013).  However, 
in this study at the stage when decreased Tor1 is predicted to occur and in turn increased 
activity of Sit4, dual phosphorylation of Hog1 is observed.  This suggests that Pbs2 is 
phosphorylating Hog1 in phase 2, additionally Sit4 could potentially facilitate the removal 
of the potential novel phosphorylation of Hog1 by Sch9.   It is postulated that as a 
consequence of the signalling described in phase one, including inhibition of Rim15 which 
is involved in the induction of the oxidative stress response, this could result in increased 
levels of cellular reactive oxygen species (ROS) (Weinberger et al. 2010).  As such, this 
could lead to stress related Pbs2 dependent activation of Hog1 via the canonical pathway 
(Smith et al. 2004).   
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Following dual phosphorylation of Hog1 by Pbs2, activated Hog1 is then able to 
translocate to the nucleus to drive expression of both stress responsive and potentially 
lipid regulatory genes via Msn2/4.  It was demonstrated in chapter 4 that S. cerevisiae 
SREBPs Ecm22 and Mga2, contain full STRE elements within their promoter regions. 
Furthermore, Spt23 and Upc2 contain conserved regions of these STREs, PDS elements 
(Figures 4.43 and 4.44).  This further supports a role for Msn2/4 as a key component in the 
transcriptional regulation of cellular lipid accumulation in S. cerevisiae.  This suggested 
that Msn2/4 holds a role in regulating neutral lipid levels via driving expression of SREBPs.  
However, whether this regulation is dependent on Hog1p or Rim15p is unclear and would 
require further investigation. 
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Figure 6.3: Phase two of the proposed Saccharomyces cerevisiae model, Pbs2 dependent regulation of lipid homeostasis by Hog1. As nutrients become depleted in the environment, the cell inhibits 
TORC1, which in turn inactivates Sch9 and activates the phosphatase Sit4. Sit4 may act directly on Hog1, dephosphorylating the novel phosphorylation added by Sch9 or its autophosphorylation. Activation of the 
canonical pathway, via Pbs2, results in dual phosphorylation of Hog1 which translocate to the nucleus and activates transcription both directly and indirectly via Msn2/4. Msn2/4 is also activated both directly and 
indirectly, by Rim15, following Sch9 inhibition. 
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6.5 The role of Sty1p in the regulation of lipogenesis 
It has been demonstrated in Chapter 4 that lipid accumulation is similarly attenuated in 
Sty1 MAPK pathway mutants of S. pombe, highlighting that the regulation of lipid 
accumulation is conserved in S. cerevisiae at the point of the MAPK.  Interestingly, in the 
case of S. pombe the regulation of lipid accumulation may extend further upstream to the 
level of the MAPKK, Wis1 as a similar decrease in lipid was also observed upon its deletion 
(Figure 4.48 and 4.49).  Due to the extensive use of S. pombe as a model organism it is 
possible that the role of the upstream MAPKK may also be conserved in a mammalian 
system.   
The mechanisms underlying how lipid accumulation is regulated by Sty1 are unclear in 
comparison to S. cerevisiae as there is much less known about lipid accumulation and 
regulation.  There is a further level of complexity added as Sty1 does not only serve to 
regulate the response of cells to stress, but also modulates and plays an important role in 
other pathways including cell cycle regulation (Sturgill and Hall 2007).  However, it is 
feasible that lipid accumulation could occur via a similar two phase system in S. pombe. 
As described in Chapter 1 it is important to note that Tor2 in S. pombe is analogous to S. 
cerevisiae Tor1 (mammalian mTORC1) and vice versa.  It has been reported that Tor2 
function in S. cerevisiae is similarly regulated to Tor1 in S. cerevisiae with respect to 
nutrient availability which is concomitant with phase one of the proposed S. cerevisiae 
model, as discussed below.  
Tor2 is activated in conditions where nutrient supply is plentiful and is inactivated in when 
nitrogen is restricted (Nakashima et al. 2010).  S. pombe contains at least three Sch9 (S6K) 
homologues Sck1, Sck2 and Psk1.  Although it is largely unclear whether TOR complexes in 
fission yeast interact with S6K homologues, it has been suggested that, in nutrient rich 
conditions, Tor2 phosphorylates Sck1 and Sck2 (Nakashima et al. 2012b).  Furthermore it 
was demonstrated in vitro that Psk1 function is dependent on Tor2 phosphorylation 
(Nakashima et al. 2012b).   
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Taken together it is possible that Sck1, Sck2 or Psk1 could interact with and activate Sty1, 
as is the case with the model for S. cerevisiae.  This connection is supported by the recent 
suggestion that Sck1 may elicit a biological response to nutrient availability through 
regulation of the Sty1 pathway in S. pombe (Mudge et al. 2014). Additionally an 
interaction of Sty1 with Sck2 has been suggested in connection with life span extension.  
Zuin et al. (2010) showed that lifespan promotion via deletion of sck2 was dependent on 
the function of the Sty1 pathway (Zuin et al. 2010b).  Although no evidence for an 
interaction with Psk1 and Sty1 has been found, these two studies demonstrate that Sty1 
and S6K homologue signalling in fission yeast is interconnected, highlighting the possibility 
that Sty1 is a potential downstream target of S6Ks. 
However, as Wis1 was also found to be involved in regulating lipid accumulation, 
activation of the upstream MAPKK in a S6K dependent manner could serve as an indirect 
means of Sty1 activation (Figure 6.3).  It is unknown following the present study whether 
Sty1 is activated at phase 1, a similar time course experiment of Sty1 phosphorylation by 
Phos-tag is required to identify if there is a potential Wis1 independent activation of Sty1.  
Following on from this mass spectrometry of purified protein could be used to identify 
novel phosphorylated residues, as discussed for Hog1 in Chapter 4.  Furthermore, to 
clarify interaction of the S6K homologues in S. pombe with Wis1/Sty1 
immunoprecipitation could be used to determine protein-protein interactions at the point 
where Sty1pathway components are required.   If Sck1, Sck2 or Psk1 signalling does result 
in activation of Sty1 in phase 1, then modulation of lipid regulatory proteins identified via 
bioinformatics could be Sty1 dependent.  Targets identified included Dga1, Plh1 (Lro1), 
Pps1 (Cho) along with SREBP proteins.  This highlights that the lipid regulatory targets of 
Hog1 and Sty1 may also be conserved. 
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Figure 6.4: Phase one of the proposed Schizosaccharomyces pombe model of regulation of lipid homeostasis by Sty1. Under conditions where nutrients are available, the TORC2 is active, this 
in turn can activate the protein kinase Psk1. It is possible that Psk1 can be activated directly by an unknown mechanism, related to the lipogenic switch. It is postulated that Psk1 may phosphorylate both 
Wis1 and Sty1, possibly on novel residues. Wis1 and Sty1 may also autophosphorylate themselves through an unknown mechanism. Sty1 phosphorylation is also regulated via the phosphatases Pyp1 and 
Pyp2, possibly at the well characterised dual sites phosphorylated by Wis1, which may not be required for the lipogenic switch. Once phosphorylated, Sty1 is retained in the cytoplasm where it can potentially 
interact with a number of targets including lipid regulatory proteins including Pps1, Plh1, Sre1 and Sre2. The SREBP like proteins, Sre1 and Sre2 may then translocate to the nucleus, where they can activate 
transcription of a number of lipogenic genes. 
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Phase two of the proposed model for MAPK mediated regulation of lipid accumulation 
may also be similarly conserved (Figure 6.4).  In response to decreased nitrogen Tor2 is 
inhibited which results in decreased phosphorylation of Psk1.  The major difference 
between the models proposed for S. cerevisiae and S. pombe is that Sty1 is activated by 
dual phosphorylation in response to reduced levels of Tor2 signalling in S. pombe 
(Petersen and Nurse 2007), which occurs due to loss of Sty1 inhibition by Pyp2 and Pyp3 
phosphatases.  Nevertheless, this still indicates that Sty1 would be active in phase 2 
conditions.  As with Hog1, dually phosphorylated Sty1 is then able to translocate to the 
nucleus and potentially drive expression of key lipogenic genes.  It has been demonstrated 
that phosphorylation of Hmg1, a HMG-CoA reductase which catalyses the first step in 
ergosterol synthesis, within the cytoplasm requires active Sty1 (Burg et al. 2008).  This 
further strengthens the connections made between Sty1 and SREBP regulation made by 
the present study (Figures 4.59 and 4.60).  Along with this it also highlights that dually 
phosphorylated Sty1 in phase 2 may activate cytosolic targets initially before translocation 
to the nucleus. 
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Figure 6.5: Phase two of the proposed Schizosaccharomyces pombe model of regulation of lipid homeostasis by Sty1. Under conditions of nutrient limitation, both TORC2 , Psk1, Pyp1 and 
Pyp2 are inhibited. Once dually phosphorylated by Wis1, Sty1 can translocate to the nucleus where it can possibly activate a number of targets both directly and indirectly, via the transcription factors Rst2, 
Sre1 and Sre2, including lipid regulatory proteins such as Pps1, Plh1, Sre1 and Sre2. Sty1 can also activate the transcription factors Pap1 and Atf1, but these don’t appear to be important for the lipogenic 
switch. 
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Whether components downstream of Sty1 contribute to regulating lipid accumulation by 
the Sty1 MAPK pathway is unknown.  Evidence presented in Chapter 4 suggested that 
direct downstream targets of Sty1, the transcription factors Atf1 and Pap1, do not play a 
significant role in the accumulation of cellular lipids (Figures 4.54 and 4.55).  This may be 
due to a transcriptional response not being largely required for lipid accumulation via 
Sty1.  As discussed in Chapter 4, the Sty1-KD mutant had an intermediate lipid phenotype, 
with levels determined to be between that of wild type and Δsty1 cells (Figure 4.54 and 
4.55).  Although the kinase dead form of the Sty1 protein can be dually phosphorylated 
and translocate to the nucleus, it is unable to phosphorylate any of its targets. Further, it 
has been demonstrated that the Sty1-KD, following oxidative stress, cannot be recruited 
to the promoters of genes (Reiter et al. 2008). The partial effect on lipid accumulation of 
the Sty1-KD may suggest that Sty1 may not have a pivotal role in activating transcription in 
the regulation of lipid accumulation.  Alternately, transcriptional activity of unknown 
downstream targets, other than those screened in the present study, may be required. 
However, this study specifically looked at recruitment of Sty1 to a limited number of 
stress induced gene (Reiter et al. 2008).  Therefore, it is suggested that Sty1-KD could 
potentially be recruited to promoters of lipid regulatory genes but with less efficiency, as 
has been noted for Hog1 kinase dead mutants (Ferrigno et al. 1998).   
To evaluate the recruitment of Sty1 to promoters of lipid regulatory genes, downstream 
targets of the potential S6K-Sty1 pathway via could be identified by microarray analyses in 
cells deleted for S6K homologues sck1, sck2 and psk1 along with wis1 and sty1. Further, to 
aid in the identification of whether the main target proteins of Sty1 are in the cytoplasm 
or the nucleus, a  mutant equivalent to that of the S. cerevisiae NMD5 mutant, which 
would prevent Sty1 translocation to the nucleus (Reiser et al. 1999), could also be 
employed in the aforementioned experiment.  Additionally, in order to identify whether a 
transcriptional response is required by the Sty1 MAPK pathway recruitment of Sty1 and 
Sty1-KD to promoters of downstream targets could be investigated by chromatin 
immunoprecipitation (ChIP) experiments. 
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6.6 Potential role for p38 signalling in tumour associated lipogenesis 
Based on observations made in yeast, the effect of the p38 MAPK pathway could serve to 
similarly regulate lipid accumulation.  It has been well described that mTOR and p38 
signalling are upregulated in many cancers including glioma (Carracedo et al. 2008, 
Demuth et al. 2007).  
As described in Chapter 1, mTORC1 is well documented in driving the accumulation of 
lipids contributing to the lipogenic phenotype of gliomas.  Constitutively active EGFR-PI3K-
Akt signalling drives mTORC1 signalling which is constitutively active irrespective of 
cellular nutrient levels.  One of the targets of mTORC1 in mammalian cells is S6K, the 
mammalian equivalent to S. cerevisiae Sch9.  Although there may be an added level of 
complexity in mammalian systems, it is suggested that the role of EGFR-PI3K-AKT coupled 
with TOR and S6K with respect to p38 signalling in lipid synthesis may be conserved to 
that of Hog1.  Previous work has demonstrated that upregulated TOR-S6K signalling 
activates p21-activated kinases (PAKs) which can in turn activate p38 (Kumar et al. 2006, 
Rousseau et al. 2006, Zarubin and Han 2005). Specifically in the case of glioma it has been 
found that increased Pak1 correlates with aggressiveness and short survival (Aoki H. et al. 
2007). 
P38 signalling may be sustained even in periods where cancerous cells may switch from 
glycolysis to oxidative phosphorylation under conditions of lactic acidosis in solid tumours.  
This persistent signalling may result from increased steady state ROS levels resulting from 
the preceding increased glycolytic rate (El Sayed et al. 2013).  Specifically for gliomas, this 
is supported by the demonstration that augmented p38 activation via ROS contributes to 
the tumorous capacity of glioma initiating cells (Sato et al. 2014). 
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6.7 Lipogenesis as a therapeutic target for cancer 
Research published over the past decade demonstrates that targeting metabolic 
regulatory components in cancer is a potentially viable program for treatment in 
conjunction with other adjuvant therapy options such as chemotherapy.  Furthermore 
lipid metabolism is becoming an emerging concept for the treatment of glioma as 
reviewed by (Guo D. et al. 2013).  Some of the components regulating lipid synthesis 
discussed in Chapter 1, and compounds developed to potentially target them in cancer are 
summarised in Table 6.1.  
 
Table 6.1: Compounds developed to target aberrant metabolism in human disease. Targets include 
glucose uptake, enzymes regulating key steps in glycolysis and fatty acid synthesis.  Further targets include 
upstream signalling elements that impact on downstream processes, such as mTORC1. 
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The TOR pathway has presented an attractive target for the treatment of gliomas. Despite 
the central role of the mTOR pathway in driving gliomagenesis, inhibitors including 
rapamycin, in clinical trials have generally presented inadequate efficacy.  This is likely due 
to the fact that rapamycin cannot inhibit all downstream mTORC1 activity (Cloninger et al. 
2011).  Simultaneous inhibition of downstream lipid regulatory elements in conjunction 
with mTORC1 may be a good additional therapeutic strategy.  However, it is suggest that 
this may be a rather paradoxical approach due to the large number of substrates that may 
be activated by upstream oncogenic signalling.  Additionally, due to the inherent ability of 
cancerous cells to adapt to changes in their environment, they similarly may reprogram 
their metabolism to evade downstream blockades. Further to this it was demonstrated 
that inhibition of TOR upregulates ERK signalling (Akhavan et al. 2010), suggesting the 
potential that p38 could also be similarly upregulated.  This is supported as it has been 
shown more recently that inhibition of mTORC1 through the use of rapalog RAD001, 
increases the activation of p38 in glioma cells (Grzmil et al. 2014).  Furthermore, in 
glioblastoma where patients were treated with lapatinib to inhibit constitutively active 
EGF, enhance cleavage and nuclear translocation of SREBP-1 was found to be induced.  
Although this response was suggested to be mediated via Akt signalling it was found to be 
independent of mTORC1.  This serves as an explanation as to why rapamycin inhibition 
was ineffective in these tumours (Guo D. et al. 2009a), but also highlights that another 
pathway is driving lipid synthesis, possibly via a p38 dependent mechanism. 
As described in Chapter 1, p38 can act as an oncogene and tumour suppressor dependent 
on stress signal received and the type of cell in which it is expressed, presenting the 
dilemma of inhibition or enhancement for cancer treatment (Sui et al. 2014).  It has been 
demonstrated that p38 activation in many solid tumours, especially in pancreatic tumours, 
mediates a pro-apoptotic response.  However, in glioma cells it was found that enhanced 
susceptibility to cytotoxicity via temozolomide treatment was enhanced by p38 inhibition 
(Stupp et al. 2005).  It was also shown that p38 may be a prognostic marker for high grade 
gliomas correlating immunohistochemical nuclear and cytoplasmic staining with a worse 
prognosis (Sooman et al. 2013). 
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Taken together, it is suggested that inhibition of mTORC1 in glioblastoma would be 
ineffective due to persistent signalling via MAPK pathways, including p38.  Therefore 
inhibition of mTORC1 and p38, along with surgery and chemotherapeutic treatment, may 
be a more effective strategy for the treatment of glioma, particularly those exhibiting a 
lipogenic phenotype.  In agreement with the present study, it is starting to emerge that 
dual inhibition of mTORC1 and p38 or its downstream targets is indeed a viable treatment 
option for glioma (Grzmil 2014, Cloninger 2011). 
6.8 Conclusions 
Since the elucidation that upstream oncogenic signalling contributed significantly to 
downstream processes including tumour associated lipid formation, much work has 
sought to identify potential upstream lipid regulatory mechanisms.   Knowledge of what is 
regulating downstream processes involved in lipid accumulation not only results in a 
better understanding of lipid synthesis regulation, but also facilitates production of novel 
therapeutic strategies.  Such treatment options will ultimately serve to ameliorate the 
aggressiveness of lipogenic solid tumours, including glioma.  Utilisation of yeast as a model 
organism allows rapid assessment of regulation of processes via signalling pathways.  
Further, many components de-regulated in cancer, such as mTORC1 and lipid metabolism, 
are largely conserved from yeast to mammalian systems.   
The present study has also highlighted that employment of oleaginous yeast species may 
be a good complementary strategy for the investigation of lipid accumulation via stress-
activated MAPK pathways.  Owing to their ability to accumulate large amounts of lipid and 
their apparent possession of functional MAPK pathways and ATP citrate lyase activity. 
Through the use of an optimised Nile red assay, a novel role for HOG and Sty1 stress 
response pathways in lipid accumulation has been determined in S. cerevisiae and S. 
pombe. It has been further demonstrated in S. cerevisiae that the activation of Hog1 in 
response to the requirement to accumulate lipid, may be distinct from the canonical 
activation step of the HOG pathway by Pbs2.   
The regulation in S. pombe appears to be largely conserved to that of S. cerevisiae 
although further work is required to identify the role of Wis1 and potential downstream 
components.  Although Hog1 and Sty1 are evolutionarily distant from mammalian p38, 
294 
 
there is a high level of structural and functional conservation between them.  The 
involvement of Hog1 and Sty1 in lipid accumulation demonstrates that the potential 
mechanisms highlighted in this study may be similarly conserved in mammalian cells.  
Therefore, treatment of lipogenic glial tumours may be improved via conventional 
chemotherapeutic and surgical intervention, coupled with the combined inhibition of 
mTORC1 and p38. 
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A1. Plasmid map of pRS315 
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A2. Plasmid map of CLLp001 – pRS315 HOG1 plus 1kb promoter 
upstream of ATG cloned into XbaI and SacI sites of pRS315 (2.3KB) 
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A3. Plasmid map of CLLp002 – pRS315 Lipomyces starkeyi MAPK plus 1kb 
promoter upstream of ATG cloned into XbaI and SacI sites of pRS315. 
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A4. Plasmid map of pRS313 
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A5. Plasmid map of pCLLp004 – pRS313 HOG1 plus 1kb promoter 
upstream of ATG cloned into XbaI and SacI sites of pRS313 (2.3KB) 
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A6. Plasmid map of pFA6a-KanMX6 
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A7. Plasmid map of pFA6a-natMX6 
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A8. Alignment of MAPK genomic DNA sequences from S. cerevisiae (HOG1), 
S. pombe (sty1) and L. starkeyi (LSMAPK)  
 
HOG1       ATGACC------ACTAACGAGGAAT----------TCAT--TAGGA-------------- 
sty1       ATGGC--------------AG-AAT----------TTAT--TCGTA-------------- 
LSMAPK     ATGGCCGATTTCA-T--C-AGGTATGTGCGTGCGGTTATCTTCGGATGCATCAGTGCTGA 
 
 
HOG1       -CA-----------CAGATATTCGGTAC-------------------A-G---------- 
sty1       -CA-----------CAAATATTCGGTAC-------------------ATG---------- 
LSMAPK     CCATTGTCAGAACCCAGATCTTCGGCACCTCCTTCGAGATCACCAGCA-GGTACAACTTT 
 
 
HOG1       -------TTTTC-------GAGAT---C-----ACAAA---------TAGATACAATGAT 
sty1       -------TTTT--------GAAATTACC-----AC------------TAGATATAGCGAC 
LSMAPK     TACATCTTTTTCCGCAATTGAGATCGCCTACTGAC--AGTAGTCGCTTAGATATGCCGAT 
 
 
HOG1       TTAAACC--CCG-TTGGGATGGGGGCATTTGGGTTGGT---------------------- 
sty1       TTA---CAGCCGATTGGCATGGGCGCCTTTGGCCTCGT---------------------- 
LSMAPK     CTGAA-C--CCGGTTGGAATGGGTGCGTTCGGTTTGGTGTGGTATGTGACGGACGCCTGC 
 
 
HOG1       -------------------TTGCT-------------------CAGC-------CACGGA 
sty1       -------------------TTGTT-------------------CAGC-------GAAGGA 
LSMAPK     ATAATACTTAGCTGTCAAGTTGTTTATTCATCTGACATCTATCCAGCTCCGCTCGA--GA 
 
 
HOG1       -CA-CT---T----TGACATCTCAGCCAGTTGCCATTAAGAAAATCATGAAACCTTTT-- 
sty1       TCAGCTAACTGGAATGA-AT--------GTCGCTGTTAAGAAAATTATGAAACCCTTTAG 
LSMAPK     TCAGCTTACCG----GA-----CAGGCAGTCGCTATTAAAAAGATCATGAAGCCGTTTAG 
 
 
HOG1       TCCACTGCAGTGCTGGCCAAAA-GGACATATCGTGAACTAAAACTACTAAAACATCTAAG 
sty1       T--ACTCCGGTACTGG-CAAAACGTACCTATCGGGAATTAAAACTATTAAAGCATTTAAG 
LSMAPK     --CACACCAGTTTTGT-CTAAGCGAACATATAGAGAGCTGAAGTTGTTAAAGCATCTTCG 
 
 
HOG1       ACACGAGAAC-TTGATTTGCCTTCAGGA-C-ATATTTCT--TTCTCCATTGGAAGATATA 
sty1       GCATGAGAATATT-ATTAGC-TT---GAGCGATATTTTTATTTCTCCCTTTGAAGATATT 
LSMAPK     TCACGAGAAC-GTGATTT-CCCT---GAGCGACATCTTTATTTCTCCGCTCGAAGATATC 
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HOG1       TATTTTGTCACGGAA-TTACAAGGAACAGAT-TTACATAGACT-CTTGCAAACA---AGA 
sty1       TATTTTGTCACGGAGCTT-CTGGGAACAGATCTT-CATAGACTACTT----ACATCGCGA 
LSMAPK     TACTTTGTCACGGAA-TTGCTAGGCACAGACCTT-CATCGATTGCTC----ACCTCGCGA 
 
 
HOG1       CC-CTTGGAAAAGCAATTTGTTCAGTATTTCCTATACCAAATTCT---AAGGG-----GT 
sty1       CC-TTTAGAGACGCAATTTATACAATACTTCTTATACCAAAT-CTTGCGAGGGCTCAAGT 
LSMAPK     CCACTT-GAAAAGCAGTTTATACAATATTTCTTGTACCAGAT-ATTGC--GTG-----GT 
 
 
HOG1       TTAAAATACGTTCACTCCGCGGGCGTCATTCA---TAGAGATTTGAAACCGAGCAACATT 
sty1       TT-------GTTCATTCTGCCGGTGTTATTCACCGT---GATCTGAAACCCAGTAACATC 
LSMAPK     TTGAAATATGTTCATTCAGCTGGCGTTATTCATCGT---GACTTAAAGCCGAGCAATATC 
 
 
HOG1       CTGAT-T-AATGAAAACTGTGATTTGAAG------------------------------- 
sty1       TTAAT-T-AACGAAAATTGCGATTTAAAA------------------------------- 
LSMAPK     CT--TGTGAACGAGAATTGTGATTTGAAGGTATTCCTCCTCGAGTTCCAAGACTTCTGAA 
 
 
HOG1       -ATTTGC-----GATTTCG----------------------GTCTAGCAAGAATTCAAGA 
sty1       -ATCTGC-----GATTTCG----------------------GTTTGGCTCGTATTCAAGA 
LSMAPK     CATTTGCTGATGGATTTCGACAAATTAGATTTGCGACTTTGGCTTGGCTCGTATTCAGGA 
 
 
HOG1       CCCTCAAATGACAGGCTATGTTTCCACTAGATACTACAGGGCACCTGAAATCATGCTAAC 
sty1       CCCTCAAATGACGGGCTATGTTTCTACTCGTTATTACCGTGCACCTGAGATTATGTTAAC 
LSMAPK     TCCGCAAATGACGGGATATGTCTCCACGCGATATTATCGGGCACCAGAGATCATGCTTAC 
 
 
HOG1       GTGGCAAAAATATGACGTCGAGGTCGACATTTGG--TCCGCTGGTTGTATTTTTGCCGAA 
sty1       TTGGCAAAAGTACAACGTCGAAGTTGATATTTGGAGT--GCGGGTTGTATTTTTGCTGAG 
LSMAPK     GTGGCAAAAGTACGACGTCGAGGTTGACATATGGAGT--GCAGGATGTATCTTTGCTGAA 
 
 
HOG1       ATGATTGAA-GGTAAGCCTTTGTTCCCTGG--GAAA-GATCATGTTCACCAATTTTCGAT 
sty1       ATGATTGAA-GGAAAACCCTTGTTTCCCGGCCG--A-GACCACGTTAACCAGTTTTCTAT 
LSMAPK     ATG-TTGGACGGAAAGCCATTGTTTCC-AG--GAAAGGACCATGTGAATCAGTTTTCGAT 
 
 
HOG1       CATCACTGACTTGTTGGGATCTCCGCCAAAG--GATGTGATAAAT----ACTATTTGTTC 
sty1       AATCACGGAATTGTTGGGAACGCCGCCTATG--GAAGT----AATTGAGACGATTTG--C 
LSMAPK     TATCACTGAACTCTTGGGAACTCCACC--TGACGACGT--T--ATCCACACGATTTG--C 
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HOG1       CG--AAAAT-----------------------------------------------AC-- 
sty1       AGTAAAAAC-----------------------------------------------ACAC 
LSMAPK     AGCGAGAACGTGAGTCTATTTTTAATCCTTTAGTGCAATATTTTGACGACATGTAGACA- 
 
 
HOG1       T---CTAAAATTTGTT--ACTTCG-TTACCACACA--GAGATCC----AA-TTCCATTTT 
sty1       TTCGC-----TTTGTTCAA--TCA-TTGCCTCAAAAGGAGA-------AAGTTCC-TTTT 
LSMAPK     TT-GC---GATTTGTGAAA--TCGCTT--C-CAAA--GAGA--CAGAGAA-TACCACTCT 
 
 
HOG1       -CTGAAAGATTTAAAA-CAGTCGAACCT--GATGCCGTA--GACCTTTTGGAAAAAATGC 
sty1       GCTGAAAAGTTCAAAAAC-GCCGATCCA--GATGC--TATTGATCTGTTAGAAAAAATGC 
LSMAPK     -CCCAAAAATTTAGAGGC-GCCGATCCTCTG--GCA--ATCGACCTACTAGAAAAGATGC 
 
 
HOG1       TGGTTTTTGATCCTAAG-AAGAGAATCACTGCGGCGGATGC-CTTG-GCTC----AT--C 
sty1       TTGTCTTTGATCCT-CGTAAGCGTATTAGTGCTGCTGATGC-TTTG-GCTC----ATAAC 
LSMAPK     TAGTATTTGACCCG-CGCAAGAGGATTACTGCTGCAGAGGCGCTTGCGCACGAGTAT--C 
 
 
HOG1       ---CTTATTCGGCTCCTTACCACGATCCAACGGATGAACCAGTAGCCGATGCCAAGTTC- 
sty1       TATCTT-----GCTCCATACCATGATCCTACTGATGAGCCTGTTGCTGATG--AAGTTTT 
LSMAPK     TA---------GCGCCATATCACGATCCGTCTGATGAACCTGTTGCAGAGGAGAAGTTT- 
 
 
HOG1       -GATTGG-CACTTTAA--TGACGCTGATCTGC-----CTGTCGATACCTGGC-GTGTTAT 
sty1       TGACTGGTCATTCCAAGATAA---TGATTTAC-----CTGTGGAGACTTGGAAG-GTCAT 
LSMAPK     -GATTGGTCA-TTCAA--------TGGTATACAAATGCTAT-------T------GTTAT 
 
 
HOG1       -GATGTACTCAGAAATCCTAGACTTC------CATAAGATTG-GTGGCAGTGATGGACAG 
sty1       -GATGTAC----------------TC------C----GA--G-GT--------T------ 
LSMAPK     GGATG--C-CAG---T----GATTTCAGTTTGC-TA--ATTGAGT-GC-----T----AG 
 
 
HOG1       AT--TGATATATCTGCCACGTTTGATGACCAAGTTGCTGCAGCCACCGCTGCCGCGGCGC 
sty1       -T--TG-------T----CGTTT------------------------------------- 
LSMAPK     ATGCTG----ATCTTCCA-GTT----GA-----TT------------------------- 
 
 
HOG1       AGGCACAGGCTCAGGCTCAGGCTCAAGTTCAGTTAAACATGGCTGCGCATTCGCATAATG 
sty1       ---CAC-----------------------------AACATGG------------ATAATG 
LSMAPK     -----C---CT--------GG--------------AA---GG-TG---------ATGATG 
336 
 
 
 
HOG1       GCGCTGGCACTA--CTGGAAAT----GAT---CACTCAGATATAGCTGGTGGAAACAAAG 
sty1       --------A--A--CTG---------------CAATC--------CT-----AA------ 
LSMAPK     ----------TATTCCG-AGATATTAGATTTCCA--CA-ATATAGATGGCGGA------- 
 
 
HOG1       TCAGCGATCATGTAGCTGCAAATGACACCATTACGGACTACGGTAACCAGGCCATACAGT 
sty1       ------------------------------------------------------------ 
LSMAPK     -----------GTAGTT-----T--CAC-----CGGA--A---TAA-------------- 
 
 
HOG1       ACGCTAATGAGTTCCAACAGTAA 
sty1       ----------------------- 
LSMAPK     ----------------------- 
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A9. Alignment of promoter region of MAPK genomic DNA sequences from 
S. cerevisiae (HOG1) and L. starkeyi (LSMAPK)  
Promoter regions 
HOG1      ----GGACCCATTCCGATTTTCCCATTTGGTTCTTGCGCGTGCTGATTCCGACACGCGCG 
MAPK      AAGGAGAGCAGTTCCAAGT-------CTAGTAGCTCGACCTTGTGGTTCCCACTCGCAAG 
               ** *  **** * *        * **   *   * *  ** **** ** ***  * 
 
HOG1      TCTATAAATAGCATGAAGTATCCGCACACCGCAGCGTTAGTGAGGT---------GAGGG 
MAPK      ACTATCACCAGGAGGATTGTTTCCACCTACGCCTCGTGCTTGAATGACATGAAGAGTCGA 
           **** *  ** * **    * *   *  ***  ***   ***            *  *  
 
HOG1      TGGCAGCAAGCTAATTCCCGCAT-----------CTGGAATCTGAAC------------- 
MAPK      TTGCACGCACTTGATTCCAAGGTCAGCTTGACGTATGACGTGTGGACTTCGAAAACGAAT 
          * ***   *  * *****    *            **   * ** **              
 
HOG1      T------GCCCCTTTTGGACTAACCGTGTGGTTCATGGGTGGGCGAAGTGCGCAACCTCG 
MAPK      TTACCTTACGCCAGCGTTACGGTCCATTATGTGGACGCCGATTGGAAGTGTAAAAGGCCA 
          *       * **      **   ** *   **  * *       ******   **   *  
 
HOG1      AAGGTTTTCTTTTGCGTGTCGGATTTTACATCCGGCGGTAGCGCATGATGCCATGGCTGG 
MAPK      CCTGCATTCTTTCACGT-----ATTTTCCGTATCCGCACACTGCCCAGTGCCATCAGGAC 
             *  ******  ***     ***** * *        *  **    ******       
 
HOG1      CTCCAGATACATCCTCAGGGCACCAGCATCTATAATTAGATTGGCGCAACATGGCTGGCT 
MAPK      CTTGGGATTT-TGCTCGGGGGTCGACTTCTTAG-----------GGTTCCAAGTGCAAGT 
          **   ***   * *** ***  * *     **             *   ** *      * 
 
HOG1      GCACTGCTGTCTTCACTTCTTTCTTTTTCCGGCAATGAATGATGTA--TGTTTTGTGGCA 
MAPK      GAATTCGAGTTTTCCCATCGCTAGTCACCGACCCGGGAAAACCGTCATTCAGTTGCGGCC 
          * * *   ** *** * **  *  *   *   *   ***    **   *   *** ***  
 
HOG1      AAAGGGTCCGCATTGTACCTGTTTACAGTTGAGATTATCGTTTTTGGTAGCCCTTCATTA 
MAPK      AT----------------------ACCAAGAAGAAAACACAGTT--------CCCCGTCC 
          *                       **     ***  *     **        *  * *   
 
HOG1      CGGCATAACGTATTAAGTTTCTTTTATTTTGCTTTGCCCTGGTTTAAAAGACAATG-TCG 
MAPK      GATCAACACCAGTTAAGCTTCTTTGGGCCTACTTAGTACTGCGGTGGGAGACCACGCTGG 
             **  **   ***** ******     * *** *  ***   *   **** * * * * 
 
HOG1      A----------------------------------------TTAAAAGTTAATTTTAATC 
MAPK      AATCGTAGGTGCTGCAATTCCTTTTTTTGAAATTCCTACAATTTGATCTTCATGACATAA 
          *                                        **  *  ** **   *    
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HOG1      GATTGAAGGAAATAAGAGGAATAGCGCAAGTTGTTAGGAAAGCGTTCTTTATCTCCAAGA 
MAPK      TATTGGCGGATGGGCCTGTAAAGTGGCAAACTGA----------------AACCGACAGG 
           ****  ***       * **    ****  **                 * *    **  
 
HOG1      CTTTGCCCTGTATATAATTA----AACACCTCAAAGCGCTTCGTCATGGATGGAGATTA- 
MAPK      ACTTTCCTTGTGAATGTGACGCTAAGCTAAGACTCGGGATTCCAAATTGCAAGAGTAACT 
            ** ** ***  **         * *        * * ***   ** *   ***      
 
HOG1      ---TTCGGCATTTTGACATACAGGAGTGCCACATGCGAAAGCGGAGTGGGCGTATTCTCT 
MAPK      TTTGTTACAATCGAAACCAGTGGAAATTCCAAGTTGTTCGGACAAGGTAAACTACTGAAT 
              *    **    **     * * * ***  *      *   **      ** *   * 
 
HOG1      GGTTACCCTACATGGTCTGGCGGCGTTATTATACGGGAGGATCTTCGAAGGGAAGGAAGG 
MAPK      GAT--------ATGTGTTGCCGGTCTGCGGCTCGCG----------GAGGAGAGAGAAAA 
          * *        ***   ** ***  *     *   *          ** * **  ***   
 
HOG1      AAAAAAAAAAAGAAAAGGCCAACGAAAAGCAAA-TATTATCTATCGTCGAAATTATCATA 
MAPK      GTTTAGCGAAAGTTAAGGCTACGTCATGGAGCAGCCGGCTTGGAGGTCGGACCGATGCAG 
              *   ****  ***** *    *  *   *      *     **** *   **     
 
HOG1      CTATCTTACAATAAGAGTAGTA-ATTACTTTCTTGTTTGTATAGTGGAAGAGGAATTTGC 
MAPK      CTAGCGCA----ACTCTTCTTTATCGAGCTTCTGGCTGCCATCACTGTCTGCAACGTACC 
          *** *  *    *    *  *     *  **** * *   **    *      *  *  * 
 
HOG1      GATAATAATAGCAAAAGTAACTAATCTCTAACAAGAAACCT--------TATTTATTTTC 
MAPK      GC------TCACAAGCGAATATAATCCCCACCCATCCATCTCCACACGCTTCTACGGCTC 
          *       *  ***  * *  ***** * * * *   * **        *  *     ** 
 
HOG1      TCTTTCTTCTATATTGGTAAATACTAGACTCGAAAAAAAGGAACAAAGGGAAAACAGGGA 
MAPK      GCTCTGTCCCATCCATCAACACAGTATCTGT-----CTGCTCAGCAACCGTCGTCAGTGC 
           ** * * * **      * * * **                *  **  *    *** *  
 
HOG1      AAACTACAACTATCGTATATAATA 
MAPK      TATTTAGTGATCTGCTAACACCA- 
           *  **    * *  **        
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A10. Genomic DNA sequence of L. starkeyi MAPK with six introns identified 
in yellow. 
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A11. cDNA sequence of L. starkeyi MAPK 
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